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Abstract
Molecular signaling systems allow cells to sense and respond to environmental
stimuli. Quantitative modeling can be a valuable tool for evaluating and extending our
understanding of signaling systems. In particular, studies of the mating pheromone response
system in yeast (Saccharomyces cerevisiae) have revealed many protein families and
regulatory motifs also found in higher eukaryotes. This thesis develops several
computational and experimental approaches that facilitate characterization of cellular
signaling systems, and tests these approaches using yeast mating response as a model.
Limitations in the current approach to building models of molecular systems were
addressed first. For example, published computational models are often difficult to evaluate
and extend because researchers rarely make available the information and assumptions
generated throughout model building. I developed tools that facilitate model construction,
evaluation, and extension. I used these tools to develop the YeastPheromoneModel (YPM)
information repository, in which construction of an exhaustive model of the yeast mating
system is documented (http://www.YeastPheromoneModel.org).
Next, motivated by an ability to rapidly make many derivative models from the YPM
repository and by carefully measured abundances of mating system proteins, I analyzed a
model of the mating system mitogen activated protein kinase cascade. I found that varying
the abundance of the scaffold protein Ste5, but not the abundances of other proteins, is
expected to result in a quantitative tradeoff between total system output and dynamic range.
Thus, the abundance of scaffold proteins in signaling systems may generally be under
selective pressure to support specific quantitative system behavior.
Finally, because traditional methods for characterizing signaling systems can be slow
and tedious, I postulated that time-dependent stimulation of signaling systems might increase
the richness and value of data derived from individual experiments. To do this, I devised a
custom microfluidic device to expose yeast cells to pheromone in a time-dependent manner.
I also developed computational approaches to investigate the use of time-dependent
stimulation to characterize receptor and G protein response dynamics. I found that, at least
for the receptor/G protein portion of the mating system, time-dependent stimulation does not
appear to offer significant gains for constraining kinetic parameters relative to traditional
step-response experiments.

Acknowledgements
First and foremost, I would like to thank my advisor Drew Endy, without whom this
work would not have been possible. Thank you for your support and guidance, for giving me
freedom to pursue various paths while still keeping me on track, and for seeing the value of
my work. I also owe much gratitude to my thesis committee members, Doug Lauffenburger
and Jeremy Thorner, for the support and direction that they offered throughout my research.
An additional thanks to Jeremy for help and ideas regarding the details of signaling in the
mating response system.
I would like to thank the many coworkers and collaborators who have helped me
along the way. First, I owe much to the members of the Endy lab over the years, especially
Samantha, Barry, Jason, Francois, Sri and Felix for many great discussions. Also, many
thanks to Ilya, Austin, and Bill, for without them the YeastPheromoneModel website would
not be up and running. I am grateful to Todd Thorsen and Ali Khademhosseini for their early
guidance on my microfluidics work.
I would also like to express my gratitude to the members of the Molecular Sciences
Institute for being excellent collaborators. I am grateful to Roger Brent for teaching me the
importance of scientific rigor. I worked closely with Kirsten Benjamin on the work
presented in Chapter 4, and she was instrumental in getting that work to the place that it is
now. Many thanks to Alejandro Colman-Lerner and Richard Yu for countless helpful
discussions and gifting me with their unpublished data to support my models.
I owe much gratitude to my friends at MIT and around Boston for helping keep my
life balanced. A special thanks to the strongmen Nick and Eric for our Monday-Wednesday-
Friday therapy sessions, and the Chestnut St crew Diana, Reshma and Nick (again) for being
great friends and managing to live with me for three years. I am also grateful to the many
other friends in Boston who over the past six years have provided me with either distractions
from work or scientific discussions as needed.
Finally, I would like to thank my family, both immediate and extended. My parents
raised me in a house where science was the norm, and always encouraged me to pursue my
interests. I owe my brother Garret thanks for many fun times as we were growing up, and
teaching me the value of quick wit (and a thick skin). Finally, I would like to thank my wife,
Heather, for keeping me happy and well-fed over the past five years of my life. Heather
provided me with the daily support that I needed during the more difficult times, and I could
not have asked for a better companion to support me through my thesis and make these past
few years so productive.

Table of Contents
Abstract ............................................................................................................... 5
Acknowledgem ents ............................................................................................. 7
Table of Contents ....................................................................................... 9
List of Figures ....................................................................... ....................... 13
List of Tables ................................................. ............................................... 17
Chapter 1. Introduction .................................. ................. ............ ..................... 19
1.1 Background................................................................................... ............................. 19
1.2 Yeast Mating Pheromone Response as a Model System .................................. 21
1.3 Research Overview...................................................... .............................................. 22
Chapter 2. Documenting the Model-Building Process .............................. 25
2.1 Introduction .................................................................................. ............................. 25
2.2 Results ....................................................................................... ................................ 29
2.2.1 Capture and Distribution of Model Documentation ........................................ 29
2.2.2 Integration of Model Elements Throughout Model Documentation .................... 33
2.2.3 Use of the YPM Repository............................................................ ...................... 34
2.3 Discussion and Conclusions .................................................................... .................. 35
2.3.1 W iki as a Platform for Model Repositories ........................................... 35
2.3.2 Features of Rule-Based Reaction Specification ............ ................................... 36
2.3.3 Community Use of Model Repositories .............................................. 38
2.3.4 Conclusions......................................................... ............................................... 39
2.4 Materials and Methods ................................................... ........................................... 40
2.4.1 Modeling Tools..................................................... ............................................. 40
2.4.2 YPM Repository ...................................................................................................... 42
Chapter 3. A Model of S. cerevisiae Mating Pheromone Response ............. 45
3.1 Introduction ............................................................................................................... 45
3.1.1 Overview of the Mating Pheromone Response System in Yeast ......................... 47
3.1.2 Overview of the Graphical Reaction Notation ......................................... 54
3.1.3 Benefits, Limitations, and Challenges of Modeling Cellular Signaling Systems....58
3.1.4 Scope of the Mating Model ............................................................................... 61
3.1.5 Measurement of System Parameters..................................................................... 62
3.2 G Protein Coupled Receptor.......................... ............................................................ 65
3.2.1 Signal Propagation......................... .................................................................... 65
3.2.2 Regulation and Feedback.........................................................................................93
3.2.3 Protein Abundances .......................................................................................... 109
3.3 MAP Kinase Cascade ................................................................................................. 14
3.3.1 Signal Propagation........................................................................................... 14
3.3.2 Regulation and Feedback................................................. ....................... 159
3.3.3 Protein Abundances ............................................................................................. 184
3.4 Transcriptional Machinery ...................................................................................... 194
3.4.1 Signal Propagation...........................................................................................194
3.4.2 Regulation and Feedback.................................................................................217
3.4.3 Protein Abundances ......................................................................................... 222
3.5 Coupling Between Mating Pheromone Response and the Cell Cycle ........................ 224
3.5.1 Mating Pathway Effect on Cell Cycle Progression ............................................... 225
3.5.2 Cell Cycle Effect on the Mating Pathway ............................................ 235
3.6 Morphology, Geometry, and Signal Specificity ....................................................... 248
3.6.1 Volume of Cell Accessible to Cytosolic and Nuclear Proteins ........................... 248
3.6.2 Protein Dilution Due to Cell Growth............................................ 249
3.6.3 Polarized Growth and Shmoo Formation ..................................... 251
3.6.4 Compartmental, Spatial, and Relocalization Effects ............................................. 253
3.6.5 Signaling Specificity........................................................................................255
3.6.6 Nonspecific Dephosphorylation .......................................................................... 257
Chapter 4. Effects of Scaffold Abundance on MAPK Cascade Output and
Dynamic Range ........................................ 259
4.1 Introduction ............................................................................................................. 259
4.2 R esults ...................................................................................... ............................... 261
4.2.1 Computational Investigation of MAPK Cascade Dynamic Range..................... 261
4.3 Discussion and Conclusions .................................................................................... 268
4.3.1 Ste5 Abundance Critically Affects System Dynamic Range .............................. 268
4.3.2 C onclusions....................................................... ............................................... 270
4.4 Materials and Methods ............................................................................................ 271
Chapter 5. Studying the Mating System with Time-Dependent Input ..... 277
5.1 Introduction ........................................................... .................................................. 277
5.2 R esults ...................................................................................... ............................... 280
5.2.1 A Novel Microfluidic Device for Time-Dependent Input............................... 280
5.2.2 Modeling Analysis of Time-Varying Stimulation..............................................287
5.3 Discussion and Conclusions .................................................................................... 294
5.3.1 The Stimulator Enables Time-Dependent Stimulation of Signaling Systems.......294
5.3.2 Time-Dependent Inputs May Not be Effective for Characterization of Mating
System .................................................................................... ................................... 294
5.4 Materials and Methods ............................................................................................ 297
5.4.1 M icrofluidics....................................................................................................... 297
5.4.2 M odeling.......................................................... ................................................ 298
Chapter 6. Future W ork .................................. 301
6.1 Tools for Model Building ........................................................................................ 301
6.2 Construction of Detailed Quantitative Models........................................303
6.3 Scaffold Abundance as a Regulator of Signaling Behavior .................................... 303
10
6.4 Measurement of Protein Abundances in Signaling Systems .................................... 304
6.5 Investigation of Signaling Systems Using Time-Dependent Input ............................ 306
References ..... .................................. .................................................. 309
Appendix A. Effects of Scaffold Abundance....................337

List of Figures
Figure 1-1 Schematic representation of the mating pheromone response system in yeast.... 22
Figure 2-1 The model building process. ..................................... ..... ................ 29
Figure 2-2 Screen capture of the SteS_num page from the YPM repository. .................................. 31
Figure 2-3 Screen capture of the Ste7/MAPK interactions page from the YPM repository. 33
Figure 3-1 Regulation of mating pheromone signaling ......................................... ...... 50
Figure 3-2 Example reaction: interaction of Ste2 and Gpal ........................................ 55
Figure 3-3 Example reaction: interaction of Ste2 and Gpal ........................................ 56
Figure 3-4 Example reaction: interaction of Ste2 and Gpal ........................................ 57
Figure 3-5 Example reaction: phosphorylation of Kssl at T183 by Ste7 ........................... 58
Figure 3-6 Association of pheromone and Ste2..................................... ............. 70
Figure 3-7 Dissociation of pheromone and Ste2..................................... ............ 70
Figure 3-8 Interaction of Ste2 and Gpal...................................................................... 75
Figure 3-9 Interaction of Gpal and Ste4-Stel8 ........................................ ........... 76
Figure 3-10 Interaction of Ste2, Gpal and Ste4-Ste18 ......................................... ..... . 77
Figure 3-11 Gpal exchange of GDP for GTP. ........................................ ............ 83
Figure 3-12 Interaction of Sst2 and Ste2. ..................................... .... ................ 87
Figure 3-13 Hydrolysis of GTP by Gpal ................................................... 88
Figure 3-14 Interaction of pheromone and Barl..................................... ............ 95
Figure 3-15 Pheromone degradation ........................................................................... 95
Figure 3-16 Barl degradation ......................................... .............................................. 95
Figure 3-17 Barl synthesis. ................................................................................................... 96
Figure 3-18 Ste2 degradation.............................. 100
Figure 3-19 Ste2 synthesis. .................................................... 100
Figure 3-20 Gpal degradation. ............................................................................................ 103
Figure 3-21 Gpal synthesis. .................................................. 103
Figure 3-22 Interaction of Sst2 and Fus3 .................................. 106
Figure 3-23 Phosphorylation of Sst2 at S359 by Fus3. ..................................... 106
Figure 3-24 Interaction of Sst2 and Kssl. ..................................... 107
Figure 3-25 Phosphorylation of Sst2 at S359 by Kssl ...................................... 107
Figure 3-26 Non-specific Sst2 dephosphorylation at S359. ..................................... 108
Figure 3-27 Degradation of Sst2................................... 108
Figure 3-28 Synthesis of Sst2. ............................................................................................. 109
Figure 3-29 Synthesis of Ste4-Stel8............................. 113
Figure 3-30 Interaction of Ste4-Stel8 and Ste20................................ 117
Figure 3-31 Self-interaction of Ste5. ........................................ 123
Figure 3-32 Interaction of Ste4 and Ste5 ...................................... 124
Figure 3-33 Interaction of Ste5 and Stel . ........................................ 131
Figure 3-34 Phosphorylation of Stel 1 at S302 by Ste20 ...................................... 132
Figure 3-35 Phosphorylation of Stel I at S306 by Ste20 ..................................... 132
Figure 3-36 Phosphorylation of Stel 1 at T307 by Ste20............................... 133
Figure 3-37 Interaction of Ste5 and Ste7. ..................................... 137
Figure 3-38 Phosphorylation of Ste7 at S359 by Stel. ...................................... 138
Figure 3-39 Phosphorylation of Ste7 at T363 by Stel 1 ..................................... 139
Figure 3-40
Figure 3-41
Figure 3-42
Figure 3-43
Figure 3-44
Figure 3-45
Figure 3-46
Figure 3-47
Figure 3-48
Figure 3-49
Figure 3-50
Figure 3-51
Figure 3-52
Figure 3-53
Figure 3-54
Figure 3-55
Figure 3-56
Figure 3-57
Figure 3-58
Figure 3-59
Figure 3-60
Figure 3-61
Figure 3-62
Figure 3-63
Figure 3-64
Figure 3-65
Figure 3-66
Figure 3-67
Figure 3-68
Figure 3-69
Figure 3-70
Figure 3-71
Figure 3-72
Figure 3-73
Figure 3-74
Figure 3-75
Figure 3-76
Figure 3-77
Figure 3-78
Figure 3-79
Figure 3-80
Figure 3-81
Figure 3-82
Figure 3-83
Figure 3-84
Interaction of Ste7 and Fus3. ........................................................................
Phosphorylation of Fus3 at T180 by Ste7 ............................................... 1
Phosphorylation of Fus3 at Y182 by Ste7..................................................
Interaction of Ste7 and Kssl. ........................................................................... 1
Phosphorylation of Kssl at T183 by Ste7 .............................................. 1
Phosphorylation of Kssl at Y185 by Ste7. ........................................ ........ 1
Interaction of Ste5 and Fus3. .................................... 1
Autophosphorylation of Fus3 at Y182 .................................................. I
Interaction of Ste5 and Kssl. ............................................. ...........................
Autophosphorylation of Kssl at Y185..........................................................
Interaction of Stel 1 and Fus3. ..................................... ................................
Phosphorylation of Ste 11 by Fus3. ..................................................................
Interaction of Stel 1 and Kssl. ........................................................................
Phosphorylation of Stel 1 by Kss 1 ......................................... ..............
Non-specific Ste 1l dephosphorylation at T307 ...............................................
Non-specific Stell 1 dephosphorylation at S306 ..............................................
Non-specific Stel 1 dephosphorylation at S302 ...............................................
Non-specific Ste 1l dephosphorylation. ...........................................................
D egradation of Stel 1 ........................................................................................
Ste7 dephosphorylation at T363..................................................................
Ste7 dephosphorylation at S359 ....................................................................
Degradation of Ste7.......................................................
Interaction of Fus3 and Ptp2 .........................................................................
Dephosphorylation of Fus3 at Y182 by Ptp2 ................................................
Interaction of Fus3 and Ptp3. .........................................................................
Dephosphorylation of Fus3 by Ptp3.................................. ................
Interaction of Kssl and Ptp2 ..................................... .........................
Dephosphorylation of Kssl by Ptp2. ..........................................
Interaction of Kssl and Ptp3 ...........................................
Dephosphorylation of Kssl by Ptp3. ..................................... ..............
Interaction of Fus3 and Msg5. ...................................... ..................
Dephosphorylation of Fus3 by Msg5 ...................................... ..............
Dephosphorylation of Fus3 by Msg5 ...................................... .............
Interaction of Kssl and Msg5 ...........................................
Dephosphorylation of Kssl by Msg5 ..................................... .............
Dephosphorylation of Kssl by Msg5.................................. ...............
Non-specific Fus3 dephosphorylation................... ...................
Non-specific Fus3 dephosphorylation................... ...................
Non-specific Kss1 dephosphorylation. ..................................... ...........
Non-specific Kssl dephosphorylation. ..................................... ...........
Synthesis of Fus3 .........................................................................................
Degradation of Msg5......................................................
Synthesis of M sg5 .........................................................................................
Synthesis of Ste20 .............................................................
Synthesis of Ste5 ...............................................................
150
151
151
152
153
153
154
55
155
156
161
162
162
163
163
164
164
164
164
167
167
167
173
173
174
174
175
175
176
176
177
177
178
178
179
179
179
180
180
180
180
184
184
185
187
Figure 3-85 Synthesis of Stel 1. ........................................ 188
Figure 3-86 Synthesis of Ste7........................................ ................................................ 190
Figure 3-87 Synthesis of Kss1. ........................................ 192
Figure 3-88 Synthesis of Ptp2................................... 194
Figure 3-89 Synthesis of Ptp3................................... 194
Figure 3-90 Interaction of Stel2 and Digl ...................................... 202
Figure 3-91 Interaction of Stel2 and Dig2 ...................................... 204
Figure 3-92 Interaction of Stel2 and Fus3. ..................................... 205
Figure 3-93 Interaction of Stel2 and Kssl ...................................... 206
Figure 3-94 Interaction of Digl and Fus3 ................................. 207
Figure 3-95 Phosphorylation of Digl by Fus3. ..................................... 208
Figure 3-96 Interaction of Digl and Kssl. ..................................... 208
Figure 3-97 Phosphorylation of Digl by Kssl. ........................................ 209
Figure 3-98 Interaction of Dig2 and Fus3......................................................................... 210
Figure 3-99 Phosphorylation of Dig2 and Fus3................................................................ 211
Figure 3-100 Interaction of Dig2 and Kssl. ...................................................................... 211
Figure 3-101 Phosphorylation of Dig2 by Kssl. ............................................................... 212
Figure 3-102 Phosphorylation of Stel2 by Fus3 ...................................... 213
Figure 3-103 Phosphorylation of Stel2 by Kssl. ........................................ 213
Figure 3-104 Ste 1l2 dephosphorylation ...................................... 219
Figure 3-105 Stel2 degradation.............................. 220
Figure 3-106 Stel2 synthesis. .............................................................................................. 220
Figure 3-107 Digl dephosphorylation ...................................... 222
Figure 3-108 Dig2 dephosphorylation ...................................... 222
Figure 3-109 D ig2 synthesis ................................................ .......................................... 222
Figure 3-110 D igl synthesis. ......................................... ............................................... 223
Figure 3-111 Interaction of Farl and Fus3 ...................................... 230
Figure 3-112 Phosphorylation of Farl by Fus3 ...................................... 231
Figure 3-113 Interaction of Farl and Kssl. ........................................ 232
Figure 3-114 Phosphorylation of Farl by Kssl ...................................... 233
Figure 3-115 Interaction of Farl and Cdc28................................ 234
Figure 3-116 Farl dephosphorylation........................ 234
Figure 3-117 Farl synthesis ......................................... 235
Figure 3-118 Interaction of Cdc28 and Ste5 ...................................... 241
Figure 3-119 Phosphorylation of Ste5 by Cdc28 ...................................... 242
Figure 3-120 Dephosphorylation of Ste5.......................................................................... 243
Figure 3-121 Self-interaction of Ste5. ..................................... 245
Figure 3-122 Interaction of Ste5 and Ste4 ...................................... 246
Figure 3-123 Phosphorylation of Farl by Cdc28. ..................................... 247
Figure 3-124 Degradation of Farl. ...................................... 248
Figure 3-125 Protein dilution due to cell growth ...................................... 250
Figure 3-126 Pairwise protein interactions that may lead to supramolecular complexes.... 251
Figure 4-1 Relative measured abundances of MAPK cascade components ..................... 260
Figure 4-2 Schematic representation of the MAPK cascade model. ................................ 263
Figure 4-3 Dependence of behavior of MAPK cascade model on abundance of the scaffold
Ste5. .......................................................................................................................... 267
Figure 4-4 Dependence of behavior of MAPK cascade model on abundances of Stel 1, Ste7
and Fus3 .................................................................................................................... 268
Figure 5-1 Cutaway view of a PDMS microfluidic device.............................. 281
Figure 5-2 Stimulator chip design................................... 282
Figure 5-3 Scheme for time-dependent input. ..................................... 284
Figure 5-4 Fluid flow in the microfluidic device............................................................... 286
Figure 5-5 Yeast response to pheromone in the microfluidic device. ............................. 286
Figure 5-6 Results of parameter optimization for receptor/G protein model. ................. 289
Figure 5-7 Example time-dependent inputs ..................................... ........... 291
Figure 5-8 Parameter sensitivities to time-dependent inputs .................... .................... 292
Figure 5-9 Parameter sensitivities to time-dependent inputs .................... .................... 293
Figure. A-i Results of parameter optimization using different protein abundances ........ 340
Figure. A-2 Dependence of behavior of MAPK cascade model on component abundances.
............... . .... . ..................... 341
Figure. A-3 Results of parameter optimization for different parameter sets .................... 342
Figure. A-4 Behavior of MAPK cascade model for alternate parameter set #1.............. 343
Figure. A-5 Behavior of MAPK cascade model for alternate parameter set #2 ............... 344
Figure. A-6 Behavior of MAPK cascade model for alternate parameter set #3 ............... 345
Figure. A-7 Behavior of MAPK cascade model for alternate parameter set #4. ............... 346
Figure. A-8 Behavior of MAPK cascade model for Ghaemmaghami et al. measurements. 347
Figure. A-9 Behavior of MAPK cascade model for Slaughter et al. measurements. ....... 348
Figure. A-10 Behavior of MAPK cascade model for Maeder et al. measurements. ........... 349
Figure. A-11 Behavior of MAPK cascade model for protein abundances optimized during
param eter estim ation ......................................... ................................................. 350
Table 3-1
Table 3-2
Table 3-3
Table 3-4
Table 3-5
Table 3-6
Table 3-7
Table 3-8
Table 3-9
Table 3-10
Table 3-11
Table 3-12
Table 3-13
Table 3-14
Table 3-15
Table 3-16
Table 3-17
Table 3-18
Table 3-19
Table 3-20
Table 3-21
Table 3-22
Table 3-23
Table 3-24
Table 3-25
Table 3-26
Table 3-27
Table 3-28
Table 3-29
Table 3-30
Table 3-31
Table 3-32
Table 3-33
Table 3-34
Table 3-35
Table 3-36
Table 3-37
Table 3-38
Table 3-39
Table 3-40
Table 3-41
Table 3-42
Table 3-43
Parameter constraints
Parameter constraints
Parameter constraints
Parameter constraints
Parameter constraints
Parameter constraints
Parameter constraints
Parameter constraints
for interaction of Stel2 and Dig2................................ 204
for interaction of Stel2, Fus3 and Kssl ..................... 207
for phosphorylation of Digl by Fus3 and Kss 1.......... 209
for phosphorylation of Dig2 by Fus3 and Kssl ............ 212
for phosphorylation of Stel2 by Fus3 and Kssl ........ 214
for Ste 12 degradation and synthesis. .......................... 221
for Digl synthesis and Dig2 concentration................ 224
for Stel2 concentration ...................................... 224
List of Tables
Parameter constraints for interaction of pheromone and Ste2............................ 71
Parameter constraints for interaction of Ste2, Gpal and Ste4-Stel8 .......... 76
Additional parameter constraints for interaction of Ste2, Gpal and Ste4-Stel8.. 78
Parameter constraints for Gpal exchange of GDP for GTP.............................. 83
Parameter constraints for G protein deactivation ........................................ 88
Parameter constraints for pheromone degradation and Barl synthesis ................. 96
Parameter constraints for Ste2 degradation and synthesis. .............................. 100
Parameter constraints for Gpal degradation and synthesis .............................. 103
Parameter constraints for Sst2 phosphorylation ...................................... 108
) Parameter constraints for Sst2 degradation and synthesis........................... 109
Parameter constraints for Ste2 concentration ...................................... 110
Parameter constraints for G protein concentration and Ste4-Ste 18 synthesis... 113
Parameter constraints for Sst2 concentration. ..................................... 114
Parameter constraints for Ste5 dimerization and interaction of Ste5 and Ste4. 124
Parameter constraints for Stel 1 phosphorylation .................... .................... 133
Parameter constraints for Ste7 phosphorylation ...................................... 140
Parameter constraints for Fus3 phosphorylation. ..................................... 152
Parameter constraints for Kss 1 phosphorylation ...................................... 154
Parameter constraints for autophosphorylation of Fus3 and Kssl. ............... 156
Parameter constraints for MAPK activity. ..................................... 159
Parameter constraints for MAPK phosphorylation of Stel . ............................ 163
Parameter constraints for Stell dephosphorylation and degradation ............... 165
Parameter constraints for Ste7 dephosphorylation and degradation. ............... 168
Parameter constraints on Ptp2 and Ptp3 dephosphorylation of Fus3 ............. 174
Parameter constraints on Ptp2 and Ptp3 dephosphorylation of Kssl .............. 176
Parameter constraints on Msg5 dephosphorylation of Fus3.......................... 178
Parameter constraints on Msg5 dephosphorylation of Kssl. ......................... 179
Parameter constraints forMsg5 degradation and synthesis. .............................. 184
Parameter constraints for synthesis of Ste20 ...................................... 185
Parameter constraints for synthesis of Ste5 .................................................... 187
Parameter constraints for synthesis of Stel 1.................................. 188
Parameter constraints for synthesis of Ste7 ...................................... 190
Parameter constraints for Kss 1 synthesis and Fus3 concentration................... 192
Parameter constraints for synthesis of Ptp2 and Ptp3. ................................... 194
Parameter constraints for interaction of Stel2 and Digl............................... 203
Table 3-44 Parameter constraints for phosphorylation of Farl by Fus3 and Kssl ........... 233
Table 3-45 Parameter constraints for interaction of Farl and Cdc28 ............................... 234
Table 3-46 Parameter constraints for phosphorylation and dephosphorylation of Ste5...... 244
Table 3-47 Parameter constraints for Ste5 dimerization and interaction of Ste5 and Ste4. 247
Table 3-48 Parameter constraints for phosphorylation and degradation of Farl .............. 248
Table 3-49 Parameter constraints for nuclear and cellular volumes ................................. 249
Table 3-50 Parameter constraints for protein dilution due to cell growth ........................ 250
Table 4-1 Measurements of abundances of key components by immunoblotting........... 260
Table. A-i Optimized parameters for MAPK cascade model ........................................ 339
Chapter 1. Introduction
1.1 Background
Single cell organisms must sense and respond to environmental stimuli in order to
survive, compete for resources, and reproduce. Due to the work of many researchers, we
now have qualitative molecular maps for some of the signaling systems that eukaryotic cells
use to respond to various environmental stimuli. In many cases we know the essential genes,
proteins and small molecules that comprise these signaling systems, and we know how each
molecular species acts in eliciting the appropriate cellular responses. As still more individual
molecular details are discovered, research has been extended from identifying the molecular
constituents and their pairwise interactions, towards understanding the overall quantitative
behavior of the integrated signaling systems that help govern cellular behavior.
Quantitative computational models have proven to be useful tools for studying and
understanding cellular systems [1]. For example, many groups have built models of
eukaryotic systems that successfully recapitulate the behavior of dozens of known mutants
[2, 3], demonstrating that current knowledge about these signaling systems may be sufficient
to explain a wide range of observable system behavior. Quantitative computational models
can also aid in the interpretation of experimental data. For example, a heterotrimeric G
protein signaling model provided a potential explanation for seemingly the paradoxical
experimental observations that Regulator of G protein Signaling (RGS) proteins can
accelerate the deactivation rate of a G protein-gated ion channel without affecting the current
amplitude of the ion channel [4, 5]. Finally, appropriate use of models can aid in the
development of new hypotheses that can then be tested experimentally. For example, Sachs
et al. used multivariable cell cytometric measurements together with experimental
perturbations to generate a Bayesian network model [6, 7] that predicted two unvalidated
signaling interactions in human T cells, predictions that they subsequently confirmed
experimentally [8]. Several other uses of quantitative models are described in Section 3.1.3.
Despite the value of quantitative modeling, several challenges limit the effectiveness
of modeling as an approach for studying cellular signaling systems (see Section 3.1.3). In
my opinion, the most important challenge facing quantitative modeling has been the lack of
tools to support the construction, exchange, validation, and refinement of models. Lacking
such tools, model building has remained a largely ad hoc and inscrutable process. For
example, information collected in support of model building as well as decisions made
throughout the model building process are rarely documented. Because this information is
not made available along with models, it is difficult to evaluate and build on published
models. Thus, tools and infrastructure for collecting, organizing and publishing model
documentation are sorely needed.
Recently there has been a push to standardize model annotation and distribution [9].
These efforts are a strong step forward, but there is still much more to be done. For example,
while such standards address annotation and distribution of the model itself, they do not
explicitly consider the information and assumptions on which the model is based. There are
a few examples of publication of model documentation [3]. However, because appropriate
tools do not exist, and the publishing of model documentation is not supported by the peer-
reviewed publication process, model documentation tends to be published separately on lab-
run websites, if at all (e.g., mpf.biol.vt.edu/research/budding_yeast_model/pp for [3]).
In addition to the lack of tools to support model construction, exchange, validation
and refinement, the use of computational modeling to study signaling systems is limited by
the quantity of experimental data that can be generated. Traditional methods for studying
and characterizing cellular processes have been highly successful, and yielded much
understanding of biological systems [10]. Unfortunately, these methods can be slow and
tedious, and generally provide incomplete and incompatible information at various levels of
resolution (see Section 5.1). For example, a combination of genetic and biochemical analysis
is used to continually form and test hypotheses, and further refine our understanding of
biological systems [11]. Analysis of well-studied signaling systems typically involves
looking at changes in the state of system intermediates. Researchers generally stimulate
pathways with a fixed input (stimulus) and then observe the output (or phenotype) over time,
or at some fixed time after stimulation [ 11]. Obviously, by considering only fixed step
responses, researchers characterize system response for a limited set of possible inputs,
providing limited information about the interactions and mechanisms the determine system
behavior. This process of discovery using fixed system inputs together with genetics and
biochemistry can be slow, and generally requires many experiments to uncover any given
fact (see Section 5.1). Thus, new technologies and practices to work with existing tools to
speed up the process of discovery and characterization are sorely needed.
This thesis focuses on developing tools to extend the power of quantitative modeling
for the study of cellular systems. Specifically, I developed tools to support construction of
well-documented models, thereby facilitating the exchange, validation, and refinement of
models. I also developed tools and approaches to investigate the rapid characterization of
molecular signaling systems to inform models, as well as our general understanding of
signaling systems, using time-dependent stimulation. Practically, I developed and tested
these tools using the mating pheromone response system in yeast (Saccharomyces
cerevisiae). However, the tools that I have developed are system-independent, such that the
tools themselves, as well as the lessons learned using the yeast mating system as a model
system, are transferable to the study of other cellular systems.
1.2 Yeast Mating Pheromone Response as a Model System
The mating pheromone response system (herein also called the mating response
system, or just the mating system) in the budding yeast, Saccharomyces cerevisiae, is a
prototypic eukaryotic signal transduction pathway. Investigation of the mating response
system has provided insight into the protein families, general molecular mechanisms, and
physiological properties of eukaryotic signal transduction systems [10, 12]. As a result, the
essential components and molecular interactions that govern yeast mating response are now
relatively well understood. The yeast mating response system includes mechanisms and
components that are conserved across higher eukaryotes, including a G-protein coupled
receptor, a heterotrimeric G protein, and a MAP kinase cascade (Figure 1-1). The mating
response system detects mating pheromone in the extracellular environment and, in response,
can trigger a cell-fate decision to cease normal vegetative growth, enter cell cycle arrest,
induce the expression of many genes, initiate morphological changes, and mate. In
vertebrates, similar signaling systems control cellular proliferation, differentiation, stress
response, and sensation, and misregulation of these signaling system is often responsible for
disease states including inflammation, cancer, and cardiovascular disease [13-15].
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Figure 1-1 Schematic representation of the mating pheromone response system in yeast.
The yeast mating system can be divided into three subsystems: the receptor/G protein subsystem
(green), the MAPK cascade (blue), and the gene expression subsystem (red). The input for the
mating system in yeast cells of the MATa mating type is extracellular a-factor, a pheromone
secreted by MA Tc mating type cells. When a-factor binds the G protein coupled receptor Ste2, the
receptor stimulates release of the G0y dimer Ste4-Ste 18 from the inhibitory Ga subunit Gpa 1. Free
GPy then recruits the scaffold protein Ste5 to the cell membrane, and bridges an interaction between
the scaffold and the p21-activated kinase (PAK) family member Ste20. G0y also binds a number of
other proteins, including the scaffold protein Farl (not shown). Ste5 binds three sequentially
activated kinases of a mitogen activated protein (MAP) kinase cascade. The PAK kinase Ste20 then
phosphorylates three sites on the MAP kinase kinase kinase (MAPKKK) Ste 11. Phosphorylated
Ste 11 (Ste 11-PPP) then phosphorylates two sites on a MAP kinase kinase (MAPKK) Ste7, which in
turn phosphorylates two sites on each of two MAP kinases (MAPKs), Fus3 and Kss 1. Both active
MAPKs (Fus3-PP and Kss 1-PP) then phosphorylate transcriptional regulators (Ste 12, Dig 1, Dig2)
and thereby induce pheromone responsive gene expression. Fus3-PP also phosphorylates additional
substrates that promote morphological changes and arrest the cell cycle (for example, Farl). A
number of phosphatases (Msg5, Ptp2, and Ptp3) inactivate the MAPKs.
1.3 Research Overview
As noted above, the lack of tools to structure the model-building process may be the
largest impediment to the continued successful use of biological models to study cellular
systems. Thus, in 0, I present a suite of tools that enable the documentation and structuring
of the model-building process. I used these tools to build an online collaborative modeling
resource dedicated to a model of the yeast mating response system, the
YeastPheromoneModel (YPM) repository (http://YeastPheromoneModel.org/). The model
encoded within the YPM repository, and the corresponding information collected to
document the model, is presented in Chapter 3. This thorough model documentation, when
written in narrative form, is tantamount to a review of the molecular interactions that govern
mating response, and thus Chapter 3 can serve as a reference for researchers interested in the
mechanistic details of the mating system.
In Chapter 4, I used the YPM repository to create a model to study the consequences
of different protein abundances in the mating system MAPK cascade. This modeling work
was also motivated by carefully measured protein abundances obtained by Kirsten Benjamin
and colleagues at the Molecular Sciences Institute.
Finally, given the ability to rapidly create well-documented models of signaling
systems using the tools described in 0, the use of models to study signaling systems is again
limited by the quality of experimental data that can be generated. Thus, in Chapter 5, I
investigated the use of time-dependent stimuli for rapid characterization of cell signaling
systems as a means to generate more informative experimental data. This time-dependent
stimulation approach complements traditional tools such as genetics and biochemistry.
Specifically, I considered the use of time-dependent stimuli for the characterization of the
rate constants and affinities that govern receptor/G protein dynamics in the mating system.

Chapter 2. Documenting the Model-Building Process
2.1 Introduction
Many different tools exist to support the construction, simulation, analysis, and
distribution of computational models of biological systems. For example, model
construction, simulation, and analysis can often all be accomplished using the same software
[16], while model distribution is facilitated through various databases (for example, the
BioModels Database: http://www.biomodels.net/). Model distribution is further facilitated
by a proposed standard file format for model exchange, Systems Biology Markup Language
(SBML; http://sbml.org/) [17, 18], which is itself supported by many simulation tools [16].
Additionally, Le Nov6re et al. have proposed a set of guidelines for model curation called
MIRIAM (minimal information requested in the annotation of biochemical models) [9]. The
MIRIAM guidelines focus on annotation of model elements (for example, reactions, species,
and compartments) and distribution of models. Although researchers have developed all
these tools and standards, no tools or standards exist to support the documentation of
knowledge and reasoning during the model-building process. Lacking tools to organize the
construction and documentation of models, researchers tend to produce models that, even if
they are encoded and shared via a standard language and deposited in a curated database,
have limited use beyond their original publication.
In my experience, and as others have noted [19, 20], the model-building process
always involves at least three major steps: (i) information collection - gathering knowledge
from the literature and curated databases, (ii) information evaluation and annotation -
assessing the collected information and making a series of assumptions and inferences to
resolve conflicts and fill in gaps in knowledge, and (iii) model construction - converting the
knowledge, assumptions and inferences into a formal framework that can be analyzed and
simulated. I call the knowledge and reasoning generated during the first two steps the
"model documentation." Although all modelers must collect and evaluate information from
the literature and make assumptions to fill in gaps in published knowledge, modelers rarely
record or publish this model documentation. Thus, in the absence of tools to structure and
document the model-building process, only the model itself emerges from the process
(Figure 2-la). This current practice of model building breaks the time-honored scientific
principle of reproducibility by introducing gaps in the record of reasoning during the research
process. Despite the fact that model documentation is required to make a scientifically sound
model, only the model itself, and perhaps a brief written description of the model, is required
for publication in traditional peer-reviewed publications. Thus, there is little support for
collection of model documentation in written, distributable, and persistent forms. In contrast,
for many years, publication of DNA microarray expression profiles and other large datasets
has been accompanied by standardized supporting information deposited in public online
databases for the specific purpose of facilitating data re-evaluation [21].
In the absence of model documentation, models are often inscrutable and thus fail to
live up to their full potential. Here, I give two examples of studies that I consider
representative of high-quality work. First, Yildirim et al. constructed a model of receptor and
G protein dynamics in the yeast mating pheromone response system, but did not publish the
knowledge and reasoning that supported many of the decisions made during model building
[22]. In the resulting model, Yildirim et al. used an affinity for the pheromone-receptor
interaction that was -1000-fold weaker than the measured affinity reported by others [22-26].
Although they cited a more accurate affinity that was used in another modeling paper,
Yildirim et al. did not note the reason that their model used a significantly weaker binding
affinity. Due to this discrepancy, one cannot evaluate whether Yildirim et al. used a weaker
affinity due to error, or as a result of careful thought and consideration, for example to
compensate for ongoing pheromone degradation in their experiments that was not otherwise
captured in their model. In the Yildirim model example, publication of the justification for
this affinity and for other model assumptions would have allowed readers of the paper to
evaluate the model for themselves and better enabled other investigators to build on the
model.
In a second example, Kofahl and Klipp created a model of the yeast pheromone
response system that accurately reproduces the behavior of many known mating system
mutants [2]. In their model, Kofahl and Klipp modeled the formation of a six protein
complex - the mitogen activated protein kinase (MAPK) cascade signaling complex
organized around the scaffold protein Ste5 - as an ordered process with each protein binding
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to Ste5 in a specific sequence, and modeled the disassembly of this complex by all proteins
dissociating at the same time. There seems to be no reason a priori, nor evidence from
experimentation, to support either assumption. In the published work, Kofahl and Klipp
stated (but did not show) that theoretical studies (presumably their own unpublished work)
showed that system behavior prior to stimulation did not differ significantly when using
unordered, instead of ordered, assembly of the signaling complex. However, the authors did
not state or show whether unordered assembly of the signaling complex affected system
behavior and dynamics upon system stimulation, nor did they discuss the implications of
simultaneous dissociation. We can imagine, given the number of different complexes that
could potentially be formed via unordered assembly and disassembly, especially when
considering the multiple phosphorylation states of the kinases, that Kofahl and Klipp made
these assumptions about assembly and disassembly as simplifying assumptions to facilitate
construction and simulation of the model [27, 28]. However, the fact that the reasoning
behind the assumptions is not published deprives readers of access to the thoughts and
knowledge of these researchers about the potential importance of ordered and unordered
assembly and disassembly of the complex, and impedes the ability of outside readers to
evaluate and extend the model.
By recording and publishing model documentation, modelers would enhance the
potential value of their models in four ways. First, in recording model documentation during
the model-building process, the modeler becomes explicitly aware of the assumptions and
information on which they base their decisions, increasing the likelihood that the modeler
will make more well-informed choices and assumptions. Second, the analysis and
assessment of past findings made during the model-building process can be valuable to the
broader research community. Third, the research community would be in a realistic position
to evaluate and experimentally test models and modeling results if given access to the
knowledge and reasoning that underlie models. Fourth, access to model documentation
would enable other modelers to more readily build upon and extend previously published
models. Unfortunately, in the absence of model documentation, researchers generally build
new models from scratch rather than revise published models due to the difficulty associated
with evaluating and extending poorly-documented & inscrutable models (Figure 2-la).
Because of these benefits afforded by model documentation, I believe that the knowledge and
reasoning underlying models is as important, if not more important, than the final models
themselves.
I believe that the lack of tools and standards for documentation of the model-building
process, combined with current acceptance of inscrutable models in the published literature,
is now the largest factor hindering the successful iterative refinement and extension of
models to study cellular systems. The lack of tools and standards for documentation of the
model-building process becomes a still more serious issue given the complexity of biological
systems now under study and the increasing scope and prevalence of computational models
in biological research. Thus, to enable construction of models that abide by the scientific
principles of transparency and reproducibility, I developed a suite of free software modeling
tools that offer two major features. First, the modeling tools enable the capture and
distribution of the knowledge and reasoning generated during the model-building process.
Second, the modeling tools allow for model elements to be integrated within their cognate
documentation, and automatically extracted and assembled into a model file for simulation
and analysis. I used the yeast mating pheromone response pathway as a model system with
which to develop and test these tools, and to gain practical experience in capturing the
model-building process.
Figure 2-1 The model building process.
The tangible inputs and outputs of the model-building process (blue ovals) are captured via
publications or model repositories (green boxes). The steps of the model-building process (red text)
are shown in relation to the tangible inputs and outputs. (a) Information existing in prior publications
serves as the basis for decisions made during the model-building process. In the absence of tools to
structure the model-building process, the knowledge and reasoning generated during the model-building process - information curated from the literature and assumptions required to resolve
conflicts and gaps in the curated information - is not captured. Only the resulting model, simulation,
and analysis are captured via publication. Thus, modelers must revisit the primary literature and go
through the entire model-building process in order to construct new equally inscrutable models rather
than revise previously published models. (b) By capturing and organizing the information generated
throughout the model-building process, model repositories enable the construction, evaluation, and
modification of an initial model, and the derivation of many related models.
2.2 Results
2.2.1 Capture and Distribution of Model Documentation
I created a suite of modeling tools built on a wiki platform [29] that enables public,
open access, user-editable information repositories for modeling of cellular systems. This
suite of modeling tools consists of MediaWiki software, a custom MediaWiki extension, and
a Python script (below). I designed this suite of modeling tools to facilitate documentation of
all three steps of the model-building process: information curation, information evaluation
and annotation, and model construction. Additionally, the modeling tools facilitate
collaborative model construction and enable publication of the model and model
documentation on the internet.
I used the suite of modeling tools to develop the YeastPheromoneModel (YPM)
information repository, in which I documented construction of a model of the yeast mating
pheromone response system (http://www.YeastPheromoneModel.org) (Figure 2-1b). The
YPM repository consists of a collection of wiki pages on the internet in which I (i) organized
and summarized knowledge and inferences found in the scientific literature, (ii) inserted
hyperlinks to the MEDLINE database entries of supporting papers, (iii) explicitly stated
modeling assumptions, (iv) described the reasoning behind each assumption or decision, and
(v) listed chosen model elements (for example, species, reaction rules, and parameter values).
Other than a small number of organizational pages that present a structured interface to the
repository, each page in the YPM repository contains a single model element or set of related
model elements, as well as model documentation justifying the choice of model elements.
For example, the parameter model element defining the abundance of the scaffold protein
Ste5 is located on a wiki page containing no other model elements (Figure 2-2), whereas two
reaction rule model elements defining the interactions between both of the MAP kinases
Fus3 and Kssl and their upstream MAP kinase kinase Ste7 are located together on a single
page in the repository (Figure 2-3).
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Figure 2-2 Screen capture of the Ste5_num page from the YPM repository.
The Ste5_num YPM repository page defines a parameter (ste5_num) that sets the number of Ste5
molecules per cell used in the YPM repository model. The modeling tags are shown to highlight the
portion of the page that is used in the formal YPM repository model. The abundance of Ste5 was
measured by four different groups. One measurement is inconsistent with the other three, and
because the methods used to measure this spurious value contained many sources of error, this
measurement was discarded. The average of the remaining three measurements was used in the YPM
repository model. The SteSnum page contains hyperlinks to the MEDLINE database entries of the
supporting papers, and links to other relevant pages in the YPM repository.
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2.2.2 Integration of Model Elements Throughout Model Documentation
I chose to use BioNetGen language (BNGL) [30] as the formal modeling language for
the tools developed here, and thus for the YPM repository itself. BNGL uses rule-based
specification of reactions allowing for a small set of reaction rules to encode a large number
of elementary chemical reactions (see Discussion). BNGL models can be readily converted
into Systems Biology Markup Language (SBML) models thereby enabling model simulation
and analysis in many different modeling platforms [17, 18]. I chose BioNetGen instead of a
different rule-based reaction generator tool (for example, Moleculizer [27] or Kappa [31 ])
because model elements are defined in BNGL as unformatted text using an intuitive, simple
syntax.
The simple readable syntax of BNGL enabled easy integration of formal model
elements throughout the YPM repository. By integrating the model elements within their
cognate documentation, I facilitated construction of my model, evaluation of the choices
made during model construction, and coordination of changes to the documentation and
model elements. Integration of the model and model documentation was in part motivated
by literate programming, where a computer programming language is combined with a
documentation language to produce a document that, while executable, more closely
resembles a piece of literature than a computer program [32]. The direct coupling between
the model elements and documentation (by integrating the model elements with the
documentation) reinforced the close relationship and near-synonymous information of the
model elements and documentation. I suspect that other modelers may likewise be interested
in integrating model elements within model documentation, although the modeling tools
developed here give modelers freedom to organize model repositories as they see fit.
Figure 2-3 Screen capture of the Ste7/MAPK_interactions page from the YPM repository.
The Ste7/MAPK_interactions repository page contains information collected from the published
literature concerning the interaction between the MAP kinase kinase Ste7, and both of the MAP
kinases Fus3 and Kssl. The page also contains comments on the collected information and
hyperlinks to the MEDLINE database entries of supporting papers. Below the assembled
information about the Ste7-MAPK interactions, the knowledge is summarized, assumptions are
stated, and the reaction rules are described. Finally, the form BNGL model elements describing
the chosen reactions are given.
To enable automated identification and extraction of formal model elements from
repositories, I demarcated model elements with Extensible Markup Language (XML) tags.
By defining model elements directly via XML tags, automated identification of model
elements is independent of the organization of the repository. Given this, I wrote two
software tools to interpret the modeling tags - one tool to control how model elements are
displayed within a model repository, and a second tool to extract all model elements from a
repository and compile the resulting set of model elements into a valid BNGL file. The first
software tool was a MediaWiki extension that enables the viewing or hiding of modeling tags
for any particular page in the model repository. The XML-style modeling tags are hidden in
the default view of repository pages. The MediaWiki extension introduces a "show modeling
tags" tab at the top of pages containing model elements, and when this tab is selected an
inclusive page view is generated in which the tags are displayed, allowing for easy
identification of the model elements (Figure 2-2). I also wrote a Python
(http://www.python.org/) script to identify and extract all model elements from a repository
and compile the model elements, stripped of modeling tags, in a properly-formatted BNGL
text file that can then be used as input to the BioNetGen simulation software. In addition to
generating a model file, the Python script produces static HTML copies of repository pages
that can serve as unchanging documentation for the extracted model. Thereafter, modelers
can continue to edit the repository without fear of affecting previously extracted models and
their cognate documentation. The extracted model and documentation are stored within the
repository, and can also be downloaded for convenience. In the YPM repository, the Python
script can be executed by clicking on a link in the site.
2.2.3 Use of the YPM Repository
The YPM repository contains a model of the entire yeast mating pheromone response
system, which any modeler can extract from the site and use. Additionally, any member of
the yeast and systems biology communities can edit the model and model documentation
throughout the YPM repository. However, I do not expect that other modelers are
necessarily interested in modeling the entire mating system using the identical assumptions
that were made in developing the YPM repository model. Moreover, the reaction rules in the
YPM repository encode a reaction network that is too large to readily simulate on commonly
available computers (more than 500,000 distinct chemical species and millions of individual
elementary chemical reactions), necessitating simplification before the model can be used.
Thus, the YPM repository model is meant to serve as a well-documented foundation from
which to produce many derivative models, perhaps with restricted scope or with different
assumptions (Figure 2-lb). For example, I created and studied a model of the mitogen
activated protein kinase cascade of the mating pheromone response system that I derived
from the full system model encoded by the YPM repository (Chapter 4). Modelers can create
a new page in the YPM repository and record any changes made to the model after extraction
(for example, altering the assumptions or reducing the scope) in order to maintain thorough
documentation of the resulting derivative model.
2.3 Discussion and Conclusions
2.3.1 Wiki as a Platform for Model Repositories
I chose to build this suite of modeling tools on a wiki platform for five reasons. First,
the internet-based wiki platform enables modelers to easily share models and model
documentation with other researchers. Second, the unstructured environment of the wiki
(which is essentially a collection of easily-editable and interlinked web pages) allows the
modeler to organize models and documentation as they see fit, and to reorganize this
information with little difficulty. Third, the wiki software tracks all changes made to all
entries, so that users can easily see what changes have been made to any page, and by whom.
Fourth, the particular wiki software that I used, MediaWiki, allows researchers to add
features to the wiki interface (for example, the extension that I wrote to control how model
element tags are displayed). Finally, the collaborative environment of the wiki platform
enables multiple researchers, or even an entire community, to contribute to a shared model
and repository. However, researchers can easily configure different permissions (in the wiki
software) for viewing and editing model repositories. For example, modelers may choose to
use the modeling tools to (i) build private, internal models, (ii) publish and distribute both
models and documentation without granting editing privileges to other researchers, or (iii)
enable other researchers to directly edit model repositories in order to create collaborative
community models, such as the YPM repository model.
Colleagues at the Molecular Sciences Institute (Berkeley, CA), led by David Soergel,
had previously invested considerable effort in developing a custom standalone software tool
for collaborative building and documentation of models, which they called Modeler's
Notebook and Datastore (MONOD; unpublished). The fact that MONOD was a custom tool
made it possible for us to incorporate powerful features into the tool. For example, MONOD
stored model elements as software objects and formally defined the relationships between
these objects. This object-oriented representation allowed for computational manipulation
and analysis of the model directly within the model documentation environment. Another
feature this object-oriented design enabled would allow modelers to select which model
components to include in a particular model, and MONOD would automatically generate the
relevant reactions accordingly. In contrast, model elements are stored in wiki-based model
repositories as simple text, with no formal relationship between model elements prior to their
conversion into a BNGL file for simulation by BioNetGen. Despite the fact that the custom
interface and underlying database for MONOD was well suited to modeling needs, the same
custom design made it difficult to navigate and edit information stored within MONOD. By
contrast, the flexible wiki environment enabled easy entry, editing, and retrieval of model
documentation, and allowed development of extensions to facilitate identification and
extraction of model elements. The extensible nature of the MediaWiki software should allow
researchers to develop extensions that provide additional features and functionality as
needed, for example enabling model manipulation (such as extraction of particular model
elements of interest) and analysis within the repository itself. We suspect that continued
development of the wiki environment to enable flexible data entry and the nucleation of
collaborative communities of researchers (below) might be necessary first steps towards
supporting more sophisticated model documentation tools and environments.
2.3.2 Features of Rule-Based Reaction Specification
The suite of modeling tools that I developed uses BioNetGen Language (BNGL) as
the formal language for encoding model elements. BioNetGen uses rule-based specifications
of reactions to allow users to generate and simulate computational models containing large
sets of reactions based on small sets of reaction rules. Reaction systems that are comprised
of proteins that have multiple binding and modification sites and that include multiprotein
complexes can quickly grow to thousands or tens of thousands of different species [27, 28,
33]. The difficulty of manually specifying all possible species and reactions has forced
modelers to make unwarranted omissions and simplifying assumptions, such as ordered
addition of proteins in the formation of a multiprotein complex. In contrast, a rule-based
specification allows inclusion of all possible species and reactions. For example, a reaction
rule may state that protein A interacts with protein B with the same association and
dissociation rate constants regardless of whether A is phosphorylated or B is pre-bound to
other binding partners. If A has two phosphorylation sites and B is a scaffold protein with two
other binding partners, each of which also has two phosphorylation sites, then this single
reaction rule, in principle, specifies over a hundred elementary chemical reactions that would
otherwise need to be recorded manually.
Beyond dealing more easily with large combinatorial sets of related reactions, rule-
based reaction specification offers three additional advantages. First, rule-based reaction
specification better reflects our natural language descriptions of molecular events, as
researchers typically offer descriptions of reactions (i.e., reaction rules) rather than list all
possible combinations of macromolecular complexes that could take part in the reaction.
Second, because reactions are encoded by rules, modelers can readily change assumptions
and interactions, as the modeler merely has to update the relevant rules rather than all of the
underlying elementary chemical reactions. Third, because rule-based reaction specification
allows researchers to specify complex models without being forced to make unwarranted
simplifications, rule-based models can more accurately represent the most detailed and
current knowledge of systems. Thus, the documentation of a rule-based model may be
tantamount to a comprehensive biochemical review of the system, further increasing the
value of a well-documented model. Indeed, a detailed description of the yeast mating
pheromone response system, based on the information that I assembled to document the
YPM repository model, is largely presented in Chapter 3.
2.3.3 Community Use of Model Repositories
I designed the suite of modeling tools to enable online publication of model
repositories. Additionally, by basing the modeling tools on wiki technology, I facilitated
collaborative editing of repositories. For example, I enabled any member of the yeast and
systems biology communities to participate in editing the YPM repository. I believe that the
collaborative environment of the wiki will help computational modeling of cellular systems
in two ways. First, models would be more accurate and enable better predictions if the model
elements were chosen based on public discussions yielding fine-grained views of the facts,
measurements, uncertainties, assumptions, alternative mechanisms, and omissions that
underlie the model-building process. Second, community repositories would allow many
modelers to share a common foundation: a "base model" and its documentation. Because a
base model extracted from a repository should be thoroughly documented in the repository,
modelers need only document the changes made to the base model to create well-
documented derivative models. Thus, by enabling the creation of many well-documented
derivative models, I have decreased the burden for each modeler to develop their own
models. However, I acknowledge that some researchers may want to create their own
tailored model directly rather than work from a community model. In this case, the wiki
platform also enables the construction of private models.
I developed the suite of modeling tools to serve experimentalists in addition to
computational modelers. For example, although I designed the YPM repository to reflect the
organization of BNGL models and to include embedded BNGL model elements, I intended
that the YPM repository be a general resource to facilitate mechanistic and quantitative
understanding of the yeast mating pheromone response system. Experimental researchers are
fundamentally interested in the same thing as modelers: understanding how biological
processes work. Like modelers, experimentalists are concerned with how experimental
evidence suggests specific molecular mechanisms, which is exactly what documentation of
the model-building process highlights. Additionally, the same researchers are increasingly
performing both experimental and modeling work. Therefore, I expect that the knowledge
and reasoning captured in the YPM repository, or any public model repository, would be
useful to experimental communities, and that experimentalists may also become important
direct contributors and editors of model repositories. Moreover, experimental researchers
could conceivably use repositories like the YPM repository as a means to rapidly distribute
new experimental findings to the relevant research community.
As our knowledge of complex biological systems becomes ever more refined, it will
be increasingly necessary for researchers to work together. Effective collaboration will
require means of communication that are rapid and detailed, while remaining flexible and
easy to use. The current mix of communication though journal publications, email, phone
calls, conference talks, and personal meetings will become inadequate as the size and
complexity of biological systems under study and the number of collaborating groups
studying the systems increase. Furthermore, effective collaborations will require an evolving
but coherent community understanding of the systems under study. Such an understanding
may be embodied in a model (in some ways analogous to a review article as described
above), but updated in a distributed and asynchronous fashion by an entire research
community, and discussed in real time as researchers make new discoveries or have new
insights. Community model repositories may serve as one means of enabling improved
scientific communication and collaboration.
2.3.4 Conclusions
I developed a suite of tools to document and share the knowledge and reasoning
generated during the model-building process. The modeling tools offer two significant
features: the ability to capture and publish the knowledge and reasoning generated
throughout model building, and the ability to integrate model elements directly into this
model documentation. Documentation of model construction serves several purposes: (i) to
structure the model-building process and enable modelers to make well-informed decisions,
(ii) to capture and share the analysis and assessment of past findings made during the model-
building, (iii) to communicate the knowledge and reasoning underlying models so that
researchers can more readily evaluate published models, and (iv) to enable modelers to more
easily extend published models to build new models. As such, thorough model
documentation can transform an inscrutable model into a model that abides by the scientific
principles of transparency and reproducibility. I have also advocated and provided tools for
developing collaborative community models, with which researchers can cooperate on the
formidable tasks of building and refining ever more complex models of biological systems.
To develop and test these tools, I created the YeastPheromoneModel repository
(http://www.YeastPheromoneModel.org), a collaborative community repository for modeling
and sharing information about the yeast mating pheromone response system. I expect that
the most substantial benefits of making well-documented scientific models will be realized as
future researchers are able to readily evaluate and extend published models. Likewise, I
expect that the most substantial benefits of collaborative model construction will be realized
as future researchers add directly to public knowledge and model resources like the YPM
repository, in addition to distributing findings via traditional publication. I also hope that my
work will help initiate a discussion of model documentation guidelines that complement
MIRIAM, the proposed set of guidelines for model annotation and distribution [9].
2.4 Materials and Methods
2.4.1 Modeling Tools
The suite of modeling tools that I developed consists of MediaWiki software (version
1.9.3), a custom MediaWiki extension "ModelExtension.php", and a Python (version 2.5;
www.python.org) script "extract_model.py". The MediaWiki software is available on the
MediaWiki website (http://www.mediawiki.org/), and both the MediaWiki extension and the
Python script are available online [34].
To allow the MediaWiki extension and Python script to identify model elements
embedded within a repository, I devised a scheme for identifying the modeling elements with
XML tags. XML tags are a standard means of signifying that the enclosed elements have a
particular meaning. Different classes of model elements are defined via unique tags to
ensure that molecule definitions, reactions, and parameters can be properly identified and
processed. I used four classes of XML tags, corresponding to four modeling blocks in
BNGL files: molecule type tags, seed species tags, reaction tags, and parameter tags.
Molecule type definitions are bracketed by <modelMoleculeType> tags and seed species are
flanked by <modelSeedSpecies> tags. Reaction rule statements are comprised of the rules
themselves and any relevant parameters. The ensemble of the reaction rules and the
associated parameters is bracketed by <modelRxnFull> tags. Between the <modelRxnFull>
tags, the rules are bracketed by <modelRxnRule> tags and the associated parameters are
bracketed with <modelRxnParam> tags. Parameter assignment equations, where parameters
are either assigned a specific value or defined as a function of other model parameters, are
bracketed with <modelParameter> tags.
Models are extracted from the repository via a Python script. The script visits each
page in the repository that is a member of one or more wiki page categories (which are
specified in the script). By only visiting the subset of wiki pages that are specified by their
membership in specific page categories, the script and modeling tools can function as part of
a larger wiki and in combination with other models within the same wiki repository. The
script makes a static HTML copy of each visited page in the wiki to serve as documentation
for the model being extracted. The script also retrieves the raw wikitext from the "edit"
version of each page visited. The script uses a Python HTML/XML parser called
BeautifulSoup (version 3.0.4, www.crummy.com/software/BeautifulSoup/) to parse the
contents of the edit page and identify the model elements based on the modeling tags. The
model elements are lightly edited upon extraction from the repository to conform to BNGL
syntax standards (for example, extra spaces and wiki markup are removed). Finally, the
model elements are assembled into a valid BNGL file. For example, to populate the
"parameters" model block of the BNGL model file, the script retrieves all text between
<modelParameter> tags on all visited pages, deletes any internal wiki markup and extra
spaces, and stores the remaining characters as a line to be written to the nascent model file.
The Python script follows the same procedure to collect the information to populate the
"molecule types," "seed species," and "reaction rules" blocks in the BioNetGen input file.
Once all of the pages have been visited, the script writes the "molecule types", "seed
species", "parameters" and "reaction rules" model blocks to the newly created model file.
Upon completing extraction of all model elements into a BNGL model file, the Python script
updates an HTML page, the Extracted Models Log page, with links to the documentation and
model file. Extracted models are given a date-and-time stamp for their unique identification.
2.4.2 YPM Repository
The YPM repository consists of a small set of organizational wiki pages which
present an interface to the three types of model element wiki pages that comprise the bulk of
the repository: Species, Reaction and Parameter pages. The Species, Reactions, and
Parameters page categories were chosen to mirror the organization of the BioNetGen input
file. Each Species, Reaction and Parameter page contains a single model element, or a set of
related model elements, and the necessary accompanying documentation.
Species: Each elemental molecule (ligand or protein; for example, the MAPK Fus3)
in the YPM repository model has its own Species page. A species page contains a natural
language description of information pertaining to that molecule, hyperlinks to the MEDLINE
database entries of supporting papers, and links to relevant Reaction pages. In addition,
Species pages include two BioNetGen model elements: molecule type and seed species. For
example, the definition of the Fus3 molecule type is currently
Fus3 (docking_site, T180-none~PO4 ,Y182~none~PO4) , which indicates that Fus3 contains
a site for binding other proteins (called docking_site) , and two modification sites (called
T180 and Y182) each of which has two possible states, none (unphosphorylated) or Po4
(phosphorylated). Seed species define the initial states and concentrations used as seed
species in the model (that is, species initially present upon simulation). For the YPM
repository model, the individual molecules are used as seed species (with their total
monomeric concentration used as the initial concentration), rather than using multiprotein
complexes. Thus, the starting point of a simulation does not represent the steady state in the
absence of pheromone, but represents a non-steady state point that is meant to be equilibrated
in a simulation before addition of pheromone.
Reactions: Each Reaction page in the YPM repository contains a group of related
reaction rules. For example, the Ste7/MAPK_interactions page includes binding of both
MAPKs to the MAPK kinase Ste7 (Figure 2-3). Each reaction rule section (for example,
binding of the Fus3 MAPK to the Ste7) includes descriptions of and hyperlinks to published
literature, explicit statements of assumptions, and assessments of the strength of support for
the assumptions. In addition, each reaction rule is given by a Reaction Definition in
BioNetGen syntax, along with definitions of parameters and links to Parameter pages. For
example, the statement that Ste7 with an empty MAPK-binding site and empty Ste5 binding
site (regardless of any modification of the Ste7 molecule) binds reversibly to Fus3 with an
empty Ste5-binding site (regardless of any other modification or binding states of the Fus3
molecule) would be depicted as: Ste7 (Ste5_site,MAPK_site) + Fus3 (docking_site)
<-> Ste7 (Ste5_site ,MAPK_site!1) . Fus3 (docking_site! ) . The forward rate constant
is defined as kon_Ste7_ MAPK and the reverse rate constant as koff_Ste5_MAPK, and links are
given to the Parameter pages for these rate constants.
Parameters: A Parameter page contains a value for the parameter (or an expression
as a function of other model parameters), the source and trustworthiness of the value,
comments, literature citations, and links to additional relevant pages within the repository
(Figure 2-2).

Chapter 3. A Model of S. cerevisiae Mating Pheromone
Response
This chapter will be published as a comprehensive review of the yeast mating system by
Thomson, Thorner, and Endy [35]. In case of differences between the text of this chapter
and the eventual peer-reviewed publication, future readers should consider the published
manuscript as the ultimate reference for our current understanding and opinion of the
workings of the yeast mating pheromone reseponse system.
3.1 Introduction
As described in Chapter 2, the YPM repository serves as an online resource for
information about yeast mating response system. Although I designed the YPM repository as
a means to document, maintain, and distribute a model of the full mating system, I intended
that the YPM repository also serve as a general resource to facilitate mechanistic and
quantitative understanding of the yeast mating system. In this chapter I provide a natural
language description of the documentation, as well as a description of the model elements
(for example, species, parameters, and reactions) that comprise the YPM repository model.
[For simplicity, I refer to the YPM repository model as the Mating Model in this chapter.]
By presenting detailed documentation of the Mating Model, I essentially review the
quantitative and mechanistic features of the yeast mating pheromone response system.
As described in 0, I encoded the Mating Model using the rule-based BioNetGen
language. I also produced a complementary and unambiguous graphical description of the
pathway that is based on the graphical BioNetGen notation [36, 37]. An explanation of the
graphical notation that I employ can be found in Section 3.1.2. A tutorial on BioNetGen
syntax can be found on the BioNetGen wiki site (http://bionetgen.org).
Section 3.1.1 gives a brief overview of the mating pathway and describes some of the
known system-level behaviors of the pathway. Section 3.1.4 defines the scope of this chapter
as well as the scope of the Mating Model. Section 3.1.5 discusses some of the experimental
measurements of key system parameters found throughout the review (e.g., rate constants
and protein abundances). Sections 3.2 through 3.6 describe the entire mating system,
covering the receptor-G protein signaling subsystem, the MAP kinase cascade subsystem, the
gene expression subsystem, the interaction between the mating system and the cell cycle, and
additional modeling and signal transduction considerations.
Sections 3.2 through 3.6 are broken down into subsections, each focused on specific
sets of closely related events in mating signaling. For example, all reactions concerning
activation of the MAPKKK Ste 11 are considered together in Subsection 3.3.1.c, including
binding of Stel 1 to the scaffold Ste5, and phosphorylation of Stel at three residues. The
subsections in Sections 3.2 through 3.4 are organized into categories: Signal Propagation,
Regulation and Feedback, and Protein Abundances. Each subsection is generally divided
into five parts, as appropriate: (i) summary, (ii) experimental data, (iii) interpretation and
assumptions, (iv) numbers and rates, and (v) computational and graphical representations.
Parts (i) and (ii) succinctly summarize and then elaborate on the experimental evidence. I
provide a higher level of detail where there is more uncertainty about the underlying
mechanism, and less detail where the mechanism is well understood. In part (iii) the
experimental evidence is then evaluated and interpreted, and I detail the likely mechanistic
events and the formal representation for the Mating Model. Assumptions required to fill in
gaps in experimental evidence are explicitly stated, and the elementary chemical reactions
that best express the events for the section are described. In part (iv) I describe and evaluate
the quantitative measurements - rate constants and protein abundances - that define or
constrain the relevant Mating Model parameters. In part (v) the formal Mating Model
elements (i.e., reactions and parameters) are presented using an unambiguous rule-based
graphical notation, which is described in Section 3.1.1. Model parameters are presented in
tables below the graphical notation. In some cases, portions of parameter names have been
bolded and italicized to emphasize differences between parameters. Figures and tables
whose contents comprise the formal Mating Model are presented with a grey background,
whereas figures and tables whose contents are not part of the Mating Model have a white
background. The graphical reaction notation used in this chapter is complemented by a
complete BioNetGen language description of the Mating Model [34].
3.1.1 Overview of the Mating Pheromone Response System in Yeast
Budding yeast can exist as either haploid or diploid cells, with haploid cells being
either a or a mating type (also called MA Ta or MATa). Haploid cells secrete small peptide
pheromones, a-factor from a-cells and a-factor from a-cells, as a means of alerting nearby
cells of the opposite mating type to their presence. When haploid cells detect the pheromone
produced from the opposite mating type, they can temporarily cease cell cycle progression
(see Section 3.5.2) and commence highly polarized growth in the direction of the source of
the pheromone via the formation of a projection called the "shmoo" (see Section 3.6.3).
When mating partners contact each other, the haploid cells fuse to form a single a/a cell,
which then eventually resumes growth as a diploid [12].
The pheromone response system coordinates the physiological events required for
successful mating. To function properly, the mating pathway must combine information
about cell cycle position and extracellular pheromone dose. For example, cells must arrest
and mate during the correct stage of the cell cycle such that the newly formed diploid cell
only receives a single copy of each chromosome from the two mating partners [38]. The
mating pathway also establishes cell landmarks for polarized growth via localized activation
of proteins that reorganize the cytoskeleton (see Section 3.6.3).
Many mating system components responsible for signal transduction and initiation of
transcription of mating genes also set and reinforce the internal landmarks used to direct
polarized growth (see Section 3.6.3). Thus, the mating system is not entirely separable from
the coordinated morphological response that the system initiates. The mating system is also
not entirely distinct from other molecular signaling networks in the cell. For example, the
mating pathway shares essential components with at least two other molecular signaling
systems (see Section 3.6.5), the invasive/filamentous growth (IVG) system and the high
osmolarity glycerol (HOG) system. The mating system must integrate cues from these
related signaling system, as well as from the cell cycle (see Chapter 3.5), in order to make a
"decision" about whether to mate or not.
The mating pathways in MATa and MATa cells are not identical. Whereas a-factor is
an unmodified peptide [39, 40] that can be easily synthesized in vitro , a-factor is
farnesylated and carboxymethylated [41, 42] causing a-factor to adsorb to hydrophobic
surfaces and making a-factor more difficult to synthesize [43]. Thus, mating response in
MATa cells is more conveniently studied than response in MATa cells, and correspondingly,
the majority of the yeast pheromone response pathway literature deals with response of
MATa cells to a-factor. For this reason, in this thesis I focus only on signal transduction for
one of the two yeast mating types, MA Ta, in response to pheromone. I briefly summarize
and discuss the differences in signaling between MATa and MATa cells in Section 3.1.1.e.
3.1.1.a Signal Transduction
a-factor is detected by Ste2, a G protein-coupled receptor (GPCR) in the plasma
membrane of MATa cells, and a-factor is detected by Ste3, a GPCR in the membrane of
MATa cells (see Section 3.2.1.a). The receptor associate on their cytoplasmic face with a
heterotrimeric G protein composed of Gpal (the Ga subunit) and Ste4-Stel8 (the GUy
subunit). Binding of pheromone to its receptor results in activation and dissociation of the
associated heterotrimeric G protein (see Sections 3.2.1.c and 3.2.1.d). Both the Ga (Gpal)
and GPy (Ste4-Stel8) G protein subunits are lipid-modified so that each remains membrane-
localized upon dissociation. GUy, no longer sequestered by Gpal, now can bind a number of
proteins and initiates signaling through a MAP kinase cascade. G protein deactivation and
reassociation are accelerated by a Regulator of G protein Signaling (RGS) protein, Sst2 (see
Section 3.2.1.e).
Ste5, a protein that serves as a scaffold for the MAP kinase cascade, is one of the key
proteins that bind GPy (see Section 3.3.1.b). Ste5 also binds the MAP kinase kinase kinase
(MAPKKK) Stel 1, the MAP kinase kinase (MAPKK) Ste7, and the partially redundant MAP
kinases (MAPKs) Fus3 and Kssl (see Sections 3.3.1.c, 3.3.1.d, and 3.3.1.e). A p21-activated
kinase (PAK) family protein, Ste20, also binds Goy and the small G protein Cdc42 at the
plasma membrane. Ste20 phosphorylates and activates Stel 1 when Ste20 and Stel 1 are co-
localized at the membrane via Ste5 and Gpy (see Section 3.3.1.c). Active Ste 1 then
phosphorylates and activates Ste7, which in turn phosphorylates and activates Fus3 and Kssl
(see Sections 3.3.1.d and 3.3.1.e). The active MAP kinases phosphorylate many target
proteins in the cell. Importantly, the MAP kinases also enter the nucleus and phosphorylate
Digl, Dig2 and Stel2, relieving repression of Stel2 and initiating transcription of many
pheromone-responsive genes (see Sections 3.4.1.a and 3.4.1.b). The products of the
pheromone-responsive genes modify mating system behavior, the cell surface, cell
morphology as the cell is prepared for fusion with a potential mating partner.
3.1.1.b Regulation and Feedback
The yeast mating pathway includes many forms of regulatory control and feedback,
which serve to both promote and attenuate the magnitude and duration of signaling (Figure
3-1). Broadly, in response to pheromone treatment, expression from several genes is
upregulated and the concentration of their products increased, whereas some proteins are
inhibited, stabilized or degraded. Due to the large number of such regulatory controls and
the fact that many of these regulatory controls seem to act in opposition, the net role played
by each is often unclear and the overall integrated mating system control architecture remains
to be fully understood at a "systems" level. However, several studies have shown that Sst2 is
the primary negative regulator of mating system activity (see Section 3.2.1.e).
More specifically, in response to pheromone treatment, MA Ta cells increase
expression of the secreted protease Barl, which degrades a-factor, attenuating signaling and
promoting resumption of vegetative haploid growth (see Section 3.2.2.a). Endocytosis of the
receptor Ste2 is stimulated upon pheromone binding (see Section 3.2.2.b). However,
expression of STE2 is also upregulated in response to pheromone treatment, eventually
replenishing the cell surface with new Ste2 molecules. Expression of the Ga subunit is also
upregulated, as is expression of the RGS protein Sst2, promoting sequestration of the Gi3y
subunit and attenuation of signaling (see Sections 3.2.2.c and 3.2.2.d). In opposition to its
increased expression, Sst2 phosphorylation and degradation occur in response to pheromone
treatment (see Section 3.2.2.d). In the MAP kinase cascade, the MAPKKK Stel and
MAPKK Ste7 are degraded more rapidly after cells are exposed to pheromone, whereas
expression of the MAPK Fus3 (but not Kss I) is upregulated (see Sections 3.3.2.a, 3.3.2.b,
and 3.3.2.c). There are no known phosphatases for Stel 1 and Ste7, perhaps highlighting the
importance of degradation in resetting the activity of these two kinase. Although Fus3 is
upregulated in response to pheromone, so is one of the three MAPK phosphatases, Msg5 (see
Section 3.3.2.f). Regulation of transcriptional activity is similarly complex, with both the
transcription factor Stel2, and one of its repressors, Dig2, being upregulated (see Sections
3.4.2.a and 3.4.2.b). Further complicating matters, Stel2 degradation is increased in
response to activation of the mating pathway.
Figure 3-1 Regulation of mating pheromone signaling.
Post-translational activation reactions are shown via green arrows, and inhibition ordegradation reactions via red arrows. Slower timescale transcriptional upregulation reactions
are given as blue arrows. Thin lines denote interactions that facilitate the associated reactions.
3.1.1.c System-Level Properties
Conservation of EC50 through pathway
In the mating pathway, the dose-dependent activation of pheromone-mediated gene
expression closely mimics the dose-dependent occupation of Ste2 receptor molecules on the
cell surface. In fact, the concentration of pheromone required for half-maximal response
(EC50) is approximately conserved through pheromone-receptor association [44, 45] (see
also Section 3.2.1 .a), G protein activation [45], MAPK phosphorylation [44], mating gene
expression [26, 45-49] and cell cycle arrest [45]. Observation of this dose response
alignment phenomenon requires that Barl dependent degradation of pheromone be
eliminated such that the extracellular pheromone concentration is not altered over time. Dose
response alignment is also seen in steroid hormone [50] and EGF [51, 52] response systems.
In the mating pathway, the EC50 alignment appears to be maintained, at least in part, by a
Fus3-specific feedback, which may exist in order to maximize information transmission
through the mating pathway [44]. Sensitive information transmission through the pathway
may support the efficient selection of a suitable mating partner in shallow or complex
gradients of extracellular pheromone [44].
Graded vs. switch-like dose response
Several studies have investigated whether the mating pathway produces a graded or
switch-like response in individual cells. Some studies have reported that pheromone-
responsive gene expression is graded across a range of pheromone concentrations [44, 53,
54], while others have reported that pheromone-mediated gene expression is at least in part
switch-like [55, 56]. Further complicating matters, both graded and switch-like behavior
have been observed simultaneously; with increasing pheromone concentration, all cells
respond increasingly and a group of strong-responders forms, although the strong-responders
are not entirely separable from the rest of the population [54].
Although the mating pathway may respond to pheromone in a partially graded
manner, the decision to enter cell cycle arrest and mate is essentially binary; a cell either
arrests or it does not, and it either finds and mates with a partner or not. Thus, the multiple
feedback loops and forms of regulation within the pathway may serve to reinforce an initially
graded response yet allow for a more switch-like response over time. However, the dynamic
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progression of the graded or switch-like response to pheromone has not been fully
investigated.
Adaptation and desensitization
When exposed to mating pheromone yeast halt cell cycle progression and attempt to
mate. However, if mating is unsuccessful after prolonged exposure to pheromone, mating
pathway activity drops and cells recommence growth and division as haploids [57-59].
Recovery from arrest is primarily mediated by Barl-dependent degradation of pheromone
[60, 61]. In the absence of Barl, cells take longer to recover from pheromone-mediated cell
cycle arrest, but eventually recover and resume vegetative growth [62]. Adaptation is also
delayed in the absence of Sst2 [59, 63].
3.1.1.d Cell-to-Cell Variation in Mating Response
Individual yeast cells display significant cell-to-cell variation in their response to
pheromone treatment [54, 55], with almost a 4-fold difference in pheromone-mediated gene
expression between the strongest and weakest responding cells [53]. A significant portion
(-50%) of variation in gene expression response can be removed by cell cycle
synchronization via chemical inhibition of Cdc28 or shift of Cdcl5-2ts to a restrictive
temperature [53]. Thus, the interactions between the cell cycle and the mating pathway (see
Section 3.5.1) are responsible for the majority of variation in mating response across cells in
an asynchronous population. Colman-Lerner et al. further found that at high doses of
pheromone, the remainder of the cell-to-cell variation in pheromone-responsive gene
expression is primarily due to differences in the capacity of individual cells to transcribe and
translate genes (accounting for -75% of variation), rather than differences in activation of the
mating pathway itself (accounting for -25% of variation). They also found that at lower
doses of pheromone, cell-to-cell differences in the activation of the mating pathway have a
greater effect on pheromone-mediated gene expression, accounting for -60% of cell-to-cell
variation once cell cycle effects have been eliminated [53]. Thus, especially at high
pheromone concentrations, the cell-to-cell variation in pheromone-induced gene expression
is dominated by pre-existing differences in cell state rather than by variability in the timing
of individual reactions during pathway response.
Given that pre-existing cell-cell differences account for much of the observed
variation in mating response, it might be expected that the concentrations of proteins in the
mating pathway vary significantly from one cell to the next. The reported cell-cell
coefficient of variation in mating protein levels is -0.3 [64]. Some mating pathway genes are
expressed in a cell cycle dependent manner, while others are not (see Section 3.5.1).
However, the concentrations of protein products of cell cycle regulated genes and non-cell
cycle regulated genes exhibit the same coefficient of variation, suggesting that cell-to-cell
variability in protein concentrations is not entirely cell cycle dependent [64]. Because
Colman-Lerner et al. found that some cells had a higher capacity to transcribe and translate
genes into protein products [53], the concentrations of pathway proteins within any
individual cell may be strongly correlated, although such correlations have not been
investigated directly.
3.1.1.e Signaling Differences Between a- and a-Cells
Differences in mating pathway signaling between a- and a-cells appear to occur
primarily at the level of the pheromone peptides, receptors, and gene expression machinery.
What is known about the core of the signaling pathway is identical between the two cell
types. As expected, MATa and MATa-specific genes are regulated by different mechanisms.
a- and a-factor are processed differently prior to secretion. Both a-factor and a-
factor are expressed from two genes: MFAJ and MFA2 each encode a single a-factor repeat
[65], and MFal and MFa2 each encode multiple a-factor repeats [66]. a-factor is processed
from a precursor containing multiple copies of the peptide in the endoplasmic reticulum and
Golgi bodies, and is released into the extracellular environment via secretory vesicles [40,
67]. In contrast, a-factor is processed in the cytosol from a precursor containing a single
peptide copy [68, 69] and secreted by a dedicated ATP-dependent transporter Ste6 [70, 71].
a-factor is farnesylated and carboxymethylated [41, 42], making a-factor a hydrophobic and
poorly-diffusing molecule [43]. a-factor precursor is modified for efficient processing in the
secretory pathway but the ultimately secreted a-factor is unmodified [39, 40]. Expression of
a-factor, a-factor, and Ste6 is upregulated in response to pheromone treatment [72]. MATa
cells produce and secrete the specific a-factor protease Barl in response to pheromone [60,
53
61]. Although an a-factor degradation activity has been reported [73, 74], these reports have
still not been confirmed, suggesting that an enzyme that degrades a-factor may not exist.
Both pheromone receptors Ste2 and Ste3 are constitutively replenished in the absence
of pheromone, and rapidly internalized in the presence of their cognate pheromone.
However, turnover of Ste2 and Ste3 are regulated by different mechanisms. Ste2
internalization in the presence of a-factor is regulated by Yckl and Yck2, and does not
depend directly on the mating pathway [75, 76]. In contrast, Ste3 internalization in the
presence of a-factor does not require Yckl or Yck2, but does require a functional mating
pathway [77]. Internalized Ste2 is degraded whereas internalized Ste3 can be recycled to the
cell surface [78, 79], perhaps in compensation for the fact that Ste3 expression is not
upregulated in response to pheromone. Internalization of both Ste2 and Ste3 are addressed in
more detail in Section 3.2.2.a.
The MA Ta-specific protein MATal (also called al) binds the next to Mcml on the
UAS of MA T-specific genes to mediate their expression, and the MATa-specific protein
MATa2 (also called a2) represses the expression ofMAlTa-specific genes [80]. In MATa
cells, neither al nor a2 is expressed, and in the absence of these regulators MA Ta-specific
genes and not MATa-specific genes are expressed [80]. Haploid specific genes that are
expressed in both mating types are regulated by Mcml alone [80]. Pheromone-inducible
mating-type specific genes are also regulated by al and Mcml, but Mcml binds to the UAS
of these genes cooperatively with Stel2 (see Section 3.4.1.b).
3.1.2 Overview of the Graphical Reaction Notation
Throughout this chapter, Mating Model reactions are depicted using a graphical
notation based on the BioNetGen language, using specific binding and modification sites on
proteins to define each reaction. Binding sites on molecules in the Mating Model,
graphically denoted by circles within molecules, are used as connection points to form an
interaction between two proteins. Modification sites, denoted by rectangles within
molecules, contain text that defines the state of the modification site. Here I describe the
notation using a series of example reactions, starting with Figure 3-2 which describes an
example interaction between the receptor Ste2, and the G protein a subunit Gpal. The
Mating Model description of the interaction between Ste2 and Gpal is given in Section
3.2.1.c.
Figure 3-2 Example reaction: interaction of Ste2 and Gpal.
The basis of the interaction between Ste2 and Gpal in Figure 3-2 is the formation of a
bond between the molecules. This bond forms between the Gpal binding site on Ste2 (Gpal
site), and the Ste2 binding site on Gpal (Ste2 site). Both sites are represented by unfilled
(white) circles on the left side of the reaction to show that these sites are unbound. On the
right side of the reaction the binding sites are denoted with filled (black) circles connected
via a black bar to show that these sites are interacting. In Figure 3-2 I include no information
about whether other events (e.g., an interaction between Ste2 and pheromone, or the
GDP/GTP-bound state of Gpal) impact the rates of association and dissociation of the Ste2-
Gpal complex.
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Figure 3-3 Example reaction: interaction of Ste2 and Gpal.
Figure 3-3 contains more information than Figure 3-2. Here, the ca-factor and Sst2
binding sites are shown on Ste2 (aF site and Sst2 site), and the Ste4 binding site and
nucleotide are shown on Gpal (Ste4 site and nuc). For simplicity I modeled the nucleotide
binding site nuc as a modification site rather than as a binding site. Note that the difference
between the top and bottom reaction in Figure 3-3 is that the Ste4 site on Gpal is unbound in
the top reaction, while occupied in the bottom reaction. In this case, I am not concerned
about what the Ste4 site is bound to, so I do not include an interactions or binding partner.
The binding or modification sites whose states do not affect the reaction rate (aF site, Sst2
site and nuc) are shaded in the same colors as the molecules. Thus, Figure 3-3 states that the
affinity of interaction between the Gpal site on Ste2 and the Ste2 site on Gpal is only
dependent on whether Gpal is bound to anything via its Ste4 site (unbound in the top
reaction, and bound in the bottom reaction), and not dependent on the state of any of the
other binding or modification sites (which are shaded in both reactions).
I
I
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In Figure 3-4 I introduce two additional features to the graphical notation. First, the
binding sites that participate in the reaction are highlighted on the left with a magenta outline
and highlighted on the right via magenta fill instead of black fill. The different color is used
to facilitate identification of components that change state within complex reactions. Second,
rather than show the reaction twice, with the Ste4 site left unfilled in one reaction and filled
in the other, I use a half filled circle to denote that the affinity of interaction depends on the
state of that site. The affinities are then given in a table below the reaction. For complex
reactions whose rates depend on the states of many components, this approach simplifies the
graphical depiction and improves readability.
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Figure 3-4 Example reaction: interaction of Ste2 and Gpal.
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Figure 3-5 Example reaction: phosphorylation of Kssl at T183 by Ste7.
In Figure 3-5 I present a final example of the graphical reaction notation: the
phosphorylation of one residue of the MAPK kinases Kss 1 by the MAPKK Ste7, changing
T183 from the unphosphorylated state (none) to the phosphorylated state (pT). In this case,
Ste7 is able to phosphorylate Kss I when the two molecules are bound via the MAPK site on
Ste7 and the Docking site on Kss 1. The rate is independent of whether Ste7 is bound to
anything via its Ste5 site (shaded), but does depend on the phosphorylation state of Ste7
(S359/T363 is half filled) or the phosphorylation state of a different phosphorylation site on
Kssl (Y185 is half filled).
3.1.3 Benefits, Limitations, and Challenges of Modeling Cellular Signaling Systems
Quantitative models provide an often necessary and potentially powerful tool for
organizing, exploring and testing our understanding of cellular and molecular signaling at the
molecular and mechanistic level [1, 81]. Quantitative modeling has several complementary
purposes. Models can be used to evaluate the completeness of knowledge for the molecular
and species interactions that define a particular system. Agreement between the behavior
encoded via a computational model and experimental data can suggest that existing
knowledge is not insufficient to describe what is known about a system. Models leading to
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results that are inconsistent with experimental observations are even more interesting; given
carefully constructed models, disagreement between model and observed behavior may
reflect gaps in our understanding of the system. Appropriate use of models and experiments
can aid in the development of new hypotheses to resolve disagreements, and these
hypotheses can then be tested experimentally. For example, Sachs et al. used a Bayesian
network model to help predict two novel signaling interactions in human T cells, which they
subsequently confirmed experimentally [8]. As a second example, Hao et al. used a
quantitative model of the yeast mating pathway to predict that the degradation of the RGS
protein Sst2 is accelerated by pheromone treatment, a prediction that they also confirmed
experimentally [82].
Quantitative models of signaling pathways can also be used for design or selection of
potential therapeutic treatments [83]. For example, computational studies involving the
phospholipase C [84] and NF-KiB [85] pathways have suggested novel therapeutic treatments
that are designed to interfere with erroneous pathway signaling in cancer cells. Model
behavior can also be investigated in an attempt to understand how evolutionary pressures and
drift can impact system architecture. For example, Bhalla et al. used a combination of
computational and experimental approaches to investigate the architecture of the MAP kinase
1,2/protein kinase C (PKC) system [86]. Bhalla et al. found that the system architecture may
have evolved to enable either monostable or bistable response based on environmental cues
that govern phosphatase abundance. Finally, increased understanding of the architecture of a
natural system such as the MAPK PKC system can help guide researchers as they build
complex artificial regulatory circuits [87]. For example Basu et al. engineered circuits in
Escherichia coli for multicellular pattern formation [88]. Multicellular pattern formation is a
hallmark of the type of complex behavior that mediates cellular differentiation during
development of multicellular organisms.
Although quantitative modeling is clearly a successful approach for studying
signaling systems, we must keep in mind that models are typically massive approximations
of the physiochemical properties of components and events that underlie the molecular
interactions involved. Despite our ever-increasing understanding of the physical and
chemical nature of the intracellular environment (for example, see [89-93]), the elementary
chemical reaction framework that I have adopted for the models presented herein relies on
several assumptions, some of which are known to be false. For example, in my models of the
mating system I do not consider spatial effects (see Section 3.6.4), and thus I am implicitly
assuming that mating system components are homogeneously distributed throughout the
cytosol. However, some pathway components are localized to the nucleus, others to the
cytosol, and still others are associated with the plasma membrane. Additionally, there is
some evidence that at least one signaling component, the phosphorylated form of the MAPK
Fus3, forms a stable concentration gradient in the cytosol of pheromone-treated cells [94].
In addition to physical assumptions that underlie models, simulation of models also
implicitly requires an additional set of assumptions. For example, the elementary chemical
reaction framework that I employ can be represented mathematically via the "chemical
master equation" and evaluated using a number of discrete reaction event algorithms, or
approximated mathematically via ordinary differential equations (ODEs) and evaluated using
approximately exact ODE numerical integration algorithms [95]. The representation and
simulation of system behavior via either method assumes a dilute and homogeneous
distribution of components [95-97]. As conceded above, signaling components are known to
be heterogeneously distributed throughout the cell. The additional assumption of dilute
components is also not formally true; the cell interior is well-known as a crowded molecular
environment [89, 93]. Additionally, both the chemical master equation representation and
the ODE representation for elementary chemical reactions are fundamentally based on
heuristic models of the underlying physical processes of diffusion, molecular collision, and
chemical bond rearrangement; both mathematical representations for elementary chemical
reactions have physical interpretations that require similar assumptions of dilute
homogeneous distribution of components, as well as the assumption that classical mechanics
are sufficient to describe molecular events [96, 97].
In addition to the many limitations imposed by the assumptions made during
construction and simulation of quantitative models, several practical factors hamper the
effectiveness of modeling as a tool for studying molecular signaling pathways. One
challenge encountered is the frequent lack of accurate values for model parameters (such as
protein abundances, rate constants, etc.) and absence of high quality temporal or spatio-
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temporal data. Recent efforts have produced temporal data for the mating system [44, 45,
53] which can be extraordinarily useful for constraining model behavior (for example, see
Chapter 4 and Chapter 5). Models of the mating system and most other cell signaling
systems still suffer from a lack of reliable estimates for model parameters. However, in my
opinion, the most important challenge facing quantitative modeling is the lack of tools to
support the construction, exchange, validation, and refinement of models, as discussed in 0.
3.1.4 Scope of the Mating Model
As described in Section 3.1.1, the mating system does not operate in isolation from
other cellular functions. The mating system shares components with other molecular
signaling networks (see Section 3.6.5). Also, some signaling components from the mating
system are involved in the morphological response elicited by the mating program (see
Section 3.6.3). Finally, the mating pathway is significantly coupled to the cell cycle (see
Chapter 3.5).
I carefully defined the boundaries of the Mating Model in order to create a self-
consistent model of the mating system. I consider a self-consistent model to be a model in
which the abundances and activities of all of the molecular species in the model are governed
by reactions within the model. Other than the concentration of mating pheromone, which is
considered to be externally controlled in the Mating Model, the model is a 'closed system'
with no additional inputs. I chose to include in the Mating Model only those interactions that
govern detection of pheromone, transmission of dose information, and activation of
pheromone-responsive gene expression. Feedback interactions that fall within these bounds
(e.g., upregulation of mating induced genes in response to pheromone treatment) were also
included in the model. The Mating Model does not include interactions between the mating
system and the cell cycle, other signaling system, or morphological effectors. For example,
if I had included the interactions between the mating system and the cell cycle in the Mating
Model, then I would have needed additional reactions to control the abundances and
activities of those cell cycle components that interact with the mating system components -
essentially, I would have needed to integrate a cell cycle model into the Mating Model.
However, the interactions between the mating system and other relevant cellular
systems are certainly worthy of discussion, even though these interactions are not included in
the Mating Model. Particularly, I extensively examine the interactions between the cell cycle
and the mating system in Chapter 3.5. Because the interactions between the mating system
and the cell cycle are complex, but reasonably well understood, I treat these interactions at
the same level of detail as I treat other pathway events (i.e., at the level of elementary
chemical reactions). The reactions and molecules presented in Chapter 3.5 are meant
facilitate construction of future models that consider both the cell cycle and the mating
system.
3.1.5 Measurement of System Parameters
The dynamic and quantitative response of the mating system is influenced by many
parameters (e.g., rate constants, binding affinities, protein abundances). Throughout this
chapter, these parameters are defined along with the elementary chemical reactions that I
chose to include in the Mating Model. Although much is known about the operation of the
mating pathway, many of the parameters that determine the precise pathway response are
unknown or poorly described. The majority of the parameters used in published models of
the mating pathway have been selected to maximize agreement between specific model-
based simulations and selected experimental data. As such, these 'optimized' parameter
values provide some information, however limited, on the potential values of the actual rate
constants, protein abundances, and other pathway parameters. Throughout this chapter I
report parameter values based on actual measurement, or experimentally determined
constraints on parameter values. I also report and comment on parameter values used in the
modeling literature, including how the values used in past models compare with measured
values or constraints.
3.1.5.a Rate Constants and Binding Affinities
The Mating Model makes use of many rate constants and binding affinities. In the
few cases for which rate constants or binding affinities have been measured or constrained
experimentally, the majority of the experiments were performed in vitro. Reaction rate
constant values can differ significantly across in vivo and in vitro measurements (e.g., see
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Section 3.2.1.a). However, in many cases, constraints on parameter values, such as upper or
lower limits, can be inferred from experimental results. Throughout this chapter I report both
the measured values, and any relevant constraints garnered from the literature. I also report
the rate constants and binding affinities used in published models of the mating pathway.
However, because different models have used different sets of elementary chemical
reactions, the parameters used in other models do not always correspond directly to
parameters in the Mating Model (I note such cases).
3.1.5.b Protein Abundances
The cellular abundances and concentrations of many key mating pathway proteins
have been measured experimentally, often multiple times via different methods. Because
reported protein abundances often vary greatly, I evaluate the methods used and discuss how
differences in experimental methodology may inform our confidence in the reported values.
Additionally, because some studies report cellular abundances and other report cellular
concentrations, I must consider the accessible cell volume in order to convert protein
concentrations into protein abundances. Throughout this chapter, I compare and comment on
the different experimental measurements of protein abundances, and also the different
abundances used in past modeling studies.
Experimentally measured abundances
Several recent studies have included systematic measurement of the abundances or
concentrations of mating pathway proteins. For simplicity, I comment on these systematic
studies here, and individual measurements throughout the text.
In one systematic study, Ghaemmaghami et al. measured the abundances of protein
products encoded by 80% of all known yeast open reading frames, including many protein
products involved in the mating pathway [98]. In order to facilitate this substantial
undertaking, Ghaemmaghami et al. generated strains in which each open reading frame was
tagged with a tandem affinity purification (TAP) epitope. Total cell extracts from each strain
were analyzed via SDS-polyacrylamide gel electrophoresis and western blotting, and
absolute protein abundances were estimated using a TAP-specific antibody and three purified
TAP-tagged protein standards.
Kirsten Benjamin and colleagues at the Molecular Sciences Institute also used
immunoblotting to measure protein abundances (see Chapter 4). However, by focusing only
on mating pathway and related cell signaling proteins, Benjamin et al. were able to make
several key improvements over the methods used by Ghaemmaghami et al. For example,
Benjamin et al. used protein-specific antibodies for each protein of interest rather than using
a common antibody and epitope tag. The use of custom antibodies for each protein avoided
potential changes in the expression and turnover of tagged proteins. Benjamin et al. also
prepared a calibration standard for each measured protein by using His6-tagged recombinant
protein purified from E. coli and spiking it into protein extracts prepared from yeast deletion
mutants lacking each protein of interest. This protein-specific calibration standard accounted
for protein-to-protein differences in solubilization during protein extraction and efficiency in
protein transfer to the blotting membrane. Thus, where the protein measurements in the
Benjamin dataset disagree with those in the Ghaemmaghami dataset, I am inclined to favor
the Benjamin data.
The intracellular concentrations of mating pathway proteins were also recently
measured by Maeder et al. [94] and Slaughter et al. [99] via fluorescence correlation
spectroscopy (FCS). FCS requires that the proteins of interest be fused to a fluorescent
protein, potentially altering the expression, processing, localization or turnover of these
proteins. For example, Maeder et al. noted that all protein fusion strains exhibited a slightly
decreased mating response [94], which is indicative of either altered protein concentrations
or activities. Nevertheless, because the measurements were made in vivo, the FCS data are
not affected by the same sources of error that can affect western blot measurements (e.g.,
protein loss during extraction and handling). Thus, the Maeder and Slaughter datasets
provide a good complement to the Ghaemmaghami and Benjamin datasets.
Abundances used in models
Most modeling studies of the yeast mating pathway report the concentrations, not
abundances, of the proteins that make up the signaling system. Thus, I use the stated cell
volume from each modeling study in order to convert the reported model concentrations into
cellular abundances. The absolute abundance used in past modeling studies can then be
directly compared to the reported experimental abundances.
For two prior modeling studies, my conversion of modeled protein abundances to
absolute protein abundances warrants discussion. First, Kofahl and Klipp reported the
concentrations for proteins used in their model of the mating pathway, but did not explicitly
state what cell volume was used to convert protein abundances given in their cited references
to these concentrations [2]. Based on the values presented, I surmise that the accessible
cytosolic volume used in their model was between 55 fL and 83 fL (for comparison, I assume
an accessible cytosolic volume of 29 fL- see Section 3.6.1). Second, Shao et al. assumed
that all cytoplasmic proteins are localized to a 13 fL volume in the shmoo tip [100].
Although localization of Ste2 [101, 102], Gpal [103], Ste4-Stel8 [104], Ste20 [105], Ste5
[94, 106-111], and Ste7 [107] to the site of polarized growth has been detected more than one
hour after pheromone treatment, is it not clear how rapidly these proteins relocate upon
pathway activation. Relocalization of these proteins to the mating projection is, in most
cases, moderated by interactions among other proteins that are themselves localized to the
shmoo tip (see Section 3.6.4). Thus, unbound proteins should be freely-diffusing and able to
explore the entire cytosol, while bound proteins may be restricted to the mating projection.
Additionally, Stel and Fus3, although located within the mating projection, are also found
throughout the cytosol during mating response [94, 107]. Therefore, the assumption of
mating projection localization does not necessarily hold during the first hour of mating
response for most cytosolic mating proteins, and does not hold at all for Fus3 and Ste 11.
However, despite my criticisms of the Shao model, I do not consider the effect of localization
of protein complexes to the mating projection at all in the Mating Model (see Section 3.6.4).
Shao et al. also implicitly assume a nuclear volume of 13 fL, which is much larger than the
measured nuclear volume of 2.9 fL (see Section 3.6.1).
3.2 G Protein Coupled Receptor
3.2.1 Signal Propagation
3.2.1.a Pheromone Binding to G Protein Coupled Receptor (Ste2)
Summary
Mating pathway signaling is initiated through the binding of a mating pheromone
peptide (ca-factor) to a G protein coupled receptor (GPCR). I focus on MA Ta cells, where the
a-factor pheromone secreted by MA Ta cells binds to the GPCR Ste2 (see Section 3.1.1).
Although the affinity of some GPCRs for their ligand is affected by the state of the associated
G protein, in the yeast mating pathway the state of the G protein appears to have only a
modest effect on the affinity of Ste2 for a-factor under physiological conditions.
Experiments and evidence
a-factor binds to Ste2
Pheromone binds specifically to Ste2, and to no other site on the yeast cell surface
[25]. Pheromone binding to intact cells has been measured by several different research
groups, with good agreement in the observed affinity [23-26, 48, 112-118]. These
experiments were performed either in strains lacking the BAR I gene that encodes an a-factor
specific protease, or in the presence ofp-tosyl-L-arginine methyl ester (TAME), which
inhibits Barl and prevent a-factor degradation [61]. Cells were also treated with potassium
fluoride (KF) and sodium azide (NaN3). Sodium azide interrupts energy-dependent cellular
processes, including receptor endocytosis, ensuring that internalization of receptor-bound
pheromone does not affect measurement of pheromone-receptor binding. Fluoride from KF
complexes with trace aluminum in the media and Ga-bound GDP to produce Ga-GDP-A1F 4
[119]. GDP-AlF4 mimics the transition state for GTP hydrolysis [120], thus the Gc Gpal
presumably adopts an active conformation and dissociates from Ste2 [121].
Pheromone-receptor binding is largely unaffected by G protein state
It has been shown for some GPCRs that the affinity of the receptor for the ligand
depends on the state of the corresponding G protein, presumably because the GPCR
conformation changes upon the GPCR binding to the GDP-bound GOuJy complex. For
example, ligand binding experiments carried out on membrane preparations have shown that
the affinity of the muscarinic acetylcholine receptor for one agonist ([3H]-oxotremorine-M) is
reduced in the presence of saturating amounts of GTP [122]. Thus, the agonist preferentially
binds receptors that are coupled to inactive GDP-bound G proteins. In the same set of
experiments, the receptor binds another agonist (L-[benzilic-4,4'-3H]quinuclidinyl benzilate)
with the same affinity regardless of the presence of GTP [ 122], demonstrating that the effect
of G protein state on the interaction between the GPCR and agonist is not universal.
Two different routes have been taken to investigate whether the state of the
heterotrimeric G protein (comprised of the Ga Gpal, the G3 Ste4, and the Gy Ste 18) affects
the affinity of Ste2 for a-factor. Several groups have studied the binding of a-factor to Ste2
in membrane preparations, while others have examined the effect of deleting Gpal on the
binding of a-factor to Ste2 on intact cells. Although it is generally assumed that the Ga and
the GPy subunits dissociate from each other and from Ste2 upon binding of Ga to GTP (and
consequent G protein activation), this has not been shown definitively (see Section 3.2.1.c)
[123]. Using partially purified membrane preparations from yeast cells, it was found that
Ste2 binds to a-factor with low affinity (Kd 2 150 nM) in the presence of GTP[y-S] (which
presumably locks the G protein in an activated state that does not bind Ste2), and binds with
high affinity (Kd = 17 nM) in the absence of GTP[y-S] [124]. However, the effect of GTP[y-
S] on the binding affinity is contingent on conditions of relatively high ionic strength and pH
8.0. When the membrane fractions are resuspended at low ionic strength and pH 6.0, more
similar to typical media conditions, Ste2 binds to a-factor with high affinity regardless of the
presence of GTP[y-S] [124]. Related experiments have shown that Ste2 has high affinity (Kd
- 14 nM) for a-factor in membrane preparations containing the G protein and low affinity
(Kd = 155 nM) when purified away from the G protein [112], and that a-factor dissociates
much more rapidly (> 5-fold) from Ste2 in membrane preparations in the presence of GTP[y-
S] [48]. These in vitro experiments suggest that activation of the G protein and subsequent
dissociation of the G protein from Ste2 can result in the receptor changing from a high
affinity state to a low affinity state under some reaction conditions.
In vivo assays paint a different picture. Deletion of Gpal (in combination with
deletion of the G3 Ste4 or the cell cycle inhibitor Farl to prevent lethality; see Section 3.5. 1)
results in only moderate decreases in the affinity between a-factor and Ste2: 3.5 nM in
wild-type cells and 4.8 nM in gpalAfarlA cells [117], or 4.2 nM in wild-type cells and 9.1
nM in gpalA ste4A cells [24]. These in vivo experiments suggest that, in the intact cell, the
effect of the G protein on the affinity of receptor for pheromone is small.
Distilling evidence into elementary chemical reactions
Although the in vitro experiments hold some advantages over the in vivo experiments,
the in vivo experiments may be a better model for the effect of the G protein on receptor-
pheromone interactions. The in vitro assays (using membrane preparations) isolate the
receptor and G protein from other interactions with soluble proteins, perhaps giving a better
indication of the precise effect of G protein state on the affinity of Ste2 for a-factor in the
absence of other factors. However, the membrane preparations may lack important cellular
proteins that normally interact with either the receptor or the G protein in vivo. In vivo
binding experiments in GPAI+ cells are conducted in the presence of KF, which is thought to
cause activation and dissociation of the G protein. These experiments give a mean affinity of
5.2 nM (see below), which is much less than the -150 nM measured using membrane
fractions in the presence of GTP or GTP[y-S], which also presumably promote activation and
dissociation of the G protein. Thus, the membrane preparations may be lacking factors
present in the intact cells that help determine the relevant in vivo effect of the G protein on
the pheromone-receptor affinity.
Based on the premise that the Gpal deletion experiments are better representations of
the effect of the G protein on pheromone binding, it appears that the binding of inactive G
protein to Ste2 causes an approximately 2-fold increase in pheromone-Ste2 affinity. Since
this is a minor difference in affinity (and it is not entirely clear if the changes in affinity
observed upon deletion of Gpal are statistically significant) I make the provisional
assumption for modeling purposes that there is no change in affinity of the receptor for
pheromone upon activation of the G protein.
Thus, the Mating Model includes pheromone binding to the receptor with the same
affinity regardless of the whether or not the receptor is G protein-associated. Additionally, in
the absence of evidence to the contrary, I assume that no other intracellular interactions of
Ste2 with other proteins and no covalent modifications (e.g., glycosylation, phosphorylation,
ubiquitination) of the receptor alter the affinity interaction between Ste2 and pheromone.
There is an additional complication with modeling the pheromone-Ste2 interaction:
pheromone exists is in the extracellular volume which, on a per cell basis, is much greater
than the intracellular volume. Thus, even given saturating amounts of pheromone such that
all Ste2 molecules become pheromone-bound, the extracellular pheromone concentration will
not be significantly depleted. Because I am not explicitly considering different compartment
in the Mating Model (e.g., intracellular and extracellular volumes; see Section 3.6.4), I must
balance the association and dissociation reactions such that the concentration of extracellular
pheromone is unchanged. I ensure that the extracellular concentration of pheromone in the
Mating Model does not change by adding a pheromone molecule to the products during
association, and removing a pheromone molecule from the products during dissociation.
Numbers from experiments and models
The measured values for the binding affinity between a-factor and Ste2 are fairly
consistent, with a mean affinity of 5.4 nM (at 220 C) and a standard deviation of 2.5 nM
across nine measurements [23-26, 48, 112, 113, 118]. The low standard deviation reflects
good agreement across most measured values. Affinities of 0.8 nM [114] and 22 nM [115]
were omitted as outliers, although there are no specific reasons to believe these values are
suspect.
The association and dissociation rate constants have been individually measured in
some cases. For example, Jenness et al. measured a dissociation rate constant of 9x 104 S-1 at
22 0 C [116]. A similar value of 1.1 x10-3 s-1 was measured for a fluorescent pheromone
analog at 00 C [117]. This same analog has an association rate of 1.6x 105 M-'s-1 at O'C.
Interestingly, this gives an affinity of 6.9 nM, which is close to the affinity of pheromone
binding to Ste2 at 220C. Thus, the binding kinetics may be largely temperature insensitive,
or this pheromone analog binds differently than does wild-type a-factor yet coincidentally
has the same binding kinetics at 00 C as does WT a-factor at 220C.
In a previous modeling study, Yi et al. used an association rate constant of 2 x 106 M
1s-I and dissociation rate constant of I x 10-2 S-1 [45]. The resulting affinity is 5 nM, in good
agreement with measured values. However, it is important to note that Yi et al. used a
dissociation rate constant that is 10-fold higher than the measured values, thus making the
association rate constant also 10-fold higher than expected. Since Yi et al. compared
modeling results to downstream experimental results (G protein activation and gene
expression), it is possible that the 10-fold increases in association and dissociation rates were
chosen to facilitate a fit between their models and experimental data. The values from Yi et
al. were later cited by Yildirim et al., although they used an association rate that was -2000-
fold slower, resulting in an affinity that is -2000-fold weaker than measured values [22].
Perhaps Yildirim et al. used a weak affinity to compensate for ongoing pheromone
degradation in their experiments that was not directly captured in their model.
A model from Kofahl and Klipp used an association rate constant of 2x 10
4 M-1 -
(100-fold slower than the rate used by Yi et al. and 10-fold slower than the measured rate)
and a dissociation rate constant of 1 x10 -2 S-1, and cited Yi et al. for these values [2]. The Ste2
abundance in the Kofahl and Klipp model was 10-fold higher than the measured abundance
(see Section 3.2.3.a), perhaps in compensation for the decreased association rate.
Computational and graphical representations
Figure 3-7 Dissociation of pheromone and Ste2.
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Figure 3-6 Association of pheromone and Ste2.
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3.2.1.b Heterotrimeric G Protein Subunit (Gpal, Ste4, and Stel8) Interactions
Summary
Both Gpal and Stel8 are permanently associated with the plasma membrane via
various post-translational modifications. Ste4 interacts constitutively with Stel 18, and is thus
also localized to the plasma membrane.
Experiments and evidence
Gpal is primarily plasma membrane associated
Gpal is primarily associated with the plasma membrane [125-127]. Gpal is
myristoylated [128-130] and palmitoylated [126, 131]. Elimination of myristoylation
prevents palmitoylation and plasma membrane association, but not association with GPy
[126]. Elimination of palmitoylation results in localization to internal membranes instead of
to the plasma membrane, and an increased basal and pheromone-induced pathway activity
[127].
Ste4 and Stel8 are permanently associated and membrane-bound
Ste 18 is farnesylated and palmitoylated, and loss of either modification eliminates
membrane localization [132] and mating response [131-134]. Membrane targeting of
unmodified Stel8, via fusion with a transmembrane domain, restores mating [111],
suggesting that the primary purpose of these modifications is membrane localization.
Ste4 and Ste 18 are thought to exist exclusively as Ste4-Ste 18 heterodimers. Ste4 is
associated with the plasma membrane in wild-type cells [126], but disruption of Stel8 results
in relocalization of Ste4 to the cytoplasm [135]. Additionally, deletion of either Ste4 or
Stel8 greatly destabilizes the product of the other [135]. Thus, Stel8 and Ste4 likely form a
stable complex, and Stel 18 localizes Ste4 to the plasma membrane.
Table 3-1 Parameter constraints for interaction of pheromone and Ste2.
Kd_Pheromone Ste2 5.4 x 10-9 M
koff PheromoneSte2 10-3 s'
konPheromone Ste2 = kof Pheromone_Ste2 + Kd Pheromone Ste2 . 1.9 10s M-' s-
Distilling evidence into elementary chemical reactions
For simplicity, I treat Ste4 and Stel8 as a non-dissociable complex that is always
localized to the plasma membrane. Previous modeling efforts have also treated Gby as a
non-dissociable complex [2, 45, 82, 100, 136]. I assume that the fractions of Gpal and Ste4-
Stel 8 that are not at the plasma membrane are inactive, and can thus be ignored for signaling
(see Section 3.2.3.b for more details). The interactions between the Ga Gpal and the G3y
Ste4-Stel 8 are covered in the following section.
3.2.1.c G Protein Coupling to Receptor
Summary
In the absence of pheromone, Gpal (Ga) assumes a GDP-bound state, and thus
associates with both the GPCR Ste2, and Ste4-Stel 8 (Gpy). In the presence of pheromone,
Ste2 facilitates the exchange of GDP for GTP on Gpal (see Section 3.2.1.d). GTP-bound
Gpal rapidly dissociates from Ste2 and Ste4-Stel8. Ste2 and Ste4 appear to bind
cooperatively to Gpal. Gpal-GTP has a decreased affinity for Ste4, and given the
cooperative binding of Ste4 and Ste2 to Gpal, dissociation of Ste4-Stel8 from Gpal may be
sufficient to result in dissociation of Ste2 from Gpal.
Experiments and evidence
Gpal-GDP and Gpal-GTP bind Ste4-Stel8 with different affinities
Gpal interacts with Ste4 via two-hybrid, but not with Stel 8 [137]. Crystal structures
of Ga proteins show how the addition of GTP reorganizes the structure of Ga proteins to
decrease their affinity for Gpy subunits [138-140]. Dissociation of activated G proteins has
been shown in vitro [121, 141, 142], and in vivo [143] for some Ga-Gpy pairs. As further
confirmation of G protein dissociation, a FRET (Fluorescence Resonance Energy Transfer)
reporter between CFP-Gpal and Ste 18-YFP decreases in FRET efficiency upon pheromone
treatment [45].
Despite the evidence that Gpal dissociates from Ste4-Stel8 upon activation, there
remains a possibility that the G protein undergoes a conformational shift rather than
dissociation. A FRET pair between rat Gail-YFP and human G 1I increases in FRET
efficiency upon exposure to agonist [144], and constitutive activation of human Gas and Gai3
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does not decrease their association with GPfIy 2 [143]. Also, a fusion between Gpal and Ste4
restored mating ability to a gpalA ste4A strain [123], although it is unclear if the peptide
linker between Gpal and Ste4 was sufficiently long to allow enough separation to mimic
dissociation.
Gpal binds Ste2
Mutational analysis suggests that Ga subunits bind directly to their cognate receptors
[145]. Mutational studies of Gpal [ 146] and homology modeling using rhodopsin and
tranducin crystal structures [147] suggest that Gpal also binds directly to its receptor Ste2,
although to my knowledge, direct binding of Gpal to Ste2 (in the absence of Ste4-Ste 18) has
not been shown. Less Gpal co-precipitates with Ste2 in the presence of a-factor than does in
the absence of a-factor [148], demonstrating that Gpal dissociates from Ste2 in the presence
of pheromone.
G protein association with Ste2 is coupled to Gpal Ste4-Stel8 association
In Section 3.2.1.a I outlined membrane preparation experiments in which, given the
presence of GTP[y-S], Ste2 has a decreased affinity for pheromone. In these same
experiments, the absence of functional Gpal or Ste4 results in the same decreased affinity for
pheromone [124]. The fact that the absence of Gpal or Ste4 has the same effect as treatment
with GTP[y-S] suggests that both the Ga and the Gpy subunits are required for efficient
coupling of the G protein to Ste2.
Distilling evidence into elementary chemical reactions
Enough evidence exists to specify a reasonable mechanistic model for G protein
assembly and coupling to Ste2. Although there may not be direct evidence that Gpal
dissociates from Ste4 upon activation (exchange of GDP for GTP), dissociation seems most
likely as it fits with the canonical GPCR model [120]. Evidence also suggests that Gpal
dissociates from Ste2 upon activation. The interaction between the G protein and Ste2 is
likely mediated by Gpal, as no evidence exists suggesting that Ste4-Stel 18 can interact with
Ste2 in the absence of Gpal. Thus, the suspected defect in G protein association with Ste2 in
the absence of Ste4 (from the membrane preparation experiments) suggests that Gpal only
binds Ste2 with high affinity when Gpal is bound to Ste4-Stel 8. Assuming that Ste4 and
Ste2 bind cooperatively to Gpal (i.e. the requirement of Ste4 for efficient association
between Gpal and Ste2 necessarily implies that Ste2 also strengthens the interaction between
Ste4 and Gpal), a reasonable model for the interactions between Ste2, Gpal and Ste4 is as
follows. Active Gpal has a decreased affinity for Ste4. Upon dissociation from Ste4, Gpal
then has a reduced affinity for Ste2 and rapidly dissociates from Ste2 as well. It is also
possible that activation of Gpal directly results in Gpal having a reduced affinity for both
Ste2 and Ste4, although I currently ignore this possibility.
Several additional assumptions must be made to unambiguously specify the
interactions between Ste2, Gpal and Ste4-Stel 8. I assume that Sst2 does not affect the
affinity or kinetics of the interactions of Gpal with Ste2 and Ste4 (this is discussed further in
Section 3.2.1 .e). Also note that the assumption made in Section 3.2.1.a that G protein
coupling to Ste2 does not affect the affinity of Ste2 for pheromone is equivalent to assuming
that pheromone binding to Ste2 does not affect the interaction between Ste2 and the G
protein. Additionally, I assume that phosphorylation of Ste2 by Yckl or Yck2 (see Section
3.2.2.b), phosphorylation of Ste2 by any other proteins, and phosphorylation of Ste4 in
response to pheromone (see Section 3.2.1.g) does not affect any of the binding affinities or
rates. Because Ste20 and Ste5 interact with Ste4-Stel8 in a pheromone-dependent manner
(see Sections 3.3.1.a and 3.3.1 .b), I assume that Gpal only interacts with Ste4-Stel 18 dimers
that are not bound to either Ste20 or Ste5.
Ste2 also forms dimers [149], and Ste2 proteins within a Ste2 dimer may cooperate to
activate Gpal [46]. Here, I assume that each Ste2 interacts with and activates its own G
protein. Section 3.2.1.f details Ste2 dimerization and also a discussion on why I have chosen
not to include this event in the Mating Model.
Numbers from experiments and models
The affinity and binding kinetics of G protein association with Ste2 are unknown.
The affinity and kinetics of inactive or active Gpal association with Ste4 have also not been
measured experimentally. In a model, Yi et al. [45] used a rate constant of 1 molec-' s' for
association between inactive Gpal and Ste4, although it is unclear how this rate was derived.
The Yi et al. rate has since been referenced in two subsequent computational models:
Yildirim et al. used a value of 5.8 x 10-4 molec' s-1 and referenced this to Yi et al., but did
not explain the -2000-fold difference in the values [22]; Kofahl and Klipp used a value of
3.3 x 1010 M' s-1 and referenced to Yi et al. [2] - this rate is likely too high for a bulk
solution reaction as it is near the upper limit of possible reaction rates given diffusion
constraints [150, 151].
Computational and graphical representations
Figure 3-8 Interaction of Ste2 and Gpal.
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Table 3-2 Parameter constraints for interaction of Ste2, Gpal and Ste4-Stel8.
Kd_Gpal GDP_Ste4Stel8 < Kd_Gpal GTP_Ste4Ste 8
Kd_Ste2Gpal GDP_Ste4Stel8 < Kd_Gpal GDP Ste4Stel 8
Kd_Ste2Gpal GDP_Ste4Stel8 < Kd_Ste2Gpal GTP_Ste4Stel 8
Kd_Ste2Gpal GTP_Ste4Stel8 < Kd_Gpal GTP_Ste4Stel 8
See below for further constraints.
It is important to note that because of the nature of the interactions between Ste2,
Gpal and Ste4-Stel8 (i.e., there is more than one path from one state to another state; Figure
3-10), there are constraints on the binding rates [152]. These constraints are known as
"detailed balance", "microscopic reversibility", or "Wegscheider's condition". For example,
the cycle involving GDP-bound Gpal, Ste2 and Ste4-Stel8 is shown in Figure 3-10. There
is an analogous cycle for GTP-bound Gpal, Ste2 and Ste4-Stel 8.
Gpal
Kd_Gpal GDP_Ste4Ste 18
Kd_Gpal GTP_Ste4Stel8
Kd_Ste2Gpal GDP_Ste4Stel8
'2Gpa1 GTP_Ste4Ste18KdSte
Figure 3-9 Interaction of Gpal and Ste4-Stel8.
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For the case shown in Figure 3-10, detailed balance requires that K1 x K3 = K2 x K4.
This merely imposes the restriction that the factor by which Ste4-Ste 18 alters the affinity of
Gpal for Ste2 is the same as the factor by which Ste2 alters the affinity of Gpal for Ste4-
Stel8. If I assume that this factor is the same for GDP- and GTP-bound Gpal, I can define it
as: Ste2_Gpal_Ste4Stel 8_coop_factor = Kd_Gpal GDP_Ste4Stel 8 + Kd_Ste2Gpal GDP_Ste4Stel8 =
Kd_Gpal GTP_Ste4Stel8 + Kd_Ste2Gpal GTP Ste4Stel8. I can further define another factor,
Gpal_GTP_modulating_factor = Kd_Gpal GTP_Ste4Stel8 + Kd_Gpal GDP_Ste4Stel8, the factor by which
GTP alters the affinity between Gpal and Ste4-Stel 18. Based on the detailed balance and the
assumption that Ste2_Gpal_Ste4St4St8_coopactor applies to both GDP- and GTP-bound Gpal,
then the factor by which GTP alters the affinity between Gpal and Ste4 is not affected by
Ste2.
3.2.1.d G Protein Activation
Summary
In the absence of other factors, dissociation of GDP from Gpal occurs slowly.
Pheromone-bound Ste2 acts as a guanine nucleotide exchange factor (GEF) for Gpal,
causing Gpal to release GDP much more rapidly. A GTP molecule is then able to bind to
Gpal completing the nucleotide exchange process and rendering Gpal into an active
conformation. The GDP dissociation is rate limiting in both innate and GEF-mediated
nucleotide exchange and is unaffected by the presence of the RGS protein Sst2. Studies
using mammalian heterotrimeric G proteins suggest that association of Ga with G3 may not
significantly alter the rate of nucleotide exchange.
Experiments and evidence
Pheromone-bound receptor accelerates Gpal nucleotide exchange
Rates of nucleotide exchange (both in the absence and presence of GEFs) have been
measured for many Gca proteins and clearly demonstrate that GEFs accelerate the rate of
GDP dissociation from Ga (see below). Using purified Gpal and the RGS (regulator of G
protein signaling) protein Sst2, it has been shown that the presence of the Sst2 does not affect
either the rate of GDP release nor the rate of subsequent GTP binding, at least in the absence
of Ste2 and GPy [153]. The presence of GTPase accelerating RGS proteins (see Section
3.2.1.e) has no effect on nucleotide dissociation rates for other Ga proteins as well [154].
Table 3-3 Additional parameter constraints for interaction of Ste2, Gpal and Ste4-Stel8.
Ste•Gpal•_Ste4SteI8_coop_factor > 1
GTPjmodulatinqgfactor > I
Kd Ste2 GpaISt.4Stea = KdcSte2_Gpal + Ste2_GpalSte4Stel8scoop factor
Kd Ste2GpalGDP Ste4Ste18 = Kd_GpaiGDPSte4Stei8 + Ste2_Gpal Ste4Stel8_coopjfactor
KdGpal GTP Ste4Stel8 = GTPjmodulatingjactor x KdJGpal GDP Ste4Stel8
KdSte2Gpal GTPSte4Stel8 = GTP.modulatingJactor x KdGpal GDP Ste4Stel8 +
Ste2_Gpa1__Ste4Stei 8toopJactor
GDP dissociation is the rate limiting step in nucleotide exchange
Mukhopadhyay and Ross, using a recombinant rat Ga protein, measured the
dissociation rate of GDP from Ga and estimated the association rate constant of GTP binding
Ga [154]. They determined that GTP association would only be rate limiting at
concentrations of GTP less than 15 pM, which is well below the physiological concentration
of GTP [155]. Using four different recombinant rat Ga proteins, Linder et al. determined
that the rate of nucleotide exchange (dissociation of GDP followed by association of GTPyS)
and the overall rate of GTP hydrolysis were approximately equal to the rate of GDP
dissociation, even at sub-physiological concentrations of GTP, indicating that GDP
dissociation was rate-limiting [156]. Also using recombinant rat proteins, GDP dissociation
was found to be rate-limiting in cycles of GDP binding and release in the presence of
agonist-bound receptor [157], again suggesting that GDP dissociation from Gpal is rate
limiting in exchange of GDP for GTP.
Gfly may not affect the nucleotide exchange rate
As described in Section 3.2. 1.c, Goy has a higher affinity for GDP-bound Gpal than
for GTP-bound Gpal, suggesting that GPy may alter the affinity of Gpal for GDP. The
effect of Goy on the affinity of Gpal for GDP has been measured directly with a two rabbit
G proteins, Go and Gs [158, 159]. In addition to decreasing the dissociation rate of GDP
from the Ga [159], the presence of Gpy also causes an increase in the association rate of
GDP with Ga [158]. However, at physiological concentrations of Mg2+, G3y may mainly
affect the association rate between GDP and Ga while having little effect on the dissociation
rate (see below).
Distilling evidence into elementary chemical reactions
It is clear that pheromone-bound Ste2 increases the dissociation rate of GDP from
Gpal. Since GDP dissociation is rate-limiting in nucleotide exchange, I assume that GTP
association follows immediately after GDP dissociation. Because the cellular concentration
of GTP is much higher than that of GDP [155], I ignore rebinding of free GDP to Gpal. I
assume that at physiological levels of Mg2+, the effect of Giy on nucleotide exchange is
minimal and can be ignored. Although nucleotide binding and dissociation was only shown
to be independent of Sst2 in the absence of Gpy and Ste2, I assume that the rate of GDP
dissociation is unaffected by Sst2 under all circumstances.
Numbers from experiments and models
Innate GDP dissociation
In the absence of Gpy, the overall rate of Gpal-mediated GTP hydrolysis at 300 C
(including nucleotide hydrolysis, GDP dissociation, and association of a new GTP molecule)
is 0.037 min-1 (6.17 x 104 s-1), and this rate is unaffected by the presence of Sst2 [153].
Since GDP dissociation is rate limiting, this rate represents the dissociation rate of GDP from
Gpal. This rate measurement fits well with the rates measured for GDP-dissociation from
various rat olfactory Ga proteins, which range from 0.025 min-' to 0.19 min-' [156].
GDP dissociation in the presence of G/37
Although the effect of Gpy on GDP dissociation has not been measured for Gpal, it
has been investigated for other G proteins. The dissociation of GDP from two rabbit Ga
proteins (Gsa and Goa) is slowed 3-5 fold by the presence of the corresponding Gpy
subunits in vitro [158, 159]. The effect of G3y decreases with increasing Mg 2+
concentration. Yeast cells in standard SD or YPD media or contain about 15 to 50 mM
Mg 2+, assuming homogeneous distribution throughout the cytoplasm, nucleus and various
organelles [92, 160]. Interestingly, at Mg 2+ concentration in excess of 1 mM, the dissociation
rate of GDP from Goa is 2-fold higher in the presence of the Gpy than it is in the absence of
the Gpy [158]. This experiment suggests that at physiological concentrations of Mg2+, the
Gpy subunit has only a small effect on the dissociation rate of GDP from Gpal.
The dissociation of GDP from purified Ga is biphasic [158], with about 50-67% of
the G proteins corresponding to the slower rate [154, 159, 161]. The faster dissociation
occurs about 5-10-fold more rapidly than the slow GDP dissociation. The slower rate is
thought to result from a combination of a sub-stoichiometric number of receptors and
improperly reconstituted G proteins that are not receptor-accessible (E. Ross, personal
communication).
GDP dissociation in the presence of both GEF and GPy
The effect of pheromone-bound receptor on the GDP dissociation rate has not been
measured quantitatively. As a representative rate, in the presence of a ligand-bound receptor
GDP dissociates from the rat Gq at a rate of 1.5 s-1 [154]. Since this measurement was done
in the presence of 2 mM Mg2+, I assume that the presence of the GPy had little effect on the
rate of GDP dissociation. Assuming that pheromone-bound Ste2 increases the Gpal-GDP
dissociation rate to 1.5 s-1 , this represents a -2500-fold increase in the rate of nucleotide
exchange over the innate rate (6.17 x 10-4 s-1', see above).
Numbers from models
In a computational model of the receptor-G protein portion of the pheromone
response pathway, Hao et al. used a bulk rate of G protein activation of 5.25 x 10-5 min 1
(8.75 x 10-7 s') in the absence of pheromone [82]. Assuming that GDP dissociation is much
slower than either GTP binding or dissociation of Gpal from G3y, this rate represents the
GDP dissociation rate. Given the measured value of GDP dissociation from Gpal in the
absence of Ste4-Stel 8 (6.17 x 10-4 s1), this would represent a decrease in dissociation of
GDP by 700-fold due to the presence of GPy. In contrast, the presence of Goy has a 0.5-5
fold effect on the dissociation of GDP from rat Gsa and Goc (depending on the Mg2+
concentration) [158, 159]. Hao et al. also did not provide a reference for their rate, likely
because it is a result of manual or automated parameter tweaking to achieve a better
agreement between the model and their experimental data.
Rates of G protein activation in the presence of pheromone-bound receptor have also
been published in computational modeling papers. These rate correspond to a second-order
reaction where pheromone-bound Ste2 (appearing in the reaction as a catalyst) only
transiently interacts with the G protein to cause nucleotide exchange and G protein
dissociation. Thus, the rates are a combination of the rate of receptor association with the G
protein, dissociation of GDP, binding of GTP, and subsequent dissociation of Gpal from
both Ste2 and Ste4-Stel 8. If I assume that the GDP dissociation rate is rate limiting out of
all of these steps, I can estimate a lower limit on the rate of GDP dissociation used in these
modeling studies.
Yi et al. used a pheromone-induced G protein activation rate constant of 0.1 molec l' s-
[45]. Since they assume 10,000 molecules of Ste2 per cell, saturating amounts of
pheromone would result in a G protein activation rate of 103 -1, such that the entire
population of G proteins would be activated on a timescale of milliseconds. This rate of
activation is nearly 1,000-fold more rapid than the GEF-mediated GDP dissociation observed
for rat Gq [154]. Also, given the measured rate of GDP dissociation in the absence of
pheromone (6.17 x 10 4 s-1), the rate used by Yi et al. represents a GEF-mediated increase in
GDP dissociation of over 1,600,000-fold. It is not clear whether a GEF-mediated 1,600,000-
fold increase in GDP dissociation rate is physiologically realistic.
Kofahl & Klipp used a pheromone-induced G protein activation rate constant of 6 x
104 M-1 s-1, and reference this number to Yi et al. [2]. The authors assume a receptor
concentration of 1666.67 nM, so that saturating amounts of pheromone would result in a first
order G protein activation rate of 0.1 s-d (this rate is much different than the 0.1 molec-' s-1
used by Yi et al., which approximately corresponds to a first order rate constant of 103 S-1).
Again assuming that GDP dissociation is rate limiting, this would represent the rate of GEF-
mediated GDP dissociation. If receptor association with the G protein were limiting, then all
I could say is that the rate of GEF-mediated GDP exchange must be faster than 0.1 s-1. Thus,
although this number is apparently derived from the rate used by Yi et al., it is in much better
agreement with what I might expect given the rate measured for rat Gq (1.5 s').
Hao et al. used a G protein activation rate constant as a function of the fraction of
Ste2 molecules that are bound to pheromone [82]. For saturating amounts of pheromone, the
rate of G protein activation is 1.75 minl', or -0.03 s-1. This rate is appreciably slower than
the measured value for rat Gq, but is similar to the value used by Kofahl and Klipp. Again, if
Ste2 association with the G protein is limiting, this suggests that (according to their model),
the rate of GEF-mediated GDP dissociation is faster than 0.03 s-1.
Computational and graphical representations
3.2.1.e G Protein Deactivation
Summary
Gpal is able to hydrolyze bound GTP into GDP and inorganic phosphate. Sst2, a
GTPase accelerating factor (GAP) and regulator of G protein signaling (RGS) protein binds
Gpal, resulting in rapid GTP hydrolysis. Although Sst2 can interact directly with Gpal, an
interaction between Sst2 and Ste2 is required for efficient membrane localization of Sst2 and
for Sst2-accelerated nucleotide hydrolysis in vivo. The interaction between Sst2 and Ste2 is
eliminated by Yckl and Yck2 phosphorylation of the C terminal tail of Ste2. Finally,
evidence suggests that other than accelerating GTP hydrolysis on Gpal, Sst2 does not
otherwise affect nucleotide exchange and association of Gpal with Ste4-Stel 8.
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Figure 3-11 Gpal exchange of GDP for GTP.
Table 3-4 Parameter constraints for Gpal exchange of GDP for GTP.
kcat_GpalGDP_GTP = 6.2 x 10 s"1
kcat_PheromoneSte2Gpal GDP_GTP - 1.5 S1
Experiments and evidence
Sst2 accelerates Gpal nucleotide hydrolysis
Purified recombinant proteins were used to show that Sst2 increases Gpal-catalyzed
GTP hydrolysis in vitro [153]. RGS proteins have similarly been shown to accelerate GTP
hydrolysis for other heterotrimeric G proteins [154, 157]. As has been shown for other RGS-
G protein pairs [162], binding between Sst2 and Gpal is similar in the presence of GDP and
GTPyS, and is increased in the presence of GDP-A1F4- [153]. Since Gpal-GDP-A1F 4
mimics the transition state of Gpal during GTP hydrolysis [120], it appears that Sst2
accelerates nucleotide hydrolysis by stabilizing the transition state of Gpal.
The interaction between Sst2 and Ste2 is required for Sst2 activity
In addition to interacting with Gpal, Sst2 also binds Ste2. A variety of genetic and
biochemical experiments demonstrate that Sst2 binds directly to the C terminal tail of Ste2
(residues 297-431) via the two DEP domains on Sst2 (residues 27-145 and 250-362) [163].
Mutation of these DEP domains results in a phenotype similar to the deletion of Sst2,.
although it is unclear if these mutants retain their ability to interact directly with Gpal.
Deletion of Ste2 eliminates localization of Sst2-GFP to the membrane, demonstrating that
Sst2 interacts more weakly with Gpal than with Ste2 and that the interaction with Gpal is
insufficient for proper membrane localization of Sst2 [163]. Coupling of the N-terminal 419
residues of Sst2 (which contains the DEP domains) to the RGS domain from another RGS
protein (Rgs2) greatly mitigates the increased pheromone sensitivity caused by deletion of
Sst2, demonstrating that the DEP domains, not the RGS domain, are likely responsible for
the specificity of Sst2 [163].
The interaction between Sst2 and Ste2 is eliminated by Yck-dependent Ste2 phosphorylation
Sst2-GFP colocalizes with the endocytosis deficient Ste2(7K-to-R)-mCherry only at
the shmoo tip, but colocalizes with Ste2(7K-to-R)-mCherry all around the cell periphery in
cells lacking Yckl and Yck2 [163]. Since newly synthesized Ste2 is primarily directed to the
shmoo tip [164, 165], these experiments suggest that Sst2 does not interact with older Ste2
molecules that have been on the cell surface for a sufficiently long time to be phosphorylated
by Yckl or Yck2 (see Section 3.2.2.b) and diffuse away from the shmoo tip. Mutation of the
19 serine and threonine residues on the C terminal tail of Ste2 results in colocalization of
Ste2 and Sst2 around the entire cell periphery even in the presence of Yckl and Yck2 [163].
By not interacting with phosphorylated Ste2, Sst2 likely avoids being endocytosed along
with Ste2 (see Section 3.2.2.b).
Sst2 does not affect G protein dynamics beyond accelerating GTP hydrolysis
Gpal bind to different regions on Ste2, Gpal and Ste2 bind to different regions on
Sst2, and Sst2 and Ste2 bind to different regions on Gpal, suggesting that all three proteins
can bind each other simultaneously, perhaps cooperatively [163]. The weak affinity of Sst2
for Gpal is largely unchanged by the presence of GDP or GTP [166], indicating that Sst2
may not have a significant effect on association of GDP- or GTP-bound Gpal with Sst2-
bound Ste2. Additionally, overexpression of Sst2 inhibits mating [167], demonstrating that
Sst2 does not interfere with the interaction between Gpal and Ste4-Stel8.
Distilling evidence into elementary chemical reactions
In order to determine a mechanism of action, I need to resolve the relative importance
of the Ste2 and Gpal interactions with Sst2. Evidence suggests that the interaction between
Sst2 and Ste2 is required for proper localization of Sst2 to the membrane and shmoo tip.
Because Sst2 and Gpal bind to different regions on Ste2, Gpal and Ste2 bind to different
regions on Sst2, and Sst2 and Ste2 bind to different regions on Gpal, it is likely that all three
proteins can bind each other simultaneously [163]. The affinity of Sst2 for Gpal is weak and
unaffected by the presence of GDP or GTP, thus I assume that the binding of Sst2 directly to
Gpal is negligible and that the Sst2-Gpal interaction has little effect on the association of
Gpal with an Sst2-Ste2 complex (i.e., there is no cooperativity). Evidence also suggests that
Sst2 does not affect the interaction between Gpal and Ste4-Stel 18, which necessarily implies
that Ste4-Stel8 does not interfere with the ability of Gpal to interact with Sst2-bound Ste2. I
assume that the interaction between Sst2 and the MAP kinases Fus3 and Kss 1 (see Section
3.2.2.d) does not interfere with the interaction between Sst2 and Ste2.
Given the interactions between Sst2, Ste2 and Gpal, it is reasonably straightforward
to specify the mechanism of nucleotide hydrolysis. When GTP-bound Gpal is associated
with an Sst2-bound Ste2 molecule, then the rate of GTP hydrolysis is fast. When GTP-
bound Gpal is not in a complex with Sst2, the GTP hydrolysis rate is slow. I assume that
neither Ste2 by itself, nor Ste4 affect the GTP hydrolysis rate.
Numbers from experiments and models
The innate and Sst2-mediated nucleotide hydrolysis rates of Gpal have only been
directly measured at 00C. At 0oC, the innate hydrolysis rate is 0.006 min-' (104 s-'), and the
Sst2-mediated hydrolysis rate is > 4 min-' (0.0667 s-') [153]. These rates represents a 667-
fold increase in hydrolysis in the presence of the RGS Sst2, which is in line with the
increases observed for other RGS and G protein pairs [154, 157]. Since rates of Gpal-
catlyzed GTP hydrolysis have not yet been measured at 220 C or 300 C, I use the Gq/1 1-
catalyzed GTP hydrolysis rates. In the absence of the RGS, the hydrolysis rate is 0.6 min-' to
0.9 min t (1 x 10-2 S-1 to 1.5 x 10-2 s- 1) [161], and in the presence of different RGS proteins,
the hydrolysis rate varies from 1.1 s- to 27 s" [154, 157]. I assume an innate GTP hydrolysis
rate on the order of 10-2 -1 and an Sst2-mediated hydrolysis rate on the order of 10 s-.
Numerous modeling efforts also include the rates of nucleotide hydrolysis, though
often the source of the rates are unclear or confounded by compound reactions involving
association with Sst2 and G protein re-association. Yi et al. estimated an innate hydrolysis
rate of 0.004 s-1 by fitting a model to G protein activation data [45]. They similarly estimated
a bulk rate of hydrolysis of 0.11 s 1 in cells with WT amounts of Sst2. This rate does not take
into account how many of the Gpal molecules are associated with Sst2 molecules. The
innate rate is close to the rates measured for Gq/11 [161], but the RGS-mediated rate is at
least 10-fold lower than the rates for Gq/11, perhaps accounting for the fact that not all active
Gpal molecules may be associated with Sst2 molecules. Hao et al. assumed a rate of 5.8 x
10-5 s-1 for nucleotide hydrolysis followed by G protein re-association in the absence of Sst2
[82]. Hao et al. used a rate constant of 58 mM-1 s-' for the same reaction with Sst2 acting as
a catalyst. Given the concentration of Sst2 used in this model (50 nM), the minimum Sst2-
mediated nucleotide hydrolysis rate would be 0.003 s-, which is close to the rate used by Yi
et al. and the rates measured for Gq/11 in the absence of RGS proteins. Yildirim et al. used a
value of 0.001 s-1 for nucleotide hydrolysis in the absence of Sst2 (referencing this to the
0.004 s1 used by Yi et al.) [22]. This same model uses a rate of 1.35 x 10-5 molec-1 s1 for the
hydrolysis rate where Sst2 acts as a catalyst (referencing this to the 0.11 s- used by Yi et al.).
Given their concentration of 2000 molecules per cell of Sst2, the minimum Sst2-mediated
nucleotide hydrolysis rate is 0.027 s1 . Kofahl and Klipp used a rate of 0.0055 
nM-1 s-1 for
the hydrolysis rate where Sst2 acts as a catalyst, and reference this value to the 
0.11 s-1 used
by Yi et al. [2]. Because simulation of the Kofahl model begins with no Sst2 present, and
Sst2 is produced continually in the model, it is difficult to map their rate constant 
to a first
order rate constant for comparison.
Computational and graphical representations
Figure 3-12 Interaction of s t2 and te2.
Figure 3-12 Interaction of Sst2 and Ste2.
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Figure 3-13 Hydrolysis of GTP by Gpal.
Table 3-5 Parameter constraints for G protein deactivation.
kcat_Gpal GTP GDP - 10-2 s-1
kcat_Sst2Ste2Gpal GTP_GDP - 10 s-
3.2.1.f Receptor Dimerization
Summary
Ste2 forms homodimers, and exists in this form throughout the entire Ste2 life cycle.
Ste2 dimerization appears to be important for proper membrane trafficking. Ste2 dimers are
also functional units for activation of the mating pathway and for endocytosis. However, the
means by which Ste2 dimers participate in membrane trafficking, G protein activation and
endocytosis are not known.
Experiments and evidence
Ste2 forms dimers
Specific interactions can be detected between Ste2 molecules in vivo by both FRET
[46, 149, 168] and BRET [169], suggesting oligomerization. This specific interaction can
also be detected by co-precipitation of differentially tagged Ste2 molecules [170]. Spectrally
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resolved FRET shows that nearly all cellular Ste2 exists as homodimers in the absence of
pheromone [149]. Overall FRET efficiency is unchanged by pheromone treatment, [168],
precluding the possibility of disassembly of the Ste2 dimers in response to pheromone, but
not the possibility of the formation of higher order oligomers. Ste2 forms dimers with equal
efficiency in the endoplasmic reticulum and the plasma membrane [171].
Ste2 dimers are functional units for trafficking, signaling, and endocytosis
Ste2 mutants that cannot form dimers when expressed at wild-type abundances
collect in the endoplasmic reticulum and are poorly targeted to the plasma membrane [172],
suggesting that dimerization is required for efficient trafficking. When poor membrane
presentation is accounted for, dimerization-deficient Ste2 mutants have signaling defects that
are proportional to the strength of the dimerization defects [172]. These dimerization-
deficient Ste2 bind pheromone with near wild-type affinity [172], suggesting that the
signaling defect is in G protein activation. The signaling defect of a pheromone-binding
mutant is unchanged by coexpression of wild-type Ste2 [168]. Likewise, coexpression of a
Ste2 mutant defective in G protein-association with a Ste2 mutant defective in pheromone-
binding does not rescue signaling beyond the expression of either mutant by itself [46].
These results indicate that signal cannot be transmitted in trans through a Ste2 dimer.
However, two different Ste2 mutants that are each defective for G protein association are
able to partially rescue pheromone sensitivity when coexpressed [46], suggesting that Ste2
molecules may cooperate to bind or activate G proteins. Ste2 dimers are also functional units
of endocytosis, as pheromone-binding defective Ste2 mutants are selectively endocytosed in
the presence of pheromone only when coexpressed with wild-type Ste2 [170].
Distilling evidence into elementary chemical reactions
It is clear that Ste2 forms oligomers, likely dimers, and these dimers are important for
proper trafficking of Ste2 to the plasma membrane. Additionally, because Ste2 dimers are
functional units for signaling and endocytosis, Ste2 may remain in dimers for the entire Ste2
life cycle. However, the functional significance of Ste2 dimerization on signal transmission
is not entirely clear. Evidence suggests that Ste2 monomers within a dimer may cooperate to
bind or activate G proteins. The stoichiometry of this interaction is not known; does a Ste2
dimer bind a single G protein, or two G proteins? Circumstantial evidence suggests that both
Ste2 molecules in a dimer may need to bind pheromone for proper G protein activation.
First, coexpression of a Ste2 mutant deficient for pheromone-binding with wild-type Ste2
results in signaling severe defect similar to the expression of the mutant itself. Second,
coexpression of a Ste2 mutant defective in G protein-association with a Ste2 mutant
defective in pheromone-binding did not rescue signaling beyond the expression of either
mutant by itself. However, coexpression of two different G protein-association mutants
results in partial rescue of signaling. Thus, when paired with a Ste2 that is defective in G
protein binding, it is more beneficial for the second Ste2 in the dimer to be able to bind
pheromone efficiently than to bind the G protein efficiently.
Because the exact implication of Ste2 dimerization is not clear, and the mechanism by
which Ste2 dimers function to activate G proteins is unknown, I do not include Ste2
dimerization in the Mating Model.
3.2.1.g Gxt (Gpal) Mediated Signaling
Summary
Active Gpal itself may contribute to mating pathway activation, not just through de-
repression of GPy. A constitutively active Gpal allele suggests that Gpal may cause
signaling through activation of a phosphatidylinositol 3-kinase. Other mechanisms for Gpal-
mediated pathway activation may exist as well. However, the details of these mechanisms
are not known.
Experiments and evidence
Active Gpal causes signaling through the mating pathway
When overexpressed in wild-type cells (which also contain wild-type Gpa 1), the
GTPase-deficient Gpal-Q323L mutant significantly enhances Fus3 and Kssl
phosphorylation and Fus 1-lacZ expression in both the absence and presence of a-factor, and
causes a constitutive shmoo morphology [173, 174]. There are several factors which suggest
that this pathway activation occurs independently of Ste4 release. First, the cells used in
these experiments also contain wild-type Gpal which should be able to sequester Goy.
Second, although Gpal-Q323L expression causes significant transcriptional response and a
shmoo morphology in the absence of pheromone, Gpal-Q323L expression does not trigger
cell cycle arrest, which normally results from mating pathway activation (see Section 3.5.1)
[173, 174]. Finally, the pathway activating effects of Gpal-Q323L overexpression and Ste4
overexpression are approximately additive across a range of pheromone concentrations
[173]. Interestingly, although Gpal-Q323L mediated-activation appears to be independent of
GPy release, it does require Ste4, Stel 1, and Ste7, consistent with activation of the MAPKs
[173].
Active Gpal activates PI3K, which causes signaling
Two components of the only phosphatidylinositol 3-kinase (PI3K) in yeast have been
implicated in Gpal-mediated mating pathway activation. Deletion of either Vpsl5 or Vps30
in cells overexpressing Gpal-Q323L greatly reduces Fus3 phosphorylation (but not Kssl
phosphorylation) and Fus -lacZ expression [174]. Similarly, in wild-type cells, deletion of
either Vps 15 or Vps30 greatly reduces pheromone mediated Fus3 phosphorylation (but not
Kss I phosphorylation) and mating efficiency, and results in a 5- to 7-fold decrease in
pheromone sensitivity [174].
Both Vpsl5 and Vps34 interact with Gpal, although Vpsl5 interacts preferentially
with inactive Gpal, and Vps34 with active Gpal [174]. Whereas Gpal is primarily localized
to the plasma membrane, Gpal-Q323L is localized largely to the endosome and this
localization is facilitated by Vps 15 and Vps34. Vps 15 bears some sequence similarity to GP
proteins, and given that GPy complexes are thought to help localize Ga proteins to the
plasma membrane, Vpsl5 may serve the role of G3 and recruit Gpal to the endosome [174].
Finally, expression of Gpal-Q323L causes a small but significant (less than 2-fold) increase
in cellular phosphatidylinositol 3-phosphate (PI3P), the product of PI3Ks.
Phosphatidylinositols are lipids, thus PI3Ps are restricted to membranes. This increased
production of PI3P is sufficient to relocalize a weak PI3P-interacting protein, Beml, to the
endosome [174]. Thus, active Gpal may result in a sufficient accumulation of PI3P to act as
a second messenger, localize other factors, and propagate a mating signal through as yet
unknown mechanisms.
Other mechanisms for active Gpal activity
As was found for Vpsl5 and Vps34, Scpl60 interacts in vitro with active Gpal and
deletion of Scpl60 also eliminates the pathway hyperactivation caused by Gpal-Q323L
[173]. However, the group that discovered the interaction between Gpal and Scpl60 has
pursued research on Gpal-dependent pathway activation but has not published any work on
the role Scp 160 plays in mating response since 2003, suggesting that Scp 160 may not be
directly involved.
Fus3 also interacts with Gpal in vitro, binding preferentially to active Gpal [103].
Prior treatment of Fus3 with phosphatase decreases the interaction, suggesting that Gpal
interacts more efficiently with active Fus3. Mutation of the putative MAPK docking motif
on Gpal (K21E R22E) decreases pheromone-dependent phosphorylation of Ste4 and greatly
decreases mating efficiency [103], suggesting that recruitment of active Fus3 to the site of
active Gpal is important for mating function. However, phosphorylation of Ste4 does not
seem to be an important outcome of the interaction between Fus3 and Gpal because mutation
of the phosphorylation sites on Ste4 have no observable effect on signaling, cell cycle arrest,
mating efficiency or adaptation [175]. The interaction between Gpal and Fus3 may be
important for Fus3 phosphorylation of another target, and Ste4 phosphorylation may be
incidental.
Distilling evidence into elementary chemical reactions
Gpal interacts with the PI3K complex, Scp160 and Fus3, and all of these interactions
are implicated in efficient signaling or mating. However, it is unclear whether these
interactions participate in the same process or in separate processes to enhance signaling and
mating. For PI3K activation, it is not known how active Gpal in WT cells would be
localized to the endosome where it could interact with Vpsl5 and Vps34. Perhaps active
Gpal is endocytosed along with the receptor and transferred to the endosome where it
activates the PI3K. Alternatively, some fraction of Gpal may already be localized to the
endosome, and may be activated by internalized receptor. Potentially, endosomal Gpal may
not be attenuated by Sst2 because Sst2 localization is determined by the interaction between
Sst2 and Ste2 and this interaction is inhibited by endocytosis-inducing phosphorylation of
Ste2 (see Section 3.2.1.e), making it unlikely that Sst2 relocalizes to the endosome upon Ste2
endocytosis [176].
Deletion of either Vpsl 5 or Vps34 diminishes mating response and these two proteins
are required for increased production of PI3P in response to pheromone, suggesting that PI3P
is an important second messenger in mating response. PI3P may help to relocalize some
signaling proteins to the endosome, causing further activation of the mating pathway by an as
yet unknown mechanism. The mechanism by which Scpl60, an RNA binding protein,
activates the mating pathway is also unknown. Finally, evidence suggests that active Gpal
may relocalize active Fus3, perhaps to facilitate phosphorylation of another protein localized
to the site of G protein activation. Again, it is unclear how relocalization of Fus3 may
enhance mating, and if signaling via Fus3 relocalization is related to PI3K activation in the
endosome.
None of the mechanisms of action of Gpal-dependent pathway activation are well
understood. Although the recent discovery of Gpal-mediated activation of the PI3K
complex looks promising, until more details are worked out it would be extremely difficult to
represent our limited knowledge of this signaling process, or the other two processes
discussed above, in a mechanistic model. Thus, I omit Gpal-dependent pathway activation
from the Mating Model.
3.2.2 Regulation and Feedback
3.2.2.a Pheromone Degradation and Protease Upregulation
Summary
MATa cells secrete the protease Barl, which degrades a-factor. Conversely, an a-
factor specific protease has not been identified. Expression of Barl is upregulated in
response to pheromone treatment.
Experiments and evidence
Barl is secreted into the extracellular environment where it degrades a-factor
Extracellular a-factor is degraded in the presence of MA Ta cells, but not in the
presence of MATc cells [61]. The product of the BARI gene, which has significant sequence
homology with pepsin-like proteases, is responsible for this degradation of a-factor [60,
177]. Barl cleaves a-factor between L6 and K7, and has strict specificity for a-factor and
closely related peptides [61, 177]. Barl is heavily glycosylated during processing and export
[60, 177].
An a-factor specific protease has not been identified
On group reported an a-factor protease activity [73, 74], although their results have
not been subsequently substantiated [10] suggesting that the MA Ta cells may not secrete an
a-factor specific protease.
BAR1 expression is upregulated upon pheromone treatment
The BAR1 upstream activating sequence contains pheromone response elements [178]
and Barl expression is upregulated in response to pheromone treatment [179].
Distilling evidence into elementary chemical reactions
Extracellular Barl degrades a-factor, and because deletion of Barl prolongs
pheromone-mediated cell cycle arrest, the a-factor fragments produced by Barl must lose
their ability to stimulate the mating pathway. Thus, I model a-factor degradation via a two
step process, with Barl first binding then degrading a-factor.
There are several complications associated with including Barl in a model. As is the
case with pheromone, Barl is in the extracellular space and not in the intracellular space.
Thus, the concentration of Barl depends on the per-cell synthesis rate, the concentration of
cells, and the degradation rate. Because Barl is not intracellular, Barl is not subject to
dilution due to cell growth (see Section 3.6.1). To balance constitutive Barl synthesis, I
assume that Barl has some limited lifespan in the extracellular medium before it is rendered
inactive.
Because Barl is synthesized in a pheromone-dependent manner, I assume that both
its basal synthesis rate (in the absence of pheromone) and pheromone-induced synthesis rate
are governed by Stel2 activity, as described in Section 3.4.1.b.
Numbers from experiments and models
The kinetics of Barl mediated a-factor degradation have not been measured. By
tracking the degradation of a-factor in the presence of MA Ta cells, Ciejek et al. estimate that
a-factor is degraded by Barl at an overall rate of at least 107 molecules per minute per cell
[61]. This rate is complicated by the upregulation of Barl in response to pheromone.
Because most models are fit to data generated by studying barl cells, most models
do not include Barl-mediated degradation of a-factor. Only Kofahl and Klipp included Barl
in their model [2]. They modeled pheromone degradation as a one-step second order
process, with a rate constant of 5 x 105 M- 1' s- 1.
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Table 3-6 Parameter constraints for pheromone degradation and Barl synthesis.
kexport_Barl = ksynth Stel2_Barl x Cytosol_volume x Cell_concentration
3.2.2.b Receptor Downregulation and Upregulation
Summary
The Ste2 population is continually turned over via ubiquitination, internalization and
degradation of receptors, and synthesis of new receptor molecules. The rate of receptor
internalization is increased by pheromone treatment. Both constitutive and pheromone
induced Ste2 internalization are dependent on the Yckl and Yck2 kinases, and independent
of mating pathway function. The MA Ta receptor protein Ste3 is synthesized and internalized
in a similar manner, although pheromone-mediated increase in Ste3 internalization is not
dependent on Yckl and Yck2. Expression of both Ste2 and Ste3 is upregulated in response
to pheromone treatment in their respective cell types.
Experiments and evidence
Ste2 internalization is increased in the presence ofpheromone
The number of a-factor binding sites on the surface of yeast cells decreases shortly
after pheromone treatment [23, 180]. Additionally, internalization of radioactively labeled
a-factor has also been observed [181]. The internalization rate for Ste2 in the absence of
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pheromone is about 10-fold slower than the internalization rate in the presence of pheromone
(see below) [23, 75].
Ste2 is phosphorylated, ubiquitinated, endocytosed, and degraded
Ste2 is constitutively phosphorylated in the absence of pheromone, and hyper-
phosphorylated in the presence of pheromone [26, 75, 76]. Phosphorylation of S331, S338
and/or S339 has been shown to be responsible for ubiquitination at K337, which in turn is
sufficient for internalization of Ste2 [75, 182]. Mutation of these serines to alanines has only
a modest effect on both constitutive and pheromone induced internalization, indicating that
there are other sites on the C-terminal tail of Ste2 that are also responsible for internalization
[75]. Because Ste2 forms dimers (see Section 3.2.1.f), unoccupied Ste2 molecules can be
endocytosed along with liganded Ste2 molecules [170]. After endocytosis, internalized
pheromone and receptor are both degraded in the vacuole [23, 181-184]. 7.5 minutes after
pheromone treatment, 40% of the initial Ste2 population remains at the cell surface, and only
10% remains inside the cells [182], suggesting that internalized Ste2 is rapidly degraded.
Yckl and Yck2 mediate Ste2 internalization in a mating pathway independent manner
Deletion of Yckl and Yck2 eliminates constitutive and pheromone-induced hyper-
phosphorylation and internalization of Ste2 [75]. Deletion of Ste4 does not affect receptor
internalization dynamics (both in the presence and absence of pheromone) [76], indicating
that Yckl and Yck2 mediate receptor internalization independently from mating pathway
function. Thus, it is suspected that ligand-bound receptors adopt a conformation that is a
better substrate for Yckl and Yck2 [10]. Myo5 is also implicated in pheromone-dependent
(but not constitutive) receptor endocytosis [185].
Ste3 is endocytosed and degradation
As is the case for Ste2, Ste3 is constitutively phosphorylated in the absence of
pheromone, and hyper-phosphorylated in the presence of pheromone [77]. However unlike
Ste2, Ste3 hyper-phosphorylation in response to pheromone treatment requires a functional
mating pathway and does not depend primarily on Yckl and Yck2 [77]. Constitutive
endocytosis of Ste3 is initiated through ubiquitination of the C-terminal cytoplasmic tail
[186]. Pheromone-dependent Ste3 endocytosis does not require ubiquitination, and can lead
to recycling of Ste3 to the cell surface instead of degradation [78, 79].
Ste2 and Ste3 are upregulated in response to pheromone
The STE2 gene upstream activating sequence binds Stel2 and Mcml [187-189], and
in the presence of a-factor, Ste2 expression is upregulated [23, 72, 190, 191]. Ste3
expression is also rapidly upregulated in response to treatment with a-factor [192].
Consistent with upregulation of Ste3 expression, Matal, Mcml and Stel2 bind to the STE3
gene upstream activating sequence (UAS) [189, 193, 194], and the STE3 UAS is sufficient to
confer a-factor induction [195].
Distilling evidence into elementary chemical reactions
The mechanics of receptor downregulation are complex. For simplicity I consider
only MATa cells. Pheromone-bound receptors must be selectively phosphorylated by Yckl
and Yck2. This phosphorylation leads to ubiquitination, internalization, and degradation. In
order to model the phosphorylation of Ste2 by Yckl and Yck2, I would need reactions for
Yckl and Yck2 binding to Ste2 and phosphorylating it. Thus, either Yckl and Yck2 interact
more strongly with pheromone-bound Ste2, or Yckl and Yck2 more rapidly phosphorylate
pheromone-bound Ste2, or both. However, the net result is that upon treatment with
saturating amounts of pheromone (such that all Ste2 is pheromone-bound) the receptor is
internalized with a half time of 7 minutes (see below). To simplify the Mating Model, I
merely represent Ste2 internalization as a first-order reaction, whose rate is dependent on
whether Ste2 is pheromone-bound or not. Because evidence suggests that internalized
receptor is rapidly degraded, I assume that degradation occurs immediately upon
internalization. In the absence of evidence to the contrary, I assume that binding of Gpal or
Sst2 to Ste2 does not affect its internalization rate. Because the interaction between Sst2 and
Ste2 is eliminated by Yck-dependent Ste2 phosphorylation [163], I assume that Sst2 is not
internalized along with Ste2, and any bound Sst2 molecules are released into the cytosol. I
also assume that Gpal is similarly released upon internalization of Ste2.
Because Ste2 is synthesized in a pheromone-dependent manner, I assume that both its
basal synthesis rate (in the absence of pheromone) and pheromone-induced synthesis rate are
governed by Stel 12 activity, as described in Section 3.4.1.b. Thus ksynth_Stel2_Ste2 and
Km_synth_Stel2_Ste2 must be selected such that in the absence of pheromone, the basal amount
of active Stel2 leads to the expected abundance of Ste2 (Ste2_conc), balancing out
constitutive internalization of Ste2 and dilution due to cell growth (see Section 3.6.1).
Numbers from experiments and models
Ste2 internalization rates have been measured multiple times in both the presence and
absence of pheromone, unfortunately not always at the same temperature. In the absence of
pheromone, the Ste2 internalization half-time was measured at 220 C to be 186 minutes [23],
at 300 C to be 45 minutes [75] and 35 minutes [26], and at 340 C to be 48 minutes [23]. I use
an internalization rate of 2.9 x 104 s-' for unliganded Ste2 at 300C, corresponding to a half-
time of 40 minutes. In the presence of saturating amounts of pheromone, the Ste2
internalization half-time was measured at 220C to be 18 minutes [23], at 300C to be 7.5
minutes [196], 8 minutes [197], 5 to 6 minutes [75, 182] and 20 minutes [26], and at 340 C to
be 10 minutes [23]. The 20 minute rate measured at 300 C appears to be inconsistent with the
other measured values. Based on the other measured internalization half-times, I use an
internalization rate of 1.7 x 10-3 S-1 for pheromone-bound Ste2 at 300 C, corresponding to a
half-time of internalization of 7 minutes.
Kofahl and Klipp [2] and Yi et al. [45] also used a simple first-order degradation
model for downregulation of Ste2, and used rates similar to the values that I selected. For
unliganded Ste2, both groups used degradation rates of 4 x 10-4 s-1. For pheromone-bound
Ste2, they used degradation rates of 4 x 10-3 s-1. The later corresponds to a degradation half-
time of 2.9 minutes, which is about 2-fold faster than any reported measurement of the
internalization half-time. Kofahl and Klipp referenced both values to Yi et al. It is unclear
whether Yi et al. measured these rates, or inferred them from the literature.
The synthesis rates of Ste2 are not explicitly known, although the overall synthesis
rate in the absence of pheromone must balance the internalization and dilution rates to
maintain the expected abundance of Ste2. Thus, in the absence of pheromone, the overall
synthesis rate must equal (kdeg_Ste2 + kdilution) x Ste2_conc.
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Table 3-7 Parameter constraints for Ste2 degradation and synthesis.
kdeg_Ste2 ; 2.9 x 10" s 1
kdeg_PheromoneSte2 = 1.7 x 10-3 s -1
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3.2.2.c Ga (Gpal) Degradation and Upregulation
Summary
Gpal is degraded at a constant rate, independent of pheromone treatment. However,
Gpal expression is upregulated in response to pheromone treatment.
Experiments and evidence
Gpal degradation is not pheromone-regulated
Gpal is degraded via the N-end rule pathway [198]. Mono-ubiquitinated Gpal is
degraded in the vacuole, and poly-ubiquitinated Gpal is degraded by the proteasome [199].
The distribution of mono- and poly-ubiquitinated Gpal is unaffected by pheromone
treatment, suggesting that Gpal degradation is not pheromone-regulated. A constitutive
Gpal mutant (N388K) that was thought to not hydrolyse GTP and thus not bind GPy is
degraded 3- to 7-fold more rapidly than wild-type Gpal [200], suggesting that association
with GPy may stabilize Gpal. However, this mutant hydrolyses GTP and binds GPy,
suggesting that the increased degradation is not due to its constitutive activity [148, 200].
Gpal expression is regulated by pheromone treatment
Gpal expression is only weakly increased in the presence of pheromone [72, 201],
explaining why upregulation of Gpal was not detected by some research groups [202].
Correspondingly, some groups have detected increased Gpal abundance in response to
pheromone treatment [82], while others have not [148].
Distilling evidence into elementary chemical reactions
Because the degradation of Gpal is not pheromone-regulated, and the functional
significance of vacuolar and proteasomal degradation is not clear, it is likely sufficient to
model degradation of Gpal as a simple first-order constant-rate process. The evidence that
binding to GPy is important for stabilization of Gpal is not convincing. I assume that when
Gpal is degraded, any bound proteins are released into the cytosol.
Gpal expression appears to be regulated in response to pheromone. I assume Gpal
synthesis in the absence and presence of pheromone are governed by Stel2 activity, as
described in Section 3.4.1.b. Thus, ksynth_Stel2 Gpal and Km_synth_Stel2_Gpal must be
selected such that in the absence of pheromone, the basal amount of active Ste 12 leads to the
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expected abundance of Gpal (Gpal_conc), balancing out degradation of Gpal and dilution of
Gpal due to cell growth (see Section 3.6.1). I also assume that by the time Gpal is trafficked
to the cell periphery, Gpal is in the GDP-bound form.
Numbers from experiments and models
Gpal has a half-life of about 50 minutes [198], corresponding to a degradation rate of
2.3 x 10-4 s-1. Because Gpal synthesis is only weakly induced by pheromone treatment, and
pheromone treatment increases Gpal abundance by approximately 50% [82],
Km_synth_Stel2_Gpal may be similar, or slightly greater than the concentration of active Ste12
in the absence of pheromone (see Section 3.4.1.b).
Only a couple of previously published models include Gpal degradation and
synthesis. Yildirim et al. used a degradation rate of 1.6 x 10-3 s-1 for free GTP-bound Gpal,
and 4 x 10-4 s-1 for free GDP-bound Gpal, citing the N388K mutation for evidence that
active Gpal is degraded more rapidly than inactive Gpal (see above) [22]. Because only free
Gpal is degraded, it is easier to calculate the turnover rate of Gpal in this model via the
constitutive synthesis rate: 0.2 molecules s-1. Given a cellular abundance of 8000 molecules,
the net degradation rate of Gpal can be calculated to be 2.5 x 10-5 s-1, corresponding to a
half-life of 460 hours. Because only free Gpal is degraded in this model, Gpal degradation
becomes much more important in the presence of pheromone.
Shao et al. included constitutive G protein degradation, as well as constitutive and
pheromone-induced synthesis of the full G protein (Gpal-Ste4-Stel8) in their model [ 100].
Constitutive degradation occurs for all inactive G proteins at a rate of 1.3 x 103 S-1,
corresponding to a half-life of about 9 minutes, considerably shorter than the measured half-
life of 50 minutes. Pheromone-dependent Gpal synthesis is modeled via a Hill function with
a Hill coefficient of 2.
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Table 3-8 Parameter constraints for Gpal degradation and synthesis.
kdeg_Gpal = 2.3 x 10
" s-
1
3.2.2.d RGS (Sst2) Downregulation and Upregulation
Summary
In response to pheromone, Sst2 is phosphorylated by the MAPKs 
Fus3 and Kssl.
Sst2 is also ubiquitinated and more rapidly degraded upon pheromone 
treatment.
Additionally, Sst2 expression is upregulated in response to pheromone.
Experiments and evidence
Sst2 is phosphorylated, ubiquitinated and degraded in response to pheromone
Sst2 is phosphorylated at S539 (as identified by mass spectrometry) in response to
pheromone [203]. S539 lies within the consensus MAPK phosphorylation sequence PXSP.
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Phosphorylation of Sst2 is eliminated infus3AksslA cells, but not infus3A cells or ksslA
cells, suggesting that both Fus3 and Kssl are capable of phosphorylating Sst2 at S539 [203].
In addition to phosphorylation, pheromone treatment results in poly-ubiquitination and
degradation of Sst2 [82]. Although it has not been shown directly, it seems likely that
phosphorylation by the active MAPKs leads to subsequent poly-ubiquitination of Sst2, which
directs Sst2 for degradation.
Sst2 synthesis is induced by pheromone treatment
Sst2 expression is induced about 4- to 5-fold by pheromone treatment [72, 191, 204],
and correspondingly, Sst2 abundance increases in response to pheromone [82, 166].
Distilling evidence into elementary chemical reactions
Although the details have not been entirely worked out, Sst2 is likely phosphorylated
by active Fus3 and Kss 1, and this phosphorylation likely signals for the ubiquitination and
subsequent degradation of Sst2. For simplicity I do not include ubiquitination of Sst2 in the
Mating Model, and assume that phosphorylation is sufficient for increased degradation of
Sst2. I also assume that both Fus3 and Kssl are equally proficient at phosphorylating Sst2
(i.e., both Fus3 and Kssl bind and phosphorylate Sst2 with the same affinity and rate
constants) and that Fus3 and Kssl can bind and phosphorylate Sst2 while Sst2 is bound to
Ste2. Furthermore, I assume that the kinetic parameters that describe phosphorylation of
Sst2 follow the relationships outlined in Section 3.3.1.f. As per Section 3.6.6, I assume that
Sst2 is dephosphorylated by nonspecific phosphatases. Because the rate of Sst2 turnover is
only moderately affected by pheromone treatment (see below), it is likely that
unphosphorylated (and possibly non-ubiquitinated) Sst2 is also degraded in the cell, although
at a slower rate than ubiquitinated Sst2. I further assume that Sst2 can be degraded when
bound to Ste2.
Sst2 expression is upregulated in response to pheromone. I assume that both its basal
synthesis rate (in the absence of pheromone) and pheromone-induced synthesis rate are
governed by Stel2 activity, as described in Section 3.4.1.b. Because the synthesis of Sst2 is
Stel2-dependent, ksynth_Stel2_Sst2 and Km_synth_Ste12_Sst2 must be selected such that in the
absence of pheromone, the basal amount of active Stel2 leads to the expected abundance of
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Sst2 (Sst2_conc), balancing out degradation of phosphorylated Sst2 and unphosphorylated
Sst2, and dilution of Sst2 due to cell growth (see Section 3.6.1).
Numbers from experiments and models
In the absence of pheromone, Sst2 has a half-life of about 45 minutes [82],
corresponding to a net degradation rate of 2.6 x 10-4 s".Because MAPK activity is still
measurable in the absence of pheromone [44, 205, 206], some Sst2 will still be
phosphorylated and degraded at an increased rate. Thus this rate of 2.6 x 104 S-1 is an upper
limit on the degradation rate of unphosphorylated Sst2. In the presence of pheromone, the
half-life of Sst2 is about 30 minutes [82], corresponding to a net degradation rate of 3.9 x 10-
4 S-1. This rate includes the rate of phosphorylation of Sst2 by the active MAPK, and is thus a
lower limit on the actual degradation rate of phosphorylated Sst2.
The rate constants that govern the synthesis of Sst2 must be selected such that they
balance the constitutive turnover (and dilution) of Sst2 to give the expected abundance of
Sst2 in the absence of pheromone. Thus, in the absence of pheromone, the overall synthesis
rate must equal (2.6 x 10-4 s-1 + kdilution) x Ste2_conc.
Sst2 degradation and synthesis is not included in many published models. Hao et al.
used a degradation rate of 8.3 x 10-4 s-1, corresponding to a half-life of 14 minutes [82]. This
rate was also used by Yildirim et al. [22]. Shao et al. did not consider Sst2 synthesis in the
absence of pheromone, but modeled Stel2-dependent Sst2 synthesis (via a Hill function with
a Hill coefficient of 2) and Sst2 degradation (half-life of 13 minutes) [100]. These rates were
selected to fit the model to experimental data from Hao et al. [100], although it is not clear
exactly what data was used.
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Table 3-9 Parameter constraints for Sst2 phosphorylation.
Kd_MAPK_Sst2 = Kd_MAPKpTpYSst2 x MAPK_unphosph_Kdfactor
Kd_MAPKpY_Sst2 = Kd_MAPKpTpY_Sst2 x MAPK_pY Kd factor
KdMAPKpT_Sst2 = Kd_MAPKpTpYSsT2 x MAPK_pT Kd factor
kcat_MAPKpYSst2_pS = kcat_MAPKpTpY_Sst2_pS + MAPKpYkcatfactor
kcat_MAPKpT_Sst2_pS = kcat_MAPKpTpY_Sst2_pS - MAPK_pTkcat_factor
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Figure 3-28 Synthesis of Sst2.
Table 3-10 Parameter constraints for Sst2 degradation and synthesis.
kdegSst2 < 2.6 x 10" s 1
kdeg Sst2pS > 3.9 x 10" s-'
3.2.3 Protein Abundances
3.2.3.a Receptor (Ste2)
Numbers from experiments and models
Ste2 abundance has been measured many times by pheromone binding assay and
Scatchard plot, with reported values varying over a full order of magnitude. Because the
abundance of Ste2 has been measured so many times, I present only a representative
sampling of the measurements: 1,100 per cell [ 114]; 3,400 per cell [26]; 3,900 per cell [24];
4,900 per cell [48]; 5,300 per cell [25]; 7,600 per cell [112]; 8,000 per cell [181]; 8,000 per
cell [207]; 11,000 per cell [118]; and 13,000 per cell [115]. All these measurements were
made at either 22°C or 300 C, and there is no obvious effect of the temperature on the
measured abundance of Ste2. Also, all of these measurements were made in the presence of
NaN3 and KF to prevent the potentially confounding effects of receptor synthesis and
internalization.
The Ste2 abundances found in past models are fairly consistent and agree reasonably
well with the literature. Yi et al. used an abundance of 10,000 molecules per cell, but did not
explain whether they measured the abundance, or derived this value from the literature [45].
Kofahl and Klipp used a concentration of 1,667 nM [2], which based on the volume that they
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used in the model (see Section 3.1.5.b) corresponds to 55,000 to 83,000 molecules per cell, at
least 10-fold higher than the 5,300 measured by Blumer et al. [25] whom they referenced.
This higher abundance of Ste2 may have been to partially compensate for the association rate
between pheromone and Ste2 that was 10- to 100-fold lower than expected (see Section
3.2.1.a). Yildirim et al. used a Ste2 abundance of 8,000 molecules per cell [22], referencing
this value to Jenness et al. [23]. Shao et al. also used an abundance of 8,000 molecules per
cell (again citing Jenness et al.) [100]. However, Shao et al. assume that all receptor
molecules concentrate within a volume of 13 fL at the shmoo tip, thus they used a Ste2
concentration of 1 ýpM in their model. The assumption that Ste2 is localized to the shmoo tip
is likely valid after extended pheromone treatment (see Sections 3.1.5.b and 3.6.3).
Because there is sufficient experimental data, I do not need to bias my choice of Ste2
abundance based on the values used in previous models. The mean measured abundance is
6,600 molecules per cell, with a standard deviation of 3,600. Thus, I use a Ste2 abundance of
Ste2_abund ; 6600, and a concentration of Ste2_conc = Ste2_abund + (Cytosol_volume x NA), where NA
is Avogadro's number. The cellular Ste2 concentration is maintained by the reactions
described in Section 3.2.2.a.
Computational and graphical representations
3.2.3.b G Protein (Gpal and Ste4-Stel8)
Numbers from experiments and models
Gpal
The abundance of Gpal was measured as part of two protein abundance datasets (see
Section 3.1.5.b): Ghaemmaghami et al. measured an abundance of 9,900 molecules per cell
[98], whereas Benjamin et al. measured 2,400 molecules per cell (Chapter 4). Additionally,
Hao et al. measured about 8,000 molecules per cell of Gpal via western blot, using purified
recombinant Gpal as a protein standard [82]. Yi et al. report an abundance of 10,000
molecules per cell of the G protein, and although they say the measurement was made by
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Table 3-11 Parameter constraints for Ste2 concentration.
Ste2abund z6600
Ste2conc = Ste2.abund + (Cytosoý-volume x NA)
quantitative western and fluorescence quantification, experimental details are not given [45].
Interestingly, both Benjamin and Hao used purified Gpal as a standard yet produced
significantly different measurements. Thus, I am limited to stating that Gpal abundance is
likely in the range of 2,400 to 8,000 molecules per cell.
Yi et al. used a G protein abundance of 10,000 per cell in their model, and they
measured this value themselves [45]. Kofahl and Klipp used a G protein concentration of
1,667 nM in their model (55,000 to 83,000 molecules per cell based on the volume they
used), likely to match their choice of Ste2 abundance (see Section 3.2.3.a) [2]. A couple of
modeling papers used a Gpal abundance of 8,000 molecules per cell [22, 82], referencing
this value to the measured abundances of 8,000 molecules per cell by Hao et al. [82] and
9,900 molecules per cell by Ghaemmaghami et al. [98]. Shao et al. also used an abundance
of 8,000 molecules per cell in their model, but they assume that all Gpal molecules are
localized to a 13 fL volume at the shmoo tip in order to convert this to a 1 pM concentration
which they used in their model (see Section 3.1.5.b) [100]. This assumption may be valid
after extended pheromone treatment (see Section 3.1.5.b).
Gpal must be myristoylated and palmitoylated to associate with the plasma
membrane and to interact with Gfy to suppress mating signal (see Section 3.2.1.b). Between
50% and 70% of Gpal is myristoylated in the absence of pheromone [82, 129], suggesting
that a significant fraction of Gpal is not able to participate in the mating pathway.
Pheromone treatment also alters myristoylation of Gpal, mainly through synthesis and
myristoylation of new Gpal molecules, with almost all Gpal being myristoylated within an
hour of treatment [ 129]. Because the mechanism of regulation of myristoylation is not
known, I make several assumptions. First, I only include myristoylated Gpal in the Mating
Model. Second, I do not consider the increase in myristoylation of Gpal in response to
pheromone treatment.
Given 60% myristoylation, the intracellular concentration of signaling-competent
Gpal in the Mating Model is Gpal_conc = 0.6 x Gpal_abund - (Cytosol_volume x NA), where NA is
Avogadro's number. Gpal abundance is maintained by the reactions described in Section
3.2.2.c.
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Ste4 and Stel8
Ste4 and Stel8 are only stable when co-expressed, and are essentially permanently
associated (see Section 3.2.1.b), so it is sufficient to measure the concentration of either Ste4
or Stel8. An abundance of 2,050 molecules per cell of Ste4, and 5,550 molecules per cell of
Stel 18 was measured by Ghaemmaghami et al. [98]. Yi et al. report an abundance of 10,000
molecules per cell of the G protein, and although they say the measurement was made by
quantitative western and fluorescence quantification, experimental details are not given [45].
Finally, Benjamin et al. measured an abundance of 2,050 per cell (Chapter 4). Because Yi et
al. do not sufficiently explain how their measurement was obtained, and the methods used by
Benjamin et al. should introduce fewer errors than the methods of Ghaemmaghami et al. (see
Section 3.1.5.b), I assume a Ste4-Stel8 abundance of 2,050 molecules per cell. Published
computational models have used a Gpy abundance that exactly matches the Gpal abundance
(see above).
Only about 40% of the total cellular pool of Ste4 and Stel 8 is associated with the
plasma membrane, and the remainder is associated with internal membranes or is in the
cytosol [135]. Although cytoplasmic Gpy is able to interact with Gpal, it is unable to
support mating signal in the presence of pheromone [131].
I only consider Gfy that is stably associated with the plasma membrane in the Mating
Model. The intracellular concentration of membrane-associated Ste4-Stel 8 is thus
Ste4Stel8_conc = 04. x Ste4Stel8_abund + (Cytosol_volume x NA), where NA is Avogadro's number.
Because Ste4-Stel8 expression is not regulated in a pheromone-dependent manner, the
maintenance of Ste4-Ste 18 abundance is not addressed elsewhere in this chapter so Ste4-
Stel8 synthesis is given below. Since I am not considering Ste4-Stel8 degradation in the
Mating Model, dilution due to cell growth is the only means of loss of Ste4-Ste 18 (see
Section 3.6.1). To offset the loss due to dilution, Ste4-Stel 8 must be synthesized at a rate of
ksynth_Ste4Stel8 = kdilution x Ste4Stel8_conc.
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Computational and graphical representations
Table 3-12 Parameter constraints for G protein concentration and Ste4-Stel8 synthesis.
Gpal_abund - 2400 to 8000
Gpal_conc = 0.6 x Gpal_abund + (Cytosolvolume x NA)
Ste4Stel8_abund z 2050
Ste4Stel8_conc = 0.4 x Ste4Stel8_abund + (Cytosol_volume x NA)
ksynthSte4Stel8 = kdilution x Ste4Stel8_conc
3.2.3.c RGS (Sst2)
Numbers from experiments and models
The cellular abundance of Sst2 was measured by two groups by quantitative western
blots: Ghaemmaghami et al. measured 6,000 molecules per cell [98] and Hao et al. measured
2,000 molecules per cell [82]. Because the latter group used purified recombinant Sst2 as a
protein standard while the former group did not (see Section 3.1.5.b), I assume that there are
2,000 molecules per cell of Sst2.
Several models have used the measured abundance of 2,000 molecules per cell [22,
82, 100]. Shao et al., who used the abundance of 2,000 molecules per cell, assumed that all
Sst2 molecules are localized to a 13 fL volume at the shmoo tip to calculate a 250 nM
concentration which they used in their model (see Section 3.1.5.b) [100]. This assumption
may be valid after extended pheromone treatment (see Section 3.1.5.b). Another model
included only expression/activation of Sst2 in response to pheromone treatment [2]. Note
that although Sst2 expression is upregulated in response to pheromone, Sst2 activation or
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stabilization in response to pheromone [203] was later shown to be false [82]. Given the
measured abundance Sst2_abund = 2000, the cellular concentration of Sst2 is Sst2_conc
Sst2_abund - (Cytosol_volume x NA), where NA is Avogadro's number. Sst2 abundance is
maintained by the reactions described in Section 3.2.2.d.
Computational and graphical representations
3.3 MAP Kinase Cascade
3.3.1 Signal Propagation
3.3.1.a PAK-Like Kinase (Ste20) Activation and Localization
Summary
When the G0y dimer and GTP-bound Gpal dissociate, GPy can bind to the MAP
kinase cascade scaffold protein Ste5 (see Section 3.3.1.b) and the PAK-like kinase Ste20.
Co-localization of Ste20 and the Ste5 signaling complex allows Ste20 to phosphorylate the
Ste5-bound MAPKKK Ste 1l and initiate signaling through the MAPK cascade (see Section
3.3.1.c). Ste20 activity is regulated primarily via an interaction with GTP-bound Cdc42.
Experiments and evidence
Ste20 binds Ste4, thereby localizing Ste20 to the Ste5 signaling complex
Ste20 co-immunoprecipitates with Ste4 (tagged with the HA epitope) in a pheromone
dependent manner, suggesting that the interaction between Ste20 and Ste4 is only enabled
upon release of the G3y Ste4-Stel8 from the Goc Gpal [208]. Mutational analysis [208, 209]
and NRM studies [210] suggests that Ste5 and Ste20 interact with residues on opposite sides
of the Gfy coiled-coil, implying that Ste5 and Ste20 might be able to simultaneously bind a
single G03y.
Ste20 activity is regulated primarily by GTP-bound Cdc42
In the absence of binding partners, Ste20 adopts an autoinhibitory conformation
where the inhibitory N terminal domain binds the C terminal kinase domain [211]. GTP-
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bound Cdc42 is able to bind the CRIB (Cdc42/Rac-interactive binding) domain within the
inhibitory domain of Ste20 and relieve this autoinhibition [211]. Mutations within the CRIB
domain that selectively eliminate the interaction between Ste20 and Cdc42 greatly decrease
mating pathway activity [211, 212], implying that Cdc42 plays an important role in Ste20
activation. Full deletion of the Ste20 CRIB domain eliminates Cdc42-binding but has only a
minor effect on pheromone-induced gene expression, cell cycle arrest and polarized growth
[105, 211, 213]. This observation is consistent with the notion that it is the CRIB domain
that is responsible for autoinhibition, and removal of this domain bypasses the need for
Cdc42-mediated activation of Ste20. However, although overexpression of a constitutively
active (GTPase deficient) Cdc42 allele is sufficient to increase kinase activity of Ste20,
pretreatment of cell with pheromone does not increase kinase activity of Ste20, suggesting
that Ste20 activity is not significantly regulated by pheromone [211, 214].
Ste20 activity may also be regulated in part via an interaction with di-palmitoyl
phosphatidic acid in the plasma membrane. In the presence of di-palmitoyl phosphatidic
acid, but not other similar phosphatidic acids, Ste20 autophosphorylation is increased [215].
However, in vivo evidence for di-palmitoyl phosphatidic acid regulation of Ste20 is weak
[215], suggesting that this may not be an important mechanism for Ste20 regulation during
mating response.
Ste20 is phosphorylated by Cln2-Cdc28 in vitro [216], and the in vivo
phosphorylation of Ste20 at 13 sites correlates with Cln2-Cdc28 activity [216, 217]. The
sub-cellular localization of Ste20 is also regulated in a cell cycle dependent manner.
However, the activity of immunoprecipitated Ste20 is independent of cell cycle [216],
suggesting that Cdc28-mediate phosphorylation may affect Ste20 localization but not Ste20
activity. The interaction between Beml and Ste20 is also important for proper Ste20
localization, and has a moderate effect of mating signaling [218].
Distilling evidence into elementary chemical reactions
Because the activity of Ste20 does not appear to be regulated in either a cell cycle or
pheromone dependent manner, it is likely not necessary to explicitly include the activation of
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Ste20 in the Mating Model. Likewise, since the cell-cycle dependent phosphorylation of
Ste20 has no known effect on pheromone response, I can overlook these reactions as well.
The interaction between Ste20 and Ste4 can only be detected after pheromone
treatment, suggesting that like Ste5, Ste20 can only interact with GPy that is no longer bound
by Gpal. Based on the mutational analysis, I assume that-a single Goy can simultaneously
bind Ste5 and Ste20, although this has not been shown directly. In the absence of evidence
to the contrary, the simplest assumption is that Ste5 and Ste20 do not bind cooperatively to
GOy.
Numbers from experiments and models
The affinity of the interaction between Ste20 and Ste4 has not been measured. This
interaction has also not been considered widely in the modeling literature. Kofahl et al.
assumed an association rate of 5 nM-' min-' (83 M-M1 s-) and a dissociation rate (which
included the dissociation of the entire Ste5 signaling complex) of 5 min-' (8.3 x 10-2 s1) [2].
Neither of these rates is attributed to a source. Schaber et al. did not include Ste20 in their
model [136]; they assumed that localization of Stel 1 to the plasma membrane via
interactions between Stell and Ste5, and between Ste5 and Ste4 were sufficient for
activation of Ste 11. Shao et al. estimated an association rate of 7 x 10-5 nM'- s' (1.2 x 10-3
pM-1 s-1) and a dissociation rate of 10-3 min-m (1.7 x 10-5 s') from fitting their model to
experimental data of Ste4 and Ste20 co-precipitation from Leeuw et al. [100, 208]. Both of
these rate constants are much lower than typical measured rate constants. There were two
problems with the Shao et al. model that may have led to the selection of these unreasonably
slow rates. First, the Shao et al. model included synthesis of Gpal and GPy in response to
pheromone, which presumably resulted in more active GPy that was also able to bind Ste20.
However, expression of Gpal, but not Ste4 or Stel8, is significantly upregulated in response
to pheromone treatment [72]. Second, the Ste4-Ste20 co-precipitation data rises quickly and
levels off before 5 minutes, and then begins to rise again after 15 minutes and levels off again
after 60 minutes. I believe that the first rise in the detected Ste4-Ste20 binding represents the
initial binding event, and the subsequent rise may be due to Cdc42-dependent relocalization
of Ste20 to the shmoo tip [105, 213] facilitating the interaction between Ste20 and Ste4. By
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fitting their model to both rises, Shao et al may have selected for rate constants that were
very slow to mimic the gradual formation of Ste4-Ste20 complexes over the course of an
hour.
Computational and graphical representations
Figure 3-30 Interaction of Ste4-Stel8 and Ste20.
3.3.1.b Scaffold (Ste5) Activation and Localization
Summary
When the Gjy dimer and GTP-bound Gpal dissociate, Gfy can bind the MAP kinase
scaffold protein Ste5 (in addition to binding Ste20). The binding between membrane-
localized Ste4 (G3) and Ste5 recruits Ste5 to the plasma membrane and this membrane
localization is required for Ste5 activation and MAPK cascade signaling. In addition to
binding Ste4, Ste5 must interact directly with the plasma membrane via its pleckstrin
homology (PH) and plasma membrane (PM) domains for stable localization near the
membrane and for signaling. Ste5 also oligomerizes, and oligomerization appears to be
coupled to Ste4 binding.
Experiments and evidence
Ste4 binds Ste5, thereby localizing Ste5 to the plasma membrane
Overexpressed Ste4 and Ste5 co-immunoprecipitate, and Ste4 interacts with the N-
terminal 214 amino acids of Ste5 in a two-hybrid assay [219]. Since the majority of the Ste4
population is permanently plasma membrane associated due to its interaction with the
farnesylated and palmitoylated Gy (Ste 18) [126, 135], the interaction between Ste4 and Ste5
localizes Ste5 to the membrane in response to pheromone treatment. The localization of Ste5
to the plasma membrane can be seen using GFP-Ste5 fusion proteins [106, 111].
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However, the interaction between Ste5 and Ste4 by itself is insufficient to localize
Ste5 to the membrane. Ste5 contains two phosphatidylinositol-binding domains, a PM
(plasma membrane) domain at residues 37-76 and a PH (pleckstrin homology) domain at
residues 388-518, both of which are required for pheromone-stimulated recruitment of Ste5
to the plasma membrane and for mating signaling [220, 221]. Both of these domains
presumably contribute to signaling by stabilizing the association of Ste5 with Ste4 via
binding nearby phosphoinositides in the membrane. Thus, it appears that Ste5 may have a
tripartite membrane localization mechanism that can greatly increase the avidity of binding to
the membrane, even if the affinity of each individual interaction is relatively low. The recent
discovery of the PM domain helps explain earlier studies in which mutation of the nuclear
localization signal of Ste5 (which overlaps the PM domain) was found to result in poor
membrane recruitment [106].
A GFP-tagged N-terminal Ste5 fragment (which contains the Ste4 binding site, the
PM domain, and most of the RING-H2 domain) constitutively localizes to the membrane in
cells lacking Ste4, demonstrating that outside of the context of the entire Ste5 protein the PM
domain can interact strongly enough with the plasma membrane to localize the protein
fragment to the cell membrane [220]. Thus, the PM domain may normally be inaccessible,
and upon Ste5 oligomerization or binding of Ste5 to Ste4 the PM domain may be revealed
(possibly due to repositioning of the RING-H2 domain - see below) such that the PM
domain can interact with the plasma membrane and stabilize association with Ste4.
Ste5 oligomerizes
When overexpressed, Ste5 has been shown to oligomerize via co-
immunoprecipitation and two-hybrid studies [222]. Ste5 contains a RING-H2 domain, which
is a member of the RING domain family whose function is implicated in supramolecular
assemblies [223]. Confirming the expected function of the RING-H2 domain, mutations in
the RING-H2 domain eliminate the ability of Ste5 to oligomerize [109, 224].
The stoichiometry of Ste5 oligomerization is unknown. Ste5 has been shown to
function when forced to dimerize via fusion to a homodimerizing GST tag [109, 224]. Ste5
mutants that are deficient in binding the MAPKKK Stel 1 or the MAPKK Ste7 can
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complement Ste5 mutants that are deficient in binding the MAPKK Ste7 or the MAPK
Fus3/Kssl, respectively [222, 225]. Individually, these mutants do not support mating
signaling, suggesting that Ste5 can not only form oligomers, but can actually function as a
dimer or higher order oligomer to transmit mating signal.
Ste4 binding is linked to Ste5 oligomerization
Although oligomerization was not found to increase upon pheromone treatment [99,
109, 226], there still remains substantial evidence that Ste5 oligomerization is linked to
membrane localization. Mutations in the RING-H2 domain selectively eliminate the
interaction between Ste5 and Ste4 as well as the ability of Ste5 to oligomerize, and thus
prevent signaling [224]. Mating response in these Ste5 RING-H2 mutants can be rescued by
fusing the mutant protein to GST. Since GST-Ste5 fusions undergo near complete
oligomerization [99, 109], forced dimerization of Ste5 appears to overcome the defects of
RING-H2 domain mutations. Interestingly, GST-Ste5 RING-H2 domain mutants are able to
support signaling and mating in the absence of STE4, whereas wild-type GST-Ste5 remains
dependent on STE4 for signaling and mating [224]. Thus, the RING-H2 domain may play an
inhibitory role in signaling, and in the context of the wild-type protein this inhibition is
relieved upon binding to Ste4 [224]. These findings demonstrate that forced dimerization of
Ste5 does not bypass the need for Ste4, and Ste4 binding or membrane association may act to
relieve an inhibition of signaling conferred by the Ste5 RING-H2 domain. Oligomerization
of Ste5 may in fact act synergistically with Ste4 binding.
Membrane association activates Ste5
Localization of Ste5 to the plasma membrane serves two roles: to co-localize Stel 1
and its activating kinase Ste20, thereby stimulating the initiation of the MAP kinase cascade
(see Section 3.3.1.c), and to promote the ability of Ste5 to facilitate transmission of the signal
from activated Ste 1l to the downstream kinases. Expression of a constitutively active Stel 1
mutant is insufficient to cause signaling in the absence of pheromone, demonstrating that
Stel 1 activation is not the sole effect of Ste5 membrane localization [227]. Coexpression of
the constitutive Stel 1 mutant with Ste5 mutants that are artificially localized to the plasma
membrane or internal membranes (via different membrane-targeted domains) results in
signaling in the absence of pheromone [227]. Thus, membrane localization, and perhaps
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subsequent interactions between the PH and PM domains and the membrane, is sufficient for
activation of Ste5 and efficient signal propagation.
Distilling evidence into elementary chemical reactions
It is difficult to construct a mechanistic model that is consistent with all of the
experimental observations. Evidence supports the idea that Ste5 oligomerization and Ste4-
Ste5 binding are coupled processes, although this has not yet been proven outright. The
exact role that the Ste5 RING-H2 domain plays in either of these events remains unknown,
although the role of the RING-H2 domain may not be important for a computational model
of signaling dynamics. Evidence also suggests that, for signal propagation, Ste5 must either
be in an active conformation conferred by specific mutations in the RING-H2 domain and
GST-forced dimerization, or conferred by stable association with the membrane via the Ste5
PM and PH domains, via a membrane-targeted appendage fused to SteS, or via binding to
Ste4. It is unclear if activation of Ste5 via artificial membrane targeting also induces Ste5
oligomerization, and thus whether Ste5 oligomerization may be related to Ste5 activation.
Activation of Ste5 may optimize the alignment between, or allosterically activate, the
associated kinases (Ste20, Stel 1, Ste7, and Fus3 or Kssl) to facilitate signaling [228].
Additionally, oligomerization of Ste5 may be required for efficient signaling through the
MAPK cascade if phosphorylation occurs in trans across kinases bound to different Ste5
scaffolds in the same complex. These issues are addressed in greater detail in Sections
3.3.1.c, 3.3.I.d, and 3.3.1.e.
Although the Ste5 PH and PM domains are absolutely required for membrane
localization of Ste5 in response to pheromone, it is likely not necessary to model these
interactions independently from Ste4 binding. No evidence exists to indicate a specific
function for these interactions in wild-type cells other than to stabilize the association of Ste5
with Ste4 and to enable Ste5 to remain at the plasma membrane. However, the Ste5 PH
domain is the primary target by which the G cyclin-CDK complex inhibits pheromone
signaling in the late G1 and S phases of the cell cycle (see Section 3.5.1) [229]. However, I
am ignoring cell cycle effects in the Mating Model (see Section 3.1.4). Thus, it is likely
sufficient to bundle together the functions of the PH and PM domains with the function of the
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Ste5-Ste4 interaction, and simply include in the Mating Model a single composite reaction
that is responsible for localizing Ste5 to the plasma membrane.
In order to specify a mechanism and a corresponding set of reaction rules, several
assumptions need to be made to account for gaps in our knowledge. Because Ste5 can
function when forced into a dimer, and appears to function as an oligomer, it is reasonable to
assume (at least for modeling purposes) that Ste5 functions as a dimer. It is not known
whether Ste5 dimerization or binding to Ste4 is affected by prior binding of Ste5 to Ste 11,
Ste7, Fus3 or Kss1, nor by the phosphorylation states of these kinases. The simplest
assumption would be that none of these factors impact Ste5 dimerization or the affmityof
Ste5 for Ste4. It is also unclear whether each molecule of Ste5 in a dimer binds a separate
Ste4 molecule, or if the two Ste5 molecules interact with a single Ste4 molecule. In the
absence of evidence to the contrary, I assume that each Ste5 in a dimer can interact with a
separate Ste4 molecule. Because of the evidence cited above that suggests the
oligomerization of Ste5 and its binding to Ste4 are mechanistically linked, I assume that Ste5
dimerization and Ste5 binding to Ste4 are cooperative processes, such that a Ste5-Ste5 dimer
has higher affinity for Ste4 than a Ste5 monomer and a Ste5-Ste4 dimer has higher affinity
for a second Ste5 than does a free Ste5.
Numbers from experiments and models
In addition to uncertainty in the mechanisms, little is known about the rate constants
for Ste5 dimerization and association with Ste4. Fluorescence recovery after photobleaching
(FRAP) studies using Ste5-GFP show that Ste5 rapidly associates and dissociates from Ste4
at the shmoo tip, with a half-time for recovery of 8.2 seconds [107]. Assuming that diffusion
along the membrane in and out of the shmoo tip is not the major cause of the fluorescence
recovery, this rate potentially represents a series of dissociation events. Ste5 must dissociate
from Ste4, and possibly from other Ste5 molecules, to allow for association of unbleached
Ste5 molecules into these complexes. Thus, the dissociation of Ste5 monomers or dimers
from Ste4 occurs with a half-time of at most 8.2 seconds, with a corresponding dissociation
rate constant of at least 8.5x 10-2 -1. The association of Ste5 with Ste4 occurs rapidly once
Ste4 is released from Gpal; concentration of Ste5-YFP at the cell periphery can be detected
-10 seconds after pheromone treatment [44]. By 40 minutes after pheromone treatment, the
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majority of Ste5-GFP is located at the shmoo tip [230], and remains there for at least two
hours after pheromone exposure [106, 111].
Several research groups have published computational models that include the
interaction between Ste4 and Ste5, although no published computational modeling paper has
yet included dimerization of Ste5. Kofahl and Klipp [2] used a Ste4-Ste5 association rate of
1.7x 106 M-s-1, and a dissociation rate of 8.3x 10-2 s-1. Although not explicitly referenced, the
dissociation rate is likely derived from the FRAP studies of Ste5-GFP [107]. In this Kofahl
and Klipp model, association of Ste5 with Stel 1, Ste7 and Fus3 is required prior to Ste5
binding Ste4, such that only a small portion of the Ste5 population is capable of binding Ste4.
Similarly, Schaber et al. [136] require association of Ste5 with Stel 1 and Fus3 or Kssl prior
to binding between Ste5 and Ste4 (Ste7 is not included in this model). The authors used an
association rate of 1.7x105 M1's - ' and a dissociation rate of 1.7x10-' s-1. It is difficult to
compare these numbers with the rates from the Kofahl and Klipp model as the concentrations
of the proteins in these models also differ. Shao et al. [100] used an association rate of
8.3x 105 M-'s -' and a dissociation rate of 8.3x 10-2 s-1. The dissociation rate was referenced to
the FRAP studies of Ste5-GFP [107]. In the Shao et al. model, prior assembly of Ste5 with
the kinase proteins was not required. Instead, all complexes that included Ste5 were allowed
to associate with and dissociate from Ste4 such that the entire Ste5 population was available
to bind Ste4.
Computational and graphical representations
A Ste4-Ste5-Ste5-Ste4 complex can be formed via multiple routes, in a similar
fashion to the formation of Ste2-Gpal-Ste4 complexes. Thus, as described for G protein-
receptor interactions in Section 3.2.1.c, the parameters governing association of Ste4 with
Ste5, and Ste5 with Ste5 are subject to constraints. I define the factor by which a single Ste4
increases the ability of Ste5 to dimerize (which is identical to the factor by which Ste5
dimerization increases the ability of the Ste5 dimer to bind a single Ste4) as
Ste4Stel 8Ste5_Ste5_coopfactor. I also define the factor by which prior binding of two Ste5
molecules to Ste4 affects the ability of these Ste5 molecules to dimerize as
Ste4Stel8_Ste5_Ste4Stel8Ste5_coop_factor. All of the constraints among the affinities are given
in Table 3.3.1.b-1.
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Figure 3-31 Self-interaction of Ste5.
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Figure 3-32 Interaction of Ste4 and SteS.
Table 3-14 Parameter constraints for Ste5 dimerization and interaction of Ste5 and Ste4.
Ste4Stel 8_Ste5_Ste5_coop_factor > 1
Ste4Stel 8_Ste5_Ste4Stel 8Ste5_coop_factor > 1
Kd_Ste4Stel8Ste5_Ste5 = Kd_Ste5_Ste5 + Ste4Stel 8_Ste5_Ste5_coop_factor
Kd_Ste4Ste18Ste5_Ste4Stel8Ste5 = Kd_Ste5_Ste5 + Ste4Stel 8_Ste5_Ste4Stel 8Ste5_coop_factor
Kd_Ste4Stel8_Ste5Ste5 = Kd_Ste4Stel8_Ste5 + Ste4Stel 8_Ste5_Ste5_coop_factor
Kd_Ste4Stel 8_Ste5Ste5Ste4Stel8 = Ste4Stel 8_SteSte5_coopfactor x Kd_Ste4Stel 8_Ste5 +
Ste4Stel8_Ste5_Ste4Stel8Ste5_coop_factor
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3.3.1.c MAPKKK (Stell) Activation
Summary
Ste20 phosphorylates Ste 11, and this phosphorylation relieves the inhibition of the
Stell C-terminal catalytic domain by the Stell N-terminal domain. Stell interacts with
Ste5 and Ste50, and both interactions are required for efficient signaling and mating.
Although it is generally assumed that Ste4 and Ste5 mediate the interaction between Stel 1
and Ste20 (as I do in the Mating Model), it is also possible that Ste50 is responsible for
mediating this interaction.
Experiments and evidence
Stel I is phosphorylated by Ste20
Ste20 is able to phosphorylate Stel 1 in vitro [214, 231]. The in vitro phosphorylation
of a Stel fragment (residues 175-424) by Ste20 is prevented by mutation of Stel 1 residues
S302, S306 and T307 to alanine [231]. Mutation of these three residues to alanine in vivo
eliminates halo formation, FUS 1-LacZ expression and mating, whereas mutation to aspartic
acid results in constitutive activation of the pheromone response pathway, indicating that
these residues are responsible for activation of Stel 1 [231]. Each single alanine mutant is
able to function like wild-type Stel 1, suggesting that activation of Ste 11 is not caused by
phosphorylation on only one particular residue.
Inhibition of the Ste l I catalytic domain is relieved by phosphorylation ofStel l
The N-terminal domain of Ste I I (residues 1-424) and the C-terminal catalytic domain
of Stel 1 (residues 424-738) interact by yeast-two hybrid and co-precipitate, and this
interaction is disrupted by the S302D S306D T307D mutant that mimics activation [231].
The triple aspartic acid N-terminal domain mutant still interacts with Ste5 and Ste50,
suggesting that the primary purpose of phosphorylation may be to relieve intra-molecular
interactions that inhibit the catalytic domain. Supporting this idea, the catalytic domain of
the constitutive STE11-4 allele is unable to interact with the N-terminal domain [231].
Interestingly, both Ste50 [232] and Ste5 [233, 234] are also implicated in relieving the Stel 1
auto-inhibition, suggesting that the interactions between Ste50 and Stel 1, and Ste5 and Stel 1
may also play roles in relieving inhibition of the Stel 1 catalytic domain.
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Stel l binds Ste5
Ste5 and Stel 1 interact via yeast two-hybrid and co-immunoprecipitation assays,
even in the absence of other pathway components [235-237], suggesting that the interaction
between Ste5 and Stel 1 is direct. Since both Ste5 and Ste20 bind to GPy upon pheromone
treatment (possibly to the same GPy dimer, see Sections 3.3.1.a and 3.3.1 .b), Stel and Ste20
become co-localized and potentially aligned for efficient Ste20-mediated phosphorylation of
Stel 1. The interaction between Ste5 and Stel 1 does not appear to be modulated by
pheromone treatment; pheromone treatment does not alter the amount of Stel -myc that co-
purifies with GST-Ste5 [236], nor the degree to which fluorescently tagged Ste5 and Stel 1
associate as measured by fluorescence cross-correlation spectroscopy (FCCS) [94]. As
further confirmation, a Stel 1 mutant that cannot be activated (S302A S306A T307A)
interacts with Ste5 to the same degree as wild-type Stel 1, as measured by yeast two-hybrid
[231]. Mutation of Ste5 to disrupt binding between Ste5 and Stel 1 eliminates mating [225,
228], demonstrating that the interaction between Ste5 and Stel 1 is required for mating.
Mating can be partially restored by creating a new interaction between Stel 1 and the Ste5
signaling complex via heterologous dimerization domains [228] or protein fusions [238].
Stel I binds Ste50
Overexpressed Stel 1 and Ste50 co-purify in ste50A, stel IA, ste50Astel lA, ste2OA,
ste50Aste2OA, ste5A, gpalA, ste4A, and Ste4Hpl (defective for Gpal binding) strains,
suggesting that SteSO0 and Stel interact directly and constitutively [57]. This interaction is
mediated by the heterotypic sterile alpha motif (SAM) domains found on both Ste ll and
Ste50 [232, 239]. The interaction between the Stel 1 SAM domain and the Ste50 SAM
domain has been detected by co-purification [232, 240], yeast two-hybrid [239, 240], and
surface plasmon resonance [240]. Deletion of the Ste50 SAM domain [239] or the Stel 1
SAM domain [232] results in mating efficiency and FUS1-lacZ expression similar to those
observed upon deletion of SteS0 itself. Thus, Ste50 appears to contribute to mating response
via interaction with Ste 11. Functional assays using the high osmolarity glycerol (HOG)
pathway show that the SAM domains of Stel 1 and Ste50 can be swapped without
consequence, as long as both proteins do not contain the same SAM domain [241]. Although
T42 lies within the SteS0 SAM domain and phosphorylation of Ste50 at T42 is important for
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mating in ste20A cells, similar amounts of Stel 1-myc co-precipitate with Ste50-T42A and
Ste50-T42D suggesting that phosphorylation of Ste50 at T42 does not affect the interaction
between Ste50 and Stel 1 [242]. Additionally, the amount of Stel 1-myc that is co-
precipitated with Ste50 is unchanged by exposure to pheromone and osmolarity [232],
suggesting that activation of Stel 1 does not affect its interaction with Ste50. Mutation of the
phosphorylated residues on Stel 1 to alanine to prevent phosphorylation (S302A S306A
T307A), or to aspartic acid to mimic phosphorylation (S302D S306D T307D) does not alter
the yeast two-hybrid interaction between Stel and Ste50 [231], further confirming that
Stell activation does not affect the affinity of Stel 1 for Ste50.
Stel 1 has also been shown to self associate both in vivo and in vitro. In vivo
association was detected by yeast two-hybrid [243] and co-purification of overexpressed
myc-Stel 1 with overexpressed GST-Stel 1 [57]. In both cases, the pheromone response
pathway was left intact, so other proteins in the pathway (for example, Ste50 or Ste5) may
mediate this interaction. In fact, the Stel 1 and Ste50 SAM domains form a heterotrimer (two
Stel 1-SAM, one Ste50-SAM) [244, 245], suggesting that Stel 1 and Ste50 may themselves
form a trimer. In vitro, the SAM domain from Stel I self-associates with a Kd of about 0.5
mM [244, 245]. Since this represents a concentration of tens of millions of Stel 1 proteins
per cell (far higher than the actual abundance of Stel 1 - see Section 3.3.3.c), it seems
unlikely that Stel 1 self-association occurs via its SAM domain in vivo.
Ste50 may facilitate the interaction between Stel l and Ste20
Ste50 contains a Ras association (RA) domain that associates with GDP- and GTP-
bound Cdc42 with equal affinity [246]. The RA domain is required for Ste50 mediated
activation of the high osmolarity glycerol (HOG) [241, 247] and filamentous growth (FG)
[246] pathways. HOG and FG response can be restored to ste50A or Ste50-ARA cells by
artificially targeting Ste50 or Stel 1 to the membrane, or by fusing the RA domain to directly
to Stel 1 [241, 246]. Ste50 and Ste20 bind to different regions on Cdc42, suggesting that a
single Cdc42 might be able to simultaneously bind to Ste50 and Ste20 [247]. Thus, it
appears that in both the HOG and FG pathways, Ste50 facilitates phosphorylation of Stel 1
by simultaneously binding Ste 1l and Cdc42 such that Cdc42-bound Ste20 can phosphorylate
Ste 11.
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The interaction between Ste50 and Cdc42 also appears to be important for mating
response, as expression of just the Ste50 SAM domain (a deletion of the RA domain) in a
ste50A background results in a more severe defect in FUS1-lacZ expression [232, 248] and
mating efficiency [232, 239] than Ste50ASAM or ste50A strains. The increase in severity of
the defect upon expression of the Ste50 SAM domain varies from source to source [232, 239,
248], making it difficult to determine how important this effect may be.
Distilling evidence into elementary chemical reactions
There is significant uncertainty regarding the exact mechanisms of activation of
Stel 1. I know that Ste20 phosphorylates Stel 1, and this phosphorylation appears to relieve
an interaction between the C-terminal kinase and N-terminal domains of Stel 1.
Interestingly, the interaction between Ste50 and Stel 1 also appears to interfere with Stell 1
auto-inhibition, although it has not been shown that this interaction increases the Stel 1
kinase activity.
One conventional model is that upon pheromone treatment, Ste5 localizes Stel 1 to
the plasma membrane and facilitates the interaction between Ste20 and Ste 11. The
interaction between Stel 1 and Ste5 is constitutive, and both Ste5 and Ste20 have been shown
to interact with Ste4 in a pheromone dependent manner. Both Ste5 and Ste20 may be able to
simultaneously bind a single Ste4 molecule (as I have assumed, see Section 3.3.1.a),
facilitating phosphorylation of a bound Ste 1 molecule. If Ste5 and Ste20 cannot both bind
to a single Ste4 molecule, then the interaction between Ste20 and Stel 1 may be facilitated by
the co-localization of both Ste20 and Ste 11 initially to the plasma membrane, and later
during mating response to the shmoo tip.
The role that Ste50 plays in activation of Stel 1 and mating signal transduction as a
whole is not clear. Ste50 may serve one or more non-exclusive roles. First, Ste50 may act
only on Stel 1 itself and serves to stabilize the active conformation of Ste 11 or allow for
easier activation of Ste 11. This could be tested in vitro, but to my knowledge has not been
done so yet. This possibility would suggest that only the interaction between Ste50 and
Stel 1 would affect pathway activity. However, deletion of the Ste50 RA domain reduces
mating efficiency more than deletion of the Ste50 SAM domain that moderates the
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interaction between Ste50 and Stel 1. Second, Ste50 may help stabilize the formation of the
signaling complex involving Ste20 and Stel 1. Ste50 interacts with Cdc42, which interacts
with Ste20, which interacts with GPy, which interacts with Ste5, which interacts with Stel 1,
which interacts with Ste50 (see Section 3.6.3 and Figure 3-126). If all of these interactions
can occur simultaneously, then Ste50 may act to help stabilize this complex. Third, Ste50
may be directly responsible for mediating the phosphorylation of Ste 11 via the interaction
between Ste50 and Ste20-bound Cdc42; Ste5 may only be required for active Stel to
phosphorylate Ste7. This third possibility is supported by several subtle pieces of evidence.
Deletion of the Ste50 RA domain results in a slightly stronger mating defect than deletion of
the SAM domain or deletion of the entire Ste50. This observation suggests that the Ste50
SAM domain may compete with another interaction (possibly binding of Ste 11 to Ste5), such
that when Ste50 is unable to link Stel 1 to Cdc42 and Ste20 (by deletion of the Ste50 RA
domain), the Ste50 SAM domain by itself has a negative impact on signaling. This
possibility would also mean that Stell 1 is activated by the same mechanism in the pheromone
response pathway as it is in the HOG and FG pathways. If this possibility were true, then
there may be no specific upregulation of Ste 11 activity in response to pheromone. Mating
signal might be caused by re-localization of Ste5 to the membrane, where Stel is
phosphorylated by Cdc42-bound Ste20 (Cdc42 is membrane associated). Since Stel 1 is
phosphorylated exclusively at the plasma membrane, there should exist some gradient of
active Ste 11 with the highest concentration at the membrane [249], so re-localization of Ste5
to the plasma membrane would enhance the local concentration of active Stell near Ste5.
This effect would be enhanced over time as G3y molecules are clustered to one site on the
cell periphery which becomes the shmoo tip.
Several experiments could help to differentiate between these possibilities. First, one
could investigate in vitro whether Stel I can simultaneously bind Ste5 and Ste50. Using
purified Ste20, Stel 1 and Ste7, one could investigate whether Ste50 facilitates the
phosphorylation of either Stel 1 or Ste7. Another important experiment would be to observe
whether mutation of Ste5 such that it no longer binds Stel 1 prevents activation of Stel 1 or
not.
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The significance of the Stel -Ste50O trimers is also unclear. It is unknown if the
interaction between the C- and N-terminal domains of Stel 1 occurs intra- or inter-
molecularly. If this interaction is inter-molecular, then the occurrence of the Stel 1-Ste 1-
Ste50 trimer may be a result of subsaturating amounts of Ste50 such that Ste50 binds the N-
terminal of a Stel 1 molecule whose C-terminal kinase domain is bound by the N-terminus of
another Ste 1 molecule.
Because there are still many unknown factors surrounding the role Ste50 plays in
regulating mating response, it would be wise to make the most conservative assumption: Ste5
regulates the interaction between Stel 1 and Ste20, and Ste50 acts as an unregulated factor
that facilitates the activation of Stel 1. Although the interaction between Ste50 and Stel 1 is
vital to signal propagation, it may not be important to include this interaction in a
computational model since the interaction is not regulated.
Thus, a simple likely mechanism is that Ste 1l binds Ste5 with the same affinity and
rates independent of the phosphorylation state of Stel 1, whether or not Ste5 is bound to GPy
or the other kinases (Ste7, Fus3 or Kss 1), the dimerization state of Ste5, and whether or not
Stel 1 is bound to Ste50. In this simple model, Ste20, bound to a Gpy-Ste5-Stel complex,
can phosphorylate the Stel I within the complex in a distributive ordered fashion (i.e., Ste20
phosphorylates Stel 1 on three sites in a particular order, and each phosphorylation event is a
separate reaction). Because the role that Ste50 plays is unclear, it is reasonable to assume for
now that the effect of Ste50 is factored into the rates of Stel binding to Ste5 and the rates of
Stel 1 phosphorylation, such that Ste50 can be omitted from the Mating Model.
Numbers from experiments and models
Binding kinetics for the interaction between the Stel 1 SAM domain and the Ste50
SAM domain have been measured by surface plasmon resonance (kon - 0.40 gM-ls-l , koff=
0.026 s-1, Kd = 65 nM) [240], although these numbers are not needed for the Mating Model
since this interaction is not omitted from the model. Unpublished data suggests that Ste 1l
binds to Ste5 more tightly than either Ste7 or Fus3 (1 ItM [250]) binds to Ste5 [236]. Two
groups used fluorescence cross-correlation spectroscopy to estimate effective affinities of
about 90 nM [94] and 123 nM [99] for association of Ste5 with Stel 1. These affinities
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represent the overall affinity of interaction, including any indirect linking of Ste5 to Ste 11 via
other proteins. In the absence of a plausible set of interactions that would link Ste5 and
Ste 11 indirectly, I assume that the average of these two measurements, 107 nM, is a
reasonable measure of the direct interaction.
Only a few published computational models include reactions for the binding of
Stel 1 to Ste5, and for the phosphorylation of Stel 1. Kofahl and Klipp [2] used association
and dissociation rates for the Stel 1-Ste5 interaction of 1.7 x 107 M-'s'- and 0.08 s-1
(respectively), and Shao et al. [100] used similar rates of 1.7 x 107 M-'s l 1 and 0.17 s- . Both
Kofahl and Klipp, and Shao et al. used a rate constant for Stel triple phosphorylation of
0.33 s-' .
Computational and graphical representations
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Figure 3-34 Phosphorylation of Stell at S302 by Ste20.
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Figure 3-35 Phosphorylation of Stell at S306 by Ste20.
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Table 3-15 Parameter constraints for Stell phosphorylation.
KdSte5_Stell 1.07 x 10-7 M
3.3.1.d MAPKK (Ste7) Activation
Summary
Ste7 interacts with Ste5. Active Stel 1 phosphorylates Ste7, activating Ste7 kinase
activity. Phosphorylation of Ste7 may occur in trans across a Ste5 dimer, with Ste 11 and
Ste7 bound to different Ste5 monomers.
Experiments and evidence
Ste7 interacts with Ste5
Ste5 and Ste7 interact via yeast two-hybrid and co-immunoprecipitation, even in the
absence of other pathway components [235-237], suggesting that this interaction is direct.
An interaction between fluorescently tagged Ste5 and Ste7 can be detected by fluorescence
cross-correlation spectroscopy, and the strength of the interaction does not change in
response to pheromone treatment [94, 99].
Ste7 interacts with Ste5 via the Ste7 C-terminal kinase domain [237], whereas Ste7
interacts with Fus3 and Kssl via the Ste7 N-terminal domain [237, 250-254], suggesting that
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Figure 3-36 Phosphorylation of Stell at T307 by Ste20.
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Ste7 may be able to bind both Ste5 and Fus3 (or Kssl) at the same time. In vitro, binding
between Kssl-myc and Ste5 can only be detected in the presence of Ste7 [255], further
confirming that Ste7 can be bound to both Ste5 and a MAPK.
Ste7 is phosphorylated in vivo by active Stel 1 (see below) and active Fus3 (see
Section 3.3.2.d). Mutation of the residues on Ste7 that are targeted by Fus3 to glutamic acid
residues to mimic phosphorylation (Ste7 S106E T116E S130E T137E T147E T149E S471E,
or Ste7-E7), or mutation of the residues on Ste7 that are targeted by Stell to glutamic acid
residues (Ste7 S359E T363E, or Ste7-EE), does not alter the amount of Ste7 that co-
precipitates with Ste5 [256]. Conversely, when all nine phosphorylation sites are mutated to
glutamic acids (Ste7-EE-E 7), less Ste7 is co-precipitated by Ste5, indicating that hyper-
phosphorylated Ste7 may have a reduced affinity for Ste5 [256]. However, the activation
loop mutations, S359E T363E, may not be a good model for activation of Ste7 in vivo, as
Ste7-EE fails to support transcription and cell-cycle arrest in the absence or presence of
pheromone [256, 257].
Ste7 is activated by Stell
Stell can phosphorylate Ste7 both in vitro [258] and in vivo [259]. Stell
phosphorylates Ste7 at S359 and T363, and mutation of either of these sites to alanine or
valine is sufficient to eliminate mating response [258, 260]. Both Stel 1 and Ste7 bind to
Ste5 [236], and mutations to Ste5 that decrease its interaction with Stel 1 or Ste7 greatly
decrease mating efficiency [225]. Binding of Stel 1 to Ste5 may help relieve the inhibitory
effect of the N-terminal region of Stel 1 on the kinase domain of Stel 1 [233, 234], supporting
the idea that Stel 1 and Ste7 must be bound to Ste5 for activation of Ste7.
Ste7 may be activated by phosphorylation in trans across a Ste5 dimer
Efficient mating response appears to require Ste5 oligomerization and/or activation
(see Section 3.3.1.b). Additionally, Ste5 mutants with decreased affinity for Stel 1 or Ste7
nearly eliminate mating, whereas co-expression of these mutants restores mating [225].
These experiments suggests either that localization of Ste 11 and Ste7 to within a single
complex is sufficient to restore mating, or that Stel 1 can phosphorylate Ste7 specifically in
trans across a Ste5 dimer, with Stel 1 and Ste7 bound to different Ste5 molecules. When
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association of Stel 1 or Ste7 with Ste5 is restored to the Stel 1- or Ste7-binding deficient Ste5
mutants via a heterodimerization domain (essentially testing the forced localization
hypothesis), mating is only very weakly restored [228](C. Inouye and J. Thorner,
unpublished observations). Because interallelic complementation has a much stronger
mating phenotype than forced localization of the kinases, the interallelic complementation
study suggests that Stel 1 phosphorylates Ste7 in trans across a Ste5 dimer. Finally, cells
with hyperactive Stel 1 or Ste20 mutants have increased basal pathway activity, but still
respond to pheromone [227]. The increase in response observed upon pheromone
stimulation may be caused at least in part by increased efficiency of Ste7 phosphorylation
due to pheromone dependent dimerization of Ste5, and possibly a conformational change in
Ste5 upon binding to GPy that aligns active Ste 11 and Ste7 (see Section 3.3.1.b).
Distilling evidence into elementary chemical reactions
It is unclear whether hyper-phosphorylation of Ste7 affects the affinity of the
interaction between Ste7 and Ste5. Mutants suggest that hyper-phosphorylation of Ste7 by
Fus3 may only decrease the affinity of Ste7 for Ste5 when Ste7 is also phosphorylated by
Stel 1. However, the mutations used to mimic phosphorylation by Ste7 do not appear to be a
good model for Ste7 activation in vivo, suggesting that the altered affinity of hyper-
phosphorylated Ste7 for Ste5 may not occur in vivo. I assume that this binding affinity is not
affected by hyper-phosphorylation of Ste7, binding of the other kinases to Ste5, dimerization
of Ste5, and binding of Ste5 to G3y. Based on the fact that the binding sites for Ste5 and
Fus3 (and Kssl) are on different parts of the Ste7 primary structure, and Ste7 help mediate
association of Kss 1 with Ste5, I assume that binding of Ste7 to a MAPK does not affect its
ability to interact with Ste5.
Although conventional wisdom has it that Stel 1 and Ste7 must both bind to the same
Ste5 monomer for active Stel 1 to phosphorylate Ste7, evidence suggests otherwise. First of
all, experiments using interallelic complementation show that active Ste 1 is able to
phosphorylate Ste7 when the two kinases are unable to bind to the same Ste5 monomer. The
mating observed via interallelic complementation is much more efficient than the mating
observed when Stel 1 or Ste7 are artificially targeted to the Ste5 complex. Thus, it appears
that Stel 1 can phosphorylate Ste7 in trans across a Ste5 dimer (or higher order oligomer). I
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further assume that Stel 1 must phosphorylate Ste7 in trans across a Ste5 dimer, as it seems
sterically unlikely that Stel 1 is positioned to phosphorylate Ste7 both in trans across a ste5
dimer and in cis on the same Ste5 monomer. Mating signal caused by a constitutively active
Stel 1 allele can be further augmented by pheromone treatment, suggesting that mating
pathway activation increases Ste5 dimerization or otherwise alters the conformation of Ste5,
resulting in superior alignment between Stell 1 and Ste7. Because Ste5 dimerization does not
increase significantly upon pheromone treatment [109, 226], I assume that binding to GPy (or
equivalently, recruitment to the plasma membrane, see Section 3.3.1.b) is required to induce
a conformational change in Ste5 that allows for efficient phosphorylation of Ste7. Thus, the
mechanism that I encode in the Mating Model is active Stel 1, bound to one Ste5 monomer in
a Ste5 dimer, phosphorylates Ste7 bound to the other Ste5 monomer, and this
phosphorylation only occurs if the Ste5 dimer is localized to the membrane via at least one of
the Ste5 monomers in the dimer associating with a GPy molecule. I assume that
phosphorylation does not occur at all when both Stel and Ste7 are bound to the same Ste5
monomer, and that the rate of phosphorylation is insignificant when the Ste5 dimer is not
bound to a Goy. I further assume that Ste7 phosphorylation occurs in an ordered distributive
fashion, where S359 is phosphorylated first, followed by phosphorylation of T363.
Finally, the relative (and absolute) activities of the different Stell phospho-species
are not entirely known. Mutation of any one of the three Stell activation sites (S302, S306
and T307) to alanine results in wild-type behavior [231], suggesting that there is no
difference in activity between doubly and triply phosphorylated Stel 1. I assume that singly
phosphorylated Stel 1 has a reduced kinase activity (such that
kcat_Stel l pSpSSte5Ste4Ste5Ste7_pS = kcatStel l pSpSpTSte5Ste4Ste5Ste7_pS =
kcat_Stel lpSSte5Ste4Ste5Ste7_pS x Stel 1 pS_only_factor and kcatStel lpSpSSte5Ste4Ste5Ste7pST =
kcat_Stel lpSpSpTSte5Ste4Ste5Ste7pS_pT = kcat_Stel pSSte5Ste4Ste5Ste7pS_pT x
Stel 1.pSonly_factor), although this has not been verified experimentally.
Numbers from experiments and models
The effective affinity between fluorescently-labeled Ste5 and Ste7 molecules has
been measured by fluorescence cross-correlation spectroscopy by two groups: Maeder et al.
measured an affinity of about 120 nM [94], and Slaughter et al. measured an affinity of about
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84 nM [99]. These affinities represents the overall affinity of interaction, include any
indirect association of Ste5 with Ste7 via other proteins. In the absence of a plausible set of
interactions that would link Ste5 and Ste7 indirectly, I assume that the average measured
value, 102 nM, is a reasonable measure of the direct interaction. The rate constants for Ste7
phosphorylation have not been measured directly.
A few published computational models include Ste7-Ste5 association and Ste7
phosphorylation reactions. Kofahl and Klipp used association rate of 5 x 107 M- s-1,
corresponding to the association of a Ste7-Fus3 dimer with Ste5 [2]. They used a
dissociation rate of 1.7 s-1 (Kd = 34 nM) prior to binding of GPy to Ste5, and 0.05 s-1 (Kd = 1
nM) after binding of GPy to Ste5. Shao et al. used a similar association rate, 2 x 107 M-Is-1
for binding of unphosphorylated Ste7 to Ste5, but a drastically different dissociation rate, 1.7
x 10-3 S-1 (Kd = 85 pM) [100]. Shao et al. assumed that phosphorylated (active) Ste7 is
rapidly hyper-phosphorylated by Fus3, and that this form of Ste7 dissociates more rapidly
from Ste5, causing a slow dissociation of Ste7 from Ste5, at a rate of 8.3 x 10-3 s-1, when
Fus3 is not bound to Ste5, and a rapid dissociation, at a rate of 0.3 s'1, when Fus3 is also
bound to Ste5. None of these rates have an experimental basis. Both modeling studies
employed similar rate constants for processive double phosphorylation of Ste7 by fully active
(doubly- or triply-phosphorylated) Stel 1: 0.78 sl- [2] and 0.77 s-1 [100].
Computational and graphical representations
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Figure 3-37 Interaction of Ste5 and Ste7.
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Figure 3-38 Phosphorylation of Ste7 at S359 by Stell.
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Figure 3-39 Phosphorylation of Ste7 at T363 by Stell.
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3.3.1.e MAPK (Fus3 and Kssl) Activation
Summary
The MAPKs Kssl and Fus3 are both phosphorylated by Ste7. Although both MAPKs
bind to SteS, only phosphorylation of Fus3 appears to require Ste5. Fus3 and Kssl also form
stable complexes with Ste7 that may be enzyme-substrate complexes. Additionally, Fus3
undergoes intramolecular autophosphorylation at one residue on the activation loop, and this
autophosphorylation is accelerated by binding to Ste5.
Experiments and evidence
MAPKs are phosphorylated by Ste7
Purified active Ste7 is able to phosphorylate Fus3 in vitro, and does so primarily on
T180 and Y182 [258, 261]. Phosphorylation on these residues is necessary for activation of
Fus3 [261]. Similarly, Kssl is phosphorylated at T183 and Y185 in response to pheromone,
with Y185 being more strongly phosphorylated [262]. Strong phosphorylation on Y185 is
expected as MAP kinases tend to be phosphorylated on the tyrosine on their activation loop
before being phosphorylated on the threonine within the activation loop [263].
MAPKs bind Ste5
Ste5 interacts with Kssl and Fus3 via yeast two-hybrid and co-immunoprecipitation,
even in the absence of other pathway components [235-237], suggesting that interactions
between the MAPKs and Ste5 are direct. The interaction between fluorescently-tagged Ste5
and Fus3 molecules has been observe in vivo via fluorescence cross-correlation spectroscopy,
and the strength of the interaction does not change in response to pheromone treatment [94].
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Table 3-16 Parameter constraints for Ste7 phosphorylation.
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A 30-residue peptide from Ste5 that binds Fus3 has very low homology to the canonical
MAPK docking motif, even though this peptide interacts with the Fus3 MAPK docking
groove [254]. Binding studies using larger Ste5 fragments suggest that Ste5 interacts more
strongly with Fus3 than it does with Kssl [250]. In vitro, binding between Fus3-myc and
Ste5 can be readily detected in both the absence and presence of Ste7, whereas binding
between Kssl-myc and Ste5 can only be detected in the presence of Ste7 [255].
Additionally, overexpressed plasma membrane-targeted Ste5 localizes Fus3-GFP, but not
Kssl-GFP, to the cell periphery [107].
Overexpressed plasma membrane-targeted Ste5 localizes Fus3-GFP to the cell
periphery even when Fus3 is mutated to be catalytically inactive (K42R) or non-
phosphorylatable (T180A Y182F), suggesting that the interaction between Ste5 and Fus3 is
independent of catalytic activity and phosphorylation of Fus3 [107]. However, using the
same membrane localized Ste5, photobleaching of non-phosphorylatable Fus3-GFP at the
membrane results in a slower decrease in nuclear fluorescence than photobleaching of wild-
type or catalytically inactive Fus3-GFP. These three Fus3 alleles (WT, K42R, and T180A
T182F) all have similar nuclear import rates, suggesting that phosphorylation of Fus3 may
increase the dissociation rate from Ste5 [107].
There is also some evidence that Fus3 may bind preferentially to Ste5 dimers. First,
the interaction between fluorescently-tagged Fus3 and Ste5 was enhanced by overexpression
of GST-Ste5 but not Ste5 (as determined by fluorescence cross-correlation spectroscopy)
[99]. GST-Ste5 has been shown to undergo near complete dimerization [99, 109], suggesting
that Fus3 may interact more strongly with Ste5 dimers than with Ste5 monomers.
Additionally, a weak FRET signal can be detected between Ste5 and Fus3 at the cell
periphery in response to pheromone treatment, but not elsewhere in the cell [99]. Assuming
that Ste5 dimerization is linked to relocalization of Ste5 to the plasma membrane (see Section
3.3.1.b), this further supports the notion that Fus3 may interact more strongly with Ste5
dimers than monomers.
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Ste5 appears to play a role in Fus3 phosphorylation
Deletion of residues 143-309 from Ste5 eliminates the yeast two-hybrid interaction
between Ste5 and Fus3 and prevents the activation of Fus3 in response to pheromone [236],
suggesting that the interaction between Fus3 and Ste5 is required for the activation of Fus3.
Mutation of Ste5 such that it no longer binds Ste7 nearly eliminates phosphorylation of Fus3
in response to pheromone, whereas it only slightly decreases phosphorylation of Kss 1 in
response to pheromone [264]. Because Kssl is still phosphorylated in response to
pheromone when Ste5 cannot bind Ste7, Ste7 must also be activated. Thus, the fact that Fus3
is not phosphorylated indicates that Fus3 phosphorylation requires that Ste7 be bound to Ste5
in addition to being activated. As further support, constitutively active Ste7 can
phosphorylates Fus3 much more efficiently in vitro in the presence of a Ste5 fragment
containing the Ste7 and Fus3 binding domains [253].
Crystal structures show that a 30-residue peptide from Ste5 binds to the docking
groove of Fus3; the docking groove on Fus3 also binds the Ste7, Msg5 and Farl MAPK
docking motif peptides [253, 254]. The fact that Ste5 and Ste7 bind to the same site on Fus3
explains earlier observations that the Ste7 MAPK docking motif peptide interferes with
binding between Fus3 and Ste5 fragments [250]. Given that the interaction between Ste5 and
Fus3 is required for signaling (see above), and that the Ste7 docking motif peptide interferes
with the interaction between Fus3 and the Ste5 MAPK-binding peptide, one might expect
that the interaction between Ste7 and Fus3 would attenuate signaling. However, mutation or
deletion of one of the two MAPK docking motifs on Ste7 decreases the transcriptional
response of to pheromone [252, 254], and mutation of both MAPK docking motifs on Ste7
reduces pathway output nearly as much as deletion of Ste7 [254]. Thus, the interaction
between Fus3 and Ste7 is required for signaling. Mutations to Ste5 that were found to
prevent the interaction of the Ste5 peptide with Fus3 result in a 2-fold increase in
transcriptional output in response to pheromone [254], suggesting that the interaction
between Fus3 and Ste5 may actually attenuate response. It was later confirmed by
fluorescence cross-correlation spectroscopy that full length Ste5 bearing these mutations does
in fact have a greatly reduced affinity for Fus3 [94].
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Binding of Kssl to Ste5 does not impact Kssl phosphorylation
Kssl and Fus3 appear to have different requirements for activation. As described
above, phosphorylation of Kssl in response to pheromone treatment is only slightly
decreased by elimination of the interaction between Ste5 and Ste7 [264]. Constitutively
active Ste7 can phosphorylate Kssl in vitro in the absence of Ste5 [253]. Together, these
experiments suggest that, unlike Fus3 phosphorylation, Kss 1 phosphorylation occurs
efficiently off of the scaffold Ste5. However, like Fus3, Kssl requires an interaction with
Ste7 for activation; mutation of either one of the Ste7 MAPK docking motifs has little effect
on in vitro phosphorylation of Kssl, but mutation of both eliminates Kssl phosphorylation
[253].
MAPKs bind Ste7
Ste7 interacts in vitro with both Fus3 and Kssl with equal affinity [250-252]. Ste7
co-immunoprecipitates with Fus3 or Kss 1 (when either pair of proteins is overexpressed),
both in the absence and presence of pheromone, suggesting that the interaction between Ste7
and the MAPKs is constitutive [251]. Association between fluorescently-tagged Ste7 and
Fus3 can also be detected in vitro via fluorescence cross-correlation spectroscopy [94, 99].
Ste7 contains two partially redundant MAPK docking motifs at residues 7-19 and residues
61-72 [253]. When immune complexes with active Ste7 and inactive Fus3 (or Kssl) are
treated with Mg2+ and radiolabeled ATP to initiate kinase reactions, the presence of
saturating amounts of Ste7(1-172) (which contains the two MAPK docking motifs) is
sufficient to inhibit phosphorylation of Fus3 or Kssl [251]. This experiment suggests that
the stable complex formed between Ste7 and either MAPK must dissociate in order for Ste7
to phosphorylate the MAPKs. However, Ste7 and the MAPKs appear to interact primarily
through the redundant MAPK docking motifs on the N-terminus of Ste7, and mutation of
both of these sites eliminates pathway activity [254]. Thus, the Ste7-MAPK complex is vital
for signaling, despite the finding that the Ste7-MAPK complex does not appear to be an
enzyme-substrate complex.
Mutation of S359 and T363 on Ste7 to glutamic acids to mimic activation greatly
decreases the interaction between Ste7 and Fus3 [256]. However, although the Ste7-EE
mutant enables phosphorylation of Fus3 in vivo [257], Ste7-EE fails to support transcription
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and cell-cycle arrest in response to pheromone [256, 257], suggesting that the S359E T363E
mutations are not a good model for Ste7 activation in vivo.
Fus3 autophosphorylation is increased by binding to Ste5
Fus3 undergoes autophosphorylation in vivo, almost exclusively on Y182 within the
activation loop [261, 265]. In vitro, binding of Fus3 to a fragment of Ste5 increases Fus3
autophosphorylation by more than 50-fold, whereas binding of Fus3 to peptides from other
binding partners has minimal effect on the autophosphorylation rate [254]. The crystal
structure shows that the Ste5 peptide binds to both the C- and N-terminal lobes of Fus3,
causing a slight shift in their relative orientation. Fus3 autophosphorylation is concentration-
independent, suggesting that autophosphorylation occurs intramolecularly [254].
Intramolecular autophosphorylation of other MAPKs has also been reported [266].
Distilling evidence into elementary chemical reactions
Binding of both Kssl and Fus3 to Ste5 clearly occurs, although the relevance of
binding to phosphorylation of the MAPKs is perhaps disputable. Evidence suggests that
active Fus3 may dissociate more rapidly from Ste5 than inactive Fus3. The effect of
activation of Kss 1 on Kssl-Ste5 binding has not been investigated. In the absence of
evidence to the contrary, I assume that Kss 1 and Fus3 bind to Ste5 independently of whether
Ste5 is bound to Gy•y, Stel 1 or Ste7, and whether Ste5 is dimerized. However, I assume that
phosphorylation of Fus3 and Kss 1 increases their dissociate rate from Ste5. Since Kssl and
Fus3 are thought to bind to the same site on Ste5, only one can be bound to a Ste5 molecule
at any given time. Finally, until more conclusive evidence is available, I assume that Ste5
dimerization does not affect binding of Fus3 and Kssl to Ste5.
The interaction between Ste7 and the MAPKs is vital for the activation of the
MAPKs. Although Ste7 contains partially redundant MAPK docking motifs, modeling a
single binding site on Ste7 is likely sufficient because Ste7 has not been shown to use both
MAPK docking motifs at the same time. However, it is possible that binding of Fus3 or
Kss 1 to either of the partially redundant MAPK docking motifs on Ste7 facilitates
phosphorylation of either the tyrosine or threonine on the activation loop. The interaction
between the MAPKs and Ste7 also does not appear to be regulated by activation of Ste7 or
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the MAPKs. Thus, I assume that the rates of binding between and dissociation between Ste7
and either MAPK are unchanged by phosphorylation of Ste7, Fus3 or Kss 1. I also assume
that prebinding of Ste7 to either MAPK does not impact the interaction between Ste7 and
Ste5 (see Section 3.3.1.d). This assumption is equivalent to assuming that prebinding of Ste7
to Ste5 does not impact the interaction between Ste7 and either MAPK.
The experimental evidence does not suggest a clear mechanism for Fus3
phosphorylation. Given our current knowledge, I have determined that there are two equally
likely models. Both models require ignoring or making assumptions about some subset of
the supporting evidence.
The established model for activation of Fus3 is that both Ste7 and Fus3 must be
bound to Ste5 in order for Ste7 to phosphorylate Fus3. Supporting this model, deletion of
either the Ste7 or Fus3 binding domains of Ste5 is sufficient to eliminate phosphorylation of
Fus3, and that efficient in vitro phosphorylation of Fus3 requires Ste5. Fus3 and Ste7 might
bind cooperatively to Ste5, because the MAPK docking motifs on Ste7 are required for
activation of Fus3. However, Fus3 appears to bind competitively to Ste5 and Ste7 via its
MAPK docking groove, which conflicts with the notion of cooperative binding between Ste7,
Ste5 and Fus3. Additionally, specific mutations that reduce or eliminate binding in between
Ste5 and Fus3 do not eliminate mating signal (which is, in fact, increased 2-fold by these
mutations).
A new potential model is that Ste7 must be bound to both Ste5 and to Fus3, and Fus3
cannot also be bound to Ste5, for Fus3 activation. In this case, binding of Ste7 to Ste5 would
act allosterically to enable efficient phosphorylation of Fus3; Ste7 that is not bound to Ste5
would be a poor activating kinase for Fus3. This model is supported by the fact that Ste7
binding to Ste5 is required for efficient phosphorylation of Fus3, but not for efficient
activation of Ste7 itself. Also, this model explains the vital role of the interaction between
Fus3 and Ste7, and relieves the conflict of the MAPK docking groove on Fus3 binding
simultaneously to Ste5 and Ste7. However, deletion of a 167 amino acid segment of Ste5
that is responsible for the interaction between Ste5 and Fus3 eliminates mating response,
suggesting that binding of Fus3 to Ste5 is required for signaling. On the other hand, a large
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deletion of 167 residues may drastically alter the conformation of Ste5 to eliminate efficient
phosphorylation between upstream kinases in addition to abolishing the interaction between
Ste5 and Fus3. Supporting this, specific mutation of the MAPK docking motif on Ste5 to
eliminate binding between Ste5 and Fus3 actually increases pathway signaling.
Both proposed models conflict with some critical piece (or pieces) of evidence: the
first model cannot explain the vital role of the MAPK docking motif on Ste7 given the
requirement that Fus3 must bind to Ste5; the second model cannot explain why mating is
eliminated upon deletion of the MAPK binding domain of Ste5. However, I can more
readily propose a plausible explanation for why the latter may be true: deletion of the MAPK
binding domain may otherwise cripple Ste5 such that the alignment between the kinases is
altered and efficient phosphorylation is eliminated. Thus, I assume that the latter model is
true - Fus3 can only be phosphorylated by active Ste7 that is Ste5-bound, and when Fus3 is
bound to Ste5 it cannot be phosphorylated. As is true for other MAPK kinases (see below), I
assume that doubly-phosphorylated Ste7 phosphorylates Fus3 more efficiently than singly
phosphorylated Ste7 does, by a constant factor Ste7_pS_only_factor (such that
kcat_Ste5Ste7pSpTFus3_pT = kcat_Ste5Ste7pSFus3_pT x Ste7_pSonlyfactor, kcat_Ste5Ste7pSpTFus3_pY
= kcat_Ste5Ste7pSFus3_pY x Ste7_pS_only_factor, kcat_Ste5Ste7pSpTFus3pYpT
kcat_Ste5Ste7pSFus3pY_pT x Ste7_pS_only_factor, and kcat_Ste5Ste7pSpTFus3pT_pY =
kcat_Stete7pSFus3pT_pY x Ste7_pS_only_factor). Unlike the phosphorylation of Stel 1 and Ste7,
I do not assume ordered phosphorylation of Fus3. I assume that the phosphorylation rates are
independent of the binding of other proteins to Ste5 and of feedback phosphorylation of Ste7
(see Section 3.3.2.d). I also assume that Ste7 interacts with Fus3 with the same affinity
regardless of whether or not Fus3 and Ste7 are phosphorylated.
Activation of Kssl appears to be simpler than activation of Fus3. Because Ste7
binding to Ste5 is not required for efficient phosphorylation of Kssl and in vitro
phosphorylation of Kss 1 does not require Ste5, Kssl is likely efficiently phosphorylated
when neither Kss 1 nor Ste7 is bound to Ste5. However, it is unclear whether
phosphorylation is efficient, or occurs at all, when either of or both of Ste7 and Kss 1 are
bound to Ste5. I assume that Kssl can also be phosphorylated when Ste7 is bound to Ste5
(the same circumstances in which Fus3 is phosphorylated). Again, I assume that the binding
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of other proteins to Ste5, and feedback phosphorylation of Kssl (see Section 3.3.2.d) do not
affect the rates of phosphorylation of Kssl. As with Fus3 phosphorylation, I assume that
doubly-phosphorylated Ste7 is more catalytically active than singly-phosphorylated Ste7 by
the same constant factor Ste7pS_onlyfactor (such that kcat_Ste7pSpTKssl_pT = kcat_Ste7pSKssl..pT
x Ste7_pS_only_factor, kcatSte7pSpTKssl_pY = kcat_Ste7pSKssl_pY x Ste7_pS_only_factor,
kcat_Ste7pSpTKsslpY pT = kcat_Ste7pSKsslpY_pT x Ste7_pSonly_factor, and kcat_Ste7pSp7KsslpT_pY
= kcat_Ste7pSKsslpT pY x Ste7_pS_only_factor). Again, as with Fus3 phosphorylation, I do not
assume ordered phosphorylation of Kss 1. I assume that the phosphorylation rates are
independent of the binding of other proteins to Ste5 and of feedback phosphorylation of Ste7
(see Section 3.3.2.d). I also assume that Ste7 interacts with Kss 1 with the same affinity
regardless of whether or not Kssl or Ste7 are phosphorylated.
In addition to activation by Ste7, Fus3 also undergoes intramolecular
autophosphorylation on Y182 in the activation loop. Autophosphorylation is greatly
accelerated by binding to Ste5. Although it has not yet been shown for Kss 1, 1 assume that
binding to Ste5 increases Kssl tyrosine autophosphorylation as well. This
autophosphorylation likely results in a low level of constitutive MAPK activation, and
perhaps serves to "prime" some Kssl and Fus3 molecules for rapid activation via
phosphorylation of the tyrosine residues of their activation loops.
Numbers from experiments and models
The equilibrium binding affinities of the MAPKs binding to various Ste5 fragments
have been measured experimentally. In vitro, Fus3 binds to a 30 amino acid peptide from
Ste5 (residues 287-316) with an affinity of 4.2 gM [254], and to a larger 96 amino acid GST-
fused fragment from Ste5 (residues 241-336) with an affinity of 1 gM [250]. The latter
measurement is likely more realistic as a larger fragment of Ste5 was used. In vivo,
fluorescently-tagged Ste5 and Fus3 molecules interact with an apparent affinity of about 0.91
pM, measured by fluorescence cross-correlation spectroscopy (FCCS) [94]. Although both
the FCCS and in vitro measurement have their flaws (FCCS cannot distinguish between
direct and indirect interactions, and the in vivo measurements were done with only a
fragment of Ste5), the measured affinities are in good agreement. I use the average of the
147
two values, 0.95 rLM. Unphosphorylated Kssl associates with the 96 amino acid fragment of
Ste5 with an affinity of 6.5 piM [250]. The dissociation rate of phosphorylated Fus3 from
Ste5 can be estimated from FRAP experiments; fluorescence returns to the shmoo tip with a
half time of 0.32 s after photobleaching Fus3-GFP at the shmoo tip [107], suggesting a
dissociation rate constant of 2.1 s~'. Conceivably not all Fus3 is phosphorylated in response
to pheromone, making 2.1 s' a lower limit on the dissociation rate of phosphorylated Fus3.
The dissociation of Ste5 from the shmoo tip likely has little effect on the apparent
dissociation rate of Fus3 because the half-time of return of photobleached Ste5-GFP to the
shmoo tip is substantially longer (-8s) [107]. Likewise, the dissociation of Fus3 from Ste7 is
estimated to take 2 to 3 minutes (see below), having little impact on the measured
dissociation rate.
A few published computational models include binding of Fus3 to Ste5. Kofahl and
Klipp [2] used association rate of 5 x 107 M- S-1', corresponding to the association of a Ste7-
Fus3 dimer with Ste5 (with Fus3 binding to Ste5 instead of being tethered to Ste5 through
Ste7). They used a dissociation rate of 1.7 s-1 prior to binding of GPy to Ste5, a rate of 0.05 s'
I after binding of G3y to Ste5, and a rate of 2.3 s- for phosphorylated Fus3 (referencing this
final value to the FRAP studies in [107]). Shao et al. [100] used an association rate of 2 x
107 M-Is -1 for unphosphorylated Fus3 binding to Ste5 (they do not allow for phosphorylated
Fus3 to bind Ste5). They used a dissociation rate of 0.17 s-1 for unphosphorylated Fus3, and
3.3 s-1 for phosphorylated Fus3 (referencing this last value to the FRAP studies in [107]).
Binding between the MAPKs and Ste7 has also been measured in vitro and in vivo.
Fluorescently-tagged Ste7 and Fus3 interact in vivo with an apparent affinity of about 0.17
jpM, as measured by fluorescence cross-correlation spectroscopy (FCCS) [94]. Another
group also measured the affinity of interaction between Ste5 and Fus3 by FCCS, but they
were only able to detect an interaction, with an affinity of 0.11 PM, in the presence of
pheromone [99]. It is unclear why they were unable to detect an interaction in the absence of
pheromone. FCCS was also used to estimate an affinity of about 0.047 PM between Ste7
and Kssl [99]. GST-Fus3 interacts with Ste7 with an affinity of 0.1 jpM [252], and both
Fus3 and Kssl interact with GST-Ste7(1-98) with an affinity of 0.1 gM as well [250]. The
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affinities of Fus3 and Kssl for the individual MAPK docking motifs in Ste7 have also been
measured. Fus3 interacts with Ste7(7-19) with an affinity of 0.08 pM, and with Ste7(61-72)
with an affinity of 12 gpM; Kssl interacts with Ste7(7-19) with an affinity of 0.1 pM, and
with Ste7(61-72) with an affinity of 9 pM [253]. Since I am not independently modeling the
two binding sites, it is sufficient to say that Fus3 and Kssl interact with Ste7 with
approximately equal affinity. Averaging the measurements for both Fus3 (0.17 MM, 0.11
p.M, 0.1 pM, 0.1 ptM, and 0.08 jtM) and Kssl (0.047 ^tM, 0.1 p.M and 0.1 jtM) I get an
affinity of 0.1 pM. The estimated half time of dissociation of GST-Ste7(1-98) from both
Fus3 and Kss is 2-3 minutes (at 300 C) [251], suggesting a dissociation rate constant of
about 0.01 to 0.02 s-', and thus a corresponding association rate constant of 1 x 105 to 2 x 10s
M- s-.
Kofahl and Klipp included the interaction between Ste7 and Fus3 interaction in their
model, and used a dissociation rate of 5 x 10-2 s' [2]. Kofahl and Klipp referenced the rate
in their model to the half-time of dissociation of 2 minutes estimated by Bardwell et al. [251]
which would correspond to a dissociation rate of 5 x 10-3 s-1. Additionally, the equilibrium
constant that Kofahl and Klipp used (5 nM [251]) was later discarded as artificially low by
the same group that made the measurement [252]. Shao et al. treated the Fus3-Ste7 complex
strictly as a enzyme substrate complex with an association rate constant of 1.7 x 106 M-s-1
and a dissociation rate constant of 0.6 s- [100].
Rates of phosphorylation of Fus3 or Kssl by active Ste7 have not been measured
experimentally, either in the presence or absence of the scaffold Ste5. Rates of
phosphorylation of Fus3 and MAPKs from other systems can be found in many
computational models [2, 55, 100, 267-275]. However, despite the multitude of models,
many use the same rate constants, and the originals sources for these rates often do not
explain how the values were derived from the data. Additionally, many of these models use
Michaelis-Menten kinetics, and few allow unordered phosphorylation of the two MAPK
phosphorylation sites. In vitro rates of unordered phosphorylation of other MAPKs by their
MAPKKs have been rigorously estimated in some cases. For example, in the Markevich et
al. model [272], phosphorylation at the tyrosine residue of the MAPK p42 by MAPKK-1
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(MAPKKpSpT-MAPK - MAPKKpSpT + MAPKpY and MAPKKKpSpT-MAPKpT -4
MAPKKpSpT + MAPKpTpY) occurs with a rate constant of about I s , and
phosphorylation at the threonine residue (MAPKKKpSpT-MAPK - MAPKKpSpT +
MAPKpY and MAPKKKpSpT-MAPKpT 4 MAPKKpSpT + MAPKpTpY) occurs with a
rate constant of about 0.01 s-1 [272]. However, the affinity of the active MAPKK for the
MAPK varies greatly in the Markevich et al. model depending on the phosphorylation event
being considered. This difference in binding affinity may be reflected in the two MAPK
docking motifs on Ste7 that have different affinities for the MAPK docking grooves on Fus3
and Kssl. For models that consider only ordered phosphorylation (often with the same rate
for the first and second phosphorylation reaction), the rates vary from 0.1 s- to 10 s- [274],
although the more rigorously estimated rates tend to be less than 1 s-1 [268, 272]. Thus, I
might expect that active Ste7 would phosphorylate Fus3 with catalytic rates in the range of
0.01 s-' to 1 s 1 .
The rate of Fus3 autophosphorylation has been measured in vitro. In the presence of
Ste5(288-316), Fus3 is autophosphorylated on Y 182 with a half time of 40 min [254], which
corresponds to a rate of 3 x 10-4 S-1. In the absence of Ste5, the autophosphorylation rate is
more than 50-fold slower, which corresponds to a rate of 6 x 10-6 s-1. Because the native rate
of Fus3 autophosphorylation is so slow (a half-time of more than 30 hours), it is likely not
worth modeling the autophosphorylation for free Fus3 or Kss 1. I assume that Ste5-bound
Kss 1 is autophosphorylated at the same rate as Fus3.
Computational and graphical representations
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Figure 3-40 Interaction of Ste7 and Fus3.
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Figure 3-41 Phosphorylation of Fus3 at T180 by Ste7.
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Figure 3-42 Phosphorylation of Fus3 at Y182 by Ste7.
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Table 3-17 Parameter constraints for Fus3 phosphorylation.
Kd_Ste7_Fus3 = 0.1 14M
koff Ste7 Fus3 = 0.015 s"i
kon Ste7 Fus3 = koff Ste7_Fus3 - Kd Ste7 Fus3 , 1.5 x 105 M' s-1
Ste7 pS_only_factor > 1
kcat_Ste5Ste7pSFus3_pY = kcat_Ste5Ste7pSpTFus3_pY + Ste7_pS_onlyfactor
kcat_Ste5Ste7pSFus3p T_pY = kcatSte5Ste7pSpTFus3p TpY + Ste7_pS_only_factor
kcat_Ste5Ste7pSFus3_pT = kcat_Ste5Ste7pSpTFus3_pT - Ste7_pSonlyfactor
kcat_Ste5Ste7pSFus3p Y_pT = kcat_Ste5Ste7pSpTFus3p Y_pT - Ste7_pS_onlyfactor
Ste7
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Figure 3-43 Interaction of Ste7 and Kssl.
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Figure 3-44 Phosphorylation of Kssl at T183 by Ste7.
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Figure 3-45 Phosphorylation of Kssl at Y185 by Ste7.
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Table 3-18 Parameter constraints for Kssl phosphorylation.
Ste7_pS_only_factor > 1
Kd_Ste7_Kssl = 0.1 IpM
kcatSte7pSKssl_pY = kcat Ste7pSp7Kssl_pY + Ste7_pSonlyfactor
kcat_Ste7pSKsslpT pY = kcat_Ste7pSpTKsslpT pY + Ste7_pSonlyfactor
kcat_Ste7pSKssl_pT = kcat_Ste7pSpTKssl_pT + Ste7_pSonlyfactor
kcatSte7pSKsslpYpT = kcat_Ste7pSpTKsslpYpT + Ste7_pS_only factor
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Figure 3-48 Interaction of Ste5 and Kssl.
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Figure 3-47 Autophosphorylation of Fus3 at Y182.
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3.3.1.f Phosphorylation of MAPK Substrates
Summary
Fus3 and Kss 1 bind their substrates via a conserved docking site. Increased plasticity
of the Fus3 docking site may provide specificity of Fus3 over Kss 1 for some substrates.
Increased phosphorylation of the activation loop on Fus3 and Kss 1 likely causes higher
affinity for their substrates in addition to increased kinase activity.
Experiments and evidence
Fus3 binds some substrates with higher affinity than does Kssl
Interactions between MAPKs and their binding partners are mediated by binding of
short MAPK docking motifs to the docking site on the MAPKs [253]. Although Fus3 and
Kss I share significant sequence similarity [262], the MAPKs do not bind to all proteins with
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Ste5
Figure 3-49 Autophosphorylation of Kssl at Y185.
Table 3-19 Parameter constraints for autophosphorylation of Fus3 and Kssl.
Kd Ste5 Fus3 = 9.5 x 10-7 M
koff_Ste5_Fus3pTpY > 2.1 s -1
koff_Ste5_Fus3pTpY > koff_Ste5_Fus3
kcat_Ste5Fus3_pY = 3 x 10-4 s 1
Kd Ste5 Kssl z 6.5 x 10-6 M
koff_Ste5_KsslpTpY> koff_Ste5_Kssl
kcat_Ste5Kssl_pY = 3 x 10-4 s1
Ste5
the same affinity. Fus3 and Kssl bind with near-equal affinity to MAPK docking motif
peptides from Ste7 and Msg5 [250, 253], but Fus3 interacts more strongly with Digl, Farl
and Ste5 than does Kssl [250, 253]. Crystal structures of the MAPK docking motifs from
Farl, Ste7 and Msg5 bound to Fus3 shows that the docking motif peptides from Ste7 and
Msg5 do not induce any long-range changes in Fus3 structure [253]. Interestingly, the Farl
docking motif peptide, which binds preferentially to Fus3 over Kssl, induces rearrangement
of the Fus3 surface [253], suggesting that Fus3 may more readily undergo these
rearrangements and thus be a more permissive binding partner than Kssl.
Increased phosphorylation of the MAPKs may increase their affinity for substrates
The affinities of Kssl and Fus3 for many of their binding partners have been
measured [250, 253, 276]. However, the dependence of these affinities on the
phosphorylation state of the MAPKs has not been investigated directly. Increased
phosphorylation of the mammalian MAPK ERK2 results in increased affinity of ERK2 with
substrate proteins [277, 278]. Supporting the notion that at least Fus3 has increased affinity
for its substrate proteins when phosphorylated, a non-phosphorylatable (T 80A Y182A)
Fus3 mutant is poorly localized to the shmoo tip in response to pheromone, whereas wild-
type Fus3 is strongly localized to the shmoo tip [94]. Likewise, when Msg5, a Fus3
phosphatase, is overexpressed, shmoo localization of Fus3 is decreased, and when Msg5 is
underexpressed, shmoo localization of Fus3 is enhanced [94].
Increased phosphorylation of the MAPKs increases their kinase activities
The different phospho-forms of Fus3 have different in vitro relative kinase activities,
with increased phosphorylation resulting in increased activity [254]. The in vitro kinase
activities of the mammalian MAPK ERK2 also follow the same trend [277, 278].
Numbers from experiments and models
Although the quantitative effects of phosphorylation on binding affinity have not
been investigated for the mating pathway MAPKs, these effects have been studied for other
MAPK proteins. The Michaelis constants Km of the singly-phosphorylated forms of ERK2
(ERK2pY and ERK2pT) are about 1.5- to 2.5-fold the higher than the Km of doubly-
phosphorylated ERK2 (ERK2pTpY) [277, 278]. The Km of unphosphorylated ERK2 is even
weaker, 2- to 5-fold higher than the Km of doubly-phosphorylated ERK2. The kinase
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activity of ERK2 (kcat) increases with increasing ERK2 phosphorylation [277], so the
affinity of unphosphorylated and singly-phosphorylated ERK2 for substrate proteins must be
at least 1.5- to 2.5-fold and 2- to 5-fold (respectively) the affinity of doubly-phosphorylated
ERK2. Thus, I can use the fold-differences in Michaelis constants for the different phospho-
forms or ERK2 as approximate surrogates for the fold-differences in affinities for the
phospho-forms of Fus3 and Kss 1. I assume that unphosphorylated Fus3 and Kssl bind
substrate proteins 4-fold more weakly than the doubly phosphorylated MAPKs, and that both
mono-phosphorylated forms of Fus3 and Kssl bind their substrate proteins 2-fold more
weakly than the doubly phosphorylated MAPKs.
Unlike binding affinity, the relative catalytic activities of the various phospho-forms
of Fus3 has been measured, using myelin basic protein (MBP) as the substrate:
unphosph:pY:pTpY = 1/125:1/5:1 [254]. The ratios of the catalytic activities of the phospho-
forms of Fus3 are not too different from the ratios for of catalytic activities for the phospho-
forms of ERK2 (unphosph:pY:pT:pTpY = 1/10,000:1/35:1/12:1 [277] or unphosph:pT:pTpY
= 1/100:1/4:1 [278]). First, I assume that partial phosphorylation of Fus3 and Kssl has the
same effect for both kinases. I assume that the catalytic activity of unphosphorylated Fus3
and Kssl is negligible, and thus is not include the Mating Model. Measured in vitro, Fus3pY
has one fifth of the kinase activity of Fus3pTpY. Based on the measured catalytic rates for
ERK2, I assume that threonine-phospho-forms of Fus3 and Kssl (Fus3pT and KsslpT) are
more active than tyrosine-phospho-forms (Fus3pY and KsslpY), but less active than doubly
phosphorylated Fus3 and Kssl (Fus3pTpY and KsslpTpY). Thus, I assume that the catalytic
activity of Fus3pT is one third that of Fus3pTpY. I assume that the relative activities of the
phospho-forms of Kssl are related by the same factors as the phospho-forms of Fus3.
Several published models allow processive phosphorylation of Fus3, such that mono -
phosphorylated Fus3 does not occur [2, 56, 136]. In these models, unphosphorylated Fus3
has no kinase activity, and does not bind to substrate proteins. Shao et al. include mono-
phosphorylated Fus3 in their model, although like unphosphorylated Fus3, mono-
phosphorylated Fus3 has no kinase activity and does not associate with MAPK substrate
proteins [100].
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Computational and graphical representations
3.3.2 Regulation and Feedback
3.3.2.a MAPKKK Deactivation and Downregulation
Summary
Ste 1I degradation is upregulated in a MAPK-dependent manner upon pheromone
treatment. Stel 1 degradation likely occurs via ubiquitination. Degradation may be the
primary means of Stel 1 inactivation as there are no known Stel 1 phosphatases.
Experiments and evidence
Stel I is degraded in a pheromone and MAPK-dependent manner
No phosphatases are known to dephosphorylate Stel 1 [10], suggesting that Stel I
deactivation may be primarily mediated by dilution (see Section 3.6.2) and degradation.
Stel l-Myc, over-expressed from a Gal promoter to improve detection by western blot, has a
decreased half-life in cells exposed to pheromone [279]. Stel 1-Myc half-life is unaffected
by pheromone treatment infus3AksslA cells, suggesting that Fus3 and/or Kssl are
responsible for Stel 1 downregulation. The half-life of Stel 1-Myc is unaffected by cellular
response to high osmolarity, confirming that activation of Stel itself is not sufficient for its
increased degradation [279]. Pheromone-dependent degradation of Ste 11 likely involves
Stel 1 ubiquitination, as disruption of ubiquitin degradation processes results in loss of
pheromone-dependent degradation of Stel 1 [279].
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Table 3-20 Parameter constraats for MAPK activity.
Kd MAPK substrate = MANPK uphoh Kd factor x Kd MAPKpTpY substrate
MAPK.nphosph Kdfactor - 4
KdMAPKp4Y substrate = MAPKpY)Kdj factor x Kd)MAPKpTpY substrate
KdyMAPKpT._substrate = MAPK pTKd4jactor x KdMAPKpfpYsubstrate
MAPK p TjKdfjactor - MAPK pYJK factor - 2
kcatyMAPKpY= kcatyMAPKpTpY+ MAPKIY kcat factor
MAPKjpY kcat factor - 5
kcatLMAPKpT= kcatUMAPKpTpY+ MAPK pT kcatfactor
MAPK pT kcatfactor - 3
:::: ; ;:
: : : :-I
Distilling evidence into elementary chemical reactions
Although it has not been shown explicitly, it seems likely that Fus3 and/or Kssl
phosphorylate Stel 1, leading to ubiquitination and degradation of Stel 1. It is not clear
whether both Fus3 and Kssl act equally to downregulate Stel 1. I assume that both Fus3 and
Kssl are equally proficient at phosphorylating Stel 1 on a site that is distinct from the Ste20
phosphorylation sites (S302, S306 and T307). I additionally assume that binding and
phosphorylation of Stel 1 by Fus3 and Kssl follow the constraints outlined in Section 3.3.1.f.
For simplicity, I ignore the intermediate step of Stel 1 ubiquitination and assume that
phosphorylation directly leads to increased degradation. I also assume that unphosphorylated
Ste 1l is degraded, but at a reduced rate relative to phosphorylated Stel 1. In the absence of
information to the contrary I assume that Fus3 and Kssl can bind and phosphorylate Stell 1
while Stel 1 is Ste5-bound.
Because no phosphatases are known to dephosphorylate Ste 11, Ste 1 deactivation is
likely achieved though a combination of non-specific dephosphorylation (see Section 3.6.6),
dilution due to cell growth (Section 3.6.1), and MAPK-dependent degradation.
Numbers from experiments and models
Stel 1-Myc, when over-expressed from a Gal promoter, has a half-life of about 200
minutes in the absence of pheromone, and 50 minutes in the presence of pheromone [279],
corresponding to degradation rates of 5.8 x 10-5 s-' and 2.3 x 10 s-1 respectively. Because
MAPK activity is still measurable in the absence of pheromone [44, 205, 206], presumably
some fraction of Stel 1 will always be phosphorylated and degraded at an increased rate.
Thus, the degradation rate constant of unphosphorylated Stel 1 (kdeg_Stel 1) must be less than
5.8 x 10-5 s-1. On the other hand, in the presence of pheromone, the rate of 2.3 x 10-4 s- 1
corresponds to both phosphorylation and degradation of Ste 11, making it a lower limit on the
actual degradation rate constant for phosphorylated Stell (kdeg_Stel 1 PO4), and for the rate of
phosphorylation of Stel 1 by doubly-phosphorylated Fus3 and Kssl
(kcat_MAPKpTpY_Stel i_PO4). Additionally, some fraction of Ste 11 may be unphosphorylated
in the presence of pheromone, further suggesting that the rate constant (kdegStellPO4) is
greater than 2.3 x 10 s- 1.
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In their model of the yeast mating pathway, Shao et al. included Fus3-dependent
degradation of Ste 11 via a second order reaction [100]. However, only inactive Ste 11 can be
degraded in this model, which has not been shown experimentally. Schaber et al. included
degradation of phosphorylated (active) Ste 11 in their model [136]. However, all the rates in
the Schaber et al. model were set to either 1 min' or 0.1 min-' in order to observe the
qualitative behavior of the model, and thus these rates are not of much use here. Although
Stel dephosphorylation has not been shown to occur in vivo, several models include Stel
dephosphorylation. In their model, Kofahl and Klipp tied dephosphorylation of Stel 1 to the
dissociation of the Ste5-Stel 1-Ste7 complex, which occurs at a rate of 5 min' (8.3 x 10-2 s-1)
[2]. Shao et al. modeled a specific phosphatase that is responsible for distributive dual
dephosphorylation of Ste 11 [100].
Computational and graphical representations
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Figure 3-50 Interaction of Stell and Fus3.
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Figure 3-51 Phosphorylation of Stell by Fus3.
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Figure 3-52 Interaction of Stell and Kss1.
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Figure 3-53 Phosphorylation of Stell by Kssl.
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Table 3-21 Parameter constraints for MAPK phosphorylation of Stell.
Kd_MAPK_Stel I = MAPK_unphosph_Kd_factor x Kd_MAPKpTpY_Stel 1
Kd_MAPKpY_Stell = MAPK_pY Kd factor x Kd_MAPKpTpY_Stel 1
Kd_MAPKpT_Stel 1 = MAPK_pT Kd factor x Kd_MAPKpTpY_Stell 1
kcat_MAPKpY_Stel 1_PO4 = kcat_MAPKpTpYStel 1_P0 4 + MAPK_pY kcat_factor
kcat_MAPKpT_Stel 1_P0 4 = kcat_MAPKpTpY_Stel 1_P04 + MAPK_pT_kcat_factor
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Figure 3-54 Non-specific Stell dephosphorylation at T307.
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Figure 3-55 Non-specific Stel dephosphorylation at S306.
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Figure 3-56 Non-specific Stell dephosphorylation at S302.
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Figure 3-58 Degradation of Stell.
3.3.2.b MAPKK Deactivation and Downregulation
Summary
In response to pheromone treatment, Ste7 is ubiquitinated and degraded. Ste7
appears to be degraded via a Farl-dependent mechanism. Degradation may be the primary
means of Ste7 inactivation as there are no known Ste7 phosphatases.
Experiments and evidence
Ste 7 is ubiquitinated and degraded in response to pheromone
No phosphatases are known to dephosphorylate Ste7 [10], suggesting that Ste7
deactivation may be primarily mediated by dilution (see Section 3.6.2) and degradation.
Upon pheromone treatment, Ste7 is rapidly ubiquitinated and degraded [280]. Ste7 is
ubiquitinated by the Skp 1-Cullin-F-box (SCF) complex [281], and ubiquitinated Ste7 is
largely degraded by the ubiquitin-specific protease Ubp3 [280].
Ste7 ubiquitination is mediated by a Farl-dependent mechanism
Mutation of the phosphorylation sites that activate Ste7 kinase activity (S359A
T363A) prevents ubiquitination of Ste7 [281]. This indicates that Ste7 activation is required
for the ubiquitination and degradation of Ste7. Additionally, deletion of Fus3 and Kss 1 also
prevents Ste7 ubiquitination and degradation [281]. Fus3 and Kssl are known to
phosphorylate Ste7 in vitro [251, 261], and in vivo in response to pheromone [259].
However, a Ste7 mutant that is not phosphorylated by the MAPKs (S105A Tl 16A S130A
T137A T149A S167A S471A) is still ubiquitinated [256], indicating that phosphorylation by
the MAPKs is not required for Ste7 ubiquitination. Interestingly, deletion of Farl also
eliminates Ste7 ubiquitination in response to pheromone treatment [281]. Ste7 ubiquitination
appears to require pheromone-dependent phosphorylation of Farl and not just cell cycle
arrest (see Section 3.5.1), as arrest induced by Cdc28 temperature sensitive mutants does not
cause Ste7 ubiquitination in the absence of pheromone [281 ].
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Table 3-22 Parameter constraints for Steil dephosphorylation and degradation.
ktumover Ste1 I I 5.8 x 10'5 s'
kdegSte II < ktumover Ste II
kdeg SteIIPO,> 2.3 x 10' s-'
Distilling evidence into elementary chemical reactions
Although it is relatively clear that Farl, or some effector of Farl, is responsible for
mediating Ste7 ubiquitination and degradation, the exact mechanism remains unknown. In
the absence of the details of this mechanism, and because Farl is not included in the Mating
Model (see Sections 3.5.1 and 3.5.1), I model the degradation of Ste7 via Michaelis-Menten
kinetics, with active Fus3 acting as the enzyme. For simplicity, I assume that the degradation
rates and Michaelis constants for the different phospho-forms of Fus3 are related by the same
constants that relate the kinase activities and binding affinities of Fus3, as discussed in
Section 3.3.1.f. I also ignore ubiquitination and model a one step degradation process. I
assume that only Ste7 that is neither bound to Ste5, nor bound to a MAPK, can be degraded
in this manner. Additionally, I assume that phosphorylation of Ste7 does not affect its
degradation rate.
Because no phosphatases are known to dephosphorylate Ste7, Ste7 deactivation is
likely achieved though a combination of non-specific dephosphorylation (see Section 3.6.6),
dilution due to cell growth (Section 3.6.1), and Farl-dependent degradation.
Numbers from experiments and models
The Ste7 turnover rate in the absence of pheromone is not known. Upon pheromone
treatment, Ste7 turnover is initially slow but, about 30 minutes after pheromone treatment,
accelerates to a Ste7 half-life of about 25 minutes [280, 281]. The delay is likely due to the
time required for sufficient accumulation of Farl, which is stabilized and transcriptionally
upregulated in response to pheromone treatment. Thus, assuming Michaelis-Menten
kinetics, kdeg_Fus3pTpY_Ste7 must be at least 4.6 x 10-4 s-1 (corresponding to a half-life of 25
minutes), with kdeg_Fus3pTpY_Ste7 exactly equal to 4.6 x 10-4 S-1 if the Km is much less than
the concentration of active Fus3 in pheromone-treated cells.
Computational models have not dealt with Farl-dependent degradation of Ste7. The
only form of Ste7 down-regulation that has been included in previous models is
dephosphorylation, despite the fact that Ste7 dephosphorylation has not been observed in
vivo. Kofahl and Klipp modeled instant Ste7 dephosphorylation upon dissociation of the
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Ste5-Stel l-Ste7 complex, which occurs at a rate of 5 min' (8.3 x 10-2 s-1) [2]. Shao et al.
include a specific phosphatase for Ste7 in their model [100].
Computational and graphical representations
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Figure 3-60 Ste7 dephosphorylation at S359.
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Figure 3-61 Degradation of Ste7.
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3.3.2.c MAPK Deactivation, Degradation, and Upregulation
Summary
Both Fus3 and Kssl are dephosphorylated by the same three phosphatases; Ptp3, and
to a lesser extent Ptp2, are responsible for tyrosine dephosphorylation of Fus3 and Kss 1,
whereas the dual-specificity phosphatase Msg5 dephosphorylates both phospho-threonine
and phospho-tyrosine on Fus3 and Kssl. Fus3 is a very stable protein whose turnover is
moderately increased in response to pheromone. Fus3 expression, but not Kss 1 expression,
is upregulated in response to pheromone treatment.
Experiments and evidence
Ptp2 and Ptp3 dephosphorylate phospho-tyrosine on the MAPKs
Ptp2 and Ptp3 are protein tyrosine phosphatases [58]. Deletion of either Ptp2 or Ptp3
results in a 2-fold increase in Fus3 activity in the absence of pheromone [58], suggesting that
they may regulate the activity of Fus3 and Kssl. Incubation of Ptp3 with active Fus3 results
in decreased Fus3 phosphorylation, indicating that Ptp3 directly dephosphorylates Fus3 [58].
Ptp3 appears to be a stronger regulator of Kss I than of Fus3; in the absence of pheromone,
deletion of Ptp3 results in a greater increase in Kss 1 phosphorylation than in Fus3
phosphorylation [206]. In the presence of pheromone, deletion of Ptp3 causes increased
Fus3 phosphorylation and activation, whereas deletion of Ptp2 only has a detectable effect
when combined with deletion of Ptp3 [58]. Similarly, deletion of Ptp3, but not deletion of
Ptp2, results in increased Kss 1 phosphorylation in the absence of pheromone [206].
Together, these data indicate that Ptp3 is a stronger regulator of Fus3 and Kssl activity than
Ptp2. Correspondingly, Fus3 interacts more strongly with Ptp3 than it does with Ptp3; HA-
Fus3 co-purifies with GST-Ptp3 but not with GST-Ptp2 [282]. Ptp2 is primarily nuclear
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whereas Ptp3 is primarily cytoplasmic [125, 283], suggesting that the differential regulation
of the MAPKs by Ptp2 and Ptp3 may also be a result of the different subcellular localization
of the phosphatases.
Ptp3 and Ptp2 each contain an N-terminal CH2 motif, which have been shown to
moderate the interaction between mammalian MAPK phosphatases and MAPKs [282]. The
Ptp3 CH2 motif interacts with the docking site on Fus3 [282], suggesting the CH2 domain
may contain a cryptic MAPK docking motif and that Ptp2 and Ptp3 can only interact with
Fus3 and Kssl that are not bound to other proteins via their docking sites. The CH2 motif on
Ptp2 is more degenerate than the CH2 motif on Ptp3 [282], perhaps explaining why Ptp2
binds more weakly to Fus3.
Evidence suggests that Ptp2 and Ptp3 may interact preferentially with the phospho-
forms of Fus3 and Kss 1. The dual-specificity phosphatase MKP3 interacts with all three
phosphorylated forms of ERK2 with similar affinity (based on similar Michaelis constants)
[284]. MKP3 interacts about 10-fold more weakly with unphosphorylated ERK2 [285].
Although Ptp2 and Ptp3 are not dual-specificity phosphatases, MKP3, Ptp2, and Ptp3 all
interact with their respective MAPKs via CH2 domains, suggesting that Ptp2 and Ptp3 may
bind preferentially to phosphorylated Fus3 and Kss 1.
Msg5 dephosphorylates both phospho-tyrosine and phospho-threonine on the MAPKs
Msg5 overexpression reduces transcriptional response to pheromone treatment [286].
Disruption of Msg5 increases the kinase activity of Fus3 that is isolated from both
vegetatively growing and pheromone induced cells [206, 286]. Kinase activity of Ste7 is
unaffected by Msg5 disruption, suggesting that Msg5 acts on Fus3. In vitro, Msg5 is able to
dephosphorylate phospho-serine, phospho-threonine, and phospho-tyrosine on Fus3 [286].
Unlike Ptp3, Msg5 appears to be a stronger regulator of Fus3 than Kss 1, as deletion of Msg5
results in an increase in phosphorylation of Fus3, but not of Kss 1 [206]. However, Kssl
appears to bind slightly more tightly than Fus3 to the MAPK consensus binding motif from
Msg5 [253].
Although the mechanism of dephosphorylation by Msg5 has not been investigated, it
has been shown that a mammalian MAPK dual-specificity phosphatase MKP3
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dephosphorylate ERK2 via an ordered distributive mechanism, acting first on the phospho-
tyrosine, then after dissociation and rebinding, acting next on the phospho-threonine [284].
MKP3 interacts with all three phosphorylated forms of ERK2 with equal Km, which is 10-
fold lower than the Kd of interaction with unphosphorylated ERK2 [284]. However, Msg5 is
thought to interact with Fus3 and Kssl via a MAPK docking motif [253] and does not
contain a CH2 domain (which moderates the interaction between MKP3 and ERK2) [282],
perhaps making MKP3-MAPK binding a poor model for Msg5-MAPK binding.
Fus3 turnover is moderately increased in the presence of pheromone
In the absence of pheromone, Fus3 is a very stable protein, with no degradation
detectable over 90 minutes [55]. In the presence of pheromone, the degradation rate of Fus3
is moderately increased, but Fus3 remains very stable [55].
Fus3, but not Kssl, is upregulated in response to pheromone treatment
Fus3 expression is increased in the presence of pheromone [72, 287], and
correspondingly the Fus3 promoter is bound by Ste 12 in the absence and presence of
pheromone [287]. Correspondingly, Fus3 abundance increases in response to pheromone
(Chapter 4) [288], although many studies have failed to detect this increase [58, 205, 279,
289]. Kss I expression is not induced in response to pheromone treatment [72, 201].
Distilling evidence into elementary chemical reactions
Fus3 and Kssl are dephosphorylated in vivo by Ptp2, Ptp3 and Msg5. Ptp2 and Ptp3
only dephosphorylate phospho-tyrosine, whereas Msg5 dephosphorylates phospho-threonine
and phospho-tyrosine. Evidence suggests that Ptp2 and Ptp3 can only bind Fus3 and Kss 1
that are not bound to other proteins via their MAPK docking site. Because MKP3, Ptp2 and
Ptp3 may share a common means of interaction with their respective MAPKs, and MKP3
interacts preferentially with phosphorylated ERK2, I assume that Ptp2 and Ptp3 interact
preferentially with phospho-tyrosine Fus3 and Kss 1. I further assume that phosphorylation
of the threonine on Fus3 and Kss 1 has no effect on this interaction. Based on knockout
mutants, it appears that Ptp3 is a stronger regulator of Kss 1 that it is of Fus3. For simplicity,
I assume that Ptp3 dephosphorylates Kssl and Fus3 at the same rate (i.e., with equal kcat), but
binds more tightly to Kssl than it does to Fus3. Also, Ptp2 appears to be a weaker regulator
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of the MAPKs than Ptp2. Again for simplicity, I use the same dephosphorylation rate
constant, and model the difference in activity as a difference in affinity.
It is likely that Msg5 can also only interact with the MAPKs with free docking sites.
Although Msg5 and MKP3 interact with their respective MAPKs via different motifs, for
lack of a better alternative I use MKP3 as a model for Msg5. Thus, I assume that Msg5
interacts with the three phospho-forms of Fus3 and Kss 1 with the same affinity, but more
weakly with the unphosphorylated MAPKs. I also assume that like MKP3, Msg5 acts via an
ordered distributive mechanism, first dephosphorylating phospho-tyrosine, and only after
dissociation and subsequent rebinding can it dephosphorylate the phospho-threonine.
Although deletion of Msg5 has a more profound effect on Fus3 activity than on Kssl
activity, I do not include this asymmetry in the Mating Model because Msg5 has been shown
to bind Kssl more tightly than it binds Fus3.
In addition to dephosphorylation of Fus3 and Kssl by Ptp2, Ptp3 and Msg5, I also
assume that the MAPKs are dephosphorylated by nonspecific phosphatases, as described in
Section 3.6.6.
Fus3 degradation is regulated in a pheromone-dependent manner. However, I do not
believe that it is important to model this increased turnover for two reasons. First, the
mechanism of Fus3 degradation is not known. Second, the degradation rate of Fus3 remains
sufficiently slow (see below) such that it is unlikely to be an important regulatory feature of
the pathway.
Fus3 expression is upregulated in response to pheromone. I assume Fus3 synthesis in
the absence and presence of pheromone are governed by Stel2 activity, as described in
Section 3.4.1.b. Thus, ksynth_Stel2_Fus3 and Km_synth_Stel2_Fus3 must be selected such that in
the absence of pheromone, the basal amount of active Stel2 leads to the expected abundance
of Fus3 (Fus3_conc), balancing out dilution of Fus3 due to cell growth (see Section 3.6.1).
Numbers from experiments and models
Ptp3 and GST-Fus3 (purified from E. coli, so likely unphosphorylated) interact in
vitro with an equilibrium dissociation constant of 200 nM [282]. MKP3 interacts about 10-
fold more tightly with phosphorylated ERK2 than with unphosphorylated ERK2 [284],
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suggesting that the affinity of Ptp3 for the phospho-forms of Fus3 may be about 20 nM.
Because Ptp3 appears to be a stronger regulator of Kssl than Fus3, I assume that Ptp3
interacts with unphosphorylated Kssl with an affinity of less than 200 nM, and with the
phospho-forms of Kssl with an affinity of less than 20 nM. Because Ptp2 is a weaker
regulator of Fus3 and Kssl activity than Ptp3, I assume that the binding affinities of Ptp2 for
the various forms of Fus3 and Kss 1 are weaker than the affinities of Ptp3 for the
corresponding phospho-forms of the MAPKs.
Fus3 binds a peptide with the MAPK docking motif from Msg5 with an affinity of 2
gM, and Kssl binds this same peptide with an affinity of 0.5 gM [253]. Assuming that Msg5
also binds 10-fold more tightly to the phospho-forms of the MAPKs, it would interact with
phospo-Fus3 with an affinity of 200 nM, and with Kss 1 with an affinity of 50 nM. The dual
specificity phosphatase MKP3 dephosphorylates the various phospho-forms of ERK2 with
kcat of about 0.08 s-1 [284]. I assume that Ptp2, Ptp3 and Msg5 have similar catalytic
activity.
Dephosphorylation of Fus3 and Kss 1 has been included in several models, although
no model has considered Msg5, Ptp2 and Ptp3 individually. Kofahl and Klipp [2] used a
first-order double dephosphorylation reaction, with a rate of 0.83 s-l . Models by Paliwal et
al. [56] and Schaber et al. [136] also included first-order double dephosphorylation of Fus3,
but the rates constants in both of these models were selected in order to observe qualitative,
not quantitative, behavior of the respective models, and are not useful here.
Shao et al. modeled a two-step distributive Fus3 dephosphorylation process [100],
and Markevich et al. modeled a two-step distributive ERK2 dephosphorylation process [272].
In both models, the association rates (for the singly- and doubly-phosphorylated MAPKs) are
on the order of 3 iM-' s'1 to 50 tM-1 sl ', the dissociation rates on the order of 0.1 s-' to 1 s-1
and the dephosphorylation rates are in the range of 0.09 s- to 0.5 s-.
172
Computational and graphical representations
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Figure 3-63 Dephosphorylation of Fus3 at Y182 by Ptp2.
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Figure 3-62 Interaction of Fus3 and Ptp2.
-
'' ~'
Kd
0 MAPK site
Fus3
Figure 3-64 Interaction of Fus3 and Ptp3.
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Figure 3-65 Dephosphorylation of Fus3 by Ptp3.
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Table 3-24 Parameter constraints on Ptp2 and Ptp3 dephosphorylation of Fus3.
Kd_Ptp2_Fus3 > Kd_Ptp3_Fus3
Kd_Ptp2_Fus3pY- Kd_Ptp2_Fus3 - 10 > Kd_Ptp3_Fus3pY
Kd_Ptp3_Fus3 = 2 x 10-7 M
Kd_Ptp3_Fus3pY- 2 x 108 M
kcat_Ptp2_Fus3_pY, kcatPtp3_Fus3_pY - 0.08 s-1
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Figure 3-66 Interaction of Kssl and Ptp2.
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Figure 3-67 Dephosphorylation of Kssl by Ptp2.
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Figure 3-68 Interaction of Kssl and Ptp3.
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Figure 3-69 Dephosphorylation of Kssl by Ptp3.
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Table 3-25 Parameter constraints on Ptp2 and Ptp3 dephosphorylation of Kssl.
Kd_Ptp2_Kssl > Kd_Ptp3_Kssl
Kd_Ptp2_KsslpY ~ Kd_Ptp2_Kssl - 10 > Kd_Ptp3_KsslpY
Kd_Ptp3_Kssl < Kd_Ptp3_Fus3
Kd_Ptp3_KsslpY< Kd_Ptp3_Fus3pY
kcat_Ptp2_Kssl_pY, kcat_Ptp3 Kssl_pY - 0.08 s1
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Figure 3-70 Interaction of Fus3 and Msg5.
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Figure 3-71 Dephosphorylation of Fus3 by Msg5.
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Table 3-26 Parameter constraints on Msg5 dephosphorylation of Fus3.
Kd_Msg5_Fus3 & 2 x 10-6 M
Kd_Msg5_Fus3pT, Kd_Msg5_Fus3pY, Kd_Msg5_Fus3pTpY- 2 x 107 M
kcat_Msg5_Fus3_pY, kcat_Msg5_Fus3_pT - 0.08 s1
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Figure 3-73 Interaction of Kssl and Msg5.
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Figure 3-72 Dephosphorylation of Fus3 by Msg5.
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Figure 3-74 Dephosphorylation of Kssl by Msg5.
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Figure 3-75 Dephosphorylation of Kssl by Msg5.
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Table 3-27 Parameter constraints on Msg5 dephosphorylation of Kssl.
Kd_Msg5_Kssl = 5 x 10"7 M
Kd_Msg5_KsslpT, Kd_Msg5_KsslpY, Kd_Msg5_KsslpTpY- 5 x 108 M
kcat_Msg5_Kssl_pY, kcat_Msg5_Kssl_pT - 0.08 s 1
Fus3 Fus3
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Figure 3-76 Non-specific Fus3 dephosphorylation.
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Figure 3-77 Non-specific Fus3 dephosphorylation.
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Figure 3-78 Non-specific Kssl dephosphorylation.
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Figure 3-79 Non-specific Kss1 dephosphorylation.
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Figure 3-80 Synthesis of Fus3.
3.3.2.d MAPKK-MAPK Interaction and Feedback Phosphorylation of MAPKK
Summary
Ste7 is phosphorylated by active Kssl and/or Fus3. Feedback hyper-phosphorylation
of Ste7 by the MAPKs may act via an unknown mechanism to attenuate signaling.
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Experiments and evidence
Ste7 is hyper-phosphorylated by active MAPK
In addition to being phosphorylated on its activation loop by Ste 11, Ste7 is also
multiply phosphorylated at other sites. A portion of the Ste7 population is hyper-
phosphorylated in the absence of pheromone, and the entire Ste7 population becomes hyper-
phosphorylated in the presence of pheromone [256, 257]. This hyper-phosphorylation occurs
at seven sites on the N and C terminus of the protein [256, 257]. In the presence of
pheromone, Ste7 isolated fromfus3AksslA cells lacks hyper-phosphorylation [257],
suggesting that Fus3 and Kss 1 are responsible for Ste7 hyper-phosphorylation. Supporting
the notion that Fus3 and Kss 1 are responsible for Ste7 hyperphosphorylation in vivo, active
Fus3 hyper-phosphorylates Ste7 in vitro [257].
Hyper-phosphorylation of Ste 7 may attenuate signaling
Ste7 isolated from pheromone-treatedfus3AksslA cells lacks hyper-phosphorylation
and is more catalytically active in vitro than Ste7 isolated from wild-type cells [257],
suggesting that Fus3 and Kss 1 hyper-phosphorylation of Ste7 may attenuate Ste7 activity.
However, the mechanism by which Ste7 hyper-phosphorylation may attenuate Ste7 activity
is unclear. Mutation of these hyper-phosphorylation sites to glutamic acids (E7, to mimic
phosphorylation) or to alanines (A 7, to prevent phosphorylation) results in increased Ste 12-
mediated transcription and cell cycle arrest in response to pheromone treatment [256].
Although glutamic acid mutation (E7) moderately decreases the affinities between Ste7 and
Ste5, and Ste7 and Fus3, the E7 mutations only affects these affinities when coupled with two
glutamic acid mutations on the activation loop of Ste7 (EE-E 7) [256]. The Ste7-EE mutant
(Ste7 with glutamic acid mutations on the activation loop) supports phosphorylation of Fus3
in vitro [257] but fails to support pheromone mediated transcription and cell-cycle arrest
[256, 257], indicating that this mutant may not be a good model for Ste7 activation in vivo.
Distilling evidence into elementary chemical reactions
Mutations on the activation loop of Ste7 do not appear to be a good model for Ste7
activation in vivo. The precise effect of Ste7 hyper-phosphorylation is unclear because
glutamic acid mutation of the hyper-phosphorylation sites of Ste7 only has a significant
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effect when coupled with these activation loop mutations. Thus, I do not include Ste7 hyper-
phosphorylation in the Mating Model.
Only one past model has considered Ste7 hyperphosphorylation. Shao et al. assumed
that phosphorylated (active) Ste7 is rapidly hyper-phosphorylated by Fus3, and that this form
of Ste7 dissociates more rapidly from Ste5.
3.3.2.e Scaffold Phosphorylation
Summary
Ste5 is phosphorylated in response to pheromone treatment, and this phosphorylation
may downregulate pathway activity by interfering with membrane localization.
Experiments and evidence
Ste5 phosphorylation acts to downregulate pathway activity
Ste5 is phosphorylated in vitro by active Fus3 [254, 290]. In vivo, Ste5
phosphorylation is increased in response to pheromone treatment in wild-type, fus3A and
ksslA cells, but only increased marginally infus3AksslA cells, suggesting that both MAPKs
are capable of phosphorylating Ste5 [288]. Mutation of threonine 287 to a valine on a Ste5
fragment nearly eliminates Fus3-dependent phosphorylation in vitro, suggesting that this site
is phosphorylated [254]. In vivo, the T287V mutation results in increased transcriptional
response to pheromone, and a Ste5 mutant that does not bind Fus3 has an even greater
transcriptional response to pheromone [254]. Together, these facts indicate that Fus3
phosphorylation of Ste5 on T287 downregulates pathway activity. The same Fus3-binding
deficient Ste5 also results in increased translocation of fluorescently labeled Ste5 to the
shmoo tip [94], suggesting that Fus3 phosphorylation of Ste5 may act to downregulate
membrane localization.
Distilling evidence into elementary chemical reactions
The mechanism by which the MAPK-dependent phosphorylation of Ste5
downregulates pathway activity is unknown. Feedback phosphorylation of Ste5 may
decrease the interaction between Ste5 and Ste4, may interfere Ste5 dimerization, may hinder
membrane association of the PM or PH domains (see Section 3.3.1 .b), or may reduce
signaling via another means. Because the mechanism is not clear, I do not include MAPK-
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dependent phosphorylation of Fus3, nor the resulting signal attenuation, in the Mating
Model. Although Kofahl and Klipp [2] included Ste5 phosphorylation in their model, there
is no apparent consequence of this phosphorylation event.
3.3.2.f Phosphatase (Msg5) Degradation and Upregulation
Experiments and evidence
Msg5 synthesis and degradation are upregulated in response to pheromone treatment
Msg5 expression is upregulated in response to pheromone treatment [72, 286], and
correspondingly the abundance of Msg5 is increased 2.5 to 3 hours following pheromone
treatment [94]. The turnover rate of Msg5 may be slightly affected by pheromone treatment
[55], but it is unclear whether this difference in degradation is significant.
Distilling evidence into elementary chemical reactions
Msg5 has a half-life of about 24 minutes in the absence of pheromone, and 20
minutes in the presence of pheromone [55]. This small difference in degradation rate
suggests that Msg5 degradation is either not pheromone regulated, or only weakly
pheromone regulated. I assume that Msg5 degradation is no pheromone-regulated.
Msg5 expression is upregulated in response to pheromone. I assume Msg5 synthesis
in the absence and presence of pheromone are governed by Ste 12 activity, as described in
Section 3.4.1.b. Thus, ksynth_Stel2_Msg5 and Km_synth_Stel2_Msg5 must be selected such that
in the absence of pheromone, the basal amount of active Stel2 leads to the expected
abundance of Msg5 (Msg5_conc), balancing out degradation of Msg5 and dilution of Msg5 due
to cell growth (see Section 3.6.1).
Numbers from experiments and models
Msg5 has an average half-life of about 22 minutes [55], corresponding to a
degradation rate of 5.3 x 10-4 S-1. Previously published models do not include Msg5
degradation, and only Shao et al. [100] included pheromone-dependent phosphatase synthesis
in their model.
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Figure 3-82 Synthesis of Msg5.
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Table 3-28 Parameter constraints forMsg5 degradation and synthesis.
kdeg_Msg5 •= 5.3 x 10-4 s-1
3.3.3 Protein Abundances
3.3.3.a PAK-Like Kinase (Ste20)
Numbers from experiments and models
Ste20 abundance is not regulated by pheromone [72, 201]. Ghaemmaghami et al.
measured a Ste20 cellular abundance of 260 molecules per cell by western blotting [98], and
Benjamin et al. also used western blotting to measured a Ste20 abundance of 4,200 molecules
per cell (Chapter 4). Because Benjamin et al. accounted for more sources of error (see
Section 3.1.5.a), I assume that Ste20 is present at 4,200 molecules per cell.
Shao et al. [100] used a concentration of 1 ýpM Ste20 in their model (no source
given). Because they assume that all Ste20 is localized to a 13 fL volume in the shmoo tip,
this corresponds to a cellular abundance of 8,000 molecules of Ste20. The localization
assumption may be valid after extended pheromone treatment (see Section 3.1.5.a). Kofahl
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Figure 3-81 Degradation of Msg5.
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and Klipp also used a Ste20 concentration of 1 ýtM in their model [2], which corresponds to
33,000 to 50,000 molecules of Ste20 per cell, depending on the cell volume used in the
model (see Section 3.1.5.a).
Based on the measured abundance of 4,200 molecules of Ste20 per cell, the
intracellular concentration of is Ste20_conc = Ste20_abund + (Cytosol_volume x NA), where NA is
Avogadro's number. Because Ste20 expression is not up-regulated in response to pheromone
treatment, the maintenance of Ste20 abundance is not addressed elsewhere in this chapter so
Ste20 synthesis is given below. Since I am not considering Ste20 degradation in the Mating
Model, the only means by which Ste20 is lost is dilution (see Section 3.6.1). To offset the
loss due to dilution, Ste20 must be synthesized at a rate of ksynth_Ste20 = kdilution x Ste20_conc.
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Table 3-29 Parameter constraints for synthesis of Ste20.
Ste20_abund ; 4200
Ste20_conc = Ste20_abund + (Cytosol_volume x NA)
ksynthSte20 = kdilution x Ste20_conc
3.3.3.b Scaffold (Ste5)
Numbers from experiments and models
Although the Ste5 promoter region contains five putative pheromone response
elements [291], the promoter is not bound by Stel2 [287] and expression of Ste5 is not
upregulated in response to pheromone treatment [72]. The abundance of Ste5 was measured
as part of four abundance data sets (see Section 3.1.5.a): Ghaemmaghami et al. measured an
abundance of 1,900 molecules per cell [98], Benjamin et al. measured an abundance of 480
copies of Ste5 per cell (Chapter 4), Maeder et al. estimated that the Ste5 cytoplasmic
concentration is about 35 nM [94], which given a cytoplasmic volume of 29 fL (see Section
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3.6.1) corresponds to an abundance of about 610 molecules per cell, and Slaughter et al.
estimated a cytoplasmic concentration of 34 nM [99], corresponding to about 590 molecules
per cell. I average the values measured by Benjamin et al., Maeder et al., and Slaughter et al.
(see Section 3.1.5.a) to get 560 molecules of Ste5 per cell.
In their model, Kofahl and Klipp used a Ste5 concentration of 158 nM, which
corresponds to an abundance of 5,250 to 7,900 molecules per cell (depending on the cell
volume used in the model; see Section 3.1.5.a) [2]. Shao et al. used a Ste5 concentration of
125 nM, which given that they assume that all Ste5 is localized to a nuclear volume of 13 fL
prior to pheromone treatment, corresponds to 1,000 molecules per cell [100]. Prior to
pheromone treatment, Ste5 is relatively evenly distributed between the cytosol and nucleus
[94, 106-111], making the assumption of complete nuclear localization prior to treatment a
poor one. Even after nuclear export, Shao et al. assume that Ste5 is restricted to a 13 fL
volume in the shmoo tip. This assumption may be valid after extended pheromone treatment
(see Section 3.1.5.a). Finally, Schaber et al. used the Ste5 abundance of 1,900 molecules per
cell determined by Ghaemmaghami et al [136].
Using the average measured abundance of 560 molecules of Ste5 per cell, the
intracellular concentration is Ste5_conc = Ste5_abund - (Cytosol_volume x NA), where NA is
Avogadro's number. The maintenance of Ste5 abundance is not addressed elsewhere in this
chapter and so Ste5 synthesis is given below. The only means of loss of Ste5 is dilution (see
Section 3.6.1). To offset the loss due to dilution, Ste5 must be synthesized at a rate of
ksynth_Ste5 = kdilution x Ste5_conc.
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3.3.3.c MAPKKK (Stell)
Numbers from experiments and models
The promoter region of Ste 11 is not bound by Ste 12 either in the absence or presence
of pheromone [287], and correspondingly Stel expression is not pheromone-induced [72,
292]. The abundance of Ste 11 was measured as part of all four abundance data sets (see
Section 3.1.5.a): Ghaemmaghami et al. measured an abundance of 736 molecules per cell
[98], Benjamin et al. measured an abundance of 3,500 molecules per cell (Chapter 4),
Maeder et al. estimated a Stel cytoplasmic concentration of about 39 nM [94], and
Slaughter et al. estimated a cytoplasmic concentration of 33 nM [99]. Given a cytoplasmic
volume of 29 fL (see Section 3.6.1), the latter values corresponds to abundance of about 680
and 580 molecules per cell, respectively. The carefully measured abundances (see Section
3.1.5.a) of 3,500, 680 and 580 molecules per cell are not in good agreement Thus, I merely
assume that the abundance of Stel 1 likely lies in the range of 580 to 3,500 molecules per
cell.
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Figure 3-84 Synthesis of Ste5.
Table 3-30 Parameter constraints for synthesis of Ste5.
Ste5 abund , 560
Ste5_conc = Ste5_abund + (Cytosol volume x NA)
ksynth Ste5 = kdilution x Ste5_conc
In their model, Schaber et al. used the abundance of Ste 11 determined by
Ghaemmaghami et al. [136]. In the model developed by Shao et al., a concentration of 200
nM was used, which, given that they assume that all Ste 11 localizes to a 13 fL volume in the
shmoo tip, corresponds to 1,600 molecule per cell [100]. Although Ste 11 is recruited to the
shmoo tip upon pheromone treatment via its association with Ste5, the majority of the
cellular Stel 1 is distributed evenly throughout the cytosol [107], making this a poor
assumption (also see Section 3.1.5.a). Kofahl and Klipp used a Stel concentration of 158
nM (same as the concentration of Ste5) in their model, which gives 5,250 to 7,900 molecules
per cell (depending on the cell volume used in the model; see Section 3.1.5.a) [2].
The concentration is Stel l_conc = Stel l_abund + (Cytosol_volume x NA), where NA is
Avogadro's number. Because Stel 1 is not pheromone-induced, the maintenance of Stel 1
abundance is not addressed elsewhere in this chapter and thus Ste ll synthesis is given below.
The synthesis rate of Stel 1 ksynth_Stel 1 must offset the loss of Stel due to dilution (see
Section 3.6.1) and Fus3-dependent degradation (ktumoverStel 1; see Section 3.3.2.a):
ksynthStel 1 = (kdilution + kturnoverStel 1) x Stel l_conc.
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Figure 3-85 Synthesis of Stell.
Table 3-31 Parameter constraints for synthesis of Stell.
Stel 1 abund - 580 to 3500
Stel l_conc = Stel _abund + (Cytosol_volume x NA)
ksynth_Stel 1 = (kdilution + ktumover _Stel 1) x Stel l_conc
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3.3.3.d MAPKK (Ste7)
Numbers from experiments and models
The Ste7 promoter region is not bound by Stel2 [287] and correspondingly Ste7
expression is not upregulated in response to pheromone treatment [72]. The abundance of
Ste7 was measured as part of all four abundance data sets (see Section 3.1.5.a):
Ghaemmaghami et al. measured an abundance of 672 molecules per cell [98], Benjamin et al.
measured an abundance of 920 copies of Ste7 per cell (Chapter 4), Maeder et al. estimated
that the Ste7 cytoplasmic concentration is about 68 nM [94], and Slaughter et al. estimated a
cytoplasmic concentration of 44 nM [99]. Given a cytoplasmic volume of 29 fL (see Section
3.6.1), the latter two measurements correspond to abundances of about 1,190 and 780
molecules per cell, respectively. All four measurements are consistent with an earlier
analysis that found that there are less than 2,000 molecules of Ste7 per cell [251]. Because
the carefully measured values from Benjamin et al., Maeder et al. and Slaughter et al. (see
Section 3.1.5.a) are in good agreement, I average of these measurements to get 960
molecules of Ste7 per cell.
In their computational model of the mating pathway, Wang et al. used a cellular
abundance of 900 molecules per cell, citing the Ghaemmaghami et al. measurement of 672
molecules per cell [55]. Schaber et al. used the abundance of Ste7 determined by
Ghaemmaghami et al. [136]. Shao et al. used a Ste7 concentration of 210 nM in their model,
which, given their assumption that all Ste7 concentrates within a 13 fL volume in the shmoo
tip, corresponds to 1,600 molecule per cell [100]. This assumption may be valid after
extended pheromone treatment (see Section 3.1.5.a). Kofahl and Klipp used a Ste7
concentration of 36.4 nM, which equates to 1,200 to 1,800 molecules per cell (depending on
the cell volume used in the model; see Section 3.1.5.a) [2].
I use an abundance of 960 molecules per cell in the Mating Model, and the
concentration of Ste7 is thus Ste7_conc = Ste7_abund + (Cytosol_volume x NA), where NA is
Avogadro's number. Ste7 synthesis is given below because Ste7 synthesis is not pheromone-
induced, and is thus not addressed elsewhere in this chapter. The Ste7 synthesis rate
ksynth_Ste7 must be selected to offset the loss of Ste7 due to dilution (see Section 3.6.1) and
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Farl-dependent degradation (see Section 3.3.2.b). The degradation rate of Ste7 in the
absence of pheromone is not known, so I cannot explicitly define ksynthSte7.
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Figure 3-86 Synthesis of Ste7.
Table 3-32 Parameter constraints for synthesis of Ste7.
Ste7_abund z 960
Ste7_conc = Ste7 abund + (Cytosol volume x NA)
ksynthSte7 > kdilution x Ste7_conc
3.3.3.e MAPKs (Fus3 and Kssl)
Numbers from experiments and models
Fus3
Fus3 synthesis is regulated in a pheromone-dependent manner and addressed in
Section 3.3.2.c. The abundance of Fus3 was measured as part of all four abundance data sets
(see Section 3.1.5.a): Ghaemmaghami et al. measured an abundance of 8,480 molecules per
cell [98], Benjamin et al. measured an abundance of 20,400 copies of Ste5 per cell (Chapter
4), Maeder et al. estimated that the cytoplasmic concentration of Fus3 is about 179 nM [94],
and Slaughter et al. estimated that the cytoplasmic concentration of Fus3 is about 66 nM
[99]. Given a cytoplasmic volume of 29 fL (see Section 3.6.1), the latter two measurements
correspond to an abundances of about 3,120 and 1,150 molecules per cell, respectively.
Additionally, using purified Fus3 as a protein standard Bardwell et al. measured an
abundance of about 5,000 molecules per cell via quantitative western blot [251]. Here I am
faced with a dilemma, because all measurements span nearly an order of magnitude, and the
highest and lowest measurement were both made carefully and there is no reason to believe
that either is suspect. Thus, I merely assume that the abundance of Fus3 likely lies in the
range of 1,150 to 20,400 molecules per cell.
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Several computational models used the Fus3 abundance measured by the high-
throughput TAP study [55, 136]. Kofahl and Klipp used a Fus3 concentration of 686 nM in
their model, which corresponds to an abundance of 23,000 to 34,000 molecules per cell
(depending on the cell volume used in the model; see Section 3.1.5.a) [2]. They reference
this concentration to Bardwell et al., who measured 5000 molecules per cell of Fus3 [25 1].
Shao et al. used a Fus3 concentration of 1.2 g1 M in their model, which corresponds to 9,600
molecules per cell localized to the shmoo tip and nucleus [100].
Kssl
The Kssl promoter is not bound by Stel2 [287], and accordingly the expression of
Kssl is not regulated in a pheromone-dependent manner [72]. The abundance of Kssl was
measured as part of three of the abundance data sets (see Section 3.1.5.a): Ghaemmaghami et
al. measured an abundance of 5,480 molecules per cell [98], and Benjamin et al. measured an
abundance of 20,800 copies of Ste5 per cell (Chapter 4), and Slaughter et al. estimated a
cytoplasmic Fus3 concentration of about 53 nM [99], which given a cytoplasmic volume of
29 fL (see Section 3.6.1) corresponds to an abundance of about 930 molecules per cell.
Bardwell et al. measured an abundance of 5,000 molecules per cell by western blot [251].
All measured abundances of Kssl agree closely with the corresponding measurements of
Fus3 abundance. Like with the measurements of Fus3 abundance, the measurements span
nearly an order of magnitude, and the highest and lowest measurement were both made
carefully and there is no reason to believe that either is suspect. I can only assume that Kssl
abundance likely falls between 930 and 20,800 molecules per cell.
The Kss 1 abundance used in computational models is either taken from the high-
throughput TAP study Ghaemmaghami et al. [136], or in a non-dimensionalized model is set
equal to the non-dimensional Fus3 abundance [56]. Because Kssl expression is not
pheromone-induced, Kss 1 synthesis is not addressed elsewhere in this chapter and so is given
below. Additionally, Kssl turnover rate is not known, so it is not included in the Mating
Model. Thus, synthesis of Kssl must balance dilution due to cell growth (see Section 3.6.1):
ksynthKssl = kdilution x Kssl_conc.
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3.3.3.f Phosphatases (Msg5, Ptp2 and Ptp3)
Numbers from experiments and models
Ptp2
Although mRNA microarray data suggests that Ptp2 may be upregulated very late
following pheromone treatment (90 minutes or later) [72], a genome-wide binding study did
not detect significant binding of Stel2 to the Ptp2 promoter, either before or after pheromone
treatment [287]. Thus, I assume that Ptp2 is not pheromone-induced. Ptp2 abundance has
only been measured once, 149 molecules per cell, by Ghaemmaghami et al. [98]. Using
Ptp2_abund - 149, the total nuclear concentration of Ptp2 is Ptp2_conc = Ptp2_abund +
(Nucleus_volume x NA), where NA is Avogadro's number. Ptp2 synthesis is not addressed
elsewhere in this chapter because its expression is not pheromone regulated and so is given
below. Because the Ptp2 turnover rate is not known, and thus is not included in the Mating
Model, the synthesis of Ptp2 need only balance dilution due to cell growth (see Section
3.6.1): ksynth_Ptp2 = kdilution x Ptp2_conc.
Ptp3
The Ptp3 promoter is not significantly bound by Stel2 [287], and correspondingly
Ptp3 gene expression and protein abundance are not increased in response to pheromone
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Figure 3-87 Synthesis of Kss1.
Table 3-33 Parameter constraints for Kssl synthesis and Fus3 concentration.
Fus3_abund - 1150 to 20400
Fus3_conc = Fus3_abund + (Cytosol volume x NA)
Kssl_abund - 930 to 20800
Kssl_conc = Kssl_abund + (Cytosol_Volume x NA)
ksynthKssl = kdilution x Kssl_conc
I : - Kssq
treatment [72, 94]. The abundance of Ptp3 was measured as part of two of the abundance
data sets (see Section 3.1.5.a): Ghaemmaghami et al. measured an abundance of 768
molecules per cell [98], and Ptp3 was estimated to exist at a cytoplasmic concentration of
about 84 nM [94], which given a cytoplasmic volume of 29 fL (see Section 3.6.1)
corresponds to an abundance of about 1,470 molecules per cell. I use the average value of
1,120 molecules of Ptp3 per cell in the Mating Model.
The total cellular concentration of Ptp3 is Ptp3_conc = Ptp3_abund + (Cytosol_volume x NA),
where NA is Avogadro's number. Ptp3 synthesis is not addressed elsewhere in this chapter
because its expression is not pheromone regulated and so is given below. Because the Ptp3
turnover rate is not known, thus not included in the Mating Model, the synthesis of Ptp3 need
only balance dilution due to cell growth (see Section 3.6.1): ksynth_Ptp3 = kdilution x Ptp3_conc.
Msg5
Msg5 synthesis is regulated in a pheromone-dependent manner and addressed in
Section 3.3.2.f. The abundance of Msg5 was measured as part of three abundance data sets
(see Section 3.1.5.a): Ghaemmaghami et al. measured an abundance of 538 molecules per
cell [98], Benjamin et al. measured an abundance of only 38 molecules per cell (Chapter 4),
and Msg5 was estimated to exist at a cytoplasmic concentration of about 64 nM [94]. Given
a cytoplasmic volume of 29 fL (see Section 3.6.1), the latter measurement corresponds to an
abundance of about 1,120 molecules per cell. All measurements span nearly two orders of
magnitude, and the highest and lowest measurement were both made carefully and there is no
reason to believe that either is suspect (see Section 3.1.5.a). Because of this conflict, I
merely assume that the abundance of Msg5 likely lies in the range of 38 to 1,120 molecules
per cell.
Shao et al. assumed a concentration of dual-specificity MAPK phosphatase of 100
nM in both the shmoo tip (13 fL) and in the nucleus (13 fL), which corresponds to 1,600
molecule per cell (see Section 3.1.5.a) [100]. Wang et al. used an Msg5 abundance of 9,000
molecules per cell [55], referencing this number to Ghaemmaghami et al. (538 molecules per
cell) and to a model of ERK2 phosphorylation and dephosphorylation [272].
193
Computational and graphical representations
ksynth.tp2
Ptp2
Figure 3-88 Synthesis of Ptp2.
ksynthPtp3
Ptp3
Figure 3-89 Synthesis of Ptp3.
3.4 Transcriptional Machinery
3.4.1 Signal Propagation
3.4.1.a Transcriptional Regulator (Stel2) Activation
Summary
Digl and Dig2 bind and repress the transcriptional regulator Stel2.
Unphosphorylated Kssl, and likely Fus3 as well, bind to the Digl-Dig2-Stel2 complex and
further repress transcription. Dig 1 and Dig2 are phosphorylated by Fus3 and Kss 1 in
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Table 3-34 Parameter constraints for synthesis of Ptp2 and Ptp3.
Ptp2_abund = 149
Ptp2_conc = Ptp2_abund + (Nucleusvolume x NA)
ksynth Ptp2 = kdilution x Ptp2_conc
Ptp3_abund k 1120
Ptp3_conc = Ptp3 _abund + (Cytosol volume x NA)
ksynth_Ptp3 = kdilution x Ptp3_conc
Msg5_abund -~ 38 to 1120
Msg5_conc = Msg5_abund + (Cytosol volume x NA)
response to pheromone treatment, and phosphorylation relieves Digi and Dig2 repression of
Stel2. Stel2 is phosphorylated by the MAPKs in response to pheromone treatment, although
it is unclear whether phosphorylation is required for activation of Stel2. Stel2 is also
sumoylated in response to pheromone treatment, and sumoylation may increase Ste12
activity.
Experiments and evidence
Digl and Dig2 interact with Ste 12
Both Digi and Dig2 interact with Stel2 via yeast two-hybrid [293], and recombinant
GST-Digl and GST-Dig2 interact with Stel2 in cell lysates [293-295]. In vitro, myc-Stel2
interacts with a small amount of Digl in the absence of Dig2, and interacts with a small
amount of Dig2 in the absence of Digl [296]. However, Stel2 interacts strongly with both
Digl and Dig2 when all three proteins are present, suggesting that Digl and Dig2 bind
cooperatively to Stel2 [296]. Simultaneous binding of Digl and Dig2 to Stel2 is supported
by the fact that Digl and Dig2 interact with distinct regions of Stel2; Digl interacts with the
Stel2 N-terminal DNA binding domain (Stel2 residues 309 to 547), and Dig2 interacts with
the Stel2 C-terminal domain (residues 21 to 195) [295]. A fusion between the Gal4
activation domain and Digl or Dig2 results in constitutive expression of FUS1-lacZ in a
Stel2 dependent manner [293], suggesting that Digl and Dig2 can remain associated with
Stel2 that is bound to the Fusl promoter site. Tec , a transcription factor required for
invasive and pseudohyphal growth, competes with Dig2 to interact with Stel2 [296].
Ste12 is repressed by Digi and Dig2
Deletion of both Digl and Dig2 results in constitutive invasive growth and
constitutive expression of mating-specific genes [293, 294, 297]. Similarly, over-expression
of Stel2 by itself is lethal, whereas simultaneous over-expression of either Digl or Dig2 is
sufficient to restore viability [293]. Dig2, but not Digl, is able to repress expression
meditated by a fusion between the Stel2 DNA binding domain and the activation domain of
herpes simplex virus type 1 VP16 [295]. Because Dig2, but not Digl, is able to bind to the
Stel2 DNA binding domain, Dig2 likely represses Stel2 activity by interacting with the N-
terminal domain of Stel2. Similarly, Digl, and not Dig2, is able to repress transcription
mediated by LexA-Stel2(216-688) [295], demonstrating that Digl represses Stel2 activity
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via direct interaction with the Stel2. Either of Digl or Dig2 is sufficient for repression of
Stel2, as deletion of either one does not alter pheromone sensitivity [293, 294] or Fusl-LacZ
expression [296].
Kssl stabilizes the Digl-Stel2 complex
Inactive Kssl has been identified as an inhibitor of invasive growth [276, 297-299],
and as a weak inhibitor of pheromone response [297]. Kssl interacts directly with Stel2
[250, 276], and selective elimination of this interaction results in invasive growth in certain
yeast strains, even without disruption of the interactions between Kssl and Ste7, Digl and
Dig2 [276]. Thus, the interaction between Kssl and Stel2 appears to be required for
repression of Stel2 activity in invasive growth. Phosphorylation of Kssl decreases the
interaction between Kssl and Stel2; in vitro, phosphorylated Kssl binds more weakly to
GST-Stel2 than unphosphorylated Kssl, and in vivo, non-phosphorylatable Kssl mutants
(T183A, Y185F, and T183A Y185F) prevent invasive growth [276]. Interestingly, Kssl is
unable to repress transcription of filamentation response elements (which are active during
invasive growth) in the absence of Digl [297], suggesting that Kssl may inhibit invasive
growth by stabilizing the association between Digl and Stel2.
Fus3 may similarly stabilize the Digl-Ste 12 complex. Ste 12 immunoprecipitates
with Fus3-Myc in the absence of pheromone but not in the presence of pheromone or in the
absence of Digl and Dig2 [293]. Deletion of Kssl results in higher Fusl-LacZ transcription
than deletion of Fus3 [297], suggesting that Kssl is a better repressor of Ste 12 activity.
Supporting this notion, Fus3 interacts more weakly with Stel2 in vitro than Kssl does [297].
Digl and Dig2 are phosphorylated in response to pheromone
Fus3-Myc is able to immunoprecipitate both Digl and Dig2 in the absence and
presence of pheromone [293]. Both Digl and Dig2 that are immunoprecipitated in the
presence of pheromone have decreased electrophoretic mobility, and this decreased mobility
is eliminated by phosphatase treatment [293]. More directly, active Fus3 and Kssl
phosphorylate Digl and Dig2 in vitro [255, 294]. Although, Fus3 has a -20-fold higher
affinity for Digl and Dig2 than Kssl [250], deletion of either Fus3 or Kssl has a minimal
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effect on phosphorylation of Digl and Dig2 and Ste 12-mediated gene expression in response
to pheromone treatment [255].
Phosphorylated Digl and Dig2 likely have decreased affinity for Ste12
Because deletion of Digl and Dig2 and pheromone treatment both result in high
levels of Stel2-dependent gene expression [72, 293, 297], it seems likely that pheromone
dependent phosphorylation of Digl and Dig2 results in their dissociation from Ste12.
Supporting this notion, mutation of known phosphorylation sites on Digi greatly decreases
pheromone-mediated gene expression (Resnekov et al., in preparation). Additionally, in the
presence of pheromone, Stel2 is more strongly enriched at mating specific genes than Digl
(relative to other genes, as measured by chromatin immunoprecipitation) [300]. It is also
possible that phosphorylation of Digl and Dig2 does not cause their dissociation from Ste 12,
but merely results in an altered conformation that does not repress Stel2. For example, the
regulator Gal80 does not dissociate from the transcriptional activator Gal4 upon galactose
induction [301, 302].
Stel2 is phosphorylated in response to pheromone
Ste12 is constitutively phosphorylated in the absence of pheromone on serine and
threonine residues, but not on tyrosine residues [303]. Stel2 is rapidly phosphorylated in
response to pheromone exposure [304], again only on serine and threonine residues [303].
Mass spectrometry was used to identify two Ste 12 peptides that that are phosphorylated in
response to pheromone treatment (Resnekov et al., in preparation). Mutation of the potential
phosphorylation sites from either peptide causes a decrease in pheromone mediated gene
expression, suggesting that phosphorylation of some of these residues is important for Stel2
activation (Resnekov et al., in preparation).
There are two experiments that suggest that phosphorylation may not be important for
the activity of Stel2, and that depression may be sufficient for Stel2 activity. First, deletion
of Digl and Dig2 results in similar levels of gene expression as pheromone treatment of
wild-type cells [72]. Additionally, treatment of diglA dig2A cells with pheromone has a
minimal effect on expression of FUS 1-LacZ [293, 297].
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Stel 2 is sumoylated in response to pheromone
A small fraction of Stel2 is sumoylated in the absence of pheromone, and pheromone
treatment moderately increases the fraction of Ste 12 that is sumoylated [305]. Expression of
a Flag-SUMO-Stel2 fusion protein increases expression from the FUS1 promoter in the
presence of pheromone, but not in the absence of pheromone [305]. Sumoylation is known
to regulate the activity of transcription factors [306].
Distilling evidence into elementary chemical reactions
S. cerevisiae has a complex balance of interactions to regulate Stel2 activity and thus
pheromone induced gene expression. Clearly, Digl and Dig2 are negative regulators of
Stel2 activity. Not only do Digl and Dig2 bind cooperatively to Stel2, but their interaction
with Stel2 is stabilized by Kss 1, and possibly Fus3. Phosphorylation of Kss1, Digl and
Dig2 appears to decrease their affinity for Ste12, relieving repression.
Despite the fact that single-deletion mutants suggest that either Digl or Dig2 on its
own is sufficient for repression of Stel2, in vitro binding assays suggest that Digl and Dig2
bind cooperatively to Stel2. Kssl appears to bind Stel2 and stabilize the Digl-Stel2
interaction. Although there is less evidence for Fus3-mediated repression of gene expression,
sufficient evidence does exist to support the assumption that Fus3 acts similarly to Kssl in
this regard. Compared to Kssl, Fus3 is a weaker repressor of Fusl-LacZ expression and
binds to more weakly to Stel2. Thus, I assume that when either Fus3 or Kssl is bound to
Stel2, each has an equal ability to stabilize the association between Stel2 and Digl.
Phosphorylated Kssl has decreased ability to bind Stel2. Thus, I assume that the extent of
activation loop phosphorylation for both the MAPKs mediates their affinities for Stel2. For
simplicity, I assume that the cooperative effects of Digl and Dig2 binding to Stel2, and Digl
and MAPK binding to Ste12 are multiplicative such that Kd_Stel2Dig2_Digl = Kd_Stel2_Dig1 +
Stel2_Digl_Dig2factor, Kd_Ste12MAPK_Digl = Kd_Stel2_Dig1 + Stel2_Digl_MAPK_factor, and
Kd_Stel2Dig2MAPK Digl = Kd_Stel2_Dig1 + (Stel2_Dig l_Dig2_factor x Stel2_Dig1_MAPK_factor).
Digl and Dig2 are both phosphorylated by active Fus3 and Kssl, and this
phosphorylation also appears to relieve the inhibition of Ste 12. The most plausible
mechanism is that phosphorylated Digl and Dig2 have decreased affinities for Stel2 when
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they are phosphorylated. An alternative possibility is that pheromone-mediated
phosphorylation of Stel2 decreases the affinity of Stel2 for Digl and Dig2. In the absence
of convincing evidence either way, I assume that phosphorylation of Digl and Dig2 decrease
their affinities for Stel2. It is unclear whether Digl and Dig2 are singly or multiply
phosphorylated in response to pheromone. Because multiple phosphorylation states have not
been detected, I assume that it is sufficient to model a single phosphorylation site. Again, I
assume that the effect of phosphorylation on binding affinity is multiplicative with the
cooperative binding effects above. For example, KdStel2_Digl PO4 = Kd_Stel2_Dig1 x
Stel 2_Digl_PO4_factor, and Kd_Stel 2Dig2_DiglP0 4 = Kd_Stel2Dig2_Dig1 x Stel2_Digl_PO4_factor =
Kd_Stel2_Dig1 x Stel2_Digl_PO4 factor - Stel2_Dig 1_Dig2_factor.
Kssl and Fus3 interact with and phosphorylate Dig1 and Dig2. To simplify matters, I
assume that each MAPK can bind directly to unphosphorylated Digl or Dig2, and the
interaction between the each MAPK and either repressor is unaffected by the participation of
the repressor in any particular complex. Thus, the interaction between the MAPKs and Digl
or Dig2 does not affect the ability of either repressor to participate in any interactions. I also
assume that the binding and phosphorylation of Digl and Dig2 follows the assumptions
made in Section 3.3.1.f, and that the MAPKs only bind to unphosphorylated Digl and Dig2
molecules.
Evidence suggests that phosphorylation of multiple sites on Stel2 is required for
efficient pheromone-mediated gene expression. Phosphorylation of Stel2 is presumably
carried out by active Fus3 and Kss 1, although this has not been demonstrated directly.
Additionally, deletion of Digl and Dig2 results in a similar level of gene expression to
pheromone treatment, implying several potential mechanisms by which phosphorylation of
Stel2 may be important for Stel2 activity. Phosphorylation of Stel2 may not activate Stel2
directly, but may instead decrease the interaction between Stel2 and Digl and/or Dig2,
resulting in more unrepressed (and thus active) Stel2. Alternatively, phosphorylation of
Stel2 may simply decrease the association between the MAPK kinases and Stel2,
destabilizing the Stel2-Digl-Dig2 complex and again resulting in unrepressed Stel2.
Finally, phosphorylation of Stel2 may be directly required for Stel2 transcriptional activity.
In the absence of Digl and Dig2, there may be sufficient active Fus3 and Kssl to
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phosphorylate Stel2 in the absence of pheromone. This latter possibility would be further
supported if the MAP kinases could only phosphorylate Stel2 that was not repressed by Digl
or Dig2. I assume that the MAPKs are only able to phosphorylate Stel2 that is not bound to
either Digi or Dig2, although as outlined above, this is certainly not the only mechanism that
is consistent with available data. To simplify the Mating Model, I include only one
phosphorylation site on Stel2. It is unclear whether there are multiple MAPK docking
motifs on Stel2 that are responsible for phosphorylation at different sites, and whether these
MAPK docking motifs are distinct from where the MAPKs bind to stabilize the complex
formed between Stel2 and Digl. I assume that there is only one MAPK docking motif on
Stel2.
Although it is clear that sumoylation can affect Stel2 activity, little is known about
the regulation of Stel2 sumoylation, and the exact effect of sumoylation. Thus, I omit Stel2
sumoylation from the Mating Model.
Numbers from experiments and models
The affinities of the interactions between Digl and Stel2, and Dig2 and Stel2, have
not been measured experimentally. However, deletion of either Digl or Dig2 does not
significantly alter Fusl-LacZ expression in the absence of pheromone, suggesting that either
Digl or Dig2 alone is sufficient to repress Stel2. Thus it is likely that the affinities between
the repressors and Stel2 are high enough such that physiological amounts of either Digl or
Dig2 are sufficient to bind and repress the majority of Stel2 molecules in the cell. Given the
measured abundances of 1,390 Stel2 per cell, 4,800 Digl per cell and 1,180 Dig2 per cell
(see Section 3.4.3), and a mean haploid nuclear volume of 2.9 fL (see'Section 3.6.1), for
greater than 80% occupancy of Stel2, Digl and Stel2 would have to interact with a Kd of
less than 500 nM, and Dig2 and Stel2 would have to interact with a Kd of less than 10 nM.
For less than 20% occupation of Stel2 in the presence of pheromone (assuming complete
phosphorylation of Digl and Dig2), phospho-Digl and Stel2 would have to interact with a
Kd of greater than 10 gM, and phospho-Dig2 and Stel2 would have to interact with an
affinity of greater than 2 [tM. Given the cooperative binding of Digl and Dig2 to Stel2, the
affinities of phosphorylated Digl and Dig2 would likely need to be even weaker to allow for
sufficient de-repression of Stel 2.
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Unphosphorylated Kssl interacts with Stel2 in vitro with an affinity between 0.2 and
4 p~M [250, 276]. Fus3 interacts more weakly with Stel2 than Kssl does [276].
Phosphorylation of Kssl decreases its affinity for Stel2, although the extent of this effect has
not been quantified. Despite the fact that that Kss I (and likely Fus3 as well) stabilize the
association between Digl and Stel2, the strength of this stabilization has also not been
quantified.
The association between the MAPKs and Digl and Dig2 has been measured. Fus3
binds GST-Digl(93-111) with an affinity of 3 pM, and binds GST-Dig2(98-114) with an
affinity of 1 pM [250]. Kssl binds both Digl and Dig2 fragments about 17-fold more
weakly than Fus3 does [250], meaning that Kssl binds GST-Digl(93-111) with an affinity of
50 pM, and binds GST-Dig2(98-1 14) with an affinity of 17 pM. Because these
measurements are made in vitro, and using minimal MAPK docking motifs, the in vivo
affinities may be significantly different. The rates of phosphorylation of Digl and Dig2 have
not been measured.
Computational and graphical representations
Once again, microscopic reversibility applies to constrain the parameters governing
the interactions between Stel2, Digl, Dig2, and the MAPKs (see Section 3.2.1.c). Thus, I
define Stel2_Digl_Dig2_factor as the factor by which Digl influences the binding affinity
between Stel2 and Dig2, and the factor by which Dig2 influences the affinity between Stel2
and Digl. Also, Stel2_Digl_MAPK_factor is the same factor by which the MAPKs affect the
affinity between Stel2 and Dig 1, and the factor by which Digl affects the affinity between
Stel2 and the MAPKs.
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Figure 3-90 Interaction of Stel2 and Digl.
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Table 3-35 Parameter constraints for interaction of Stel2 and Dig1.
Ste12 DigDig2jfactor > 1
Ste12 Dig1 MAPKfactor > 1
Ste12 Dig1_PO4_factor > I
KdSte12_DigI < 5 x 10"7 M
KdSte12_DigIPO, > 10s5 M
Kd Ste12DiglPO4 = KdSte12 Dig x SteI2Dig1_PO4_factor
KdStel 2Dg2Digl = KdSte12Dig1 + Ste 12_Digl _Dig2jactor
KdStel2Dig2_DiglPO4 = Kd_Ste12_Digl x Ste12_Dig1_PO4_factor + Stel2_Dig1_Dig2_factor
Kd_Ste12MAPK DigI = Kd_SteI2_Digl + Ste12_Dig1 MAPKfactor
KdSte12MAPK DiglPO4 = Kd_Stel2_Dig1 x Ste12_Dig1_PO4_factor + Ste12_Dig1 MAPK_factor
KdSte12MAPKDig2_Dig1 = Kd_Ste12 Dig1 + (Ste12_Dig1_Dig2_factor x Stel2_Dig1_MAPK_factor)
KdStel2MAPKDig2_DiglPO4 = Kd_Ste12_Dig x Ste12 Dig_PO4_factor + (Ste12 Dig1Dig2_factor x
Stel2_DiglMAPKjfactor)
Dig2 I
Kd
44.._
- t----- r-
Dig2
Stel2
Ste12
Stel2
Kd_Stel 2_Dig2
Kd_Stel2_Dig2PO
4
Kd_Ste12Digl_Dig2
KdSte 12Dig1Dig2PO4
Figure 3-91 Interaction of Stel2 and Dig2.
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Table 3-36 Parameter constraints for interaction of Stel2 and Dig2.
Stel2_Dig2_PO4_factor > 1
KdSte12_Dig2 < 10' M
KdStel2_Dig2PO4 > 2 x 10-6 M
KdStel2_Dig2PO4 = Kd_Ste12_Dig2 x Stei2_Dig2_PO4_factor
Kd_Stel2DiglDig2 = Kd_Stel2_Dig2 
- Stel2_Digl_Dig2_factor
KdStel2DiglDig2PO4 = Kd_Stel2_Dig2 x Stel2_Dig2_P0 4 factor Stel2 Digl_Dig2_factor
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Figure 3-92 Interaction of Stel2 and Fus3.
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Figure 3-93 Interaction of Stel2 and Kss1.
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Table 3-37 Parameter constraints for interaction of Stel2, Fus3 and Kssl.
Kd Ste12 Fus3 >Kd Stel2 Kss1
Kd_Ste12_Fus3pTpY> (Kd_Ste12_Fus3pT, Kd Stel2 Fus3pY) > KdStel2_Fus3
KdStel2Digl_Fus3 = Kd_Stel2_Fus3 - Stel2_Digl_MAPKfactor
KdStel2Digl Fus3pY= KdStel2_Fus3pY÷ Ste12 Dig1_MAPK_factor
KdSte12DiglFus3pT = KdStel2_Fus3pT -- Stel 2Dig1MAPK_factor
KdStel2Dig1Fus3pTpY= Kd_Stel2 Fus3pTpY- Stel 2_Dig _MAPKfactor
Kd Ste12 Fus3 > Kd Stel2 Kssl
Kd_Stel2_KsslpTpY> (Kd_Stel2_ KsslpT, Kd_Ste12_ KsslpY) > KdStel2_ Kssl
KdStel2Digl_ Kssl = Kd_Ste12_Fus3 + Stel2_Dig1_MAPK_factor
KdStel2Digl_ KsslpY= Kd_Stel2_ KsslpY- Stel2 Digl_MAPK_factor
Kd_Stel2Digl KsslpT= Kd_Stel2_ KsslpT+ Stel2_Digl_MAPK_factor
Kd_Stel2Digl KsslpTpY= Kd_Stel2_ KsslpTp Y Ste12_Dig l_MAPK_factor
Fus3
Fus3
Kd
I
Fus3
I
none none
none pY
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Figure 3-94 Interaction of Digi and Fus3..
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Figure 3-95 Phosphorylation of Digl by Fus3.
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Figure 3-96 Interaction of Digl and Kssl.
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Figure 3-97 Phosphorylation of Digl by Kssl.
Table 3-38 Parameter constraints for phosphorylation of Dig1 by Fus3 and Kssl.
Kd_Fus3_Digl1 = 3 x 106 M
Kd_Fus3pY_Digl = Kd_Fus3pTpYDigl x MAPK_pY Kd factor
Kd_Fus3pT_Digl = Kd_Fus3pTpY_Digl x MAPK_pTKd factor
Kd_Fus3pTpYDigl = Kd_Fus3_Digl + MAPK_unphosph Kdfactor
kcatFus3pY_DiglPO4 = kcat_Fus3pTpY_Digl_P0 4 + MAPK_pY kcat factor
kcat_Fus3pT_Digl_PO4 = kcat_Fus3pTpY_Digl_P0 4 + MAPKpT_kcatfactor
Kd_Kssl_Digl = 5 x 10-5 M
Kd_KsslpY_Digl = Kd_KsslpTpY_Digl x MAPKpY Kd factor
Kd_KsslpT_Digl = Kd_KsslpTpY_Digl x MAPK_pTKd factor
Kd_KsslpTpY_Digl = Kd_Kssl_Digl + MAPK_unphosph Kdfactor
kcat_KsslpY_Digl_PO4 = kcat_KsslpTpY_Digl_PO4 + MAPKpY kcat factor
kcat_Kss p T_Digl_PO4 = kcat_KsslpTpY_Digl_PO4 + MAPK_p Tkcatfactor
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Figure 3-98 Interaction of Dig2 and Fus3.
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Figure 3-99 Phosphorylation of Dig2 and Fus3.
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Figure 3-100 Interaction of Dig2 and Kssl.
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Figure 3-101 Phosphorylation of Dig2 by Kssl.
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Table 3-39 Parameter constraints for phosphorylation of Dig2 by Fus3 and Kssl.
Kd_Fus3_Dig2 m 10"6 M
Kd_Fus3pY_Dig2 = Kd_Fus3pTpY_Dig2 x MAPKpY Kd factor
Kd_Fus3pT_Dig2 = KdFus3pTpY_Dig2 x MAPK_pTKd factor
Kd_Fus3pTpY_Dig2 = Kd_Fus3 Dig2 + MAPK_unphosphKd factor
kcatFus3pY_Dig2_PO4 = kcat_Fus3pTpY_Dig2_P0 4 + MAPK_pYkcatfactor
kcat_Fus3pT_Dig2_PO4 = kcat_Fus3pTpY_Dig2_P0 4 + MAPK_pTkcatfactor
Kd_Kssl_Dig2 m 1.7 x 10-5 M
KdKsslpY_Dig2 = Kd_KsslpTpY_Dig2 x MAPKpY Kd factor
Kd_KsslpT_Dig2 = Kd_KsslpTpY Dig2 x MAPKpT Kd factor
KdKsslpTpY_Dig2 = Kd_Kssl_Dig2 + MAPK_unphosph Kd_factor
kcat_KsslpY_Dig2_PO4 = kcat_KsslpTpY_Dig2_P0 4 + MAPK_pY kcatfactor
kcat_KsslpT_Dig2_PO4 = kcat_KsslpTpY_Dig2_P04 + MAPK_pTkcat_factor
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Figure 3-102 Phosphorylation of Stel2 by Fus3.
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Figure 3-103 Phosphorylation of Stel2 by Kssl.
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3.4.1.b Transcriptional Regulator (Stel2) Mediated Transcription
Summary
Stel2 is the key transcription factor controlling pheromone-induced genes: haploid
non-cell-type specific genes are regulated by Stel 2 homodimers; a-cell specific genes are
regulated by Stel2-Mcml heterodimers; and a-cell specific genes are regulated by Ste 12-
Mcml-Matal 1 heterotrimers. Ste 12 is also the key transcription factor controlling
filamentation genes via a Ste 12-Tec 1 heterodimer.
Experiments and evidence
Stel2 regulates haploid genes as a homodimer
Pheromone response elements (PREs), characterized by the consensus sequence
(A)TGAAACA, are found in the upstream activating sequence of pheromone-induced genes
[307-309]. Stel2 mediates gene expression via binding to PREs. In vitro, adjacent PREs
bind Stel2 five- to ten-fold more tightly than a single PRE [309], suggesting that Stel2 forms
homodimers that bind cooperatively to nearby PREs. In vivo, two or more closely spaced
PREs are required for efficient gene expression in response to pheromone treatment or Stel2
over-expression [194, 308, 309]. The orientation of the PREs also plays a significant role in
the efficiency of gene expression [194, 309]. Genes with upstream activating sequence
containing PREs but not cell-type-specific sequences (see below) are regulated by Stel2 in
both a and a cell types [10].
Stel2 regulates a-cell specific through association with Mcml
The upstream activating sequence (UAS) of a-cell specific pheromone-inducible
genes contain an Mcml binding site adjacent to a PRE [10, 187, 188, 310]. Mcml binds as a
dimer to Mcml binding sites in vitro, even in the absence of Stel2, whereas Stel2 is only
able to bind the single PRE in the presence of Mcml [187, 188]. Because Stel2 requires the
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Table 3-40 Parameter constraints for phosphorylation of Stel2 by Fus3 and Kss1.
kcatjFus3pYStei2 PO4 = kcatFus3pTpYSte12_PO4 + MAPK pY kcatjfactor
kcat Fus3pSte 2PO4= kcaFup'fte 21 O4 _ + MAPK jpT kcat factor
kcat KstpYSte••2PO 4= kcat KspTpSte2.PO4 + MAPKYkcat factor
kcat Kss1p7Ste12_PO4= kcat.KI7pYStei2PO4 + MAPK pTkcat factor
presence of Mcml to effectively bind the UAS of a-cell specific pheromone-inducible genes,
it appears that Mcml and Stel2 bind cooperatively to the UAS, but Mcml binds much more
tightly than Stel2. However, in the presence of pheromone, Stel2 is able to activate
transcription from a single PRE even in the absence of a Mcml binding site [189].
The Mcml and Stel2 binding sites in a-cell specific genes are flanked by a2 binding
sites [311]. Mata2 is only expressed in a-cells, and thus in a-cells binds to these flanking
a2 binding sites, forming a complex with Stel2 and Mcml and inhibiting erroneous
expression of a-cell specific genes [311, 312].
Stel12 regulates a-cell specific genes through association with Mcml and Matal
The UASs of a-cell specific pheromone regulated genes contain adjacent Mcml and
Matal binding sites [80, 193]. Matal is a positive regulator of transcription and like Mata2,
Matal is expressed only in a-cells. Mateal, Mcml dimers, and Ste 12 bind together to the
promoter sequence of a-cell specific pheromone regulated genes to mediate transcription
[189, 193, 313]. The UASs of a-cell specific pheromone regulated genes do not appear to
contain PREs, making it unclear whether Stel2 interacts directly with the DNA in these
complexes, or Stel2 interacts with DNA-bound Matal and/or Mcml [313, 314].
Ste12 regulates invasive andfilamentous growth genes as a heterodimer with Tecl
Stel2 and Tec bind cooperatively to filamentation and invasion response elements
(FREs) to mediate filamentous and invasive growth [315]. Each FRE is composed of a PRE
and a Tecl binding site. Additionally, Tecl and Dig2 bind competitively to Stel2 [296].
Activation of the invasive or filamentous growth pathway leads to activation of Kss I
but not Fus3 [298]. Kssl activates Stel2, and Stel2-Tecl heterodimers upregulate
filamentous and invasive growth genes. Upon pheromone treatment, both Fus3 and Kssl are
activated. Fus3, but not Kss 1, is able to efficiently phosphorylate Tec 1, leading to Tec 1
ubiquitination and degradation, and selective upregulation of mating genes [316-318]. Prior
to pheromone treatment, the majority of Stel2 is thought to exist in Stel2-Digl-Dig2 and
Stel2-Digl-Tecl complexes [296]. The majority of cellular Tec1 is degraded within 5
minutes of exposure of cells to saturating amounts of pheromone [317, 318].
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Distilling evidence into elementary chemical reactions
Different genes are up-regulated by different amounts in response to pheromone [72].
Additionally, Ste 12-meditated gene expression is regulated differently for a-cell specific, a-
cell specific, and haploid-only (both a- and a-cell type) genes. To my knowledge, other than
cell-type specificity, characteristic differences in pheromone-induced expression of these
three classes of genes have not been identified. Thus, I model all pheromone-regulated genes
using the same elementary chemical reactions, varying only the parameters governing the
strength of gene expression for each gene.
The degradation of Tec 1 in response to pheromone is required for the selective
activation of mating genes instead of invasive and filamentous growth genes. Despite the
fact that Tec is clearly physiologically important, I do not include Tecl in the Mating Model
for several reasons. Deletion of Tecl has minimal effect on Fus 1-lacZ expression in the
absence of pheromone [296], and Tecl is largely degraded within 5 minutes of pheromone
treatment. This suggests that regulation of mating genes occurs normally in the absence of
Tec 1. In order to include Tec 1 degradation, I would need to define elementary reactions for
Tecl binding to Stel2 (two rate constants), Fus3 binding to Tecl (two rate constants) and
phosphorylating it (three rate constants), Tec 1 degradation (one rate constant), and Tecl
synthesis to balance degradation in the absence of pheromone (one rate constant). None of
these rate constants are known, and evidence suggests that ignoring Tecl entirely will not
greatly affect the accuracy of the resulting pathway model.
Active Stel2 (either as homodimers, or as part of complexes with other regulatory
proteins as described above) binds to the promoter region of pheromone-regulated genes to
regulate transcription. Because each gene exists at a single copy in haploid yeast cell and
each pheromone-responsive gene contains a limited number of Stel2 binding sites, gene
expression is saturable with respect to increasing amounts of active Stel2. Thus, rather than
include reactions for binding of Stel2 to promoter sites, and subsequent transcription and
translation, the rate of production of new protein from active Stel2 can be approximated by
Michaelis-Menten-like kinetics as a function of active Stel2 (Equation 3-1). This is a very
simplified model of protein production, but is commonly used in computational models.
Each gene that is regulated by Stel2 is modeled using different values for ksynth (representing
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differing transcription and translation efficiencies) and for Km (representing differing binding
affinities between Stel2 and the promoter sites).
ksynth x Stel2 active
synth_ rate = Equation 3-1Km + Stel2 active
Numbers from experiments and models
The rates used for upregulation of different proteins are given in the appropriate
sections above and below.
3.4.2 Regulation and Feedback
3.4.2.a Transcriptional Regulator (Stel2) Deactivation, Downregulation, and
Upregulation
Summary
Stel2 is downregulated in response to pheromone treatment via a Fus3 and Farl
dependent mechanism. Ste 12 is also weakly upregulated in response to pheromone
treatment.
Experiments and evidence
Stel 2 deactivation is mediated by nonspecific dephosphorylation and dilution
No phosphatases are known to dephosphorylate Stel2, suggesting that deactivation of
Stel2 may be primarily mediated by dilution (see Section 3.6.2), non-specific
dephosphorylation (see Section 3.6.6), and degradation.
Stel 2 is downregulated in a Fus3 and Farl dependent manner
Esch et al. observed that Stel2 levels start decreasing -1 hour following exposure of
cells to saturating doses of pheromone, and drop to -10% of the initial amount 4 hours
following treatment [319]. Stel2 is also poly-ubiquitinated in a pheromone-dependent
manner [319], making it likely that ubiquitination leads to degradation of Stel2. Deletion of
Kss 1 has only a minor effect on the degradation of Ste 12, whereas deletion of Fus3 or Farl
greatly decreases Stel2 degradation [319]. Although Farl inhibits Cdc28 to cause cell-cycle
arrest, direct inhibition of Cdc28 (via a temperature-sensitive mutation) does not cause
appreciable degradation of Ste12 [319], suggesting that cell-cycle arrest is not sufficient for
pheromone-mediated Ste12 degradation.
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In contrast to what Esch et al. observed, an earlier study by Chou et al. found that
Ste 12 levels were unaffected by treatment of cells with similar concentrations of pheromone
[317]. The pheromone used by Chou et al. these experiments may potentially have gone bad
or adsorbed to the glassware and plasticware (see supp. mat. of [53]) such that they may
have been inadvertently using a much lower effective concentration of biologically active
pheromone. Alternatively, the different background strains used by Esch et al. and Chou et
al. may have different mutations that affect Stel2 turnover.
Ste 12 is upregulated in response to pheromone treatment
As measured by RNA microarray [72, 287], and by unspecified techniques [320],
expression of Stel 2 is weakly induced by pheromone treatment.
Distilling evidence into elementary chemical reactions
I assume that Stel2 is dephosphorylated by nonspecific phosphatases, as described in
Section 3.6.6. Stel2 deactivation is likely results from a combination of non-specific-
dephosphorylation, dilution due to cell growth, and degradation.
Esch et al. performed many experiments to study Stel2 degradation, whereas Chou et
al. reported a single experiment showing that Stel2 is not degraded in response to pheromone
treatment. Because Esch et al. worked out many of the details of Stel 12 degradation, I
assume their results are correct. Despite the many details uncovered by Esch et al., the
mechanism by which Fus3 and Farl regulate Stel2 degradation is unclear. Fus3
phosphorylates Farl to stabilize it (see Section 3.5.1). Thus, it appears likely that it is Farl or
some effector of Farl, and not Fus3, that is directly responsible for Stel2 degradation.
Because the mechanism by which Farl causes the degradation of Ste 12 is unknown, and Farl
is not included in the Mating Model, I model the degradation of Stel2 via Michaelis-Menten
kinetics, with active Fus3 acting as the enzyme. For simplicity, I assume that the degradation
rates and Michaelis constants for the different phospho-forms of Fus3 are related by the same
constants that relate the kinase activities and binding affinities of Fus3, as discussed in
Section 3.3.1 .f. Because Kssl is a much weaker activator of Farl, it is reasonable to assume
that the contribution from Kssl to Stel2 degradation is negligible. I further assume that
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Digl, Dig2 or either MAP kinase is able to protect Stel2 from degradation, so that only free,
unbound Stel2 is degraded by active Fus3.
I assume that Ste 12 synthesis in both the absence and presence of pheromone is
governed by Stel2 activity, as described in Section 3.4.1.b. Thus, ksynth_Stel2_Stel2 and
Km_synth_Stel2_Stel2 must be selected such that in the absence of pheromone, the basal
amount of active Stel 12 leads to the expected total abundance of Stel2 (Stel2_conc), balancing
out Fus3/Farl-dependent degradation and dilution of Stel2 due to cell growth (see Section
3.6.1).
Numbers from experiments and models
In the absence of pheromone, Stel2 is a long-lived protein with a average half-life of
about 230 minutes, whereas in the presence of pheromone Stel2 has a half-life of only 25
minutes [319]. Thus, assuming Michaelis-Menten kinetics, kdeg_Fus3pTpY_Stel2 must be at
least 4.6 x 10 4 s- (corresponding to a half-life of 25 minutes), with kdeg_Fus3pTpY_Stel2
exactly equal to 4.6 x 104 s1 if Km_deg_Fus3pTpY_Stel2 is much less than the concentration of
active Fus3 in pheromone-treated cells.
Computational and graphical representations
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Figure 3-104 Stel2 dephosphorylation.
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3.4.2.b Transcriptional Repressor (DigI and Dig2) Deactivation and Upregulation
Experiments and evidence
Digl and Dig2 deactivation is mediated by nonspecific dephosphorylation and dilution
No phosphatases are known to dephosphorylate Digl or Dig2, suggesting that
deactivation of Digl and Dig2 may be primarily mediated by dilution (see Section 3.6.2) and
degradation.
Dig2 is upregulated in response to pheromone treatment
Dig2 expression is upregulated in response to pheromone treatment [72, 294]
although Stel2 does not bind detectably to the Dig2 promoter either before, or 30 minutes
after pheromone treatment [287].
Distilling evidence into elementary chemical reactions
I assume that Digl and Dig2 are dephosphorylated by nonspecific phosphatases, as
described in Section 3.6.6. I also assume that Dig2 synthesis in the absence and presence of
pheromone are governed by Stel2 activity, as described in Section 3.4.1.b. Thus,
ksynthStel2 Dig2 and Km_synth_Stel2_Dig2 must be selected such that in the absence of
pheromone, the basal amount of active Stel2 leads to the expected total abundance of Dig2
(Dig2_conc), balancing out dilution of Dig2 due to cell growth (see Section 3.6.1).
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3.4.3 Protein Abundances
3.4.3.a Transcriptional Repressors (Digl and Dig2)
Numbers from experiments and models
Digl
The Dig promoter region is not bound by Ste 12 either in the absence or presence of
pheromone [287] and correspondingly DigI expression is not regulated by pheromone [72,
294]. The abundance of Digl was measured by two groups using western blots:
Ghaemmaghami et al. measured an abundance of 1,450 molecules per cell [98], and
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Figure 3-107 Digi dephosphorylation.
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Figure 3-109 Dig2 synthesis.
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Benjamin et al. measured an abundance of 4,800 copies of Digl per cell (Chapter 4).
Because Benjamin et al. accounted for more sources of error (see Section 3.1.5.b3.1.5.a), I
assume that Digi is present at 4,800 molecules per cell. Digl is exclusively localized to the
nucleus, so the total nuclear concentration of Dig i is Dig l_conc = Dig l_abund + (Nucleus_volume x
NA), where NA is Avogadro's number. Because Digl expression is not pheromone-regulated,
Digl synthesis is not addressed elsewhere in this chapter and so is given below. The Digl
turnover rate is not known and also not included in the Mating Model. Thus, the synthesis of
Digl need only balance dilution due to cell growth (see Section 3.6.1): ksynth_Digl = kdilution x
Digl_conc.
Dig2
Dig2 synthesis is regulated in a pheromone-dependent manner and addressed
elsewhere (see Section 3.4.2.b). The abundance of Dig2 was measured by two groups using
western blots: Ghaemmaghami et al. measured an abundance of 1,310 molecules per cell
[98], and Benjamin et al. measured an abundance of 1,180 molecules per cell (Chapter 4).
Because Benjamin et al. accounted for more sources of error (see Section 3.1.5.b3.1.5.a), I
assume that Dig2 is present at 1,180 molecules per cell. These measured abundances are
consistent with unpublished results from Olson et al. that Digl is more abundant than Dig2
[295]. Dig2 is found exclusively in the nucleus [107, 125, 293], so the total nuclear
concentration of Dig2 is Dig2 conc = Dig2_abund + (Nucleus_volume x NA), where NA is Avogadro's
number.
Computational and graphical representations
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3.4.3.b Transcriptional Regulator (Stel2)
Numbers from experiments and models
Stel 12 expression is regulated in a pheromone-dependent manner and thus addressed
elsewhere (see Section 3.4.2.a). The abundance of Stel2 was measured as part of two
abundance datasets (see Section 3.1.5.b3.1.5.a): Ghaemmaghami et al. measured an
abundance of 1,920 molecules per cell [98], and Benjamin et al. measured an abundance of
1,390 molecules per cell (Chapter 4). Because Benjamin et al. accounted for more sources of
error (see Section 3.1.5.b), I assume that Stel2 is present at 1,390 molecules per cell. Models
of the mating pathway have either used the abundance reported by Ghaemmaghami et al.
[136], or an arbitrary abundance (6,600 to 10,000 molecules per cell) not attributed to any
source [2].
Stel2 is localized exclusively to the nucleus [107, 125, 303, 321], so given the
abundance of 1,390 molecules per cell, the total nuclear concentration of Stel2 is Stel2_conc =
Stel2_abund + (Nucleus_volume x NA), where NA is Avogadro's number.
Computational and graphical representations
3.5 Coupling Between Mating Pheromone Response and the Cell Cycle
The coupling between the cell cycle and the mating response pathway is not included
in the Mating Model (see Section 3.1.4). However, to facilitate future modeling work
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Table 342 Parameter constraints for Digl synthesis and Dig2 concentration.
Digl abund i 4000
Digl ,nc e abun c(ucnvabe' xNA)
ksynthDig =,kdiution x Digl.,oonc
Dig2 abund I160
Dig2_ nc = Dig2abund.+(Nucteus-votum x NA)
Table 3.43 Parameter constraints for Stel2 concentration.
Stel,2abund a 1390
Ste2conc = Ste12 abund + (Nucleus volume x NA)
combining models of the yeast cell cycle [3, 322-326] with models of the mating pathway[2,
22, 45, 55, 82, 100, 136, 327-331], I treat the interactions between the cell cycle and mating
pathway in the same detail as other events in the mating pathway. In fact, I summarize the
evidence via a set of elementary chemical reactions. These reactions that link the cell cycle
and mating pathway are not part of the Mating Model, and the molecular species in these
reactions are not necessarily consistent with the species and reactions in the Mating Model.
For example, additional binding and modification sites were added to the molecular
definition of Ste5 for the reactions presented in Section 3.5.2.
3.5.1 Mating Pathway Effect on Cell Cycle Progression
Summary
Active Fus3 (and to a lesser extent Kssl) phosphorylates Farl. Phosphorylated Farl
is able to interact with Cdc28-bound Clnl, Cln2 and Cln3, potentially inhibiting the activity
of Cdc28-Clnl and Cdc28-Cln2, but not Cdc28-Cln3. In this manner, Farl acts to inhibit cell
cycle progression and promote cell cycle arrest. Farl is not the only means by which the
mating pathway causes cell cycle arrest, but the Farl-independent mechanisms for cell cycle
arrest are not well understood. Farl expression is also upregulated in response to pheromone
treatment.
Experiments and evidence
Active Fus3 and Kssl phosphorylate Farl
Farl phosphorylation is increased in response to pheromone treatment [332], but only
in the presence of Fus3 [255, 333]. Fus3 phosphorylation of Farl is mediated by a MAPK
docking motif at Farl residues 72-82 [103, 253]. Purified Fus3 is able phosphorylate Farl in
vitro [255, 333]. Kssl is also able to phosphorylate Farl in vitro, although it does so much
less efficiently than Fusl [255]. The low efficiency of Kss l-mediated phosphorylation of
Farl explains the strong requirement for the presence of Fus3 for Farl phosphorylation in
vivo. Mutation of T306 to alanine eliminates the pheromone-induced mobility shift of Farl
and results in a loss of pheromone mediated cell cycle arrest (see below), suggesting that
T306 is the primary site of pheromone-mediated Farl phosphorylation [334]. Farl may also
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be phosphorylated at T63 because the T63A mutation results in a mild resistance to
pheromone [334].
Phosphorylated Farl interacts with, and may repress, Cdc28-bound Clnl, Cin2 and Cln3
Co-precipitation of Farl with Cdc28, Clnl, Cln2 and Cln3 is increased by pheromone
treatment [333, 335]. However, deletion of Fus3 eliminates the pheromone-dependent co-
precipitation of Farl with Cdc28 and Cln2 [333-335]. When Farl is constitutively
expressed, co-precipitation of Farl with Cdc28 and Cln2 is still increased by pheromone
treatment [333], demonstrating that increased co-precipitation in response to pheromone is
not simply due to pheromone-induced expression of Farl [332, 336]. Farl is also responsible
for cell cycle arrest in response to pheromone treatment: deletion of Farl does not otherwise
affect mating signaling but eliminates pheromone-mediated arrest [253, 255, 333, 335-337].
Different Farl deletion mutants either display an inability to cause pheromone-dependent cell
cycle arrest and an inability to bind Cdc28, or lead to pheromone-dependent cell cycle arrest
and co-precipitate with Cdc28 [333]. Thus, Farl likely causes cell cycle arrest in response to
pheromone treatment by interacting directly with Cln-bound Cdc28 and inhibiting Cdc28
kinase activity. Farl-T306A fails to co-precipitate with Cln2 in the absence or presence of
pheromone and fails to support pheromone-mediated arrest [334], indicating that Fus3-
dependent phosphorylation of T306 is necessary for stable association of Farl with Cdc28-
Cln2 and for Farl-mediated cell cycle arrest. Supporting the importance of Fus3
phosphorylation of Farl, mutation of the MAPK docking site on Farl results in the same cell
cycle arrest defect as does deletion of Farl [253].
Direct in vitro observation of Farl-dependent Cdc28-Cln inhibition has been
inconclusive. Peter and Herskowitz found that Farl isolated from pheromone-treated cells
strongly inhibited Cdc28-Cln2 activity in vitro [338]. In the same study Farl-S87P, which
causes cell cycle arrest in the absence of pheromone and thus is considered hyperactive,
strongly inhibited Cdc28-Clnl and Cdc28-Cln2 in vitro, but not Cdc28-Clb2 and Cdc28-
Clb5. However, Peter and Herskowitz did not demonstrate whether equal amounts of wild-
type Farl isolated from vegetatively growing cell could also inhibit Cdc28-Cln2. In a
different study, Gartner et al. found that the in vitro kinase activity of Cdc28-Cln2 was only
moderately affected by pheromone treatment when Cdc28-Cln2 was isolated from cells
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overexpressing Farl and Cln2 [334]. Gartner et al. observed a constant amount of Farl co-
precipitating with Cln2 independent of pheromone treatment. Thus, whereas Peter and
Herskowitz found that Farl was a strong inhibitor of Cdc28-Cln2, Gartner et al. found that
activation of the mating pathway may only moderately affect Farl-dependent inhibition of
Cdc28.
Cell cycle arrest is mediated by Farl-dependent and Farl-independent mechanisms
Deletion of Farl eliminates pheromone-induced cell cycle arrest [253, 255, 333, 335-
337]. Constitutive Farl expression is sufficient for pheromone-mediated arrest [332, 339],
demonstrating that neither cell cycle-dependent transcription of FAR] nor pheromone-
induced transcription of FAR1 is required for Farl-dependent cell cycle arrest. Although
deletion of Farl eliminates pheromone-dependent cell cycle arrest, deletion of both Cln2 and
Farl restores pheromone-dependent arrest, albeit only at higher concentrations of pheromone
[335-337]. Deletion of Clnl as well (i.e.,farlA clnlA cln2A) restores near wild-type
pheromone sensitivity [336]. Farl-independent arrest is thought to be caused by repressed
expression of the G1/S transition cyclins Clnl, Cln2, and Clb5 by active Fus3 and Kssl [337,
340-342]. However, Farl-independent mating arrest is not specific to the G stage of the cell
cycle [229, 337, 343], suggesting that inhibition of Clnl, Cln2, and Clb5 expression may not
be the sole means of Farl -independent cell cycle arrest.
Farl expression is upregulated in response to pheromone treatment
Stel2 is required for Farl expression, and Farl expression is upregulated in response
to pheromone treatment [72, 287, 339].
Distilling evidence into elementary chemical reactions
Pheromone-mediated cell cycle arrest appears to be a result of both the Farl-
dependent inhibition of Cdc28-Clnl and Cdc28-Cln2 activity, Fus3/Kssl -dependent
repression of Clnl, Cln2, and Clb5 expression, and perhaps some third mechanism that is not
specific to the GI to S cell cycle transition. The two-pronged inactivation of the GI cyclins
appears to be necessary for normal pheromone-dependent cell cycle arrest: active Farl
inhibits Cdc28-Clnl and Cdc28-Cln2, preventing cell cycle-dependent inhibition of mating
signaling via Ste5; active Fus3 and Kssl repress Clnl, Cln2 and Clb5 expression via an as-
227
yet unknown mechanism. Potentially, Farl is necessary for the initial weakening of cell
cycle progression, preventing inhibition of mating signal and resulting in sufficient activation
of Fus3 and Kssl to repress Clnl and Cln2 expression and halt cell cycle progression. The
inhibition of Cdc28-Clnl and Cdc28-Cln2 by Farl may be especially important given that
together with Cdc28, Clnl and Cln2 activate their own expression through activation of the
transcription factor SBF [344-346].
Although Farl is generally thought of as a Cdc28 inhibitor that is important for
pheromone-mediated cell cycle arrest, Farl is also implicated in degradation of Ste7 (Section
3.3.2.b) and Stel2 (Section 3.4.2.a). Because Farl expression and degradation is strongly
cell cycle dependent, I chose not to include Farl in the formal Mating Model. However, I
describe here the reactions that govern the Farl-dependent inhibition of Cdc28 in order to
facilitate construction of models linking cell cycle and mating response.
Fus3-dependent phosphorylation of Farl appears to be required for Farl-mediated
cell cycle arrest. I assume that T306 is the primary site of Farl phosphorylation responsible
for cell cycle arrest. In vitro studies suggest that Kssl is also able to phosphorylate Farl, but
to a much weaker extent. Fus3 binds more tightly to the Farl MAPK docking motif than
Kssl (see below). I assume that binding and phosphorylation of Farl by Fus3 and Kssl is
unaffected by phosphorylation of Farl on S87 by Cdc28. Furthermore, I assume that the
kinetic parameters that describe phosphorylation of Farl follow the relationships outlined in
Section 3.3.l.f. As per Section 3.6.6, I assume that Farl is dephosphorylated by nonspecific
phosphatases.
Although in vitro evidence has been inconclusive, in vivo data supports the idea that
Farl, when phosphorylated on T306, is a potent inhibitor of Cdc28-Clnl and Cdc28-Cln2.
Thus, I assume that Farl, when phosphorylated on T306, has an increased affinity for Cdc28-
Clnl and Cdc28-Cln2. Additionally, in order to inhibit Cdc28, Farl that has been
phosphorylated on T306 is likely either immune to phosphorylation on S87 by Cdc28, or
immune to the increased degradation rate normally conferred by phosphorylation of S87 (see
Section 3.5.2). I assume that phosphorylation of T306 prevents Cdc28-dependent
phosphorylation of S87.
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Farl-independent cell cycle arrest is more difficult to represent in a model than Farl-
dependent arrest. Clnl and Cln2 expression are regulated by the transcription factor complex
SBF [347]. Active Fus3 and Kssl may somehow interfere directly or indirectly with SBF
activity. Alternatively, active Fus3 and Kss 1 may potentially cause cell cycle arrest in a
similar manner to another yeast MAP kinase, Hogl: active Hogi causes cell cycle arrest by
phosphorylating and stabilizing Sicl, an inhibitor of Clb-bound Cdc28 [348]. However, it is
unclear how stabilization of Sic 1 causes cell cycle arrest at the G 1 to S transition.
Additionally, although Stel2 generally acts as a transcriptional activator, active Stel2 has
been shown to directly repress expression of the PRY3 gene [349]. Thus, Stel2 may
potentially act as a repressor for CLN1, CLN2 and CLB5. I do not present reactions for Farl-
independent cell cycle arrest because not enough details bout this mechanism are known to
allow me to posit the most likely means by which Fus3 and Kssl could inhibit Clnl, Cln2,
and Clb5 expression.
I assume that Farl synthesis in both the absence and presence of pheromone is
governed by Stel2 activity, as described in Section 3.4.1.b. The abundance of Farl varies
significantly over the course of the cell cycle (see Section 3.5.2). Thus, ksynthStel2_Far1 and
Km_synth_Stel2_Far1 must be selected such that in the absence of pheromone, the basal amount
of active Stel2 leads to the expected total abundance of Farl when averaged over the cell
cycle (Chapter 4)[98].
Numbers from experiments and models
Fus3 binds a peptide with the MAPK docking motif from Farl with an affinity of 7
jLM, and Kssl binds the same peptide with an affinity of 46 pM [253]. The MAPKs were
isolated from vegetatively growing cells, meaning that these binding affinities are likely
representative of the affinities of the unphosphorylated MAPKs for Farl. The rates of
phosphorylation of Farl are not known, nor are the affinities of interaction between Farl and
Cdc28-Clnl or Cdc28-Cln2.
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Figure 3-111 Interaction of Farl and Fus3.
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Figure 3-114 Phosphorylation of Farl by Kssl.
Table 3-44 Parameter constraints for phosphorylation of Farl by Fus3 and Kssl.
Kd Fus3 Farl , 7 x 10-6 M
Kd_Fus3pTpY_Farl = Kd_Fus3_Farl + MAPK_unphosph Kdfactor
Kd_Fus3pY_Farl = Kd_Fus3pTpYFarl x MAPK pY Kdfactor
Kd_Fus3pTFarl = Kd_Fus3pTpYFarl x MAPK_pT_Kd_factor
kcatFus3pYFarl_pT = kcat_Fus3pTpY_Farl_pT + MAPK_pYkcat_factor
kcat_Fus3pTFarl_pT = kcat_Fus3pTpY_Farl_pT - MAPK_pT_kcat_factor
Kd Kssl Farl = 46 x 10-6 M
Kd_KsslpTpY_Farl = Kd_Kssl_Farl + MAPK_unphosph_Kd_factor
Kd_KsslpYFarl = Kd_KsslpTpY_Farl x MAPK_pY Kdfactor
Kd_KsslpT_Farl = Kd_KsslpTpY_Farl x MAPK_pT_Kd_factor
kcat_KsslpY_Farl_pT = kcat_KsslpTpY_Farl_pT+ MAPK_pY_kcat_factor
kcat_Kss1pT_Farl_pT = kcat_KsslpTpY_Farl_pT + MAPK_pT_kcat_factor
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Table 3-45 Parameter constraints for interaction of Farl and Cdc28.
Kd_Cdc28CIn_Far1pT < Kd_Cdc28CIn_Farl
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Figure 3-116 Farl dephosphorylation.
I
Farl
non
"7dc28
Farl
ksynth_Stel2_Farl
Km_synth_Ste12_Far1
Farl
none
none
stei
Stel2
Figure 3-117 Farn synthesis.
3.5.2 Cell Cycle Effect on the Mating Pathway
Summary
Cell cycle position affects the mating pathway on several different levels. Directly,
Cdc28-Cln2 and Cdc28-Clnl repress mating during the G1 to S cell cycle transition by
phosphorylating Ste5, inhibiting Ste5 membrane association. Cdc28-Clnl and Cdc28-Cln2
also phosphorylate Farl, marking Farl for degradation. Additionally, Cdc28-Cln2
phosphorylates Ste20, although the physiological consequences of Ste20 phosphorylation are
not well understood. Finally, many mating pathway components are expressed in a cell cycle
dependent manner.
Experiments and evidence
Cdc28-Clnl and Cdc28-Cln2 phosphorylate Ste5, inhibiting Ste5 membrane localization
Several experiments demonstrate that Cdc28-Clnl and Cdc28-Cln2 repress
pheromone response in a cell cycle-dependent manner. Deletion of Clnl and Cln2 eliminates
cell cycle repression of Fus1 expression, and overexpression of Clnl or Cln2 is sufficient to
inhibit pheromone-dependent Fus1 expression [350]. Overexpression of Cln2, but not Clnl,
is sufficient to eliminate pheromone-mediated cell cycle arrest [350] suggesting that Cln2 is a
stronger repressor of the mating pathway than Clnl. Evidence suggested that Clnl and Cln2
mediated repression of mating occurs at the level of Stel 1 activation [351], but the exact
mechanism, inhibition of Ste5 membrane association, was uncovered only recently.
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Phosphorylation of Ste5 by Cdc28-Cln2 inhibits both the association of Ste5 with the
plasma membrane and mating pathway activation in response to pheromone treatment [229].
Membrane association of Ste5, which relies on the Ste5 PM and PH domains, is critical for
mating pathway activation (see Section 3.3.1.b), suggesting that Cdc28-Cln2 may inhibit
pathway activation by interfering with association of Ste5 to the plasma membrane. Cln2
overexpression prevents membrane association of Ste5 and mating pathway activation [229].
However, Cln2 overexpression fails to prevent membrane association of Ste5 and pathway
activation when Ste5 is mutated so as to bypass the need for the PM domain, suggesting that
Cdc28-Cln2 may inhibit mating via the Ste5 PM domain [229].
The Ste5 PM domain is flanked by eight potential cyclin-dependent kinase (CDK)
phosphorylation sites (xS/TPx). In vitro, Cdc28-Cln2 phosphorylates a Ste5 fragment
containing these eight CDK phosphorylation sites, but only weakly phosphorylates the
remainder of the protein [229]. Mutation of all eight CDK sites to alanine (xAPx), creating
an 8A mutant, prevents Cln2-mediated mating signal repression [229]. Conversely, mutation
of all eight xS/TPx sites to xEPx (8E mutant), or to xEEx (16E mutant) in order to mimic the
double negative charge of phosphorylation, inhibits mating signaling. Furthermore, a YFP
tagged Ste5-16E mutant also fails to localize to the plasma membrane, as does a YFP tagged
wild-type Ste5 when Cln2 is overexpressed [229]. The Ste5-16E mutant co-precipitates with
Ste4 with equal efficiency as WT Ste5. The behavior of the 8A, 8E, and 16E mutants
suggests that Cdc28-Cln2 phosphorylates the CDK sites flanking the Ste5 PM domain in
order to interfere with membrane association of Ste5, and thus inhibit mating signaling.
The association of Ste5 with the membrane via the Ste5 PM domain appears to be
graded in response to phosphorylation over all eight CDK sites. Each of the eight single
alanine mutants displays a small but measurable resistance to Cln2-mediated signal
repression, suggesting that phosphorylation at all eight sites is required for full mating
pathway repression [229]. Double, triple, and quadruple alanine mutants have increasing
resistance to the effects of Cln2. A 14E mutant (mimicking seven phosphorylations) is
slightly more sensitive to pheromone than the 16E mutant, again supporting the idea that
phosphorylation at all eight sites is necessary for full repression [229]. Given the graded
nature of the inhibition of Ste5 across multiple phosphorylation events, one might expect that
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the inhibition of Ste5 membrane association would be graded across a large range of Cdc28-
Cln2 concentrations. However, a simple kinetic model predicts a switch-like drop in the
association of Ste5 with the membrane in response to changes in Cdc28-Cln2 activity [352].
Cdc28-Clnl and Cdc28-Cln2 phosphorylate Farl, targeting Farl for degradation
Farl mRNA and protein levels both vary over the course of the cell cycle [353].
However, Farl mRNA and protein levels do not vary together, suggesting that Farl mRNA
and protein levels are independently regulated. Farl is phosphorylated prior to the cell cycle
Start (the GI to S transition), at which time Farl protein levels drop rapidly [353]. Cdc28-
Clnl and Cdc28-Cln2 are able to phosphorylate Farl on S87 in both the cytoplasm and the
nucleus [354], and mutation of S87 eliminates cell cycle dependent degradation of Farl in
vivo [355]. Combined, this evidence suggests that Cdc28-Clnl and Cdc28-Cln2 mediated
phosphorylation of Farl is likely responsible for Farl degradation. In vitro and in vivo
analysis demonstrates that Farl is ubiquitinated and degraded by the G1-S degradation
system, which involves Cdc34, Cdc53, Cdc4 and Skpl [355], in conjunction with the ER-
associated degradation (ERAD) system [356]. Although Farl can be phosphorylated by
Cdc28-Clnl and Cdc28-Cln2 in the cytoplasm, Farl degradation occurs specifically in the
nucleus due to the nuclear localization of Cdc4 [354]. Unlike Farl-S87A, Farl-T306A does
not accumulate at higher levels than wild-type Farl [334]. Thus, despite the fact that
phosphorylation of Farl T306 by Fus3 is required for Farl to stably associate with Cdc28-
Cl[nl and Cdc28-Cln2 (see Section 3.5.1), phosphorylation of T306 does not appear to be
required for Cdc28-Clnl or Cdc28-Cln2 mediated phosphorylation of Farl.
Cdc28-Cln2 phosphorylates Ste20, perhaps regulating Ste20 localization
Cdc28-Cln2 phosphorylates Ste20 both in vivo and in vitro, and correspondingly
Ste20 is phosphorylated in a cell cycle dependent manner with maximal phosphorylation
during S phase [216]. Cdc28-Cln2 has been implicated in phosphorylation of at least four
different sites on Ste20 [217]. Despite the cell cycle regulation of Ste20 phosphorylation, in
vitro activity of Ste20 is largely unaffected by the position in the cell cycle from which Ste20
is purified [216]. Likewise, mutation of 12 potential phosphorylation sites on Ste20 does not
affect mating response, nor cell cycle dependent inhibition of mating response [217].
Localization of Ste20 to the bud site during cell division correlates with phosphorylation of
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Ste20, suggesting that phosphorylation may regulate localization rather than activity of Ste20
[216].
Cell cycle dependent expression of mating pathway components
Clnl and Cln2, together with Cdc28, have been shown to regulate cell cycle
dependent expression of FUS1 [350]. However, cell cycle dependent expression of FUS1
can be easily explained: Cdc28-Clnl and Cdc28-Cln2 repress the mating pathway in a cell
cycle dependent manner, and FUS1 expression is upregulated in response to pheromone
treatment [72]. In fact, the subset of components of the mating pathway whose expression is
regulated by Ste 12, and thus by pathway activity, is nearly identical to the subset of
components in the mating pathway whose expression is regulated in a cell cycle dependent
manner [72, 357]. This set of cell cycle regulated genes all have a similar pattern of
expression through the cell cycle [339, 357], suggesting that the cell cycle regulated mating
genes are regulated by a common mechanism.
Distilling evidence into elementary chemical reactions
Cdc28-Cln 1 and Cdc28-Cln2 are responsible for cell cycle dependent repression of
the mating pathway by phosphorylating Ste5 on eight sites near the PM domain.
Phosphorylation of Ste5 interferes with the ability of the PM domain to interact with the
plasma membrane, impeding relocalization of Ste5 to the plasma membrane in response to
pheromone treatment. Evidence suggests that Ste5 is more efficiently phosphorylated by
Cdc28-Cln2 than by Cdc28-Clnl. I assume that interaction between Cdc28-Clnl and Ste5 is
weaker than the interaction between Cdc28-Cln2 and Ste5, and that both Cdc28-Clnl and
Cdc28-Cln2 are equally proficient at phosphorylating Ste5 when bound to Ste5. I also
assume that Cdc28-Clnl and Cdc28-Cln2 can only bind Ste5 that is not dimerized nor bound
to Ste4, and that the affinity of the interactions are not affected by the phosphorylation state
of Ste5. Furthermore, I assume that Cdc28-Cln I and Cdc28-Cln2 phosphorylate each site on
Ste5 with equal efficiency. However, because I am representing all eight phosphorylation
sites via a single modification site, the net phosphorylation rates are not equal: there are eight
different ways to convert unphosphorylated Ste5 to singly-phosphorylated Ste5 (i.e.,
phosphorylation at any of the eight sites), only seven ways to convert singly phosphorylated
Ste5 to doubly-phosphorylated Ste5 (i.e., phosphorylation at any of the seven remaining
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sites), and so on. Thus, I assume that the net rates of phosphorylation scale with the number
of unphosphorylated residues. I assume that dephosphorylation of Ste5 also only occurs
when Ste5 is not bound to Ste4 nor dimerized, and that the net rates of dephosphorylation
similarly scale with the number of phosphorylated residues on Ste5.
Phosphorylation of Ste5 near the PM domain inhibits association of Ste5 with the
plasma membrane. Ste5 association with the plasma membrane is critical for signaling (see
Section 3.3.1.b). I assume a simple electrostatic model, where each phosphorylation
decreases the binding energy between Ste5 and the membrane (and hence Ste4 as well) by a
fixed amount. Thus, each Ste5 phosphorylation event decreases the affinity of Ste5 for Ste4
by the same factor. Because Ste5-Ste4 binding and Ste5 dimerization are coupled processes
(see Section 3.3.1.b), I must reconsider Ste5 dimerization as well. Specifically, when a Ste5
monomer that is associated with Ste4 (and the plasma membrane) binds a phosphorylated
Ste5, electrostatic repulsion between the phosphorylated sites on this second Ste5 and the
membrane will reduce the strength of the interaction between the two Ste5 molecules.
Cdc28-Clnl and Cdc28-Cln2 also affect the mating pathway by phosphorylating
Farl, leading to degradation of Farl. The interaction between Cdc28 and Farl is described
in Section 3.5.1. I assume that Cdc28-Clnl and Cdc28-Cln2 are equally proficient at
phosphorylating Farl. As described in Section 3.5.1, I also assume that Cdc29-Clnl and
Cdc28-Cln2 cannot phosphorylate Farl that has been phosphorylated by Fus3 or Kssl on
T306.
The Cdc28-Clnl and Cdc28-Cln2 dependent phosphorylation of Ste20 does not
appear to affect mating response. Localization of Ste20 is regulated in a cell cycle dependent
manner, coinciding with phosphorylation of Ste20, although it is not clear if phosphorylation
causes the altered localization, or the two events are just concurrent. Because the exact effect
of Ste20 phosphorylation on the mating pathway, and on the interactions between the mating
pathway and the cell cycle, are unknown I ignore Ste20 phosphorylation.
Finally, many mating genes are expressed in a cell cycle dependent manner. Mating
genes that are expressed in a cell cycle dependent manner have similar expression profiles
over the cell cycle. Additionally, cell cycle regulated mating genes are almost identical to
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the set of mating genes whose expression is induced by pheromone. Thus, it seems likely
that cell cycle inhibition of the mating pathway is the cause of cell cycle regulation of mating
gene expression. Therefore, cell cycle dependent expression of mating genes is accounted
for by cell cycle inhibition of the mating pathway together with Stel2-dependent regulation
of mating gene expression (see Section 3.4.1 .b).
Numbers from experiments and models
None of the reaction rates governing the effect of the cell cycle on the mating
pathway are known. However, experiments suggest that protein phosphorylation can
decrease the electrostatic interaction of a protein with the plasma membrane by about a factor
of 10 [358], and this factor of 10 was used in a simple model of Ste5 inhibition [352]. If the
10-fold difference were true for each phosphorylation event, then the affinity of Ste5 for the
plasma membrane would vary over eight orders of magnitude. The Ste5-IA and Ste5-14E
mutants suggest that full phosphorylation of Ste5 is required for full inhibition, meaning that
there is a physiologically relevant difference between Ste5-P7 and Ste5-P 8 (the 7- and 8-fold
phosphorylated forms of Ste5). Thus, the factor by which each phosphorylation affects the
affinity between Ste5 and the plasma membrane is either not constant for each
phosphorylation, or is much lower than 10.
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Figure 3-118 Interaction of Cdc28 and Ste5.
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Figure 3-119 Phosphorylation of Ste5 by Cdc28.
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Figure 3-120 Dephosphorylation of Ste5.
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Table 3-46 Parameter constraints for phosphorylation and dephosphorylation of Ste5.
Kd Cdc28Cnl Ste5 > Kd Cdc28Cin2 Ste5
kcat Cdc28CInSte5_Pl = 8 x kcatCdc28CInSte5
kcat Cdc28Cin Ste5 P2= 7 x kcat Cdc28CIn Ste5
kcatCdc28CIn_Ste5_P3 = 6 x kcatCdc28CInSte5
kcatCdc28CIn_Ste5 P4 = 5 x kcat_Cdc28CIn_Ste5
kcatCdc28CInSte5_P5 = 4 x kcatCdc28CInSte5
kcat Cdc28CIn Ste5 P6 = 3 x kcat Cdc28CIn Ste5
kcat_Cdc28CInSte5_P7 = 2 x kcat Cdc28CInSte5
kcat_Cdc28CIn_Ste5_P8 = kcat_Cdc28CIn_Ste5
kcat_dephosph_Ste5_P1 = kcatdephosph_Ste5
kcat_dephosph_Ste5_P2= 2 x kcat_dephosphSte5
kcat_dephosph_Ste5_P3= 3 x kcat_dephosph_Ste5
kcat_dephosph_Ste5_P4 = 4 x kcat_dephosph_Ste5
kcat_dephosph_Ste5_P5 = 5 x kcat_dephosphSte5
kcat_dephosph_Ste5_P6 = 6 x kcat_dephosph_Ste5
kcat_dephosph_Ste5_P7 = 7 x kcat_dephosphSte5
kcat dephosph_Ste5_P8 = 8 x kcatdephosph_Ste5
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Figure 3-121 Self-interaction of Ste5.
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Table 3-47 Parameter constraints for Ste5 dimerization and interaction of Ste5 and Ste4.
Ste4Stel 8Ste5_Ste5_coop_factor > 1
Ste4Stel 8Ste5_Ste4Stel 8Ste5_coop_factor > 1
Kd_Ste4Ste18Ste5_Ste5 = Kd_Ste5_Ste5 + Ste4Stel 8Ste5_Ste5_coop_factor
Kd_Ste4Ste18Ste5_Ste 4Stet8Ste5 = Kd_Ste5_Ste5 - Ste4Stel 8Ste5_StStel 8Ste5_coop_factor
Kd_Ste4Stel 8_Ste5Ste5 = Kd_Ste4Ste 18_Ste5 + Ste4Stel 8Ste5_Ste5_coop_factor
Kd_Ste4Stel 8Ste5Ste5Ste4Stel8 = Ste4Stel 8StSte5te5_coopfactor x Kd_Ste4Stel8_Ste5
Ste4Stel 8Ste5_Ste4Stel 8Ste5_coop_factor
Ste5_P1_factor > 1
Ste5_P2_factor = (Ste5 P1 factor)2
Ste5_P3_factor = (Ste5 _P1factor)3
Ste5_P4_factor = (Ste5 P1 factor)4
Ste5_P5_factor = (Ste5_P1 factor)5
Ste5_P6_factor = (Ste5 P1 factor) 6
Ste5_P7_factor = (Ste5_Pl_factor)7
Ste5_P8_factor = (Ste5_Pl_factor) 8
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Figure 3-123 Phosphorylation of Farl by Cdc28.
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Table 3-48 Parameter constraints for phosphorylation and degradation of Farl.
kdeg_Farl_pS > kdeg_Farl
3.6 Morphology, Geometry, and Signal Specificity
3.6.1 Volume of Cell Accessible to Cytosolic and Nuclear Proteins
The total volume of haploid yeast cells has been measured multiple times. A few
representative mean volume measurements of haploid yeast grown on glucose are 37 fL
[359], 42 fL [360, 361], 70 fL [362] and 83 fL [363]. The variation in the measured
abundance may be due to the growth conditions or the methodology of measurement. Also,
many yeast genes affect cell volume [360, 363], suggesting that the genetic background of
the strains is a likely one source of the observed variability in cell volume. Part of the cell
volume is occupied by mitochondria, vacuoles, the cell wall, the endoplasmic reticulum, the
nucleus, and other organelles that may be inaccessible to cytosolic proteins. Thus, the total
cell volume is an upper limit on the cytosolic volume accessible to soluble proteins. The
average of the cell volumes reported above is 58 fL (58 ýtm 3). The cytosol accounts for
approximately 50% of the total cell volume for another yeast species, Exophiala dermatitidis
[364]. Thus, I assume that the total accessible cytosolic volume in budding yeast is 58 fL x
0.5, giving Cytosol_volume = 29 x 1015 L.
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Figure 3-124 Degradation of Farl.
The volume of the haploid nucleus has also been measured on multiple occasions for
yeast grown on glucose: 2.4 fL [365], 2.9 fL [361], and 3.3 fL [366]. The average measured
nuclear volume is 2.9 fL. Although not all of the nuclear volume is likely accessible to
proteins, the nucleus does not contain large organelles, so I assume occlusion to be
negligible. The volume accessible to nuclear protein is thus Nucleus_volume ' 2.9 x 10
-i s L.
Because the volume of yeast cells varies over the cell cycle, I assume that constitutive
protein synthesis keeps pace maintaining constant protein concentrations over the cell cycle.
Although yeast enter cell cycle arrest when exposed to pheromone, their volume continues to
increase [53]. Thus, I assume that constitutive protein synthesis also continues at the same
pace, such that protein concentrations remain constant. Of course, pheromone treatment will
affect the concentrations of proteins whose expression is regulated in a pheromone-
dependent manner (for example, as discussed in Sections 3.2.2.a, 3.2.2.b, 3.2.2.c, 3.2.2.d,
3.3.2.c, 3.3.2.f, 3.4.2.a, and 3.4.2.b).
Computational and graphical representations
Table 3-49 Parameter constraints for nuclear and cellular volumes.
Cytosol volume z 29 x 10s L'
Nucleus volume m 2.9 x 106 L
3.6.2 Protein Dilution Due to Cell Growth
Exponentially growing yeast cells divide every 90 to 140 minutes at 300 C, depending
on growth media and culture conditions [362]. Every division event means that the contents
of the cell are divided between the mother and daughter cell. However, the cell contents are
not necessarily divided evenly or randomly between mother and daughter cells. For
example, mother cells are significantly larger than daughter cells, and the exact volumes of
the mother and daughter cells are dependent on the age of the mother cell [367].
Additionally, some proteins are specifically localized to either the mother or daughter cell
during division [368]. Finally, oxidatively damaged proteins are also preferentially
segregated to the mother cell [369]. In the absence of any information about how mating
pathway components are inherited by the mother and daughter cells during division, I assume
that all components are divided evenly among progeny. Thus, if no new proteins are being
249
made, proteins are diluted out of cells with a half-time equal to the doubling time.
Constitutive protein synthesis must therefore balance dilution in order to maintain a constant
cellular protein concentration. Dilution also provides a means to decrease the concentration
of modified proteins, as modified proteins are diluted out during growth and division and
replaced with freshly synthesized unmodified proteins. Thus, dilution due to cell growth can
reset activated signaling molecules and promote adaptation of the pathway. I assume that all
proteins and complexes in the cell are subject to the same dilution rate. Given a doubling
time of 90 to 140 minutes, this dilution rate is between 8.3 x 10-5 s-1 and 1.3 x 10-4 S-1
Computational and graphical representations
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Figure 3-125 Protein dilution due to cell growth.
Table 3-50 Parameter constraints for protein dilution due to cell growth.
kdilution - 8.3 x 10-5 s"' to 1.3 x 104 s-'
r.Sst2
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PVO PMOPI
3.6.3 Polarized Growth and Shmoo Formation
The selection and maintenance of a site of polarized growth likely requires two
complementary factors. First, signaling is reinforced at the site of polarized growth, which
may be sufficient for establishment of polarity in a weak pheromone gradient. Second,
activation of Cdc42 at the site of free GPy, in addition to reinforcing signaling directly, helps
reorganize the cytoskeleton to fix the site of mating projection formation. Although
presented briefly below, this topic is more thoroughly reviewed elsewhere [370, 371].
Signaling is reinforced at the site ofpolarized growth
Small differences in receptor occupancy are thought to be sufficient for establishment
of cell polarity in a pheromone gradient. One estimate suggests that differences in receptor
occupancy as small as 1% across a cell are sufficient to establish correct cell polarization in a
weak pheromone gradient [372]. Signaling at sites of Ste2 activation is reinforced through
multiple mechanisms that may lead to selection of a single site of activation around which
polarized growth is organized. However, the relative importances of these mechanisms for
signal reinforcement are not known. Through a series of pairwise interactions,
superstructures may form and cause aggregation of signaling complexes at a single site on
the cell periphery (Figure 3-126). These pairwise interactions include Gfy-Farl [373, 374],
Farl-Cdc24 [373], Cdc24-Beml [375], Beml-Ste5 [376, 377], Ste5-Gpy (see Section
3.3.1.b), as well as Ste5-Ste5 (see Section 3.3.1.b), Beml-Cdc42 [375, 378, 379], Cdc42-
Ste50 [247], Ste50-Stel I (see Section 3.3.1.c), Cdc42-Ste20 [105, 212, 213], Beml-Ste20
[218, 377] and Ste20-Gpy [208].
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Figure 3-126 Pairwise protein interactions that may lead to supramolecular complexes.
In addition to the potential for superstructure formation, several other mechanisms
may act to reinforce signaling. Cdc42, which is activated at the site of G protein activation
(see below), may help maintain Ste20 in an active conformation (see Section 3.3.1.a) and
enhance signaling. Newly synthesized membrane proteins (including Ste2) are trafficked to
the site of polarization via secretory vesicles [164, 165], although polarized trafficking
requires prior cell polarization. Endocytosis of Ste2 (see Section 3.2.2.a) from around the
cell periphery coupled with delivery of newly synthesized Ste2 to the site of polarization
should be sufficient for localization of Ste2 to the site of polarized growth [380], reinforcing
pathway activation at the site of polarization. Finally, the lipid composition of the plasma
membrane at the mating projection differs from the bulk of the plasma membrane [381].
Because Ste5 and Cdc24 interact directly with the plasma membrane via their PH domains
[221, 382], the altered membrane composition may serve to help reinforce the localization of
Ste5 and Cdc24 and their binding partners. Alternatively, the altered composition of the
plasma membrane in the mating projection may be a result, rather than a cause, of
localization of Ste5, Cdc24, or other signaling molecules to the mating projection.
Active Cdc42 directs polarized reorganization of actin cytoskeleton
During the majority of the cell cycle Cdc24 is bound by nuclear Farl, localizing
Cdc24 to the nucleus [383-385]. At the GI to S transition of the cell cycle, Farl degradation
is initiated by Cdc28-Clnl and Cdc28-Cln2 (see Section 3.5.1), and Cdc24 is released from
the nucleus [383, 384]. Cdc24 interacts with Rsrl (which is also known as Budl) to establish
the site for bud formation [386]. At this site, Cdc24 acts as a guanine nucleotide exchange
factor (GEF) for Cdc42, allowing Cdc42 to efficiently exchange GDP for GTP and become
active [387]. Active Cdc42 is then able to direct actin growth and polarization necessary for
bud formation [388]. In response to pheromone, Cdc28 is inhibited (see Section 3.5.1),
stabilizing Farl and allowing the Farl-Cdc24 complex to be exported by Msn5 [389]. Farl
and Rsrl appear to bind the same domain on Cdc24 [390]. Thus Farl may direct Cdc24
away from Rsrl, although there is some controversy surrounding whether Farl actually
prevents Cdc24 from binding Rsrl [370, 371]. Farl bridges an interaction between Cdc24
and Go3y to localize Cdc24 to the site of shmoo formation [373, 374]. At the shmoo site,
Cdc24 activates Cdc42 and active Cdc42 is assumed to direct the same morphological effects
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that Cdc42 directs during normal budding (polarized actin growth, exocytosis, endocytosis
and cell wall assembly) [101, 370]. In addition to the morphological effects of polarized
growth (i.e., formation of the shmoo which extends towards the mating partner), the
cytoskeletal rearrangement is necessary to fix the site of polarity [164] and for continued
localization of Cdc42 and Beml [101].
3.6.4 Compartmental, Spatial, and Relocalization Effects
Spatial effects are an important consideration when modeling a signaling pathway.
This chapter focuses mainly on the mechanistic features of the mating pathway that define a
set of elementary chemical reactions. Of equal importance are how the chemical reactions
that govern mating response are distributed over space, and how the reactions are affected by
spatially distributed signaling components. For the Mating Model, I assume that the yeast
cell constitutes a well-mixed vessel, and all components are freely diffusible. The reality of
the mating pathway as an integrated physical system is quite different. Specifically, there are
four major spatial effects that I do not address directly (or ignore completely) in the Mating
Model: protein concentration gradients, membrane localization, mating projection (shmoo)
localization, and partitioning of the cell into nuclear and cytosolic volumes.
Concentration gradients
Activation of MAPK cascades at the plasma membrane can cause a gradient of kinase
activity through the cytosol in mammalian cells [249]. A study of the mating pathway used
fluorescence lifetime imaging microscopy (FLIM) to detect a gradient of phospho-Fus3 in
yeast cells three hours after pheromone treatment [94]. As expected, phospho-Fus3 levels
are highest at the shmoo tip and lowest at the distal end of the cell. This distribution can be
explained by a simple reaction-diffusion model involving Fus3 phosphorylation at the shmoo
tip and dephosphorylation throughout the cytosol [94]. However, the gradient exists mainly
within the shmoo itself where there are many phospho-Fus3 binding sites [94]. The detected
gradient may be due to a combination of diffusible phospho-Fus3, and phospho-Fus3 bound
to a number of proteins also localized to the shmoo tip. Fluorescently-tagged Ste5 and Ste7,
two Fus3 binding proteins, form a gradient in the shmoo where Ste5 and Ste7 are presumably
associated with the plasma membrane [94]. However, the gradient formed by Ste5 and Ste7
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in the shmoo tip is much shorter than the observed gradient of phospho-Fus3, suggesting that
the phospho-Fus3 gradient cannot be fully explained by binding to Ste5 and Ste7. The
measured diffusion rate of Fus3, as determined by fluorescence correlation spectroscopy, is
4.2 gm2 s-1 [94], which means that an average Fus3 molecules would take approximately 15
seconds to cross an 8 gm long shmooing yeast cell. A reaction-diffusion model of phospho-
Fus3 shows that the shape (but not the magnitude) of the phospho-Fus3 gradient depends
only on the diffusion rate and the phosphatase activities and concentrations. The diffusion
rate of Fus3 [94] and concentrations of phosphatases (see Section 3.3.3.f) have been
measured, but the phosphatase activities are unknown (see Sections 3.3.2.c). Thus, the
computational model supports the observation that diffusible phospho-Fus3 may form a
gradient, although the model does not predict how steep this gradient may be and how much
of the observed phospho-Fus3 gradient may be due to localized Fus3 binding proteins.
Neither Stel 1 nor Ste7 have a known mechanism of dephosphorylation, which
suggests that they are slowly dephosphorylated and thus are unlikely to form gradients within
the cell. Localization of molecules to the shmoo tip also results in gradients of concentration
and activity (see below).
Membrane localization
Several key mating pathway components and complexes are membrane associated,
and thus the reaction kinetics of these molecules could differ significantly from those of
freely diffusible components [391, 392]. For example, I model the interaction between Ste2
and Gpal using normal three-dimensional mass action kinetics. However, both molecules
are membrane associated, and thus their surface densities, not volume densities, determine
the rate of interaction. Because membrane associated proteins are constrained to a two
dimensional surface, membrane associated proteins are concentrated to a smaller effective
volume than soluble proteins. The concentration of membrane associated proteins to a
smaller volume than soluble proteins increases the reaction rates of these membrane proteins.
However, membrane associated proteins also have a decreased mobility (diffusion rate)
compared to soluble proteins, which decreases the reaction rates of membrane associated
proteins. Both the increased concentration and decreased mobility effects must be accounted
254
for in order to model interactions involving membrane proteins in a physically realistic
manner [391, 392].
Mating projection localization
Many signaling components are concentrated in the shmoo in response to pheromone
treatment, specifically to the tip of the mating projection (see Section 3.6.3) [94, 101-107,
109, 111, 230]. Rates of reactions among different components that are localized via
membrane association are accelerated by their high local concentrations [391, 392]. The
Mating Model does not take into account the altered reaction rates of membrane associated
reactions.
Localization to the shmoo tip can also cause gradients of other proteins. For example,
by localizing Ste2 to the shmoo tip, G protein activity will be localized nearby [393].
Moreover, localization of components can result in gradients of activity of soluble proteins,
such as phospho-Fus3 [94].
Separation of nuclear and cytosolic volumes
I do not distinguish between the cytosolic and nuclear compartments in the Mating
Model. The system is treated as a single well-mixed compartment, where cytosolic and
nuclear components are allowed to interact. There is only one difference in the Mating
Model between cytosolic and nuclear proteins: the volume of the nucleus (Section 3.6.1) is
used to calculate the concentration of nuclear components and the volume of the accessible
cytosol (Section 3.6.1) is used to calculate the concentration of cytosolic components. Fus3
is the only protein in the Mating Model that interacts specifically with both cytosolic and
nuclear components. Fus3 is localized to both the nucleus and cytoplasm, and relative
localization is largely unchanged by pheromone treatment [94, 107, 394-396]. Ste5 is also
localized to both the nucleus and cytosol, and is rapidly shuttled between compartments [94,
106-111]. The physiological relevance of Ste5 nuclear shuttling is unclear because all Ste5
interacting proteins are found in the cytosol or in both the cytosol and the nucleus.
3.6.5 Signaling Specificity
In yeast, the mating, invasive/filamentous growth, and high osmolarity glycerol
pathways share some common components. Despite sharing components, these pathways are
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able to faithfully activate the appropriate responses and avoid cross-talk. The mating
pathway employs two schemes for maintaining signaling specificity. First, the Ste5 scaffold
(mating pathway) and the Pbs2 scaffold (high osmolarity glycerol pathway) help insulate
signaling between the three signaling pathways and prevent erroneous activation. Second,
activation of the MAP kinase Fus3 causes degradation of the Tec 1 transcription factor,
preventing expression of invasive growth response genes in response to mating pathway
activation. Cross-talk and signal specificity have been investigated computationally with
models of the mating and invasive growth pathways [136, 330], mating and high osmolarity
glycerol pathways [329], and all three signaling cascades [331]. I present a brief discussion
of signal specificity below. Signaling specificity is reviewed more thoroughly elsewhere
[397].
Mating pathway shares signaling components with other pathways
The MAP kinase cascades in the mating, invasive growth and high osmolarity
glycerol pathways all employ the MAPKKK Stel 1 as well as the Stel I activating
components Ste20, Cdc42 and Ste50 (see Section 3.3.1.c) [398-403]. The invasive growth
and mating pathways share the MAPKK Ste7 [403]. The mating pathway activates both
Kssl and Fus3 MAPKs [205] whereas the invasive growth pathway activates Kssl
exclusively [298]. Finally, the invasive growth and mating pathways both use the
transcription factor Stel2, but invasive growth also requires Tec for specificity of
transcriptional response [315, 404].
MAP kinase cascade scaffolds help maintain signaling specificity
MAP kinase scaffold proteins have become a ubiquitous feature of signaling
pathways, and more general roles of MAP kinase scaffold for maintaining signaling
specificity have been reviewed elsewhere [330, 397, 405-408].
The invasive growth pathway activates Stel 1, Ste7 and Kssl without the aid of a
MAP kinase cascade scaffold protein [397]. The high osmolarity glycerol pathway MAP
kinase scaffold Pbs2, which also doubles as a MAPKK, must be bound to the active
osmosensor Shol to facilitate Stel -dependent phosphorylation and activation of Pbs2 [247,
401]. Thus, because of Pbs2, activation of Stel 1 in the absence of activation of Shol fails to
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cause signaling in the high osmolarity response pathway, preventing erroneous activation by
signaling in the mating and invasive growth pathways. In the mating pathway, the scaffold
Ste5 is required for activation of Stel 1 (see Section 3.3.1.c), as well as phosphorylation of
Fus3 by active Ste7 (see Section 3.3.1.e). Ste5 potentially maintains signal specificity by
several means. First, membrane localization and activation of Ste5 is required for activation
of Stel 1 in response to pheromone (see Section 3.3.1.c). Second, Ste5 brings Stel 1 and Ste7
together within a complex such that Stel 1 can rapidly phosphorylate Ste7 (see Section
3.3.1.d), favoring activation of the mating pathway (and perhaps the invasive growth
pathway) over activation of the high osmolarity glycerol pathway. Finally, Ste5 is required
for activation of Fus3 by active Ste7 (see Section 3.3.1.e), thus favoring activation of mating
response over invasive growth response (see below).
Fus3 degrades Tecl to prevent expression of invasive growth response genes
Although both the mating and invasive growth pathways activate Kssl in response to
stimulus, only the mating pathway activates Fus3 [205, 298]. Active Kssl and Fus3 both
derepress and activate the transcription factor Stel2 (see Section 3.4.1.a). Stel2 is required
for expression of both mating and invasive growth response genes [307-309, 315]. In
response to invasive growth pathway activation, Tec I forms a dimer with Ste 12 to activate
invasive growth genes [296, 315]. In response to pheromone, active Fus3 triggers the
degradation of Tecl [316-318]. In the absence of Tecl, Stel2 by itself, or along with Mcml,
regulates expression of mating response genes [80].
3.6.6 Nonspecific Dephosphorylation
Although some specific phosphatases have been found to act on proteins in the
mating pathway, the majority of the known phosphorylation reactions in the mating pathway
have no known dephosphorylation counterpart. Where phosphorylation is used to signal for
degradation of a protein, for example in the case of Sst2 (Section 3.2.2.d), dephosphorylation
may not be important. Naively one might expect that phosphorylation events that activate
proteins, for example in the cases of Stel 1 (Section 3.3.1.c), Ste7 (Section 3.3.1.d), and Fus3
(Section 3.3.1.e), would be opposed by dephosphorylation events. Dephosphorylation of
Ste 1l, Ste7 and Fus3 would help to reduce spurious signaling in the absence of pheromone
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and to reset signaling once the stimulus has been removed. However, of all the activating
phosphorylation events in the pathway, only phosphorylated MAPKs are dephosphorylated
by known phosphatases (Section 3.3.2.c). The dephosphorylation mechanisms for the other
phosphorylated proteins in the pathway are not known. Perhaps these phosphatases exist but
have not yet been discovered by screens looking for suppressors of mating activity.
Alternatively, the primary means of elimination of phosphorylated Stel 1 and Ste7 may not
be dephosphorylation, but rather degradation or dilution (see Sections 3.3.2.a, 3.3.2.b, and
3.6.2). Finally, dephosphorylation may occur via the activity of a number of cellular
phosphatases that act weakly or in large numbers to dephosphorylated proteins in the mating
pathway, minimizing the effect of individual phosphatases and thus making the individual
phosphatases difficult to identify.
I found that pathway activity was too high in the absence of stimulus without nonspecific
dephosphorylation of Stel and Ste7 (unpublished modeling results). Thus, I include
nonspecific dephosphorylation in the Mating Model as a means of dephosphorylating
proteins in the mating pathway. For consistency, I assume that all phosphorylation sites on
all proteins in the Mating Model, not just on Stel 1 and Ste7, are dephosphorylated at the
same rate, kcat_nonspecificdephosph. The nonspecific dephosphorylation reactions can be
found in the appropriate Regulation and Feedback sections above.
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Chapter 4. Effects of Scaffold Abundance on MAPK
Cascade Output and Dynamic Range
4.1 Introduction
Both experimental and modeling studies have shown that the behavior of signaling
systems such as the mating system can depend strongly on the abundances (numbers of
molecules per cell) of system proteins. For example, altered expression of most mating
system components impacts the sensitivity of yeast cells to pheromone, and in some cases
can cause constitutive system activation and cell cycle arrest [248, 320, 409, 410]. As a
second example, the abundances of MAP kinase scaffold proteins (for example, Ste5) are
predicted to be critical determinants of maximal signaling output [328, 411, 412].
Although the abundances of mating system proteins have been measured in the past
[82, 94, 98, 99, 251], these reported protein abundances can vary more than 15-fold (Figure
4-1) [64]. Differences in the experimental methods used to quantify proteins may account
for much of the observed variation in reported protein abundances. Thus, in setting out to
better understand how protein abundance measurements impact quantitative signaling
response, Kirsten Benjamin and colleagues at the Molecular Sciences Institute developed and
used a new accurate immunoblotting method to generate high quality protein abundance data
for key mating system proteins, as well as for proteins from coupled systems (Table 4-1)
[64]. Motivated by these accurate protein abundances, I created a quantitative model of the
yeast mating system MAPK cascade and analyzed the impact that different protein
abundances have on system performance. I found that the abundance of the scaffold protein
Ste5 is predicted to set a tradeoff between MAPK cascade system output and dynamic range,
and that the tradeoff between system output and dynamic range may be a general property of
signaling systems that is controlled by the abundances of scaffold proteins.
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Figure 4-1 Relative measured abundances of MAPK cascade components.
A graphical representation of the relative abundances of MAPK cascade proteins (molecules per
cell) as measure by (a) Kirsten Benjamin, (b) Ghaemmaghami et al., (c) Slaughter et al., and (d)
Maeder et al. [64, 94, 98, 99]. Each protein icon represents 200 molecules per cell.
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Table 4-1 Measurements of abundances of key components by immunoblotting.
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4.2 Results
4.2.1 Computational Investigation of MAPK Cascade Dynamic Range
I rapidly created a model of the mating system MAPK cascade in BioNetGen
language [30] by using the YeastPheromoneModel repository
(www.YeastPheromoneModel.org) (0). The YeastPheromoneModel (YPM) resource is an
information repository describing the yeast mating system, and includes a detailed and well-
documented model of the entire mating system. As I was only interested in the MAPK
cascade, I pared down the full mating system model encoded by the YPM repository,
eliminating molecules and reactions not directly involved in MAPK cascade signaling.
Briefly, the model started with pheromone-dependent activation of the G protein, followed
by binding of Ste5 to the active G protein, triple phosphorylation of the MAPKKK Ste 11,
double phosphorylation of the MAPKK Ste7, and finally double phosphorylation of the
MAPK Fus3 (Figure 4-2). I defined the amount of doubly-phosphorylated Fus3 (Fus3-PP) as
the system output. To allow the model to reproduce the non-zero basal activity of the system
[44, 205, 206, 308], I included reactions for G protein activation in the absence of
pheromone. Double and triple phosphorylation events in the MAPK cascade model occurred
over multiple independent reactions such that I allowed for intermediate phosphorylation
states. Protein dephosphorylation was mediated by non-specific phosphatases for all
proteins, and by the specific phosphatases Ptp2/3 and Msg5 for Fus3. In order to facilitate
simulation and analysis, the model did not include the MAPK Kssl, Ste5 dimerization, and
feedback degradation of Stel 1 and Ste7.
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The resulting MAPK cascade model contained 23 unknown parameters. However,
the MAPK cascade model was itself not dependent on pheromone concentration. Thus, I
added to the core MAPK model an "input model" to encode the effects of pheromone
treatment on the rates of G protein activation and deactivation, linking experimental
pheromone concentration to MAPK model activation. For each pheromone concentrations
that I simulated, the input model used two different parameters: a parameter defining the G
protein activation rate and a second parameter defining the G protein deactivation rate. I
simulated the model using three different pheromone treatment conditions: no pheromone (to
establish pre-stimulation steady state system activity), sub-saturating pheromone (0.1 nM),
and saturating pheromone (50 or 100 nM; see Materials and Methods). Thus, I
simultaneously optimized a total of 29 unknown parameters, 23 parameters internal to the
cascade and 6 parameters governing model input (Materials and Methods).
I used a genetic algorithm [413] to optimize the values of the 29 unknown model
parameters by minimizing the mean squared error between computed and experimentally
measured levels of phosphorylated Fus3, as well as between computed and experimentally
measured association of Ste5 and the active G protein (Figure 4-2, Figure. A-la, and Table.
A-1). Ste5 and Fus3 activation were weighted equally. The genetic algorithm evolved a
population of 500 different members (parameter sets) over 80 generations (iterations), with
approximately half of the population members generated by crossover and approximately
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Figure 4-2 Schematic representation of the MAPK cascade model.
The model is presented as a series of rules that govern the formation and modification of
individual molecules and molecular complexes. The left column contains rules that define the
assembly and disassembly of signaling complexes, the center column contains the reactions that
govern protein activation and phosphorylation, and the right column contains reactions that define
protein dephosphorylation and turnover. The model input is the dose-dependent rates of G
protein activation and deactivation, which characterize the effects of pheromone treatment on the
activity of the G protein. Model parameters are constrained by experimental measurements of
Ste5 translocation to the plasma membrane (formation of a complex between Ste5 and the active
G protein), and experimental measurements of the model output, Fus3 phosphorylation (blue data
points are response to sub-saturating pheromone, and red data points to saturating pheromone).
The main flow of signal transduction (through the reactions that define protein activation and
phosphorylation; center column) is indicated via the grey arrow. The full unambiguous model is
also available online [34].
half by mutation at each generation (see Materials and Methods). I chose to use a genetic
algorithm rather than a direct search optimization approach because genetic algorithms
perform parallel search of the parameter space, and thus are less likely to get trapped at a
single suboptimal set of parameter values [414]. Genetic algorithms also tend to find
solutions (that is, parameter sets that result in good agreement between computed and
measured output) where other approaches may fail [415]. Additionally, genetic algorithms
can produce many distinct parameter sets that all result in qualitatively similar agreement
between computed and measured system output [416]. These additional parameter sets can
be used to verify that modeling results are not sensitive to one particular parameter set
selected during optimization (below).
Using the optimized model, I investigated the impact that different protein
abundances, and particularly the low relative abundance of Ste5, have on system
performance. To do this, I varied the abundances of Ste5, Ste 11, Ste7, and Fus3 from 10 to
106 molecules per cell and simulated the model with saturating amounts of pheromone. As
the Ste5 abundance increased, the steady-state induced output of the model (Fus3-PP) first
increased greatly, then peaked, and eventually declined (Figure 4-3a). The peak in system
output was a direct consequence of the scaffolding role of Ste5, in which Ste5 brings together
kinase and substrate to enable substrate phosphorylation: initially adding more Ste5 yielded
more ternary (kinase-Ste5-substrate) complexes, which then reached a maximum beyond
which excess Ste5 formed separate complexes with its binding partners, thereby diminishing
the number of ternary complexes. Previous modeling studies have predicted this segregation
effect [328, 417], and experimental studies with the KSR scaffold protein in Xenopus oocytes
reported observations consistent with the segregation effect: enhancement of Ras signaling
with mild KSR overexpression and inhibition of Ras signaling with strong KSR
overexpression [418]. As the Stel 1 abundance in the model increased, the computed steady-
state output increased, and then leveled off as Ste5 became saturated with Ste 11 molecules
(Figure 4-4a). With increasing Ste7 and Fus3 abundances, the system output increased,
peaked, and decreased (Figure 4-4b,c). The dependence of system output on Ste7 and Fus3
abundances was qualitatively similar to the dependence on Ste5 abundance. Ste7 and Fus3
interact with each other in the absence of Ste5, and this Ste7-Fus3 complex is unable to bind
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Ste5 in the model (Fus3 cannot be simultaneously bound to both Ste7 and Ste5 [250], but
experiments have not shown whether Ste7 can be simultaneously bound to Fus3 and Ste5).
Thus, as the abundance of either kinase increased, each kinase began to titrate the other and
prevent formation of ternary complexes. For example, at very high Ste7 abundances, Ste7
was predicted to titrate nearly all Fus3 so that little Fus3 remains to interact with Ste5 and
form the Ste7-Ste5-Fus3 complex necessary for phosphorylation of Fus3.
Unlike the MAPK model presented here, many previous models did not allow for
system activity in the absence of stimulus [2, 45, 100, 328, 417], despite the fact that this
basal system activity is biologically important (see Discussion). I noted that the computed
output of the system in the absence of pheromone (basal response) was also strongly affected
by changes in the abundance of Ste5, but only weakly affected by changes in the abundances
of other system components (Figure 4-3a and Figure 4-4). Given the strong predicted
dependence of both basal and induced system output on Ste5 abundance, I investigated the
dynamic range of the system. Specifically, the ratio of the steady-state induced output and
basal output (induction ratio) was highly sensitive to changes in Ste5 abundance (Figure
4-3a). Furthermore, the induction ratio was at a nadir near the Ste5 abundance that I
predicted would produce the highest system output. Varying the abundance of Ste5
established a tradeoff between total system output and dynamic range. I also observed this
tradeoff when I considered a different metric for dynamic range commonly used in electrical
engineering, the absolute difference between the basal and induced output, or swing (Figure.
A-2) [419]. I did not observe a tradeoff between total system output and dynamic range upon
varying the abundances of Stel 1, Ste7 and Fus3 (Figure 4-4).
I investigated how the parameters and abundances used in the model affected the
prediction that the dynamic range of the MAPK cascade is strongly dependent on the
abundance of Ste5, and that the abundance of Ste5 may reflect a tradeoff between total
system output and dynamic range. First, during optimization of the parameters to maximize
agreement between the model and experimental data, many distinct parameter sets resulted in
a good agreement between the model and the data (see Materials and Methods). I clustered
these "elite" parameter sets into five groups based on the Euclidean distance between the log
of the parameter values, and selected one parameter set from each group that gave the best
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agreement between the model and data (discarding the group containing the best-fit
parameter set used above) (Table. A-i and Figure. A-3). Each selected parameter set also led
to the prediction of a tradeoff between total system output and dynamic range as a function of
Ste5 abundance, but not as a function of Stel 1, Ste7 and Fus3 abundances (Figure. A-4,
Figure. A-5, Figure. A-6, and Figure. A-7).
I also investigated whether the predictions were dependent on the protein abundances
that I used in the model. Thus, I created three additional versions of the model using protein
abundances measured by Ghaemmaghami et al., Slaughter et al., and Maeder et al. (Figure
4-1) [94, 98, 99], and optimized the parameters in each model to maximize agreement
between model behavior and the experimental data (Table. A-i and Figure. A-1).
Additionally, I created a fifth version of the model in which I allowed the optimization
procedure to optimize protein abundances in addition to the other model parameters. In all
cases, the resulting models displayed a similar tradeoff between total system output and
dynamic range as a function of Ste5 abundance, but not as a function of Stel 1, Ste7 or Fus3
abundances (Figure 4-3b,c,d, Figure. A-8, Figure. A-9, Figure. A-10, and Figure. A-11).
However, the exact quantitative tradeoffs between system output and dynamic range were
dependent on the specific protein abundances. For example, the Ghaemmaghami et al.
abundances led to the prediction that their measured wild-type Ste5 abundance maximizes
total system output at the expense of induction ratio (Figure 4-3b), whereas the abundances
measured by Kirsten Benjamin, by Slaughter et al., and by Maeder et al. led to the prediction
that the wild-type Ste5 abundance set a compromise between high induction ratio and total
system output (Figure 4-3a,c,d; see Discussion).
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Figure 4-3 Dependence of behavior of MAPK cascade model on abundance of the scaffold
Ste5.
I simulated the steady-state system output and dynamic range using the abundances measured by
(a) Kirsten Benjamin, (b) Ghaemmaghami et al., (c) Slaughter et al., and (d) Maeder et al. [64, 94,
98, 99]. The steady-state system output (Fus3-PP per cell) in the absence of pheromone (dashed
line) and in response to saturating amounts of pheromone (solid line) are shown for a range of
Ste5 abundances (top). The induction ratio (bottom) is a measure of the dynamic range of the
signaling that is calculated by dividing the steady-state system output with saturating pheromone
by that with no pheromone. The dotted lines in all plots indicate the measured Ste5 abundances.
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Figure 4-4 Dependence of behavior of MAPK cascade model on abundances of Stell, Ste7
and Fus3.
I simulated the steady-state system output and dynamic range vs. (a) Ste 11 abundance, (b) Ste7
abundance, and (c) Fus3 abundance. The steady-state system output (Fus3-PP per cell) in the
absence of pheromone (dashed line) and in response to saturating amounts of pheromone (solid
line) are shown for a range of kinase abundances (top). The induction ratio (bottom) is calculated
from the steady-state system output. The dotted lines in all plots indicate the measured kinase
abundances. The model was constructed using the abundances measured by Kirsten Benjamin
[64].
4.3 Discussion and Conclusions
4.3.1 Ste5 Abundance Critically Affects System Dynamic Range
I used a quantitative model to explore the consequences of changing the abundances
of Ste5, Ste 11, Ste7 and Fus3. Previous models of hypothetical scaffold-based signaling
systems predicted that the scaffold abundance is a critical determinant of maximal signaling
output [328, 411, 412]. However, these earlier studies did not consider the effect of scaffold
concentration on basal system activity, nor the dynamic range of the system. Only a few
published models of the mating system have included non-zero system activity in the absence
of pheromone, and these modeling efforts did not directly investigate the importance of basal
system activity [22, 82]. Upon carefully considering the biologically important basal system
activity, I found that the abundance of the scaffold Ste5, but not other MAPK cascade
components, had a strong effect on the predicted system dynamic range. Furthermore, I
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predicted a strong tradeoff between system output and dynamic range as a function of
scaffold abundance.
By using the different available sets of protein abundance measurements, I found that
the measured abundances are predicted to dramatically impact the quantitative performance
tradeoffs of the mating system. For example, the abundances measured by Kirsten Benjamin
led to the prediction that the system may be optimized for a compromise between total
system output and high induction ratio, whereas the protein abundances measured by
Ghaemmaghami et al. led to the prediction that the system may be optimized for total system
output at the expense of induction ratio (Figure 4-3a,b). The dependence of the quantitative
system behavior on underlying component abundances confirmed the importance of accurate
protein abundance measurements for characterization and understanding of overall system
function.
Importantly, although the quantitative properties of the MAPK cascade model
depended on specific protein abundances, the qualitative nature of the tradeoff between total
system output and dynamic range was insensitive to the component abundances used in the
model (Figure 4-3). Additionally, different kinetic rate parameter sets that resulted in a good
agreement between the model and experimental data also produced the same tradeoff. Thus,
the architecture of the MAPK cascade may be the primary determinant of the predicted
tradeoff between total system output and dynamic range.
There are many reasons to suspect that the mating system basal output, induced
output, and dynamic range are finely regulated and are under selection. First, basal system
output must be high enough to maintain synthesis of several system proteins whose
expression depends on activity of the transcription factor Stel2 (for example, Ste2 and Fus3)
yet low enough to avoid triggering growth arrest [72, 420]. Second, a sufficiently high
induced system output is required to elicit the appropriate physiological changes in response
to pheromone treatment; a small number of active Fus3 molecules per cell may be
insufficient to trigger cell cycle arrest and activate Stel2 [304, 333]. Finally, recent work
suggests that the mating system may have been optimized in part to maximize the amount of
mutual information about extracellular pheromone concentration that the mating system can
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transmit, and that the dynamic range of the system may be an important determinant of the
information transmission capacity of the system [44]. Thus, selection may act to maximize
system output and dynamic range while maintaining a carefully regulated basal system
activity. Obviously these system properties are not independent, indicating that the system
may have evolved under multiple, sometimes opposing, selective pressures. Generally, the
abundance of scaffold proteins in signaling systems may be under selective pressure to
support specific quantitative system behavior.
Recently, Garrenton et al. found that upon experimentally interfering with Ste5
degradation, the increased Ste5 abundance resulted in increases in both basal and induced
system output such that the system induction ratio decreased [421]. This experimental
evidence demonstrates that perturbation of the abundance of Ste5 alters the tradeoff between
system output and dynamic range as predicted. Moreover, scaffold protein abundances in
some signaling systems may naturally be altered dynamically during stimulus response in
order to meet changing system performance requirements. For example, a system could be
optimized for high dynamic range early during activation, perhaps to discriminate between a
range of stimulus intensities, whereas at later times during activation high system output may
be more appropriate. In the mating system, the abundance of Ste5 is not thought to change in
response to pheromone [94, 99], indicating that Ste5 may not be responsible for dynamic
reprogramming of the mating system behavior. In fact, attempts to overexpress Ste5 on a 2
gtm plasmid resulted in only a two- to three-fold increase in Ste5 abundance (unpublished
observations), suggesting that the abundance of Ste5 may not only be under selection, but
may be actively regulated to support specific quantitative system behavior. Additionally,
deconvolution of changes in gene expression capacity [53] and YFP production from a
pheromone-induced promoter in response to pheromone treatment suggests that mating
system output itself is relatively constant during mating response (G. Pesce, A. Colman-
Lerner, and R. Brent, unpublished observations).
4.3.2 Conclusions
I was interested in understanding the effect of different protein abundance on the
behavior of signaling systems, and was surprised by the large variation in reported
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abundances of mating system proteins. The model of the MAPK cascade led me to predict
that the abundance of the MAPK scaffold protein Ste5 significantly affects system behavior,
and moreover sets a tradeoff between maximum system output and system dynamic range. I
used the variation in different measured protein abundance to my advantage to verify that this
prediction was not dependent on the measured abundances of system components. The
abundance of scaffold proteins in signaling systems may be under selection for specific
system behavior, and perhaps even may be altered dynamically during stimulus response in
order to meet changing system performance requirements.
4.4 Materials and Methods
The MAPK cascade model used in this study was derived from a model of the entire
yeast mating system from the YeastPheromoneModel (YPM) information repository
(www.YeastPheromoneModel.org) (0). I extracted the model of the entire mating system
from the YPM repository on January 24, 2008. 1 eliminated from this full system model the
reactions and components specific to receptor, G protein, and transcriptional activation. The
documentation for the full system model can be found at
http://yeastpheromonemodel.org/ModelDocs/2008_01_24_ 15h08m33s/Yeastpheromonere
sponse_model.html. I documented all of the modifications that I made to the full system
model file, and the reasons for each modification, on a Model Process page in the repository
(http://yeastpheromonemodel.org/wiki/Model_Processpage for 2008_0124_ 15h08m33s).
Briefly, the model of the entire system was pared down to include only species and reactions
that comprise the core signal transduction through the MAPK cascade (Figure 4-2).
I used two different experimental measurements of system response to pheromone to
constrain the parameters in the model: levels of phosphorylated Fus3 (Fus3-PP) and levels of
Ste5 associated with the plasma membrane via an interaction with Ste4 (Ste5 translocation).
The model parameters were simultaneously optimized to maximize agreement between
simulation results and experimental data from cells stimulated with sub-saturating and
saturating concentrations of pheromone (0.1 nM and 100 nM for Fus3-PP, and 0.1 nM and 50
nM for Ste5 translocation). Two input model parameters described pheromone-dependent
activation and deactivation of the G protein. These dose-dependent parameters were
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necessary to link experimental pheromone treatment to model activation. Since I considered
two pheromone treatments (sub-saturating and saturating), plus a no-pheromone case to
establish pre-stimulation steady-state system activity, I optimized a total of six values for the
two input parameters. I did not include any Fus3-dependent feedback reactions in the MAPK
model. Correspondingly, I fit the model to Fus3 phosphorylation data collected from cells
treated with a specific Fus3 inhibitor to prevent Fus3-dependent feedback reactions from
impacting the experimental data [44]. Fus3 was not inhibited before measuring Ste5
translocation as Ste5 translocation occurs on shorter timescales than Fus3 phosphorylation.
Additionally, Alejandro Colman-Lerner found that inhibition of Fus3 did not have a
significant effect on Ste5 translocation (personal communication). Collection of both Fus3-
PP experimental data and Ste5 translocation experimental data are described elsewhere [44,
64].
For the purposes of parameter optimization, I constrained all association rates to lie
between 105 M-' s- and 107 M -IS-1. Most protein-protein association rates fall in this range,
which is significantly slower than the diffusion limit of 109- 10' M-1 S- [150, 151, 422]. I
constrained all dissociation rates to lie between 10-3 S-1 and 10 s-, and all phosphorylation
rates to lie between 10-3 S 1 and 10 s 1', which are both also biologically relevant ranges [272,
277]. The rates of dose-dependent G protein activation were constrained to lie between 10-5
s-~ and 1 s-1. Because both Ste5 and Fus3 activation data were measured in arbitrary units, I
linearly scaled the data to allow for comparison with simulation results. Additionally, I
constrained the model such that at least 20% of the total Ste5 population associated with Ste4
in response to saturating amounts of pheromone, and at least 33% of the total Fus3
population became phosphorylated in response to saturating amounts of pheromone. These
thresholds were selected based on unpublished observations that a significant portion of both
Ste5 and Fus3 populations became activated in response to pheromone treatment (Rich Yu
and Alejandro Colman-Lerner, personal communication) and because in the absence of such
constraints parameter optimization generally produced very low levels of system activation.
Selection of different thresholds between 20% and 50% of the total Ste5 and Fus3
populations did not significantly alter the conclusions drawn from the model (not shown). I
did not investigate the effect of thresholds outside of this range.
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The model contained -30 unknown parameters, including those parameters that
govern the dose-dependent activation of the G protein (the exact number of parameters
depended on the protein abundances used, see Appendix A and Table. A-1). The unknown
parameters were optimized via a genetic algorithm. I wrote MATLAB (R2007a, The
MathWorks, Natick MA) scripts to use a genetic algorithm (Genetic Algorithm and Direct
Search Toolbox, v2.1) to perform parameter optimization and execute BioNetGen (version
2.0.46; [30]) simulations of the models. I numerically simulated the model with an absolute
error tolerance of 0.1 fM (-0.001 molecules per cell), and relative error tolerance of 105 .
The model was simulated for 100,000 seconds (-28 hours) to establish pre-pheromone steady
state. Following simulated pheromone treatment, I simulated the model for 1000 seconds
during parameter optimization (20,000 seconds when varying protein abundances).
Together, each pair of pre- and post-pheromone treatment simulations took -10 seconds of
computation time on a 1.8 GHz PowerPC dual-core G5 computer. I was unable to find
guidelines or examples for best configuring a genetic algorithm to optimize a model the size
of the MAPK model. Thus, I chose the configuration below in part based on the default
settings provided by the genetic algorithm tool, and in part by trial and error. I did not
attempt to find optimal genetic algorithm configurations to obtain more rapid or accurate
parameter estimates.
The genetic algorithm evolved a population of 500 different members (parameter
sets; grouped into subpopulations of size 100, 20, 100, 30, 100, 50, 100) over 80 generations.
Migration between subpopulations occurred every 20 generation, with the top 20% of each
subpopulation replacing the worse members of a neighboring subpopulation. For all other
generations, the top two members of the population were automatically retained, and half of
the remaining population was generated by crossover while the other half was generated by
mutation. The "parent" parameter sets for the crossover and mutation functions were
selected using the default genetic algorithm options: the probability of selecting a particular
parameter set was proportionally to 1/ Vn, where n is the rank of that parameter set in the
subpopulation (determined by lowest score, see below). The crossover function applied a
weighted average of the value of each parent parameter (child_value = parent 1_value +
weight x (parent2_value - parent l_value)), where the weighting was randomly chosen from
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the uniform distribution [0 1.5] such that the "child" parameter value could lie outside the
range defined by the parent parameter values. The mutation function first identified
parameter values within a parameter set to mutate; each member of the parent parameter set
had a 5% chance of being mutated. The value of each chosen parameter was multiplied by
10y, where y was selected for each parameter from a zero-mean normal distribution with
standard deviation 0.5.
Parameter sets were scored based on the mean squared error between the simulated
timecourses and the measured data, with equal weight given to Ste5 and Fus3 experimental
data. I ran the optimization using the protein abundances measured by Kirsten Benjamin
four times, and noted no significant difference between the quality of fit achieved by each
optimization, suggesting that I did not need to increase the number of generations (not
shown). I ran the optimization using the protein abundance sets measured by
Ghaemmaghami et al., Slaughter et al., and Maeder et al. twice each. I also ran the
optimization in which I treated the protein abundances as unknown parameters twice. I used
the parameters that resulted in the best fit (lowest score), as determined by lowest mean
squared error, across all optimizations for each set of protein abundances.
To investigate the dependence of the observed model behavior on parameter values, I
selected four additional parameter sets which, when using Benjamin's measured abundances,
resulted in a good agreement between the model and the data. I further selected these four
additional parameter sets to be as different as possible from each other and the best-fit
parameter set (below). I identified all parameter sets across all generations from all four
optimizations that resulted in scores within 10% of the lowest score ("elite" parameter sets).
I clustered a random subset of 5,000 of these elite parameter sets (which included the best-fit
parameter set) into five clusters based on the Euclidean distances between each pair of
parameter sets (treating the parameter sets as vectors in space n-dimensional space). To
ensure equal weighting of each parameter, I took the log of the parameter values before
clustering. The best fit (lowest score) from each group were used (Table. A-i and Figure.
A-3). I clustered only a subset of the elite parameter sets because computational cost
prohibited clustering of all -17,000 elite parameter sets. The qualitative tradeoff between
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system throughput and dynamic range was not sensitive to the particular subset of elite
parameter sets selected for clustering (not shown).
MATLAB scripts were also used to vary the abundance of Ste5, Stel 1, Ste7 and Fus3
and execute BioNetGen simulations. The model file and custom scripts are available online
[34].
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Chapter 5. Studying the Mating System with Time-
Dependent Input
5.1 Introduction
Traditional methods for studying and characterizing cellular processes have been
highly successful, and yielded much understanding of biological systems. Unfortunately,
these methods can be slow and tedious, and generally provide incomplete and incompatible
information at various levels of resolution (below). Genetics is generally the first approach
used in the study of a particular biological response or phenotype, and is often used to
elucidate pathway structure: genes are knocked out or mutated in a systematic manner, and
the genes which affect the response when knocked out are candidate members of the pathway
governing that response [423, 424]. Once the candidate genes are identified, the first-order
architecture of the signaling system can be determined through either genetic analysis (for
example, epistasis tests and other genetic crosses) or biochemical analysis (for example,
identification of the interactions of the gene products). A combination of genetic and
biochemical analysis is used to continually form and test hypotheses, and further refine our
understanding of the biological systems [ 11].
Analysis of well-studied signaling systems such as the yeast mating system typically
involves looking at changes in the state of system intermediates. Researchers generally
stimulate pathways with a fixed input (stimulus) and then observe the output (or phenotype)
over time, or at some fixed time after stimulation. For example, researchers studying the
mating system typically treat yeast cells with a fixed concentration of pheromone, and
sometimes also knock out the gene encoding the pheromone protease Barl (Section 3.2.2.a),
or treat cells with a Barl inhibitor in order to prevent changes in pheromone concentration
over the course of an experiment [45, 53, 112, 207]. Obviously, by constraining themselves
to only fixed inputs, researchers only characterize system response for only a limited set of
possible inputs, providing limited information about the interactions and mechanisms the
determine system behavior.
This process of discovery using fixed system inputs together with genetics and
biochemistry can be slow, and generally requires many experiments to uncover any given
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fact [ 11]. For example, Ste5, the mitogen activated protein kinase (MAPK) scaffold protein
from the yeast mating response system, was first discovered to be involve in mating via
genetic screens for mutants in 1974 [425]. It was about 20 years later that Ste5 was shown to
bind all three kinases in the MAPK cascade simultaneously and do so through different
binding sites suggesting its role as a scaffold [236, 426]. As a second example, in Chapter 4
I presented computational studies of the abundances of protein components in the mating
pathway. This model work was motivated by careful protein abundance measurements made
by Kirsten Benjamin and colleagues [64]. These measurements were tedious to perform, and
due to large sample-to-sample variation, individual measurements had to be repeated many
times to obtain reliable quantitation. Additionally, the abundances that Kirsten Benjamin
measured were often incompatible with the abundances measured via other experimental
methods (Chapter 4) [64].
I saw a need for new technologies and practices to work with existing tools to speed
up the process of discovery and characterization; specifically, being able to increase the
return from individual experiments would be greatly beneficial. I investigated the prospect
of using time-dependent inputs to stimulate and study signaling pathways. I loosely defined
a time-dependent stimulus as one whose magnitude or concentration changes multiple times
over the course of a given experiment, a sinusoid or a pulse train being simple examples. A
time-independent stimulus is one whose magnitude changes only once over the course of an
experiment, such as in a step response where the cells are exposed to some stimuli at a
constant concentration for a fixed period of time.
In a well-designed experiment, observations of a pathway stimulated with a time-
independent input will contain some information about the system. I hypothesized that
stimulating the same pathway with a more information-rich input (such as a time-dependent
input) instead of a time-independent input would make the observations of the system more
information-rich as well. The time-varying inputs whose utility I investigated were not
necessarily biologically relevant, nor were the responses that I expected to observe.
I believed that stimulating a signaling system with a time-dependent input would
provide more information-rich observations because time-dependent input would (i) push the
278
system into states in that it might not attain normally during response to fixed input and, (ii)
result in more complex behavior than observed under time-independent stimulation that
would allow us to learn more about the system. For example, signaling system components
generally do not sample their entire state space of possible complexes during system
response to stimulation. In the yeast mating response system, Ste5 can simultaneously bind
the MAPKKK Stel 1 (which can be phosphorylated at 3 sites), the MAPKK Ste7 (which can
be phosphorylated twice), and the MAPK Fus3 (which can be phosphorylated twice) [235-
237]. Ste5 can also simultaneously bind the G protein f3y subunit Ste4-Stel8 which has three
known phosphorylation sites [ 175], and can itself be phosphorylated in at least one place
[254, 288, 290]. Furthermore, Ste5 can form homo-oligomers [109, 222, 224]. This means
that there are, at a very minimum, 8 million distinct complexes in which Ste5 can participate.
Measurements suggest that there are about 560 Ste5 molecules per cell (see Section 3.3.3.b).
Thus, during a typical step response, the -560 Ste5 molecules per cell are likely only able to
sample a very small subset of the -8 million potential Ste5-containing complexes. I expected
that when a signaling system is exposed to time-varying stimuli, the components of the
system would be able to sample a different portion of the space of complexes in which they
exist. These differences in the internal state of the signaling system would hopefully
manifest themselves in the observable outputs from the system.
I took two parallel approaches to studying cells with time-dependent inputs. First, I
constructed a microfluidic device to enable experimental treatment of cells with discrete
time-varying input. I specifically designed a microfluidic device for exposure of yeast cells
to discrete pheromone concentrations, although the device could easily be used with other
organisms and signaling systems. I constructed a microfluidic device because I thought it
impractical to expose cells to time-dependent inputs by simply pipetting different solutions
onto cells. To complement the experimental setup, I designed computational approaches to
investigate the potential benefits of treating the yeast mating system with time-dependent
pheromone concentrations. I investigated the mating receptor/G protein subsystem because
this portion of the mating system responds rapidly to pheromone treatment, on similar time-
scales to the rapid time-dependent inputs delivered by the microfluidic device. Additionally,
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the localization of a YFP-Ste5 fusion protein can be used as a reporter activation of this
mating subsystem.
5.2 Results
5.2.1 A Novel Microfluidic Device for Time-Dependent Input
In order to stimulate cellular signaling systems with time-dependent inputs, I
developed a microfluidic device, the "Stimulator", to control the temporal concentration of a
stimulus in the extracellular environment. I designed the Stimulator not just for treatment of
yeast cells with pheromone, but as a general tool for delivering time-dependent input to cells
adhered in a microfluidic channel. I chose to use microfluidics because continuous fluid
flow over cells adhered to a microfluidic channel provides an ideal means to deliver time-
dependent input to cells [427]. There now exist many technologies to control the flow of
fluids in microfluidic channels [428], making microfluidics a flexible platform on which to
develop these tools. Additionally, microfluidic devices can be operated on a microscope
stage and visualized for real-time microscopy of cellular behavior. Finally, recently there has
been a decoupling between design and fabrication of microfluidic devices, meaning that I
could design a microfluidic chip and have it fabricated elsewhere. This decoupling allowed
me to design and implement microfluidic devices without having to become an expert at
fabrication. I had the Stimulator fabricated by the Kavli Nanoscience Institute Microfluidic
Foundry at the California Institute of Technology (http://kni.caltech.edu/foundry/index.html).
5.2.1.a Microfluidic Device Design
I manipulated fluid flow on the Stimulator chip using on-chip valves in order to
control the extracellular fluid environment. Microfluidic devices with on-chip valves can be
fabricated out of polydimethylsiloxane (PDMS) by a process known as multilayer soft
lithography, in which multiple layers of channels are fabricated within the same chip [429].
The Stimulator chip design included two layers of channels (Figure 5-la and Figure 5-2).
The channels that held the cells and media (fluid channels) were in the lower layer (fluid
layer). The fluid layer sat on a glass slide, such that the fluid channels were bounded on the
bottom by glass, and bounded on all other sides PDMS. The upper layer of channels, the
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control layer, sat on top of the fluid channels and these control channels were entirely
bounded by PDMS. The control channels were used to control the flow of fluid through the
channels of the fluid layer, and contained only water. Areas where a control channel
significantly overlapped with a fluid channel are called valves. By pressurizing control
channels using an off-chip pressure source, I deformed the thin membrane of elastomeric
PDMS separating the fluid and control channels at each valve, causing collapse of the fluid
channel (Figure 5-1 b). Thus, by pressurizing control channels, I was able to collapse and
seal off fluid channels, effectively creating closed on-chip valves in fluid channels [429].
The control channels were attached to a pressure source via an off-chip valve that I
controlled using LabVIEW (Materials and Methods). The fluid channels were -21 gtm tall,
and varied in width from 20 gtm to 30 gm at positions of restricted flow, 250 gim at valves,
and 100-200 jim elsewhere (see Figure 5-2). The control channels were also -21 jim tall,
and varied in width from 30 gm where the control channels crossed over fluid channels not
forming valves, 250 jim at where the control channels crossed over fluid channels forming
valves, and 100 pim elsewhere.
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Figure 5-1 Cutaway view of a PDMS microfluidic device.
The fluid channels (blue) are located below the control channels (red) in the device. The fluid
channel is bounded on the bottom by a glass slide (grey). The PDMS is shown as clear. Where a
control channel overlaps significantly with a fluid channel, a valve is formed. (a) When the control
channel is not pressurized, the fluid channel is unobstructed and the valve is "open". (b) When the
control channel is pressurized by an external pressure source, the PDMS separating the control and
fluid channels deforms and obstructs the fluid channel, forming a "closed" valve.
Valves
Fluid channel
ports (output)
Control channel ports Control channel port
h
Figure 5-2 Stimulator chip design.
(a) A simplified schematic of the Stimulator chip (fluid channels are shown in blue, control channels
in red). Two fluids (media and media + pheromone) enter the chip via the two fluid input ports on the
left. Each input fluid passes through a series of three parallel channels of differing width. The two
fluids come together and flow smoothly side by side in the experiment channel, and finally flow out
the output port on the right. By opening and closing valves using the control channels, I can route the
fluids through channels of differing width, and consequently vary the resistance to flow and thus the
flow rates. (b) A full schematic of the Stimulator chip. The additional fluid port on the left is used
for injecting Concanavalin A or yeast cells into the chip. There are four experiment channels on the
right (and multiple output ports) to allow for a rapid succession of four experiments on the same chip.
The additional control channels and valves allow for better control over fluid flow in the chip.
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I designed the Stimulator chip to use on-chip valves to control the flow of fluid and
exposed cells to time-dependent stimulus concentrations. One channel in the Stimulator is
called the experiment channel. I adhered cells to the glass bottom of the experiment channel
using Concanavalin A, which binds the carbohydrate-rich yeast cell wall [430]. I flowed two
fluids containing different stimulus concentrations over the stationary cells in the channel
(for example, one fluid containing pheromone and the other fluid containing no pheromone;
Figure 5-3). These two fluids fed into the experiment channel via separate feed channels.
Because of the size of the channel and flow rates, fluid flow was laminar, meaning that there
was no turbulence and thus the fluids flowed smoothly side by side. The position of this
boundary separating the two fluid streams was dynamically adjusted across the width of the
channel by opening and closing on-chip valves to vary the flow rates of the two streams
(below). Thus, as the boundary shifted back and forth across the cells (which were adhered
in the channel), the cells were exposed to time-dependent discrete concentrations of stimuli
(Figure 5-3). Cells near either wall of the experiment channel were not affected by changes
in the position of the boundary layer and thus were only exposed to a single fluid. These
cells served as positive and negative controls, ensuring that either fluid produced the
expected cellular response. The rate at which I could move the boundary between the two
flows across the cells determined the maximum frequency at which I could stimulate the
cells, - 1 Hz (see below).
I varied the flow rates of the fluids in the chip by varying the resistance to their flow.
Both fluids were driven by a constant pressure source off the Stimulator chip. By opening
and closing on-chip valves and routing the flow through narrow or wide channels (20 pM, 30
p.m or 100 gpm wide), I were able to dynamically alter the resistance experienced by each
fluid, and thus alter the flow rate of that fluid (Figure 5-2). The design of the Stimulator chip
essentially allowed for binary input to the pathway. I expect that this scheme could be
expanded to 3 or more parallel streams in laminar flow regimes whose boundaries could be
shifted across the cells, allowing for a wider range of discrete inputs (stimuli and
concentrations) within a single experiment.
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Figure 5-3 Scheme for time-dependent input.
(a) Depiction of two fluids flowing over cells in the experiment channel of the Stimulator chip. (b)
By varying the position of the boundary layer over time, (c) cells in the center of the channel are
exposed to a time-dependent fluid environment. If the fluids contain different concentrations of
stimulus, then the cells in the center of the channel are exposed to time-dependent stimulus
concentrations. Cells near the edges of the channel stay in a constant fluid environment, and can be
used as positive and negative controls.
5.2.1.b Microfluidic Device Characterization
I characterized the fluid flow in the Stimulator in three ways. First, I flowed media
and food dye side-by-side down the experiment channel in the Stimulator to visualize the
boundary layer between the two fluids. As expected, fluid flow was laminar and produced a
crisp boundary layer between the two fluids (Figure 5-4). Second, also using media and food
dye, I opened and closed valves on the chip to move the boundary layer across the majority
of the experiment channel width. The boundary layer repeatedly switched position across the
majority of the width of the channel in less than 0.4 s (Figure 5-4a). Third, by observing the
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rate at which the change in boundary layer position propagated down the channel, I estimated
that the linear fluid flow rate was -1-2 mm/s (corresponding to a volumetric flow rate of
-10-20 nL/min; not shown).
To test the Stimulator device under more relevant experimental conditions, I also
characterized the microfluidic chip with yeast cells adhered in the experiment channel. I
noted that cells in the channel slightly disturbed the smooth fluid flow. Despite this slight
disturbance, the boundary layer was distinct enough to separate the two fluids (Figure 5-4b).
In addition to verifying a sharp boundary between the two fluids using a food dye, I verified
that the Stimulator would allow clear separation of pheromone and non-pheromone in two
fluids flowing in the experiment channel. To do this, I examined yeast cells expressing YFP
under the control of the pheromone responsive PRM 1 promoter. I found that after 3 hours of
treatment, with only half of the experiment channel exposed to pheromone, only cells in the
part of the channel containing pheromone had produced significant amounts of YFP and
adopted shmoo morphologies (Figure 5-5). Cells in the other half of the experiment channel
continued normal vegetative growth.
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Figure 5-4 Fluid flow in the microfluidic device.
Two fluids, media (top) and red food dye (bottom) enter the experiment channel from the left.
Clumps of yeast cells are adhered to the bottom of the channel. (a) By independently controlling the
flow rates of the two fluids, the boundary layer between the two fluids is moved across the center of
the channel in under 0.4 s. (b) The boundary layer between the two fluids is well defined despite the
disturbance in the boundary layer by the cells in the channel.
Channel wall --
Approximate position
of boundary later
Channel wall --
Figure 5-5 Yeast response to pheromone in the microfluidic device.
Two fluids, media (top) and media containing 100 nM pheromone (bottom), entered from the left and
flowed continuously over yeast cells adhered to the bottom of the channel for 3 hours. Only cells
exposed to pheromone formed an elongated shmoo shape and expressed YFP from the pheromone-
induced PRM 1 promoter. Cells exposed only to media continued normal vegetative growth. Picture
is a bright field image false-colored with YFP fluorescence.
Media•
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5.2.2 Modeling Analysis of Time-Varying Stimulation
In parallel to the development of the microfluidic device, I investigated the potential
benefits of studying signaling systems, and the mating receptor/G protein subsystem in
particular, using tine-varying stimuli. Because the essential components and molecular
interactions of the mating system are well understood, I investigated the use of time-varying
stimulation to better characterize the rate constants and affinities that govern the rates of
molecular interactions in the system.
5.2.2.a Optimal Experimental Design
Several approaches have been taken in the past to guide the design of biological
experiments to characterize underlying system parameter. For example, many past
approaches have focused on D-optimal or E-optimal experimental design [431-434]. D-
optimal experimental design aims to maximize the global parameter estimation accuracy, a
measure of how well all parameters can be estimated simultaneously, whereas E-optimal
experimental design aims to maximize the parameter estimation accuracy of the most
uncertain parameter, that is the parameter that is most difficult to estimate [431, 432].
I was interested in investigating more directly how experimental design (in this case,
different time-dependent inputs) could impact the estimation accuracy of each individual
model parameters, not all parameter together or just the most uncertain parameter. I focused
on identifying experiments that would maximize the importance of each individual
parameter, and thus maximize my ability to estimate each parameter from the corresponding
experiment. I used parameter sensitivity as a measure of the importance of each parameter in
determining the response to each experimental condition (time-dependent input) that I
considered. Although there exist multiple means of evaluating the global sensitivity of each
parameter (that is, how sensitive the system is to large changes in the parameter value), these
methods can be computationally intensive [435]. I instead focused on the less
computationally intensive local parameter sensitivity (that is, how sensitive the system is to
small changes in parameter values) [435], and used local parameter sensitivity as a predictor
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for how accurately I could estimate a particular parameter from a given experiment (for
example, from a given time-dependent input).
5.2.2.b Parameter Sensitivity in the Receptor/G Protein Model
I rapidly created a model of the mating receptor/G protein subsystem BioNetGen
language [30] by using the YeastPheromoneModel repository
(www.YeastPheromoneModel.org) (0). As I was only interested in the receptor and G
protein dynamics, I pared down the full mating system model encoded by the YPM
repository, eliminating molecules and reactions not directly involved in receptor/G protein
signaling. Briefly, the model started with pheromone binding to the receptor, followed by
exchange of GDP for GTP on Gpal, G protein dissociation, and finally binding of Ste5 to the
free Goy subunit. G protein deactivation and reassociation was mediated by slow innate
hydrolysis of GTP to GDP on Gpal, and an accelerated Gpal GTPase activity mediated by
Sst2. I defined the system output as the amount of Ste5 associated with Gy• or, due to the
plasma membrane association of Gy• (see Section 3.2.1.b), as the amount of Ste5 at the
membrane. To allow the model to reproduce the non-zero basal activity of the system [44,
205, 206, 308], I included reactions for G protein activation (nucleotide exchange on Gpal)
in the absence of pheromone. I included Ste5 dimerization and receptor endocytosis in the
model, but did not include feedback reactions involving downstream mating system
components (for example, Fus3-mediated Sst2 degradation).
I used a genetic algorithm [413] to optimize the values of the 17 unknown model
parameters by minimizing the mean squared error between computed and experimentally
measured association of Ste5 and G3y (Figure 5-6). The genetic algorithm evolved a
population of 500 different members (parameter sets) over 80 generations (iterations), using
the identical optimization configuration as Chapter 4 (see Sections 4.2.1 and 4.4). A brief
explanation of the advantages of genetic algorithms for parameter optimization can also be
found in Chapter 4 (Section 4.2.1).. The optimized parameters that I obtained were then used
as a starting point from which to predict potentially informative experiments to further
constrain parameter values. Because the genetic algorithm produced many distinct parameter
sets that resulted in agreement between the model and the experimental observations (Figure
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5-6), I was able to use multiple "good" parameter sets to investigate the potential value of
different time-dependent inputs. I chose to use four different parameter sets in my
investigation of different time-dependent inputs. I selected these four parameter sets to be as
different as possible (see Section 4.4).
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Figure 5-6 Results of parameter optimization for receptor/G protein model.
Simulation results (solid lines) are plotted with experimental observations (circles) for four different
parameter sets (a-d) identified via parameter optimization. Because experimental observation of Ste5
localization to the plasma membrane is in arbitrary units, experimental data is linearly scaled to match
simulation results.
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In order to explore the effect of time-dependent input on the receptor/G protein
model, I then constructed a set 620 of potential time-dependent and time-independent inputs.
These inputs were comprised of one, or two pulses of pheromone of varying length of time (1
s, 10 s, 30 s, 60 s, 120 s, or 300 s), separated by varying delays (10 s, 30 s, 60 s, 120 s, or 180
s) (Figure 5-7). These 620 potential inputs also included different pheromone concentrations
(0.3 nM, 1 nM, 3 nM, 10 nM, and 1 pM). I limited the time-dependent inputs and
simulations to 5 minutes in length because the model is likely not an accurate representation
of the actual mating receptor/G protein subsystem at later times after pheromone treatment.
For example, after pheromone treatment active Fus3 (which is largely phosphorylated about
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2.5 minutes after pheromone treatment [44]) phosphorylates Sst2 causing its degradation.
Additionally, expression of Gpal, Ste2, and Sst2 is increased in response to pheromone, and
transcriptional upregulation can be detected as early as 3 minutes after pheromone treatment
[44]. Thus, I only assumed that the model was representative of the receptor/G protein
dynamics of the mating system for the first 5 minutes after pheromone treatment.
For each input, I calculated the sensitivity of model behavior to the value of each of
the 17 unknown model parameters. To calculate each parameter sensitivity, I simulated the
model twice with slightly different values for that particular parameter (2-fold increase and
50% decrease, see Materials and Methods), and calculated the mean squared error between
the outputs of the two simulations. I identified the time-dependent and time-independent
inputs that maximized the sensitivity of model behavior for each parameter. Parameter
sensitivities were less than 2-fold higher in response to the "best" time-dependent input than
in response to the "best" time-independent input (Figure 5-8a). This gain in sensitivity was
small compared to the differences in sensitivities across model parameters, which varied over
five orders of magnitude. I also investigated whether different mating system mutants may
be more amenable to analysis with time-dependent inputs. I computationally investigated
two mutants: Sst2 deletion, and coupled pheromone and receptor mutants that decrease the
affinity of the pheromone-receptor interaction. Neither of these mutants significantly
improved the ability of time-dependent inputs to increase parameter sensitivity (Figure 5-8a).
Finally, I considered three additional parameter sets that resulted in strong agreement
between the model and the data during parameter optimization (Materials and Methods).
These additional parameter sets also demonstrated minimal increases in parameter sensitivity
using time-dependent inputs (Figure 5-9).
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Figure 5-7 Example time-dependent inputs.
I (a) independently varied the length of the first pulse, the time between pulses, and the second pulse
in order to (b) create a set of time-dependent inputs. I also varied the pheromone concentration (not
shown).
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Figure 5-8 Parameter sensitivities to time-dependent inputs.
(a) Parameter sensitivities are shown via a blue bar (left), where the lower end of the bar represents
the highest parameter sensitivity observed using time-independent inputs, and the top end of the bar
represents the highest parameter sensitivity observed using time-dependent inputs. The length of the
bar represents the increase in sensitivity achieved using time-dependent inputs. This fold-increase in
parameter sensitivity can be more easily seen via bar plot (right). The parameters were ordered via
their parameter sensitivities, from lowest to highest. (b) When two pathway mutants are considered
(see text), parameter sensitivities and the fold-increase in sensitivity achieved using time-dependent
system inputs are not significantly increased.
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Figure 5-9 Parameter sensitivities to time-dependent inputs.
(a-c) Parameter sensitivities and fold-increases in sensitivity achieved using time-dependent system
inputs are shown (see Figure 5-8) for three additional parameter sets identified via parameter
optimization.
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5.3 Discussion and Conclusions
5.3.1 The Stimulator Enables Time-Dependent Stimulation of Signaling Systems
I designed and implemented a microfluidic device, the Stimulator, to expose yeast
cells to different time-dependent fluid environments. I characterized fluid flow in the
Stimulator using food dye, and found that I was able to expose cells to discrete time-
dependent fluid environments. The response time of the Stimulator allows for switching of
the fluid environment in less than 0.5 seconds, and thus the Stimulator can cycle between
fluid environments at a rate of at least 1 Hz.
Although the Stimulator chip itself is rather small (-2 cm x -3cm), significant
infrastructure is required for its operation. For example, on-chip valves where controlled by
a computer running LabVIEW via (i) a digital input/output PCI card connected to (ii) a
special controller device that trigged the opening and closing of (iii) valves on an off-chip
valve manifolds. These off-chip valves connected to control channels via a series of input
ports. It typically took -2 hours to connect control and fluid lines to the control and fluid
ports on the Stimulator chip, and to equilibrating the chip (Materials and Methods). Due to
the time required for setup of each Stimulator chip, I included four experiment channels in
the Stimulator chip to enable multiple experiments for each chip. More experiment channels
could be added to the chip to enable even more experiments per chip.
Despite the promise of the Stimulator chip, I ceased further development and
characterization because the modeling suggested that the experiments treating yeast cells
with time-dependent pheromone concentrations would not be fruitful. I ceased work on the
Stimulator before successfully observing membrane re-localization of the YFP-Ste5 reporter
in response to time-independent or time-dependent inputs in the Stimulator, although I see no
technical reasons why this could not be accomplished.
5.3.2 Time-Dependent Inputs May Not be Effective for Characterization of Mating
System
I constructed a model of receptor and G protein dynamics in the mating system. I
chose to investigate this portion of the mating system because G protein activity can be
observed via membrane re-localization of a YFP-Ste5 fusion protein, and this re-localization
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occurs rapidly in response to pheromone treatment (Chapter 4) [44]. Other reporters of
mating system activation that can be observed in vivo, for example loss of FRET between the
transcription factor Stel2 and the transcription factor repressor Digl, take significantly
longer to respond to pheromone [44] and are thus not ideally suited for characterization of
the mating system using rapid time-dependent inputs.
Although there are several approaches for design of optimal experiments, I chose to
develop my own approach. I used parameter sensitivity to identify the most informative
inputs because I was interested in designing a series of experiments that would maximize my
ability to estimate all parameters. Other approaches focus on designing a single experiment
to simultaneously estimate all parameters or estimate the most difficult parameter to estimate.
I created a series of time-dependent inputs to computationally screen in an attempt to identify
inputs that would allow for improved characterization of system parameters. Although I only
screened a limited set of inputs, these inputs were diverse, including pulses of pheromone of
different length separated by different periods of no pheromone. These inputs also spanned a
range of pheromone concentrations, from subsaturating (0.3 nM) to saturating (1 rM). None
of the time-dependent inputs that I constructed appreciably increased the sensitivity of
system behavior to individual parameter values. I also investigated two potential mating
system mutants, and multiple parameter sets, and a 2.4-fold gain in sensitivity due to time-
dependent inputs was the largest across all inputs, mutants, and parameters (Figure 5-8 and
Figure 5-9). This result suggests that time-dependent inputs would not be powerful tools for
characterizing the parameters governing receptor and G protein dynamics in the mating
system.
Despite the fact that my results do not preclude the existence of some time-dependent
inputs that would be very valuable for constraining the values of the parameters that govern
receptor and G protein dynamics, I do not believe that such time-dependent inputs exist.
First, in response to different time-dependent inputs, the system appeared to behave primarily
as a "low-pass filter", that is the outputs generally appeared to be smoothed versions of the
inputs (not shown). Low-pass filters are inherently linear systems, which means that system
response to a step input is sufficient to fully predict the response of the system to any
arbitrary input. Thus, if the receptor/G protein portion of the mating system behaves like an
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ideal low-pass filter on the timescales that we considered, then response to step input of
pheromone on these timescales should be sufficient to characterize response, and response to
time-dependent input would not help further constrain system parameters. Second, we also
simulated an earlier receptor/G protein model with various sine-wave inputs, and the system
did not show any particular sensitivity to different frequencies (not shown). This also
suggested that characterization of the receptor and G protein dynamics with time-dependent
inputs would not be a powerful tool for probing system behavior.
However, as described above, the approach that I took to investigate the use of time-
dependent inputs for characterization of the mating system is certainly not the only possible
approach. The applicability of parameter sensitivity can be somewhat limited because local
parameter sensitivity depends heavily on the specific context. That is, although parameter
sensitivity is technically computed as a function of one parameter, the sensitivity of system
behavior depends not only on the value of that parameter, but also on all the values of all
other system parameters [436]. Thus, computing the sensitivity for pairs of parameters, or
computing global parameter sensitivity may be better indicators of the overall dependence of
system behavior on specific parameter values [435]. However, calculating parameter
sensitivity in these ways is significantly more computationally intensive, and might not be
feasible for the investigation of time-dependent inputs.
Even though the modeling work suggested that the corresponding experiments would
not be informative, it may be worth performing the experiments to investigate whether the
model is able to predict system response to time-dependent inputs. Should the model
successfully predict response to time-dependent inputs, then I would simultaneously validate
both the model itself, and the prediction that time-dependent inputs are no more informative
than time-independent inputs for constraining the parameters that govern system response.
Should the model fail to successfully predict system response, then I would demonstrate the
value of using time-dependent inputs, and invalidate this computational method for
investigating the use of time-dependent inputs for system characterization.
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5.4 Materials and Methods
5.4.1 Microfluidics
The procedure for designing chips and requesting fabrication can be found on the
website of the Kavli Nanoscience Institute Microfluidic Foundry at the California Institute of
Technology (http://kni.caltech.edu/foundry/index.html). Briefly, I designed the Stimulator
chip in AutoCAD 2004 (Autodesk Inc., San Rafael CA 94903), and sent AutoCAD design
files to CAD/Art Services (outputcity.com, Bandon OR 97411) who printed 20,000 dpi
masks to be used for fabrication. The foundry was kind enough to investigate new
fabrication techniques to produce 21 ptm deep channels instead of the standard 10 tpm deep
channels. I used deeper channels to prevent cells from obstructing flow and to reduce the
cells disturbance of laminar flow.
The Stimulator chip contained a total of 23 ports for connecting channels on the chip
to off-chip pressure and fluid sources, 16 control channel ports and 7 fluid channel ports. I
connected pressure and fluid sources to microfluidic channels using Tygon tubing (ID
0.020", OD 0.060"; Cole-Parmer, Vernon Hills IL 60061) and hollow steel pins (0.020" OD,
0.017" ID; New England Small Tube Corp., Litchfield NH 03052) that connected to the
ports. The tubing that was connected to control ports were filled with water, and prior to
using a Stimulator chip I pressurize all control channels to allow the water in the tubing to
displace the air in the channels. This procedure took -1 hour. I also flowed media through
the Stimulator fluid channels for - 1 hour to eliminate air bubbles in the channels. The
experiment channel was only exposed to a solution of Concanavalin A (200 tg/mL) prior to
introduction of cells into the channel in order to maximize adsorption of Concanavalin to the
glass channel bottom. Concanavalin and cells were introduced into the chip using syringes
connected to the chip via Tygon tubing and steel pins as described above. Media and media
with pheromone were introduced to the chip via a media bottle held under a constant pressure
of -4 psi. Control channels were connected to a -20 psi pressure source via special
manifolds of 8 solenoid valves (Fluidigm, South San Francisco 94080) that was controlled by
LabVIEW software (National Instruments, Austin TX 78759). LabVIEW interfaced with the
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8-valve manifolds via a digital input/output card (PCI-DIO-32HS; National Instruments) and
a dedicated manifold controller (BOB-3 Microfluidic Valve Manifold Controller; Fluidigm).
Prior to introducing cells into the chip, I grew cells at 300 C to an OD600 of - 0.5 in
SD medium containing 2% glucose. I then briefly sonicated cells to break up cell clumps
(VirSonic Ultrasonic Cell Disrupter, power level 3; VirTis, Gardiner NY 12525). I
introduced cells into the experiment channel, and closed valves at either end of the channel to
prevent flow and allow the cells to adhere for 20-30 minutes to the Concanavalin A on the
glass bottom of the channel. I only used SD medium in the microfluidic chip because
undefined media like YPD (yeast peptone dextrose) hasten the detachment of yeast from
Concanavalin coated glass (A. Colman-Lerner, personal communication). For visualization
of the boundary layer, I used undiluted red food dye (McCormic, Sparks MD 21152) and SD
medium as the two fluids in the Stimulator experiment channel.
Microscopy was performed using a Nikon TE2000 microscope (Melville NY 11747)
and a Hamamatsu digital CCD camera (ORCA_AG C4742-80-12AG; Bridgewater NJ
08807). Images were acquired using a 60x DIC oil objective (1.40NA; Nikon). YFP was
imaged using a YPF filter set (#41028; Chroma, Rockingham VT 05101).
5.4.2 Modeling
The receptor/G protein model used in this study was derived from a model of the
entire yeast mating system from the YeastPheromoneModel (YPM) information repository
(www.YeastPheromoneModel.org) (0). I extracted the model of the entire mating system
from the YPM repository on January 24, 2008. I eliminated from this full system model the
reactions and components specific to the MAPK cascade and transcriptional activation. The
documentation for the full system model can be found at
http://yeastpheromonemodel.org/ModelDocs/2008_0124_ 15h08m33s/Yeastpheromonere
sponse_model.html. I documented all of the modifications that I made to the full system
model file, and the reasons for each modification, on a Model Process page in the repository
(http://yeastpheromonemodel.org/wiki/Model_Processpage_for_2008_01_24_15h08m33s-(
Receptor/G_protein_model)). The model of the entire system was pared down to include
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only species and reactions that comprise the core signal transduction through the mating
receptor/G protein subsystem (see Results).
I simultaneously optimized the model parameters to match model behavior to
experimentally observed Ste5 association with the plasma membrane for five different doses
of pheromone: 2.5 pM, 10 nM, 3 nM, 1 nM, and 0.3 nM. Ste5 membrane localization data
was measured by Alejandro Colman-Lerner as described previously [44]. Note that here
Ste5 membrane localization was differently measured than in Chapter 4 (the measurements
made here predate the measurements used in Chapter 4). For the purposes of parameter
optimization, I constrained all association rates to lie between 105 M -'s-1 and 107 M-'s 1 .
Most protein-protein association rates fall in this range, which is significantly slower than the
diffusion limit of 109- 10 M-1's1 [150, 151, 422]. I constrained all dissociation rates to lie
between 10-3 s-1 and 10 s-1. Most cooperative allosteric factors (such as the factor describing
the cooperative binding of two Ste5 monomers to a Ste4 molecule; see Section 3.3.1.b) were
constrained to like between 2 and 103, whereas the factor by which GTP affects the affinity
of Gpal for G3y was constrained to lie between 2 and 105.The rates of pheromone-mediate
Gpal GDP exchange and Sst2-mediated Gpal GTP hydrolysis were constrained to lie
between 0.1 s-1 and 100 s-L, and the innate Gpal GTP hydrolysis rate was constrained to like
between 10-4 s- and 10-1 s-~.Additionally, I constrained the model such that at least 20% of
the total Ste5 population associated with Ste4 in response to saturating amounts of
pheromone. This thresholds were selected based on my unpublished observations that a
significant portion of the Ste5 population became activated in response to pheromone
treatment, and because in the absence of such constraints parameter optimization generally
produced very low levels of system activation.
The model contained 17 unknown parameters. The unknown parameters were
optimized via a genetic algorithm. I wrote MATLAB (R2007a, The MathWorks, Natick
MA) scripts to use a genetic algorithm (Genetic Algorithm and Direct Search Toolbox, v2. 1)
to perform parameter optimization and execute BioNetGen (version 2.0.46; [30]) simulations
of the models. I numerically simulated the model with an absolute error tolerance of 0.1 fM
(-0.001 molecules per cell), and relative error tolerance of 10-5. The model was simulated
for 100,000 seconds (-28 hours) to establish pre-pheromone steady state. Following
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simulated pheromone treatment, I simulated the model for 150 seconds during parameter
optimization. Together, each pair of pre- and post-pheromone treatment simulations took -2
seconds of computation time on a 1.8 GHz PowerPC dual-core G5 computer. I used the
identical genetic algorithm configuration from Chapter 4. Parameter sets were scored based
on the mean squared error between the simulated timecourses and the measured data. I ran
the optimization four times, and noted no significant difference between the quality of fit
achieved by each optimization, suggesting that I did not need to increase the number of
generations (not shown). I pooled the results from all four optimizations, and from the full
pool of parameter sets I selected four different parameter sets as described in Chapter 4.
MATLAB scripts were also used to construct the different time-dependent inputs and
execute BioNetGen simulations. The model file and custom scripts are available online [34].
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Chapter 6. Future Work
Quantitative computational models have proven to be useful tools for studying
biological systems. However, as the scope of biological systems under study continues to
grow, new tools and approaches will be needed to ensure the continued success of
quantitative modeling. In this thesis, I presented my research on improved methods for
model building, and on a new integrated experimental/computational approach for studying
signaling systems using time-dependent inputs. Additionally, I presented an example use of
a well-documented model to investigate the consequences of protein abundances on signaling
in MAPK cascades. Here, I discuss how the research presented in this thesis suggests future
directions of research.
6.1 Tools for Model Building
In 0, I presented a suite of tools to document the model-building process. Using these
tools, I built the YeastPheromoneModel (YPM) repository, which contains a detailed and
well-documented model of the yeast mating pheromone response system. From the YPM
repository model I was able to rapidly create two well-documented derivative models that I
used to investigate the mating system (Chapter 4 and Chapter 5). I also used the information
collected in the YPM repository as the basis for a thorough mechanistic review of the yeast
mating system (largely presented in Chapter 3) [35].
However, despite the proven usefulness of the suite of modeling tools, there are many
additional features that could increase the value of these tools. I created this suite of
modeling tools to enable easy entry, editing and retrieval of information, and in order to
achieve this ease of use I sacrificed potential capabilities. For example, information is stored
in the wiki repositories as simple text strings, with model elements identified via simple
XML modeling tags. These modeling tags are only identified by two tools: a media wiki
extension that controls how the modeling tags are displayed on repository pages, and a
Python script that identifies and extracts model elements from the repository to construct a
full model file. Thus, the semantic information provided by these modeling tags (that is,
identification of different model elements) is only used for two limited purposes. Future
model documentation and model repository tools could interact dynamically with semantic
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repository content (for example, by maintaining an active list of all model elements), rather
than identifying model elements only when necessary for a particular task (for example,
displaying a page or extracting a model). By maintaining an up-to-date list of model
elements, including their page of origin, additional features would be enabled. For example,
it could be advantageous to browse or search only the model elements in the repository
without having to go through the slow process of model extraction. Additionally,
maintaining a dynamic list of model elements would allow for immediate model extraction.
As a final example, future tools could enable selection of particular model elements for
inclusion in a model and enable direct analysis of the model (such as construction of a
"contact map" showing the connections between molecules).
One of the key reasons for building these modeling tools on a wiki platform was to
enable easy information entry, editing, and retrieval. However, the wiki platform is also
potentially limiting, as additional features must be built within the bounds of the wiki
software capabilities. Thus, future iterations of model documentation and model repository
tools could involve custom software. For example, I briefly discussed in 0 the development
of a previous custom-built modeling tool, MONOD. Although I was motivated to document
my model of the mating response system during model construction, I was still unwilling to
continue to use MONOD due to its awkward interface, despite the potential features enabled
by the custom software. Therefore, based on my experiences with MONOD and the wiki-
based platform, I believe that maintaining an easy-to-use interface should be paramount in
the development of any new tool, and should not be sacrificed at the expense of additional
features. Currently, modelers do not generally take the time to capture sufficient model
documentation. Thus, to enable adoption of new model building tools, these tools must
minimize any barriers to use.
In addition to the easy-to-use interface of the wiki, I also believe that the internet-
enabled collaborative environment afforded by the wiki platform is also very important. As
our understanding of biological systems becomes more detailed, it will be increasingly
important for researchers to collaborate on the formidable tasks of making accurate
quantitative models of these systems (see below). Thus, I believe that future model building
tools should also enable collaborative model construction.
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6.2 Construction of Detailed Quantitative Models
As more details about the molecular mechanisms of signaling in the yeast mating
system have been uncovered, researchers have constructed increasingly complex quantitative
models of the pathway [2, 22, 45, 55, 82, 100, 136, 327-331]. The sheer volume of
information available about the yeast mating system makes the organization, evaluation and
presentation of this information difficult. Many molecular and cellular signaling systems of
academic and therapeutic interest are even more complex than the yeast mating response
system. Additionally, the amount of information that we know about signaling systems is
constantly increasing. Thus, it may not be feasible for a single author, or a small group of
authors, to develop well-documented detailed models of complex biological systems.
New approaches and tools are required to construct well-documented detailed models
of complex biological systems. Researchers must collaborate at all levels of the model
building process: information collection, information evaluation and annotation, and model
construction (0). By distributing model building efforts across many researchers, I believe
that the underlying information will be more detailed and accurate, and decisions made will
more closely reflect the views of the community instead of the views of individual
researchers. The burden of model construction could also be shared by experimental
researchers who may directly contribute their observations and thoughts. Additionally, the
time and effort required to build such a detailed model would be spread across all researchers
involved. New tools will be required to enable this collaborative approach to model building.
In 0, I described tools that I built to allow collaborative construction of well-documented
models. Future tools, perhaps similar to the tools that I developed, could be designed in such
a way to facilitate construction of well-documented derivative models that could be studied
and published in traditional publication channels (see Section 6.1).
6.3 Scaffold Abundance as a Regulator of Signaling Behavior
In Chapter 4, I investigated the impact of different protein abundances on the
behavior of the MAPK cascade in the yeast mating response system. Using a quantitative
model, I predicted that the abundance of the scaffold protein Ste5 sets a tradeoff between
maximum MAPK cascade system output and dynamic range. This prediction is difficult to
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verify experimentally because expression of many system components are regulated by
mating system activity, and thus any changes in protein abundance that affect the basal
system activity will result in altered abundance of many system components. However,
despite these complications, observations by Garrenton et al. appear to support our
computational observations [421].
The qualitative nature of the tradeoff between system output and dynamic range was
insensitive to changes in parameter values and the abundances of system components, and a
tradeoff between system output and dynamic range was not observed upon varying the
abundance of other system components. Thus, I hypothesized that the abundance of scaffold
proteins may generally set a tradeoff between output and dynamic range in other scaffolded
signaling systems. This hypothesis could be further investigated several ways. First, other
scaffolded signaling systems may not have a strong coupling between basal system activity
and protein abundance, and thus may be more amenable to direct experimental perturbation
than the mating response system. Second, models of other signaling systems containing
scaffold proteins could be used to investigate whether the abundances of the scaffold proteins
in these systems are predicted to set a tradeoff between system output and dynamic range.
Thus, computational investigation could reveal whether this tradeoff is predicted to be a
general property of signaling systems containing scaffold proteins, or is instead a property of
just the mating system, perhaps due to its specific kinetics of activation or system
architecture.
6.4 Measurement of Protein Abundances in Signaling Systems
The work presented in Chapter 4 was motivated in part by careful protein abundance
measurements made by Kirsten Benjamin [64]. However, several researchers have measured
vastly different abundances of components in the MAPK cascade of the yeast mating
response system (Figure 4-1) [64], and all of these measured abundances also resulted in
prediction of the same qualitative tradeoff between MAPK cascade output and dynamic
range across Ste5 abundances (Figure 4-3). Additionally, I created a model where I allowed
the protein abundances in the model to be optimized along with the unknown parameter
values to achieve agreement between simulation and experimental results. These optimized
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protein abundances also resulted in the same predicted tradeoff (Figure. A- 11). During
optimization, the protein abundances were constrained to lie within a 2-fold range of any of
the measured values. Thus, given only the dynamic data (Ste5 localization to the plasma
membrane and Fus3 phosphorylation), and approximate ranges for the protein abundances, I
would have been able to arrive at the same conclusion regarding the critical role of the
scaffold Ste5 in establishing a tradeoff between system output and dynamic range. These
results suggest that there may be additional "system-level" properties that can be sufficiently
defined by observation of dynamic system behavior, and perhaps rough knowledge of
parameter abundances.
However, despite the fact that the prediction of the qualitative tradeoff between
system output and dynamic range across Ste5 abundances was largely independent from the
protein abundances, the exact protein abundances that I used in the model set the quantitative
nature of the tradeoff (Figure 4-3). Thus, although dynamic data and the system architecture
may be sufficient to define (and allow researchers to investigate) qualitative system
behaviors, the quantitative aspects of these behaviors may require knowledge of the system
parameters and abundances.
Additionally, although we found that the predicted tradeoff between system output
and dynamic range were insensitive to some protein abundances parameter values, there were
a small number protein abundances and parameter values in the model that were held
constant through all simulations (Table. A-1). It is possible that one or more of these fixed
protein abundances or parameter values are important for establishing this tradeoff. The
model could be reoptimized allowing these fixed abundances and parameters to vary in order
to further confirm that the qualitative nature of the tradeoff is insensitive to parameter values
and protein abundances.
Knowledge of parameters values and protein abundances can also have a more direct
impact on our understanding of signaling systems. For example, given the excess of Fus3
over the other components in the MAPK cascade from the yeast mating response system [64]
(Figure 4-1), published conclusions that depend on the observed bulk behavior of Fus3 and
on assumptions of relatively small (or proportionate) numbers of Fus3 also require
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reevaluation. For example, the suggestions that Fus3 nucleoplasmic shuttling is unaffected
by its binding to Ste5, and that Ste7 does not anchor Fus3 in the cytoplasm [107]. Because
signaling systems like the yeast mating response system are comprised of many components,
and describing the interactions between these components can require hundreds of individual
parameters (for example, see Chapter 3), it may not be feasible now or ever for researchers to
measure all of these values. Computational models can be used to identify system
parameters and abundances on which system behavior most strongly depends, and thus
suggest which parameters and abundances may be most critical to measure.
6.5 Investigation of Signaling Systems Using Time-Dependent Input
I investigated the use of time-dependent inputs for the characterization of the
parameters governing receptor and G protein dynamics in the mating system (Chapter 5).
My computational analysis suggested that time-dependent inputs would not be effective for
constraining our knowledge about these system parameters. However, there were several
limitations to my analysis. First, I only investigated the use of binary inputs (varying
between no pheromone and some fixed concentration of pheromone). Other input signals,
including sinusoids, could prove to be valuable for characterizing the mating system. A
different microfluidic chip, or an entirely new experimental setup, may be required to
perform the corresponding experiments with these different time-dependent inputs.
However, even in the absence of an experimental platform on which to carry out the
experiments, computational analysis could suggest whether there is value in developing such
a platform. Furthermore, I only investigated the use of time-dependent inputs to characterize
system parameters. Although the reactions that govern receptor and G protein dynamics are
relatively well-understood, there are some subtleties that remain unclear. For example,
recent experiments suggest that the Regulator of G protein Signaling (RGS) protein Sst2
binds directly to the receptor rather than to Ga Gpal, and this association with the receptor is
required for Sst2-mediated acceleration of Gpal GTP hydrolysis [163]. However, it is not
clear whether Sst2 can bridge an interaction between Ste2 and Gpal to mediate accelerated
GTP hydrolysis, or whether Gpal must associate directly with Ste2 for Sst2-mediated
acceleration of GTP hydrolysis. A variety of time-dependent inputs could be screened in an
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attempt to identify inputs that result in different model behavior for the two hypotheses.
These time-dependent inputs could then be tested experimentally as a predictor for which
hypothesis may be correct.
Despite the fact that computational analysis suggested that time-dependent inputs
would not be valuable for constraining the values of parameters governing dynamics of the
mating system, unless the corresponding experiments are performed the value of time-
dependent inputs cannot be known for certain. The model on which I performed the analysis
was optimized using only time-independent inputs, and thus may not accurately predict the
system response to time-dependent inputs. The mating system could be treated with time-
dependent inputs, and should the model successfully predict system response to time-
dependent inputs, then the model will be further validated, increasing confidence that our
knowledge of the system may be sufficient to represent system behavior. Should the model
fail to successfully predict system behavior, then a valuable time-dependent input would
have been identified experimentally, rather than computationally. The model parameters
could then be re-optimized taking into account this new observed system behavior. Thus, by
performing experiments using time-dependent inputs, either the model could be further
validated, or model parameters could be further constrained.
Finally, I investigated the use of time-dependent inputs for characterization of only
the yeast mating system. Perhaps some property of the mating system makes it a poor
candidate for time-dependent characterization, whereas other cell signaling systems may
perhaps be more amenable to investigation using time-dependent inputs. Published models
of other signaling systems and could be used to investigate whether time-dependent inputs
could potentially be valuable tools for studying these systems.
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Appendix A. Effects of Scaffold Abundance
The available sets of mating pathway protein abundance measurements did not
contain abundance measurement of the same proteins. For example, Kirsten Benjamin and
Ghaemmaghami et al. measured the abundance of Ste4, whereas Maeder et al. and Slaughter
et al. did not [94, 98, 99]. Where the abundance of a protein was not measured as part of a
particular set of protein abundances, I optimized the abundance of that protein along with the
unknown model parameters (Table. A-1). Additionally, Slaughter et al. and Maeder et al.
used fluorescence cross correlation spectroscopy to measure the in vivo concentration of
Ste5-Stel 1 and Ste5-Ste7 complexes, and used fluorescence correlation spectroscopy to
measure the in vivo concentration of Ste5, Stel 1 and Ste7 [94, 99]. Based on these measured
concentrations, they then calculated the affinities of interaction between Ste5 and Stel 1, and
between Ste5 and Ste7. Because these affinities were calculated based on the measured in
vivo concentrations, I only used the affinities measured by Slaughter et al. and Maeder et al.
alongside the abundances that they measured. The affinities of interaction between Ste5 and
both Stel 1 and Ste7 were treated as unknown parameters in the models containing the
protein abundances measured by Kirsten Benjamin and Ghaemmaghami et al. (Table. A-1).
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Kirsten Benjamin's abundances
Alternate Alternate Alternate Alternate
Best-fit parameter parameter parameter parameter
Parameter Units parameters set #1 set #2 set #3 set #4
Cell volume L 2.9E-14 2.9E-14 2.9E-14 2.9E-14 2.9E-14
Fus3 num molec/cell 20400 20400 20400 20400 20400
kbind Gpal Ste4 0 InM 1/s 0.37091 0.46371 0.41792 0.23473 0.17467
kbind Gpal Ste4 OnM 1/s 0.10273 0.2917 0.085246 0.48965 0.63712
kbind Gpal Ste4 100nM 1/s 0.014296 0.009251 0.007396 0.003254 0.030761
kcat Msg5 MAPK P04 1/s 0.062661 0.25657 2.1132 1.9057 4.9236
kcat nonspecific dephosph 1/s 0.002192 0.002446 0.001619 0.00203 0.000972
kcat Ptp MAPK P04 1/s 2.8774 0.67312 5.3038 5.0353 0.079251
kcat Stel lpSpSpTSte5Ste7 pS 1/s 3.6382 1.8578 0.83271 1.3598 1.5125
kcat StellpSpSpTSte5Ste7pSpT 1/s 4.5313 0.67029 1.6805 4.2564 0.17999
kcat Ste4Stel8Ste5Stell pS 1/s 2.7582 2.0158 1.9703 0.92917 1.6866
kcat Ste5Ste7pSpTFus3_pT 1/s 0.70423 7.2285 6.4211 0.37901 2.0751
kcat Ste5Ste7pSpTFus3_pY 1/s 4.4084 3.2756 9.1151 3.8196 6.1645
kcat Ste5Ste7pSpTFus3pTpY 1/s 0.48499 3.2216 3.3734 1.1393 3.2421
kcat Ste5Ste7pSpTFus3pY pT 1/s 5.051 2.5184 3.8749 5.6989 8.4967
Kd Msg5 MAPK mM 1.4 1.4 1.4 1.4 1.4
Kd Ste5 Fus3 mM 1 1 1 1 1
Kd Ste5 Stel l mM 0.140125 0.050269 0.085606 0.120593 0.00488
Kd Ste5 Ste7 mM 0.001952 0.002586 0.002651 0.003744 0.004417
Kd Ste7 MAPK mM 0.1 0.1 0.1 0.1 0.1
kdilution 1/s 0.000128 0.000128 0.000128 0.000128 0.000128
koff Gpal Ste4 0 InM 1/s 0.034849 0.051351 0.037875 0.015203 0.009191
koff Gpal Ste4 OnM 1/s 0.000396 0.002307 0.000274 0.00173 0.000943
koff Gpal Ste4 100nM 1/s 0.048251 0.053527 0.049926 0.043558 0.03228
koff Ptp MAPK 1/s 0.064643 2.0541 3.3202 0.40314 6.4203
koff Ste4Stel8 Ste5 1/s 0.26373 0.24959 0.32662 0.44666 0.24277
koff Ste5 Fus3 1/s 2.3 2.3 2.3 2.3 2.3
kon Msg5_MAPK 1/(mM-s) 0.92293 2.6876 0.9207 1.048 4.7968
kon Ptp MAPK 1/(mM-s) 1.0082 0.99895 1.8816 2.5043 7.6125
kon Ste4Stel8 Ste5 1/(mM-s) 1.8799 1.5796 1.9209 6.6281 2.4724
kon Ste5 Stell 1/(mM-s) 0.10562 0.22282 0.13665 0.13043 1.8984
kon Ste5 Ste7 1/(mM-s) 3.775 1.8231 2.1332 1.0559 2.8241
kon Ste7 MAPK 1/(mM-s) 3.5466 2.3746 5.9287 0.83024 0.23862
Msg5 num molec/cell 38 38 38 38 38
Ptp num molec/cell 193.6644 1687.562 291.6774 103.6648 6597.752
Stell num molec/cell 3500 3500 3500 3500 3500
Stell pS only P04 factor (unitless) 2089.636 875.4747 37.421 1022.616 1786.608
Ste4 num molec/cell 818 818 818 818 818
Ste5 num molec/cell 480 480 480 480 480
Ste7 num molec/cell 920 920 920 920 920
Ste7 pS only P04 factor (unitless) 3871.182 2668.431 201.9755 2886.697 1289.28
Parameters in blue were not optimized during parameter estimation.
Parameters in red were optimized during parameter estimation.
(Table continued on next page)
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Ghaemmaghami Slaughter Maeder et
et al. et al. al. abundances
abundances abundances abundances
Best-fit Best-fit Best-fit Best-fit
Parameter Units parameters parameters parameters parameters
Cell volume L 2.9E-14 2.9E-14 2.9E-14 2.9E-14
Fus3 num molec/cell 8480 1152.6108 3126.0202 1535.23
kbind Gpal Ste4 0 InM 1/s 0.14408 0.51827 0.22099 0.25443
kbind Gpal Ste4 OnM 1/s 0.15048 0.69712 0.45474 0.068155
kbind Gpal Ste4 100nM 1/s 0.0050755 0.0036576 0.0086014 0.019244
kcat Msg5 MAPK P04 1/s 0.45352 1.1176 0.28938 0.40756
kcat nonspecific dephosph 1/s 0.0023055 0.0010458 0.0016609 0.0019483
kcat Ptp MAPK P04 1/s 2.0513 0.80977 1.5396 0.86467
kcat Stel lpSpSpTSte5Ste7pS 1/s 1.474 5.4251 5.764 2.122
kcat Stell pSpSpTSte5Ste7pS pT 1/s 0.6331 2.2777 2.7938 4.831
kcat Ste4Ste18Ste5Stell pS 1/s 0.35192 1.1319 1.2015 1.8438
kcat Ste5Ste7pSpTFus3_pT 1/s 0.57858 4.298 7.3556 6.7879
kcat Ste5Ste7pSpTFus3 pY 1/s 8.8657 4.7717 4.1195 0.86812
kcat Ste5Ste7pSpTFus3pTpY 1/s 0.60136 2.2465 8.6055 2.6079
kcat Ste5Ste7pSpTFus3pY pT 1/s 8.0643 7.6701 2.7014 3.5252
Kd Msg5 MAPK mM 1.4 1.4 1.4 1.4
Kd Ste5 Fus3 mM 1 1 0.91 1
Kd Ste5 Stell mM 0.000490711 0.123 0.089 0.023288423
Kd Ste5 Ste7 mM 0.004202339 0.084 0.118 0.022486997
Kd Ste7 MAPK mM 0.1 0.111 0.174 0.1
kdilution 1/s 0.000128 0.000128 0.000128 0.000128
koff Gpal Ste4 0 InM 1/s 0.0068791 0.02512 0.01304 0.026088
koff Gpal Ste4 OnM 1/s 0.00016565 0.00021284 0.00061339 0.00027495
koff Gpal Ste4 100nM 1/s 0.059528 0.048618 0.044828 0.042329
koff Ptp MAPK 1/s 0.015834 2.1741 2.8556 0.18211
koff Ste4Stel8 Ste5 1/s 0.14473 0.51193 0.38334 0.28442
koff Ste5 Fus3 1/s 2.3 2.3 2.3 2.3
kon_ Msg5 MAPK 1/(mM-s) 3.1054 7.5251 0.7096 0.14306
kon PtpMAPK 1/(mM-s) 0.52929 1.4339 0.36823 0.39503
kon Ste4Stel8 Ste5 1/(mM-s) 1.1975 4.1494 0.90935 0.50416
kon Ste5 Stell 1/(mM-s) 3.671 2.5608 2.959 0.78378
kon Ste5 Ste7 1/(mM-s) 5.3613 0.10858 0.10759 0.60177
kon Ste7 MAPK 1/(mM-s) 0.17671 4.0017 2.9508 6.3002
Msg5_num molec/cell 538 103.1092 1117.6832 120.5385
Ptp_num molec/cell 768 586.0184 1466.9592 713.2619
Stell num molec/cell 736 576.3054 681.0882 5594.3184
Stell pS only PO4 factor (unitless) 1109.8612 3577.25 1009.7355 520.0756
Ste4 num molec/cell 820 1283.6339 2488.8691 3639.6733
Ste5 num molec/cell 1900 593.7692 611.233 251.5184
Ste7 num molec/cell 672 768.4072 1187.5384 1753.0551
Ste7_pS only PO4 factor (unitless) 1683.5996 3411.2634 4535.8252 694.1654
Parameters in blue were not optimized during parameter estimation.
Parameters in red were optimized during parameter estimation.
Table. A-1 Optimized parameters for MAPK cascade model.
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Figure. A-i Results of parameter optimization using different protein abundances.
Simulation results (solid lines) are plotted with experimental observations (circles; error bars
represent standard error of measurement) for model parameters optimized using protein
abundances measured by (a) Kirsten Benjamin, (b) Ghaemmaghami et al., (c) Slaughter et al.,
and (d) Maeder et al. Also plotted is (e) simulation results and observations when protein
abundances were treated as unknown parameters and optimized.
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Figure. A-2 Dependence of behavior of MAPK cascade model on component abundances.
I simulated the steady-state pathway output and dynamic range vs. (a) Ste 11 abundance, (b)
Ste7 abundance, (c) Fus3 abundance, and (d) Ste5 abundance. The steady-state pathway output
(Fus3-PP per cell) in the absence of pheromone (dashed line) and in response to saturating
amounts of pheromone (solid line) are shown for a range of kinase abundances (top). The
swing (middle) and induction ratio (bottom) are calculated from the steady-state system output.
The dotted lines in all plots indicate the measured kinase abundances. The model was
constructed using the abundances measured by Kirsten Benjamin.
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Figure. A-3 Results of parameter optimization for different parameter sets.
Simulation results (solid lines) are plotted with experimental observations (circles; error bars
represent standard error of measurement) for four different sets of parameters (a-d; alternate
parameter sets #1-4) obtained during optimization using protein abundances measured by
Kirsten Benjamin.
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Figure. A-4 Behavior of MAPK cascade model for alternate parameter set #1.
I simulated the steady-state pathway output and dynamic range vs. (a) Ste 1 abundance, (b)
Ste7 abundance, (c) Fus3 abundance, and (d) Ste5 abundance. The steady-state pathway output
(Fus3-PP per cell) in the absence of pheromone (dashed line) and in response to saturating
amounts of pheromone (solid line) are shown for a range of kinase abundances (top). The
swing (middle) and induction ratio (bottom) are calculated from the steady-state system output.
The dotted lines in all plots indicate the measured kinase abundances. The model was
constructed using the abundances measured by Kirsten Benjamin.
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Figure. A-5 Behavior of MAPK cascade model for alternate parameter set #2.
I simulated the steady-state pathway output and dynamic range vs. (a) Ste 11 abundance, (b)
Ste7 abundance, (c) Fus3 abundance, and (d) Ste5 abundance. The steady-state pathway output
(Fus3-PP per cell) in the absence of pheromone (dashed line) and in response to saturating
amounts of pheromone (solid line) are shown for a range of kinase abundances (top). The
swing (middle) and induction ratio (bottom) are calculated from the steady-state system output.
The dotted lines in all plots indicate the measured kinase abundances. The model was
constructed using the abundances measured by Kirsten Benjamin.
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Figure. A-6 Behavior of MAPK cascade model for alternate parameter set #3.
I simulated the steady-state pathway output and dynamic range vs. (a) Ste 11 abundance, (b)
Ste7 abundance, (c) Fus3 abundance, and (d) Ste5 abundance. The steady-state pathway output
(Fus3-PP per cell) in the absence of pheromone (dashed line) and in response to saturating
amounts of pheromone (solid line) are shown for a range of kinase abundances (top). The
swing (middle) and induction ratio (bottom) are calculated from the steady-state system output.
The dotted lines in all plots indicate the measured kinase abundances. The model was
constructed using the abundances measured by Kirsten Benjamin.
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Figure. A-7 Behavior of MAPK cascade model for alternate parameter set #4.
I simulated the steady-state pathway output and dynamic range vs. (a) Ste 11 abundance, (b)
Ste7 abundance, (c) Fus3 abundance, and (d) Ste5 abundance. The steady-state pathway output
(Fus3-PP per cell) in the absence of pheromone (dashed line) and in response to saturating
amounts of pheromone (solid line) are shown for a range of kinase abundances (top). The
swing (middle) and induction ratio (bottom) are calculated from the steady-state system output.
The dotted lines in all plots indicate the measured kinase abundances. The model was
constructed using the abundances measured by Kirsten Benjamin.
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Figure. A-8 Behavior of MAPK cascade model for Ghaemmaghami et al. measurements.
I simulated the steady-state pathway output and dynamic range vs. (a) Ste 1l abundance, (b)
Ste7 abundance, (c) Fus3 abundance, and (d) Ste5 abundance. The steady-state pathway output
(Fus3-PP per cell) in the absence of pheromone (dashed line) and in response to saturating
amounts of pheromone (solid line) are shown for a range of kinase abundances (top). The
swing (middle) and induction ratio (bottom) are calculated from the steady-state system output.
The dotted lines in all plots indicate the measured protein abundances.
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Figure. A-9 Behavior of MAPK cascade model for Slaughter et al. measurements.
I simulated the steady-state pathway output and dynamic range vs. (a) Ste 1l abundance, (b)
Ste7 abundance, (c) Fus3 abundance, and (d) Ste5 abundance. The steady-state pathway output
(Fus3-PP per cell) in the absence of pheromone (dashed line) and in response to saturating
amounts of pheromone (solid line) are shown for a range of kinase abundances (top). The
swing (middle) and induction ratio (bottom) are calculated from the steady-state system output.
The dotted lines in all plots indicate the measured protein abundances.
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Figure. A-10 Behavior of MAPK cascade model for Maeder et al. measurements.
I simulated the steady-state pathway output and dynamic range vs. (a) Ste 1 abundance, (b)
Ste7 abundance, (c) Fus3 abundance, and (d) Ste5 abundance. The steady-state pathway output
(Fus3-PP per cell) in the absence of pheromone (dashed line) and in response to saturating
amounts of pheromone (solid line) are shown for a range of kinase abundances (top). The
swing (middle) and induction ratio (bottom) are calculated from the steady-state system output.
The dotted lines in all plots indicate the measured protein abundances.
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Figure. A-11 Behavior of MAPK cascade model for protein abundances optimized
during parameter estimation.
I simulated the steady-state pathway output and dynamic range vs. (a) Ste 11 abundance, (b)
Ste7 abundance, (c) Fus3 abundance, and (d) Ste5 abundance. The steady-state pathway output
(Fus3-PP per cell) in the absence of pheromone (dashed line) and in response to saturating
amounts of pheromone (solid line) are shown for a range of kinase abundances (top). The
swing (middle) and induction ratio (bottom) are calculated from the steady-state system output.
The dotted lines in all plots indicate the optimized protein abundances.
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